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Head and neck (HN) cancer is the fifth most prevalent malignancy worldwide with 90% 
of them categorized as squamous cell carcinomas (SCC). Carcinomas of the oropharynx, 
pharynx and the oral cavity, comprise a subset of HNSCC and are referred to as 
oropharyngeal squamous cell carcinomas (OPSCC). Up to 60% of OPSCC and 25% of 
HNSCC are positive for high-risk human papillomavirus (HR-HPV), primarily HPV16. 
HPV positive and HPV negative OPSCC’s are molecularly and biologically distinct with 
differences in risk factors, age of presentation and clinical behavior. The precise 
molecular signatures of each have been well studied with respect to gene expression, 
genetic-epigenetic modifications and mutational analysis. However, recent studies have 
identified HPV as a racially linked marker for OPSCC, where African American (AA) 
patients present with a higher percentage of HPV-negative and aggressive tumors as 
compared to European American (EA) patients. Thus, we aimed to study the HPV status 
and differential gene expression (DEG) profile of OPSCC in AA and EA patients from 
South Carolina, using Agilent 8x60k arrays and a dual marker system for HPV status. We 
characterized all the tumors into HPV-active (DNA+/E7RNA+), HPV-inactive 
(DNA+/E7RNA-) and HPV-negative (DNA-/RNA-) based on INNO-LiPA and RT-
qPCR assays. Overall, 59% of OPSCC tissue samples tested positive for HPV DNA, 
while only 48% of those harbored an active HPV infection and significant differences 
were observed when compared by race. 
vii 
We observed a higher prevalence of HPV in EA patients, both by DNA (69%) as well as 
by E7 RNA (39%), when compared to that of AA patients (40% and 10% respectively). 
Microarray analysis over a set of 36 oropharyngeal tumors and 4 normals revealed that 
HPV-inactive tumors have gene expression profiles distinct from those of both HPV-
active and HPV-negative SCC, suggesting that HPV-inactive tumors may constitute a 
group of their own. The expression of a selected panel of genes was confirmed by RT-
qPCR which was in concordance with our microarray data. Our RT-qPCR assays 
conformed to the latest MIQE guidelines and data were normalized using three reference 
genes through Biogazelle qbase+ software and the results were scaled to the control 
group (normal samples). Normalized relative quantities for each gene of interest were 
then calculated using qbase+. Selection of the most stably expressed candidate reference 
genes was done through a comprehensive study of 8 well known housekeeping/reference 
genes through Normfinder, BestKeeper and GeNorm. Our microarray studies and RT-
qPCR assays categorized HPV-inactive tumors as a distinct entity in comparison to the 
HPV-negative and –active tumors by race. Also, HPV-inactive tumors clustered closer to 
the HPV-negative tumors with one exception, suggesting the loss of function of HPV in 
the former. Overall, our results confirmed that AA patients more often present with HPV-
negative tumors in comparison to EA patients, and indicated that HPV-negative tumors 
exhibit gene expression profiles indicative of activation of epithelial mesenchymal 
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CHAPTER 1: INTRODUCTION 
1.1. Head & Neck Squamous Cell Carcinoma  
Head and neck (HN) cancer is the fifth most common malignancy worldwide with 
an annual mortality rate of 200,0001. About 90% of HN cancer can be classified as head 
& neck squamous cell carcinomas (HNSCC), while a minority are adenocarcinomas or 
non-epithelial tumors. HNSCC is highly heterogeneous and occurs in the stratified 
squamous epithelium of the upper aero-digestive tract (UADT) with common sites of 
presentation being the oral cavity, oropharynx, larynx and esophagus. About 75% of 
HNSCC are attributed to alcohol and tobacco consumption1,2, however, more recently, 
high-risk human papillomavirus (HR-HPV) infection has been recognized as a cause of 
some HNSCC3. Approximately 25% of all HNSCC, and up to 60% of oropharyngeal 
cancers are attributed to HPV, predominantly HPV164–6. Therapeutic strategies for HN 
cancer have evolved from mere identification and treatment of the target with 
surgery/radiotherapy7- the ‘anatomic era’, to the modern ‘biological era’ of targeted 
molecular therapy8. HPV-positive tumors have better prognosis and respond better to 
treatment9,10. However, a deeper understanding of the molecular pathogenesis of HPV 
positive and HPV negative OPSCC is required to increase efficacy of treatment and in 
turn improve the survival and quality of life of HNSCC patients.   
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1.2 Human Papillomavirus  
While there has been a decline in the incidence of HNSCC related to alcohol and 
tobacco consumption, the overall incidence of HNSCC is still on the rise1. This increase 
has been attributed to a surge in the HPV related oropharyngeal squamous cell carcinoma 
(OPSCC) worldwide with reports of increasing incidence from Canada10,11, the United 
States12–15 and Europe16–20. Common risk factors of HPV associated OPSCC include 
number of sexual partners, oral-genital sex, oral-anal sex, and marijuana abuse21. The 
International Agency for Research on Cancer (IARC) monograph working group reported 
that HPV16 is one of the newest etiological factors associated with OPSCC5,6.  
HPV belongs to the Papillomavididae family, which contains 29 genera formed by 
papillomavirus (PV) types comprising papillomaviruses that infect humans (170 types)22, 
non-human mammals, birds and reptiles (64, 3 and 2 types, respectively)23. HPV are 
small DNA viruses consisting of an approximately 8 Kb circular, double stranded DNA 
genome24 and an icosahedral capsid. The HPV genome is divided into three main regions: 
1) the noncoding upstream regulatory region (URR) or long control region (LCR) which 
regulates viral gene expression and holds the highest degree of variation among different 
HPV types. 2) The early (E1, E2, E4, E5, E6, E7) region involved with replication, 
oncogenesis and survival. 3) The late (L1, L2) region encoding viral capsid proteins, 
where the L1 open reading frame (ORF) is the most conserved gene in all PV types. A 
new PV type within a species is defined if there is more than 10% sequence dissimilarity 
of the L1 ORF from the closest type; into a subtype if homology is between 2% and 10% 
and a variant with less than 2% difference25. The overall sequence similarity between 
different genera of the papillomaviridae family is within 23 to 43% 25.  
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HPV infects basal cells of stratified squamous epithelium and replicates in 
cutaneous and mucosal epithelia, causing benign lesions26. The carcinogenic role of HR-
HPV most often involves disruption of E2 transcription regulator post viral integration 
into the host genome and the deregulated expression of the two viral oncogenes- E6 and 
E727,28. The E6 and E7 proteins are primarily nuclear with some cytoplasmic component 
reported for both proteins29,30. While E6 binds to and promotes degradation of the tumor 
suppressor, tumor protein 53 (TP53) gene product31, E7 binds to and promotes the 
degradation of the cellular retinoblastoma (pRb) tumor suppressor gene product32, 
thereby blocking cell cycle regulation and promoting proliferation33. The E7 protein by 
itself can produce cellular transformation and its oncogenic potential is further 
accentuated by the E6 protein, which however, is virtually incapable of transforming cells 
all by itself. The affinity of the E7 protein for pRb is higher in HR-HPV types as 
compared to low risk types, while low risk E6 interacts with E6 associated proteins 
(E6AP) but does not cause p53 degradation34–36. Hence, these phenomena explain the 
increased oncogenic potential of HR-HPV types.  
 
1.3 Role of HPV in HNSCC 
1.3.1 Biology of HPV related HNSCC 
The discontinuity of the reticulated epithelium of the tonsillar crypts renders it 
susceptible to HPV infection37 and is one of the possible determinants of the high 
prevalence of HPV-positive tumors in this anatomical region. Since viral oncoproteins 
are capable of transforming primary human keratinocytes34 from either genital38 or oral 
epithelia in vitro39–41, they clearly play a role in disrupting cell-cycle regulatory pathways 
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leading to a genetic progression to ano-genital cancer and, possibly, also to oral 
squamous cell carcinoma (OSCC)42. However, the exact mechanism by which HPV 
mediates malignant transformation of oral keratinocytes in the upper respiratory tract 
epithelia is still unclear43.   
HPV-positive cancers exhibit distinct phenotypic features including poor 
differentiation, scant keratinization and basaloid phenotype, quite different from the 
keratinizing morphology of HPV-negative squamous cell carcinoma (SCC)37. With 
respect to HPV, variable degrees of viral oncogene expression and integration have been 
observed in many case studies43. HPV-E7 mediated inactivation of pRb results in over 
expression of p16INK4A44,45, which is often used as a surrogate marker for HPV 
mediated carcinogenesis46,47. However, high p16INK4A alone has insufficient sensitivity 
and specificity as a marker of HPV positivity in different mucosal sub-sites of 
HNSCC48,49. In addition to the disruption of cell cycle control and the genome 
instability34,50,51 produced by HPV oncoproteins, other virus-driven mechanisms that may 
contribute to evasion of host immune response and tumor progression in HPV-positive 
tumors include antigen processing machinery defects, debilitated T helper cell response, 
the interplay between cluster of differentiation (CD)4+ and CD8+ T cells and lastly the 
presence of circulating and tumor T-regulatory cells (Treg)37.  
 
1.3.3 Biomarkers of HPV in HNSCC 
In surgical pathology, immunohistochemistry for p16(INK4a) is a well-known 
surrogate marker for HPV expression in cervical cancers46,47 and HNSCC52.  
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However, the sensitivity and specificity of this protein as a biomarker for HNSCC 
has been highly debated53, and with that its potential to characterize biologically active 
HPV-OPSCC increases in combination with DNA/RNA based assays for viral 
oncogenes54–56. Direct methods for identifying HPV infection include HPV DNA57,58 or 
E6/E7 mRNA59,60 detection via polymerase chain reaction (PCR) or in-situ Hybridization 
(ISH)61. There is a growing importance of RNA expression patterns typical for cervical 
carcinomas (CxCaRNA)49,56, E6*I and E6*II53,62,63 as a more reliable marker for active 
HPV infection in OPSCC49,53,62. The status of these biomarkers was recently assessed in 
combination to other established protein biomarkers of HPV mediated oncogenesis such 
as p16(INK4a)53,56 , pRb56, Cyclin D156 and p53 49,64.  
RNA-sequencing (RNA-seq)65–67, is a novel tool for detecting tumor-associated 
DNA viruses and identifying viral integration sites in various human cancers. In a recent 
study of 239 HNSCC samples available in The Cancer Genome Atlas (TCGA) database, 
HPV transcripts were detected in 36 tumors with HPV16 (30), HPV33 (5) and HPV35 (1) 
as detected types. Viral integration was observed in the host genome at known 
chromosomal sites in 24 tumors expressing E6 and E7 oncogenic proteins. RNA-seq has 
achieved complete concordance in the detection of viral and viral-host transcripts in 
HNSCC tumors when compared to other established methods, with a ~99.9% probability 
of detecting at least one viral sequence in the TCGA cohort. RNA-seq can efficiently 
detect a frequency of viral genome transcript as low as 0.0001%67.  
However, whether or not an HPV is active (i.e. the actual role of HPV in “driving” 
the cancer) probably cannot be ascertained by the detection of extremely low levels of 
viral transcripts, and a variety of molecular markers are necessary to fully define HPV-
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mediated pathogenesis in a tumor. Prevalence of HPV in HNSCC/OPSCC and various 
assays used for determination the same are as summarized in Table 1.1.  
 
1.3.4 Targeted Therapy 
Major factors considered while treating HPV positive OPSCCs include: a) the 
subsets of patients with smoking and alcohol history, b) mortality due to second primary 
tumors, and c) genetic makeup of tumor metastasis105. More recently, phase I clinical 
trials involving intra-tumor injection of the quadrivalent vaccine-Gardasil® (HPV 6, 11, 
16 and 18)106,107 or the bivalent vaccine-Cervarix® (HPV 16, 18)108 have been introduced 
as combinatorial therapies along with anticancer drugs and other vaccines in HNSCC105. 
However, one of the shortcomings in HPV mediated therapy is the lack of pre-clinical 
data from in vitro experiments.  
 
1.4 Molecular Mechanisms of Origin of HNSCC 
Gene amplification, deletions, point mutations, overexpression/inhibition and 
epigenetic modifications are the driving forces behind development of human cancer and 
these vital events are being intensely studied to understand patterns of development in 
head and neck cancer, particularly with respect to HPV. 
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Table 1.1: Prevalence of HPV in Head and Neck Cancer. 
Adapted from Lajer & Buchwald, 2010 















1988 OSCC ISH 6/51 12 16, 18 
Chang et al.70 1990 OSCC ISH/PCR 11/40 28 16, 18, 6 
Zeuss et al.71 1991 OSCC ISH 0/15 0 – 
Holladay 
et al.72 
1993 OSCC PCR 7/37 19 16, 18 
Ostwald 
et al.73 




1995 OSCC PCR 67/91 74 16, 18, 6, 
11 
Cruz et al.75 1996 OSCC PCR 19/35 55 16 
Wilczynski 
et al.76 




2001 HNSCC PCR/E6R-PCR 20/84 24 16 
Kojima 
et al.78 
2002 OSCC PCR 35/53 66 38 
Sugiyama 
et al.79 
2003 OSCC PCR 30/86 35 16 
Smith et al.80 2004 OSCC/O
PSCC 




2005 OSCC PCR 6/102 6 16, 18 
Slebos et al.82 2006 HNSCC RT-PCR 8/36 22 16 
Luo et al.83 2007 OSCC PCR based gene 
chip array 
13/51 25 16, 18, 
33, 52 
Zhang et al.84 2008 HNSCC ISH 10/30 33 – 
Chuang 
et al.85 
2008 HNSCC RT-PCR 20/59 34 16 
Simonato 
et al.86 
2008 OSCC nPCR 5/29 17 – 
Luginbuhl 
et al.87 
2009 TSCC ISH 17/48 35 – 
Avissar 
et al.88 
2009 HNSCC PCR 19/109 17 16 
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utr et al.89 
2009 OSCC/O
PSCC 
PCR 41/119 35 16 
Khovidhunkit 
et al.90 
2008 OSCC PCR 1/65 2 – 
Gudleviciene 
et al.91 
2009 HNSCC PCR 13/48 27 16 
Näsman 
et al.18 
2009 TSCC PCR 43/46 93 16, 33, 
35, 59 
Shi et al.92 2009 OPSCC PCR/RT-
qPCR/ISH/IHC 
73/111 66 16 
Straetmans 
et al.93 
2009 TSCC ISH 33/81 41 16 
Weinberger 
et al.94 
2009 OPSCC PCR/IHC 47/77 61 16 
Lassen et al.95 2010 HNSCC IHC 84/131 25 – 
Bennett 
et al.96 
2010 TSCC PCR 9/16 56 16 
Hoffmann 
et al.97 
2010 TSCC RT-PCR/IHC 21/39 53 16 
Attner et al.98 2010 BTSCC PCR/RT-qPCR 71/95 75 16, 33 
Chernock et 
al.99 
























108 15 to 57 16 
Heath et al.17 2012 OPSCC IHC/qPCR 31/83 37 16 
Gillison et 
al.14 




Liang et al.54 2012 HNSCC cLIA/GST tag 
ELISA/MPG-
SPF/IHC 
488/722 72, 71 16 
Bishop et 
al.101 
2012 HNSCC Hybrid 
capture2/ISH/IH
C/qPCR 
14/24 58 16 

















52, 56, 6, 
11, X  
Hoffman et 
al.53 
2012 HNSCC MPG-PCR/LCD 
chip array/E6*I 
mRNA/ISH 





























Deng et al. 2013 HNSCC PCR/qPCR/E2-
E6 ratio/RT-
qPCR 























1.4.1 Mutational Profile of HNSCC 
Recent whole exome sequencing of 92 fresh frozen HNSCC samples validated 288 
mutations of 39 genes (q<0.1)109. The rate of mutation in HPV positive tumors was 50% 
less as compared to HPV negative tumors109. Laryngeal cancers exhibited higher 
mutation rates and G → T transversion frequencies (P=0.008 & P<0.0001, respectively, 
rank sum tests) in HPV-negative tumors as compared to those of oropharynx and 
sinonasal cavity109. Major pathways affected by these genetic mutations involved: 
regulation of nuclear polarity (SYNE1 and SYNE2 in 20% and 8% of samples 
respectively); processes mediating calcium sensing for terminal squamous differentiation 
(RIMS2 and PCLO mutations in 11% and 12% of cases respectively); apoptosis related 
genes (CASP8 and DDX3X in 8 & 4% respectively) and genes related to squamous 
differentiation (NOTCH1, IRF6, and TP63). The product of TP63 promotes renewal of 
basal keratinocytes by a mechanism that requires down-regulation of NOTCH1 and 
Cyclin-dependent kinase inhibitor 2A (CDKN2A).  In a separate study, alterations in 
PI3K-related genes were found to be common in HNSCC (e.g., PIK3CA mutations in up 
to 20% of tumors). PI3K is a key signaling pathway in cancer, including head and neck 
cancer and multiple PI3K inhibitors are currently in clinical testing for HNSCC110,111. 
Inactivating Notch1 mutations have been recently described for the first time with respect 
to HNSCC112. While sensitizing mutations affecting the intracellular domain of the 
epidermal growth factor receptor (EGFR) are uncommon in HNSCC113, the majority of 
HPV negative HNSCC harbor inactivating mutations in tumor suppressor genes like 
TP53114 and NOTCH1112, while HPV positive tumors are described by functional 
inactivation of TP53 and Rb by viral oncoproteins115,116.  
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A molecular circuitry of HNSCC was proposed based on the observed loss and gain 
of function of some crucial genes in HNSCC in relation to viral genes (Figure. 1.1). Blue 
depicts loss of function and red gain of function, while HPV markers are depicted in 
yellow and genes hypothesized to play a role in HNSCC are depicted in light blue with 
respective fractions of tumors harboring those features117.  
These observations cumulatively emphasize the need to develop efficiently 
designed targeted therapy for HPV-positive and HPV-negative cancers, and even for 
subsets of the two, further designated by specific mutational and gene expression profiles.   
 
1.4.2 Genetic Modifications: CNV, Methylation, TCGA 
Copy number variations (CNV) between HPV-positive and HPV-negative HNSCC 
tumors have been extensively studied through comparative genomic hybridization 
(CGH)118.Observed patterns of genomic alterations include: a) losses at 3p11.2–26.3, 
5q11.2–35.2, 18q12.1– 23 and 9p21.1– 24, and gains at 11q12.1–13.4 in HPV-negative 
tumors; b) gain of 18q12.1– 23 in HPV16-positive tumors119,120; c) similar patterns of 
gene loss at 13q and gain at 20q in HPV-positive uterine cervix SCC and HPV-positive 
HNSCC tumors121 and d) higher number of chromosomal alterations and amplifications 
in HPV-negative OSCC122. 
The human genome comprises Guanine-Cytosine (GC) rich hotspots called CpG 
islands, primarily in the gene promoter region, whose cytosine residues are often 
hypermethylated by DNA methyltransferases123,124. This generally results in 
downregulation of the affected gene and, depending upon which genes are affected, may 
influence the development of cancer125–128. 
  
 
Figure 1.1: Proposed circuitry of HNSCC
Darker blue- loss of function; red
genes putatively implicated in 
represent the percentage of tumors harboring 




- gain of function; yellow- viral genes; light blue
HNSCC. The numbers listed beneath each protein 






A recent CpG island methylome screening of 15 OPSCC tumor samples, grouped 
into three cohorts based on the status of viral DNA/transcripts as DNA-/RNA-, 
DNA+/RNA- and DNA+/RNA+; revealed distinct methylation signatures between HPV-
driven and non HPV-driven OPSCCs129. Two major conclusions were as follows: 1) 
HPV-driven promoter methylation signature of 5 genes (ALDH1A2lo, OSR2lo, GATA4hi, 
GRIA4hi, and IRX4hi) strongly correlated to the clinical outcome of OPSCC patients and 
2) the presence of viral DNA alone was insufficient to explain differences in DNA 
methylation, thus emphasizing the potential role of active viral transcription in driving at 
least some of the methylation events129. However, the mechanism by which viral proteins 
direct gene silencing in HPV driven OPSCC is incompletely understood. 
TCGA is a community resource project with a readily available online tool that 
allows researchers to search, download, and analyze data across different cancer models. 
Recently, TCGA identified heterogeneous gene mutation patterns in 279 HNSCC tumors 
due to smoking, tobacco and HPV with 15 significantly mutated genes, among them 
CDKN2A(p16), TP53, PIK3CA, NOTCH1, HRAS, and NFE2L2130.  
APOBEC (apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like) 
cytidine deaminases are involved in innate immunity, RNA editing and more recently 
APOBEC-mediated mutagenesis was studied in human cancers including HNSCC131. The 
analysis spanned 954,247 mutations in 2,680 exomes from 14 cancer types, mostly from 
TCGA and depicted a rate of 58% mutations in the APOBEC gene. The study hinted 
towards a probable relationship between HPV and APOBEC as both cervical SCC and 
HNSCC were found to be enriched in APOBEC mutations. In another study involving 
239 HNSCC tumors from the TCGA database, viral integration sites were identified in 24 
 14 
HNSCC tumors expressing E6 and E7 oncogenes both within the viral and host 
genomes67. The viral integration was observed in chromosomes 1, 3, 5, 9, 13, 14, 15, 16, 
18, 19 and 21 with majority of them involving known cancer genes like TP63, RAD51B 
and SERPINB3 etc67. While we are not quite at the point of being able to trace a true 
picture of all of the possible mutational avenues of HNSCC development, data are 
accumulating at a high rate and this classification may become possible in the near future. 
The next step, then, will be to connect specific mutations with molecular mechanisms 
that can be utilized for the design of individualized therapeutic approaches. 
 
1.4.3 Biomarkers of HNSCC 
HNC treatment involves targeting receptor tyrosine kinases (RTKs) like the 
EGFR132. However, despite EGFR overexpression in about 90% of tumors133 the 
response to treatment is poor134. This has led to the continuing search of more RTK’s that 
may serve as therapeutic targets. Among these, the mesenchymal epithelial 
transition/hepatocyte growth factor receptor (MET/HGFR), which controls growth, 
invasion and metastasis in cancer cells, has been recently proposed as a new therapeutic 
target for HNSCC in view of its crosstalk with the EGFR135 and its potential as an 
inducer of cancer stem cell phenotype136. MET is under the control of TP53137 and 
therefore should be downregulated in E6 expressing cells. This could be an important 
marker and driver of proliferation in HPV-negative tumors. The MET oncogene has been 
proposed as a therapeutic target for HNSCC136. However, differential expression of MET 
between HPV-positive and HPV-negative tumors has not yet been described. Remodeling 
of extracellular matrix (ECM) by matrix metalloproteinases (MMP’s) plays an important 
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role in tumor invasion and metastasis. The expression profile of proteinases involved in 
the HNSCC-associated degradome are specific to histopathologic characteristics such as 
grade, location, size and metastasis of tumor138. One such proteinase, a disintegrin and 
metalloprotease 12 (ADAM12) is positively regulated by the EGFR and its 
overexpression has been implicated in migration and invasion of oral squamous cell 
carcinoma (OSCC) cells139. Matrix metalloproteinases (MMP’s), a family of zinc-
dependent endopeptidases, degrade ECM and their overexpression has been well 
documented in HNSCC tumors, cell lines and cancer-associated fibroblasts138,140–144. 
More recently, HPV8 expressing transgenic mice and p16 positive cervical cancer cell 
lines were reported to have overexpression of MMP2, 9, 13 and 14145,146.   
Two of the important genes up-regulated in HPV positive cancers include well 
documented CDKN2A111,122,147 and minichromosome maintenance complex component 2 
(MCM2), whereby MCM2 has been reported as a probable biomarker to assess pre 
dysplastic lesions of TSCC with elevated levels in severe epithelial dysplasia as 
compared to advanced SCC 148. 
Transforming growth factor beta-2 (TGFβ2) was recently noted as a contextual 
oncogene or tumor suppressor in HNSCC in view of its dichotomous role in disease 
progression149. TGFβ receptor II (TGFβRII), Smad2, and Smad4 are often downregulated 
during disease progression, with a concomitant upregulation of TGFβ1 ligand150. This 
deregulation has a two-fold impact which leads to more aggressive and less differentiated 
tumors due to receptor attenuation, and inhibition of anti-tumor immunity by TGFβ1 
while activating tumor-enhancing inflammation in the microenvironment. In a recent 
study, BRCA1 was suggested as one of the biomarkers that may allow to predict the 
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taxane sensitivity of HNSCC with acquired Cisplatin resistance151. IGFBP3 modulates 
the biovailability of IGF and has been reported to have anti-angiogenic property in 
HNSCC152.  
Homeobox genes regulate growth & differentiation during embryogenesis by 
coding for specific transcription factors. One such homeobox gene complex is SIX1 
which is involved in organ development. Overexpression of Six1 facilitates breast cancer 
metastasis by inducing epithelial-mesenchymal transition (EMT)153 and it is being 
referred to as a novel target for inhibiting tumorigenesis. Thus, it would be interesting to 
look for its role in HNSCC. Table 1.2 summarizes some of the key genes mutated and 
deregulated of HNSCC. 
In view of current biomarkers and cellular processes of HPV and non-HPV driven 
HNSCC, Figure 1.2 summarizes recently proposed hallmarks of tumorigenesis in HN 
cancer117. (A) Squamous differentiation and cellular proliferation is regulated by TP63 
and Notch1 in normal adult mucosa, whereby the former maintains the levels of basal 
differentiation markers- Keratin5/14 and the latter is responsible for differentiation into 
spinous and granular layers. Figure 1.2(B) depicts hallmarks of HNSCC progression. The 
loss of TP53 and CDKN2A, amplification of CCND1, and loss of TGFBR2/SMAD4 
causes abnormal proliferation and abrogation of apoptosis117. However, disrupted cell 
cycling may still be compensated by intact differentiation and apoptotic programs. Loss 
of NOTCH1 and/or abnormal expression of TP63, in combination with dysregulated 
“survival” genes (e.g. CASP8, PIK3CA, EGFR), may remove additional barriers to tumor 
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Figure 1.2: Hallmarks of HNSCC tumorigenesis117 
(A) The normal process of squamous morphogenesis in the adult mucosa and role 
of two major proteins TP63 and Notch1. Light blue depicts rare stem cells in 
basal layer undergo terminal differentiation through asymmetric cell division. (B) 
Pathways altered in HNSCC pathogenesis. The color codes are as follows: red- 
putative and established tumor suppressors; green- oncogenes; brown- other 
relevant genes/proteins; blue- viral proteins. (C) Schematic of HNSCC hallmarks. 
The precise order of acquisition of distinct alterations is still not clear. Multiple 
genes (e.g. TP53, TP63 and Notch1) may play a role in more than one hallmark. 
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Loss of cell adhesion genes (e.g. FAT1) may permit release of cells from the 
mucosal lining, while invasion through the basement membrane is promoted by TGFB1 
and SMAD3117. Figure 1.2 (C) describes the purported sequence of acquisition of 
alterations leading to proliferation, poor differentiation, cell survival and invasion. 
 
1.5. Clinical and Molecular Classification of HNSCC 
1.5.1 Molecular Classification 
Molecular phenotypes of HPV associated OPSCC’s were first categorized into 
three major classes based on copy number of HPV DNA and p16 expression: HPV-active 
(HPV16 DNA positive/p16 expressing cancers), HPV-inactive (HPV16 DNA 
positive/p16 non-expressing) and HPV-negative tumors (no HPV16 DNA/p16 non-
expressing) 52,94.  
The first ever global gene expression profiling of HPV16 E6 and E7 expressing 
HNSCC tumors revealed up-regulation of transcription and cell cycle specific genes in 
comparison to HPV-negative tumors82. A comparison between the expression profiles of 
84 HNCs, cervical cancers and site matched normal epithelia confirmed upregulation of 
this subset of genes in HPV-positive HNC and cervical cancers187. On the other hand a 
novel relationship between HPV status and a set of testis-specific genes was ascertained 
based on upregulation of this family of genes187. 
Immunologic profiling of HPV-positive and HPV-negative OPSCC/HNSCC has 
revealed contrasting signatures37 such as: enrichment of circulating CD8+ T cells in 
HPV-positive OPSCC resulting in better response to therapy188, higher proportions of 
effector and memory T cells as compared to HPV-negative tumors189, differential 
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expression of major histocompatibility class I receptors (MHC I)190 and lastly, strong 
adaptive immune response in HPV-positive vs. an innate immunity in HPV-negative 
HNSCC, which corroborates with a better survival rate in HPV-positive OPSCC 
patients191.  
To better describe the molecular and functional changes in different kinds of 
HNSCC, a more comprehensive genome wide analysis was conducted at four major 
functional levels viz., methylome, genome, transcriptome and miRNome192. 
1.5.2 Clinical Classification 
In a recent study, integrated genomic analysis and validation methodology was 
employed to classify HNSCC tumors based on tumor site and histology with well-defined 
biological and clinical relevance193. Biological characteristics of highly expressed genes 
were considered within each group to categorize tumors as basal (BA), mesenchymal 
(MS), atypical (AT), and classical (CL) subtypes. These expression types were well-
represented in defined experimental model systems comprising 19 esophageal and 18 
upper aerodigestive tract cell lines from the Cancer Cell Line Encyclopedia194 following 
the same methodology. BA and CL types were derived from their counterparts in Lung 
squamous cell carcinoma (LUSC)195; where BA types shared similar expression patterns 
with basal cells during early stages of development of SCC and CL types were indicative 
of genomic alterations like deletion of 3p and 9p, amplification of 3q, and focal 
amplification of both EGFR and CCND1. Thirdly, MS depicted tumors with pronounced 
epithelial-mesenchymal transition pathways and AT type portrayed either 9p deletion or 
absence of EGFR amplification. CL and AT types also expressed stem cell markers like 
 23 
SOX2 and ALDH1. Lastly, these signatures were termed complementary to 
classifications based on HPV status and CCND1 CNV193. 
Another genome wide approach was employed to identify novel differentially 
methylated CpG dinucleotides found in tumors at various anatomic sites, as well as those 
in relation to HPV status in the oropharynx 196. The oropharyngeal HPV-methylation 
study exclusively found more than twice the number of differentially methylated CpG 
dinucleotides in HPV positive tumors (564 loci) as compared to HPV negative tumors, 
arising from the same site196. While 74% of HPV negative CpG loci were represented in 
HPV positive tumors, the latter expressed an additional profile of 360 loci which were 
exclusive for the group itself and most of it was attributed to hypermethylation in the 
CpG loci of CDKN2A64 and GALR1197 genes. 
 
1.6. Epidemiology of HNSCC 
The global HNC incidence for OPSCC cases is high- 263,020 oral cavity, 213,179 
thyroid gland, 150,677 larynx, 136,622 pharynx, and 84,441 nasopharynx cases per year 
198,199
. The incidence of OPSCC is 2.5 times greater in men than in women where the age-
standardized incidence rates are 13.5 versus 11.5 for males in developed and developing 
countries, respectively1. Incidence within female population are, 3.0 versus 5.1, in 
developed and developing countries, respectively1. Transmission of HPV in OPSCC 
occurs both sexually and asexually15, where the incidence increases with more than 5 
sexual partners200 and in active smokers200. Synergistic effects of alcohol3 and human 
immunodeficiency virus (HIV)-33% 201,202 have also been described.  
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More recently, HPV has been characterized as a risk factor based on race, life style 
and sexual behavior impacting survival outcomes for African American (AA) and 
European American (EA) patients with OPSCC 203. The rate of HPV-associated tumors is 
much lower in AA patients as compared to EA patients204,205. Overall, AA patients tend 
to present with more HPV negative OPSCC and have worse prognosis as compared to 
both HPV-positive and HPV-negative EA patients203,204. South Carolina ranks third in the 
USA in OPSCC mortality, with most common sites of tumor growth being tongue, gums 
and tonsils 206. A study from Georgia found that younger age groups, Non-Hispanic 
Whites and Hispanics experienced greater increases in incidence for HPV-associated 
sites, while HNC incidence declined for Non-Hispanic Blacks independent of HPV-
association 207.  
In this study, we employed gene expression profiling by microarrays, and 
quantitative real-time PCR to investigate the gene expression profiles of HPV-positive 
and HPV-negative OPSCC derived from AA or EA patients, to attempt an identification 
of gene expression changes that would characterize and distinguish these tumors, and 
provide clues as to the molecular basis of the disparate distribution and clinical behavior 
of the same. In this context, we implemented state-of-the-art methods for gene expression 
assessment by RT-qPCR. 
 
1.7. Reverse Transcription - Quantitative Polymerase Chain Reaction 
Ever-since the advent of Real-Time quantitative PCR 208,209 in 1996, the technique 
has been extensively implemented in quantitative estimation of gene copy number and 
expression analysis. This is primarily because of increased demand to support phenotypic 
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observations with quantitative molecular data and as a supporting assay for protein 
expression studies 210. Furthermore, quantitative Polymerase Chain Reaction (qPCR) 
based studies were becoming highly unreliable due to low experimental transparency and 
inconsistency between laboratories leading to failures in replication of published data 211. 
The use of various statistical analysis tools, in the absence of proper guidelines for data 
interpretation, added to the ever-growing variability between similar studies 212. A 
comparative analysis of multiple Real-Time qPCR quantification methods reported 
considerable differences in their performance 213. Thus, a case for ‘Minimum Information 
for Publication of Quantitative Real-Time PCR Experiments’ guidelines was proposed to 
target the reliability of Real-Time PCR results 214. 
 
1.7.1 Minimum Information for quantitative estimation (MIQE) 
The MIQE (pronounced mykee) guidelines describe the minimum information 
necessary for evaluating qPCR experiments and encompasses a complete disclosure of all 
reagents, sequences, and analysis methods used by a researcher. These guidelines were 
designed in order to fully assess the validity of the protocols through a checklist of 
essential and desirable parameters which accompany the initial submission of a 
manuscript, and are later published in abbreviated form or as an online supplement. The 
list of essential and desired parameters is given in Table 1.3.  
To remove ambiguity associated with Real Time-PCR, quantitative-PCR and 
Reverse Transcriptase-PCR, the term ‘qPCR’ was proposed for quantitative real-time 
PCR and ‘RT-qPCR’ for reverse transcription–qPCR.  
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Table 1.3: MIQE checklist for authors, reviewers and editors214 
ITEM TO CHECK IMPORTANCE 
EXPERIMENTAL DESIGN   
Definition of experimental and control  groups E 
Number within each group E 
Assay carried out by core lab or investigator's lab? D 
Acknowledgement of authors' contributions  D 
SAMPLE   
Description E 
     Volume/mass of sample processed D 
    Microdissection or macrodissection E 
Processing procedure E 
     If frozen - how and how quickly? E 
     If fixed - with what, how quickly? E 
Sample storage conditions and duration (especially for FFPE # samples) E 
NUCLEIC ACID EXTRACTION   
Procedure and/or instrumentation E 
     Name of kit and details of any modifications E 
     Source of additional reagents used  D 
Details of DNase or RNAse treatment E 
Contamination assessment (DNA or RNA) E 
Nucleic acid quantification  E 
     Instrument and method E 
     Purity (A260/A280)  D 
     Yield D 
RNA integrity method/instrument E 
    RIN/RQI or Cq of 3' and 5' transcripts  E 
    Electrophoresis traces D 
 Inhibition testing (Cq dilutions, spike or other)  E 
REVERSE TRANSCRIPTION   
Complete reaction conditions E 
     Amount of RNA and reaction volume E 
    Priming oligonucleotide (if using GSP) and concentration E 
     Reverse transcriptase and concentration E 
     Temperature and time E 
     Manufacturer of reagents and catalogue numbers D 
Cqs with and without RT D* 
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Storage conditions of cDNA D 
qPCR TARGET INFORMATION   
If multiplex, efficiency and LOD of each assay. E 
Sequence accession number E 
Location of amplicon D 
     Amplicon length E 
     In silico specificity screen (BLAST, etc) E 
     Pseudogenes, retropseudogenes or other homologs? D 
          Sequence alignment D 
     Secondary structure analysis of amplicon D 
Location of each primer by exon or intron (if applicable) E 
     What splice variants are targeted? E 
qPCR OLIGONUCLEOTIDES   
Primer sequences E 
RTPrimerDB Identification Number  D 
Probe sequences D** 
Location and identity of any modifications E 
Manufacturer of oligonucleotides D 
Purification method D 
qPCR PROTOCOL  
Complete reaction conditions E 
     Reaction volume and amount of cDNA/DNA E 
     Primer, (probe), Mg++ and dNTP concentrations E 
     Polymerase identity and concentration  E 
     Buffer/kit identity and manufacturer  E 
     Exact chemical constitution of the buffer D 
     Additives (SYBR Green I, DMSO, etc.) E 
Manufacturer of plates/tubes and catalog number D 
Complete thermocycling parameters E 
Reaction setup (manual/robotic) D 
Manufacturer of qPCR instrument E 
qPCR VALIDATION   
Evidence of optimisation (from gradients)  D 
Specificity (gel, sequence,  melt, or digest) E 
For SYBR Green I, Cq of the NTC E 
Standard curves with slope and y-intercept E 
     PCR efficiency calculated from slope E 
     Confidence interval for PCR efficiency or standard error D 
     r2 of standard curve E 
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Linear dynamic range E 
     Cq variation at lower limit E 
     Confidence intervals throughout range D 
Evidence for limit of detection  E 
If multiplex, efficiency and LOD of each assay. E 
DATA ANALYSIS  
qPCR analysis program (source, version) E 
     Cq method determination E 
     Outlier identification and disposition E 
Results of NTCs  E 
Justification of number and choice of reference genes E 
Description of normalisation method E 
Number and concordance of biological replicates D 
Number and stage (RT or qPCR) of technical replicates E 
Repeatability (intra-assay variation) E 
Reproducibility (inter-assay variation, %CV) D 
Power analysis D 
Statistical methods for result significance E 
Software (source, version) E 
Cq or raw data submission using RDML D 
 
 
All essential information (E) must be submitted with the manuscript. Desirable 
information (D) should be submitted if available. If primers are from RTPrimerDB, 
information on qPCR target, oligonucleotides, protocols, and validation is available 
from that source214. 
(#) FFPE, formalin-fixed, paraffin-embedded; RIN, RNA integrity number; RQI, RNA 
quality indicator; GSP, gene-specific priming; dNTP, deoxynucleoside triphosphate214.  
(*) Assessing the absence of DNA with a no–reverse transcription assay is essential 
when first extracting RNA. Once the sample has been validated as DNA free, inclusion 
of a no–reverse transcription control is desirable but no longer essential214. 
(**) Disclosure of the probe sequence is highly desirable and strongly encouraged; 
however, because not all vendors of commercial predesigned assays provide this 
information, it cannot be an essential requirement. Use of such assays is discouraged214. 
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These guidelines further accelerated the development of an XML-based real-time 
PCR data markup language (RDML) for the consistent reporting of real-time PCR data 
215
. This consortium is active in the development of appropriate and standardized 
terminology, guidelines on minimum information for biological and biomedical 
investigations, and a flexible and universal data file structure with tools to create, process, 
and validate RDML files215. 
 
1.7.2 Normalization of RT-qPCR 
Many statistical analysis tools have evolved over the past decade to accurately 
quantify differential expression of genes with respect to reference/housekeeping genes 
whose levels remain constant across varying experimental conditions216–221. Each tool 
developed to overcome the limitation of the previously existing tool whereby factors like 
assessment with multiple reference genes219,220,222, primer efficiency correction221, inter-
run calibration223, gene and sample maximization strategies221 and tissue specific panel of 
reference genes224,225 have now gained relevance226. While geNorm220 was the first 
efficient tool to compare a panel of multiple reference genes, thus ranking them based on 
their stability values (M value), BestKeeper219 could assess variation in up-to 10 
reference genes in an array of 100 samples, Normfinder227 returned top two candidate 
reference genes based on sample groupings and the more recent software qbase+ 





1.8. Study Rationale 
Considering the limitations of present therapies to cure tumor relapse, a profound 
understanding of the HNSCC molecular biology and associated tumorigenicity is 
required to devise efficient therapeutic measures targeting specific cellular and sub-
cellular signaling pathways in view of its recent etiological factor-HPV. With the 
unveiling of a mutational landscape, differential gene expression and an epigenetic 
profile of HPV driven HNSCC, other risk factors critical for efficient prognosis remain to 
be explored which include racial and geographical differences in a population, which is in 
turn guided by the genetic make-up of the individuals. This study specifically explored 
the molecular basis for the racial differences in prevalence and mortality rate of HNSCC 
between AA and EA South Carolinians.  
Thus, our approach allowed us to determine whether or not HPV types other than 
HPV16 play an important role in HNSCC in AA, and began dissecting the molecular 
profiles of HNSCC in the two racial groups. This is the first study of its kind in South 
Carolina and includes a direct assessment of the prevalence of HPV in HNSCC, 
particularly AA men and women, for which there is a paucity of data.  
 
Our study allowed us to determine whether or not HPV types other than HPV16 
play an important role in HNSCC in AA, and began dissecting the molecular profiles of 
HNSCC in the two racial groups. With the increasing emphasis on accurate determination 
of HPV activity in the OPSCC tumors and observed trends of HNSCC disparities among 
AA and EA patients, our study delineates the patterns of HPV active, inactive and 
negative tumors based on viral oncogene expression.  
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Lastly, the differential gene expression analysis of OPSCC samples revealed that 
HPV-negative and HPV-inactive tumors clearly segregate from HPV-positive OPSCC in 
terms of GO and DEGs (both within a race and in the combined sample set). 
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CHAPTER 2: MATERIALS AND METHODS 
2.1. Tissue Samples 
This retrospective cohort study included a total of 65 fresh frozen oropharyngeal 
samples collected from African American and European American patients at the 
Medical University of South Carolina (MUSC), Charleston, SC. The tissue sample set 
included 56 tumor biopsies and 9 normal benign uvula or uvula and tonsil tissue samples. 
The study was approved by the MUSC Institutional Review Board (IRB) and USC’s IRB. 
A written consent for the use of tissues was obtained from patients according to the 
MUSC Standard Tissue Collection consent. 
 
2.2. Extraction of Nucleic Acids 
A) Tissue Homogenization 
Fresh frozen tissue samples were homogenized by a motor driven, handheld 
homogenizing system which consists of a porcelain/zirconium miniaturized mortar and 
pestle (CryoGrinder™, OPS diagnostics LLC, Product no.CG 08-010) and a cordless, 
3.6V, three position screwdriver (Black & Decker®). The CryoGrinder™ was used along 
with CryoCooler™ (OPS diagnostics LLC, Product no.CG 08-07), a portable cryogenic 
station which maintained temperatures much below -130°C for up to 5 hours with the 
help of a Liquid Nitrogen absorbing Pillow (OPS diagnostics LLC, Product no.CG 08-
08). 
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Briefly, the CryoCooler™ was disinfected with 70% Isopropyl Alcohol and the 
reservoir was charged with liquid nitrogen using the absorbent pillow. The level of liquid 
nitrogen was adjusted such as it reached 1-2cm above the perforated platform. Prior to 
this; spatula, pestles and mortars were decontaminated with Ambion® DNAZap™ and 
then autoclaved at 121°C for 15mins. Post sterilization and cooling, spatula, pestles and 
mortars were placed on the perforated platform of the CryoCooler™ along with a sterile 
Petri dish (VWR® International, Catalog no. 25384-168), sterile individually wrapped 
disposable forceps (VWR® International, Catalog no. 97001-199), a sterile disposable 
scalpel (BD Biosciences, Catalog no. 371620) and a nuclease free 1.5 mLmicrofuge tube 
for about 15 minutes. The frozen tissue samples were handled individually with fresh 
gloves each time, to avoid any cross contamination and the sterile Petri dish was used as 
an additional platform for fragmenting the frozen tissue in the chamber of CryoCooler™. 
Tissue was split into two major parts; one part was used for homogenization and the other 
for immunohistochemical staining (see section 2.9). The size and weight of fragmented 
tissue was maintained under 5mm and 100mg (~ 20-50mg) respectively, for efficient 
grinding. The pre-cooled pestles were handled by wearing Cryo-gloves (Tempshield, 
Product no.11-394-322) and the screwdriver was set at maximum rotation speed for 
grinding of tissue fragments. Pulverized tissue was transferred to a labeled microfuge 
tube with the help of a sterile spatula and used for the extraction of nucleic acids. 
B) TRIzol extraction  
TRIzol® Reagent (Ambion®, by Life Technologies, catalog no. 15596-018) was 
used to simultaneously extract genomic DNA and total RNA from fresh frozen tissues 
according to manufacturer’s instructions with an additional step of back extraction 
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protocol for higher purity DNA. Briefly, 700ul (for <50mg tissue) or 1000ul (for 50 – 
100mg tissue) of TRIzol® Reagent was added to the pulverized frozen tissue, and the 
mixture was incubated at room temperature for 10min. To this, 0.2mL of chloroform per 
ml TRIzol® Reagent was added and vortexed for 15 seconds. The homogenate was 
incubated at room temperature for 3 min and centrifuged at 12,000xg for 15min at 4°C. 
The upper aqueous phase containing the RNA was carefully transferred to a fresh 
nuclease-free microfuge tube. Meanwhile, the organic phase containing DNA and protein 
was stored at 4°C., Isopropanol (0.5ml, 100%) was added to the aqueous phase and the 
mixture was incubated at room temperature for 10min, followed by centrifugation at 
12000xg, 4°C for 10min. The supernatant was discarded and the pellet was washed with 
1 mL75% EtoH/mLof TRIzol® Reagent by centrifugation at 7,500xg, for 5min at 4°C. 
The RNA pellet was air-dried (not completely, it should remain translucent and not turn 
white) and resuspended in RNAase free water at 55-60°C for 10-15min.  
For DNA Isolation, any remaining aqueous phase was removed from the organic 
phase by centrifuging at 12000xg for 5min at 4°C. To the interface-organic phase, 500 µl 
of back extraction buffer (BEB - Guanidine Thiocyanate (4 M), Sodium Citrate (50 mM), 
Tris (1M)) per 1 mL of TRIzol® Reagent was added for initial homogenization. The 
sample was vigorously mixed by inversion for 10 sec and incubated at room temperature 
for 10 min on a shaker, followed by a centrifugation at 12,000xg for 30 min at room 
temperature. The upper, aqueous phase containing DNA was transferred to a clean tube, 
while the interphase and organic phase were stored at 4°C for subsequent protein 
isolation. DNA was precipitated by adding equal volume of isopropanol/mL of TRIzol® 
Reagent to the samples, which were then mixed by inversion and incubated at room 
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temperature for 10min. DNA was collected by centrifugation at 12000xg for 15min at 
4°C and resultant pellet was washed with 1mL of 75% EtoH per 1mLTRIzol® Reagent 
as previous. Washing steps were repeated for a total of three times. DNA was 
resuspended in 200ul TE buffer (10mM TrisCl, 1mM Ethylenediaminetetraacetic acid, 
pH8) for 5-6 hours at room temperature.  
After resuspension in TE buffer, additional washing steps with 
chloroform/isoamylalcohol (24:1) were performed to completely remove residual 
guanidine from the samples, and at each step phases were separated by centrifugation and 
the upper, aqueous phase collected.  An equal volume of Chloroform:Isoamyl (CI, 24:1) 
was added directly to the resuspended DNA and mixed by inversion.  The mixture was 
centrifuged at 12,000xg for 15 min. at room temperature to separate the phases. For DNA 
precipitation, the aqueous phase was transferred to a new tube, to which 3M Sodium 
Acetate pH 5.2 (10% of the volume) and 2.5 volumes of 95-100% of ethanol were added. 
Total RNA was also isolated from Normal Human Keratinocyte (NHKc) and D4 
Differentiation Resistant (D4DR) cells with Agilent Total RNA Isolation Mini Kit 
(Product no. 5185-6000) according to the manufacturer’s instructions. These two samples 
were used as Inter-Run Calibrators for RT-qPCR experiments and as template for primer 
efficiency assays.  
C) Quantification of Nucleic Acids 
Quality and quantity of total RNA and genomic DNA were assessed by NanoDrop 
2000c UV-Vis spectrophotometer (Thermo SCIENTIFIC). The integrity of total RNA 
was also determined by automated capillary-electrophoresis on an Agilent 2100 
BioAnalyzer (a microfluidics-based platform for quantification and quality control of 
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nucleic acids) using the 6000 Nano Assay. Agilent 2100 Expert Software automatically 
yields an electropherogram of each sample which contains the RNA integrity number 
(RIN) and concentration along with a visual representation of the two ribosomal RNAs 
(18s and 28s) bands. Tumor heterogeneity and mishandling of freshly biopsied tissues 
during freezing procedures are probable causes for variable RIN (range N/A – 9) in 
human tissue samples. Thus, only RNA samples with RIN ≥ 6.3 were included in 
downstream applications such as microarrays and q-PCR.  
 
2.3. HPV Genotyping and HPV Early Gene Expression Analysis 
A) INNO-LiPA Assay 
The presence of HPV DNA in the oropharyngeal tissue samples was detected by 
using the INNO-LiPA HPV Genotyping Extra (Innogenetics Inc., reference no. 81073) 
assay according to manufacturer’s instructions. Briefly, genomic DNA was diluted to 
5ng/µl and 2 µl were used for amplification on an Applied Biosystems GeneAmp PCR 
System 2700, using the INNO-LiPA HPV Genotyping Extra Amp kit (Innogenetics Inc., 
reference no. 81074). The INNO-LiPA HPV Genotyping Extra 228,229 (Innogenetics Inc.) 
assay is based on the reverse hybridization principle: specific primers (SPF10 primers 
57,58
 are used to amplify a 65bp fragment of the Late 1 (L1) region of the HPV genome in 
the presence of biotinylated dNTP’s. Amplification is followed by denaturation and 
hybridization with type specific oligonucleotide probes which are immobilized as parallel 
lines on nitrocellulose strips. Additionally, primers specific for the human gene 
HLADPB1 (Major Histocompatibility Complex, Class II, DP Beta 1) are included as an 
experimental control for sample quality and extraction. Hybridization is followed by 
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stringent washing and binding with streptavidin-conjugated alkaline phosphatase which 
yields a purple precipitate in the presence of the chromogen BCIP/NBT (5-bromo-4-
chloro-3'-indolyphosphate p-toluidine salt/nitro-blue tetrazolium chloride). In summary, 
the amplification kit synthesizes the standardized biotinylated amplicons which are 
subsequently hybridized using a single nitrocellulose typing strip. These predesigned 
strips have 4 experimental control lines and 28 sequence-specific DNA probe lines for 
HPV types, which include 18 high-risk HPVs (16, 18, 26, 31, 33, 35, 39, 45, 51, 52, 53, 
56, 58, 59, 66, 68, 73, 82), 6 low-risk HPVs (6, 11, 40, 43, 44, 54, 70), and 3 other non-
classified HPVs (69, 71, 74). The test was termed satisfactory if the human DNA control 
probe was positive, after which hybridization results for all HPV typing probes were 
recorded to determine the specific type present in the sample.  
B) HPV-E7 and E6/E7 Expression Analysis 
The active or inactive status of HPV in the HNSCC samples was determined by 
type specific RT-qPCR for HPV E7 oncogene. Briefly, expression of HPV E7 oncogene 
was assessed for HPV 16 and 66; while for HPV 35, 52 and 58, E6/E7 junction was 
analyzed for expression. The primer efficiencies were calculated as given in section 2.8.  
 
2.4. RNA Amplification and Labeling for Microarray Analysis 
Thirty six OPSCC tumor samples and four normal tissue specimens (benign 
uvulaand normal tonsil) were considered for gene expression analysis based on their HPV 
status and racial background. The RIN for RNA samples included in this study was in the 
range of 6.3 – 8.7.  
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Agilent’s Low Input Quick Amp Labeling Kit (Catalog no. 5190-2306) was used to 
generate fluorescently labeled complementary RNA (cRNA) by linear amplification of 
mRNA from total RNA. RNA Spike-in from Agilent One-Color RNA Spike-In Kit 
(Product no. 5188-5282) was used as an internal control following the manufacturer's 
instructions. The cRNA amplification schematic is as given in Figure 2.1. The One-Color 
Microarray-Based Gene Expression Analysis (Low Input Quick Amp Labeling) protocol 
is summarized below: 
Synthesis of c-DNA 
200ng of total RNA was mixed with diluted spike-in controls and primed with T7 
oligo (dT) promoter primer for first strand c-DNA synthesis. The c-DNA master mix was 
prepared by adding 0.1M DTT, pre-warmed 5x First Strand Buffer (80°C), 10mM dNTP 
mix and AffinityScript RNase Block Mix in that order, and incubated with the primed 
RNA. Thus, first strand c-DNA synthesis was accompanied by second strand cDNA 
bearing the T7 promoter sequence at its 3΄end. 
Labeling and Amplification 
The second strand c-DNA obtained from the previous step served as template for T7 
RNA polymerase-dependent transcription, the product of which was labeled with 
Cyanine 3-CTP (Cy 3-CTP) (Perkin Elmer Life Sciences, Inc, Boston, MA, catalogue no. 
NEL622001KT) to generate fluorescently labeled amplified cRNA. Cyanine dyes 





Figure 2.1: Schematic of cRNA amplification. [Adapted from Agilent One-color 
Gene Expression manual, version6.5] 
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Purification of Labeled Amplified cRNA 
Spin columns from Qiagen’s RNeasy mini kit (Catalog no. 74104) were used to 
remove any unincorporated Cy 3-CTP’s, primers and polymerases from labeled amplified 
cRNA according to the manufacturer’s protocol.  
Quantification of cRNA 
Florescent dye labeling density of Cy 3 along with the purity of nucleic acid in 
labeled cRNA amplicons was measured by NanoDrop 2000c UV-Vis spectrophotometer. 
Cy 3 dye concentration (pmol/µl), RNA absorbance ratio (260nm/280nm) and cRNA 
concentration (ng/µl) were determined and recorded from the microarray application of 
the spectrophotometer’s operating software. The total yield and specific activity of each 
reaction were calculated as follows: 
Total yield of cRNA (µg)  
= {(Concentration of cRNA) x 30µl (elution volume)} / 1000 
Specific Activity of fluorescent dye (pmol/µg cRNA)  
= (Concentration of Cy 3 / Concentration of cRNA) x 1000 
Calculated yield and specific activity of the labeled products were well above 
minimum recommended values for an 8-pack microarray format. Total cRNA yield for 
all the labeled products was 2.913 - 7.74µg (recommended minimum 0.825µg), while 
specific activity of cyanine dye was 8.58 – 18.35 pmol/µg cRNA (recommended 





2.5. Microarray Hybridization and Image Acquisition 
The following steps were performed under dim light conditions as they involved 
light sensitive fluorescent dyes. Agilent’s Gene Expression Hybridization kit (Product no. 
5188-5242) was used according to the manufacturer’s instructions and the 8x60K 
microarray slides were used.  
Preparation of Samples  
Sample preparation steps involved fragmentation of cRNA to obtain optimum size 
for hybridization and a blocking agent to control nonspecific binding. For all the forty 
samples, 600ng of Cy 3-labeled linearly amplified cRNA was incubated with pre-warmed 
10 x blocking agent (37°C), nuclease free water and 25 x fragmentation buffer in a total 
volume of 25 µl at 60°C for 30 min, in a PTC-100 thermal cycler (M. J. Research Inc., 
USA). This fragmentation reaction was stopped by adding 25µl of 2X GEx Hybridization 
buffer HI-RPM and the resulting hybridization mixture was mixed carefully by pipetting 
to avoid bubbles, centrifuged at 13,000 revolutions per minute (rpm) for 1 min and placed 
on ice for loading immediately. 
Hybridization Assembly 
The user guide (G2534-90001) from Agilent Microarray Hybridization Chamber 
Kit (Product no. G2534A) was referred for instructions on slide loading, assembly and 
disassembly of chambers. Fragmented labeled cRNA was hybridized to SurePrint G3 
Human Gene Expression 8x60K v2 Microarrays (Catalog no.G4858A-039494) according 
to the manufacturer’s protocol. The 8x60K microarrays contain eight individual arrays on 
one slide, each containing 60,000 oligonucleotide probes covering the entire known 
complement of human genes. Hybridization experiments were done in batches of 8 
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samples/day on a total of five microarray slides overall, to accommodate all the 40 
samples. A clean gasket was placed facing up in the rectangular section of the chamber 
base and 40µl hybridization sample was carefully loaded in the center of each well of the 
slide without touching the gasket. Once all the samples were loaded onto the slide, the 
array slide was put facing down (numeric barcode facing up) on the gasket slide and the 
sandwiched assembly was clamped safely. This assembled slide chamber was placed in 
the rotisserie rack in a hybridization oven and incubated at 65°C with the rotator set to 
10rpm for 17 hours. Meanwhile, Gene Expression Wash Buffer 2 (Catalog no. 5188-
5326) was warmed overnight at 37°C to prepare for next day washing. 
Washing 
Prior to washing, gene expression wash buffers 1 and 2 were prepared by 
addingTriton X-102 (final concentration 0.005%), immediately after opening a fresh 
container. This is done to reduce the artifacts generated during washing of arrays. After 
17 hours of hybridization, the hybridization chamber was disassembled in GE Wash 
Buffer 1 (Catalog no. 5188-5325) and the slide was repeatedly washed for 1 min each in 
separate slide staining dishes containing fresh GE Wash Buffer 1 followed by pre-
warmed (37°C) GE wash buffer 2. The array slide was then dried in a coplin jar, by 
dipping it in 100% Acetonitrile for 30 seconds. Acetonitrile scavenges ozone, thus 
preventing degradation of the cyanine dye.  
Scanning 
After washing and drying, the slides were put in a slide holder with Agilent Ozone-
Barrier Slide Cover on top (Product no. G2505-60550) and immediately scanned using a 
High Resolution Agilent DNA Microarray Scanner System (Catalog no. G2565CA). 
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AgilentG3_GX_1Color profile was selected from the control panel and scanned under 
green channel with scan area of 61 x 21.6 mm at 5µm resolution. The images were saved 
as 20bit Tagged Image File Format (TIFF) files. Post scanning, slides were exposed to 
nitrogen vapors in a 50mLconical tube covered with aluminium foil and stored in an 
orange slide box, in the dark.  
 
2.6. Data Analysis 
Data were extracted from TIFF images with Agilent Feature Extraction Software 
version 10.7.3, where background correction was also performed. The quality control 
(QC) metric set was generated post extraction and results were reviewed in three ways; 
project summary, QC report which included both a summary on the header and a table of 
metric values and QC chart returned values of each metric compared across all 
extractions in FE Project. In brief, QC metric helps in indentifying wash artifacts, 
exposure to ozone and hybridization to cRNA from degraded total RNA. Thus, any 
deviation from normal trends helps in closer inspection of obtained results. Proper 
alignment of the grid with the four corners of the array was also analyzed through QC 
report. Subsequently, background-corrected data was uploaded into Agilent GeneSpring 
GX version 11.5.1 for analysis. In this process, data were log2 transformed, quantile 
normalized and base line transformed using the median of all samples. Then, data were 
filtered by flags in such a way that 75% of the samples in at least one of the treatment 
groups would have a “detected” flag. Differentially expressed genes were determined by 
analysis of the data using the non-parametric Mann-Whitney unpaired test. Cutoff values 
of 0.02 and 2 were used for p-value and fold change, respectively. Gene ontology (GO), 
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pathway analysis and hierarchical cluster analysis were also performed with GeneSpring. 
For the latest, Euclidean similarity metrics and Wards linkage rule230 were used along 
with Kruskal-Wallis non-parametric one-way analysis of variance(ANOVA)231 . 
Top canonical pathways, upregulated and downregulated genes along with most 
significant biomarkers were also identified using the Ingenuity Pathway Analysis (IPA©, 
Ingenuity Systems Inc. 2000-2013) for differences in HPV negative OPSCC tumors 
between AA and EA patients. 
 
2.7. RT-qPCR 
A) c-DNA Synthesis and Quantification 
In-vitro transcription 
Complementary DNA (c-DNA) was synthesized from total RNA (1µg – 100ng) 
with iScript™ cDNA synthesis Kit (BioRad, catalogue no. 170-8890) in reaction 
volumes of 40µl or 60 µl per manufacturer’s instructions. The reaction was conducted in 
an Applied Biosystems thermal cycler (Gene Amp® PCR system 2700) and c-DNA was 
stored at -20°C.  
Ribogreen Assay  
To achieve uniform template concentration for qPCR assays, c-DNA was 
quantified by Quant-iT™ RiboGreen® RNA Assay (Invitrogen, Reagent-A Catalog no. 
R11491). The Quant-iT™ RiboGreen® was originally designed for quantification of up 
to 1ng/mLof RNA; however, its use can be extrapolated to any single stranded nucleic 
acid. Ribogreen® is a fluorescent dye which binds to single stranded nucleic acids. 
Briefly, 7µl of freshly transcribed c-DNA was hydrolyzed with 2.1µl 1M Sodium 
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Hydroxide and 1.8µl 0.25M Ethylenediaminetetraacetic acid, at 70°C for 15 min and then 
neutralized with 3.5µl of 2M HEPES (N-(2-Hydroxyethyl) piperazine-N'-(2-
ethanesulfonic acid)) buffer. High Range (1000ng/mL– 20ng/ml) assay was performed if 
the starting concentration of RNA was ~1 µg, while Low Range Assay (50ng/mL– 
1ng/mL) was performed for lower RNA concentrations. RNA standards and ribogreen 
dilutions were prepared for the respective assay, according to the manufacturer’s 
protocols. The fluorescence intensities were measured from top (excitation=480nm, 
emission=540nm) in a 96well format with a Beckman Coulter Multimode Detector DTX-
880 and the results were interpreted through Multimode Analysis Software version 
3.1.0.1. All the samples were diluted to a constant concentration of 0.07ng/µl and a total 
of 560pg c-DNA was used per reaction in RT-qPCR.  
 
B) Primer Design and Reaction Efficiency  
Eighteen target genes were shortlisted as a validation set for differentially 
expressed genes by RT-qPCR assays. These genes were selected based on their well-
documented or novel relevance in disease mechanism, prognosis and treatment in head 
and neck cancers. Eleven Reference genes (B2M, ATP5B, CYC1, GPDH, SDHA, TOP1, 
EIF4A2, UBE2D2, SCLY, PRDM4 and ENOX2-var1) were chosen from classic and 
advanced lists of Human geNorm kits (Primerdesign Lmtd.). The National Center for 
Biotechnology Information Reference Sequences for mRNA (NCBI RefSeq RNA) was 
obtained to design primers for RT-qPCR. 
Primer Designing 
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For the target genes, primers for TGFβ2 and TP53, were as given in the online 
database RTPrimerDB (ID2676 and ID1186, respectively); custom oligonucleotide 
primers for the remaining genes were synthesized and analyzed in-silico. Primers were 
designed using both Real-Time PCR sciTool (Integrated DNA Technology) and Primer-
BLAST software (NCBI)232, while the  analysis for hairpins, primer dimers and 
heterodimers was carried out through OligoAnalyzer sciTool (Integrated DNA 
Technology).  
For Primer-BLAST software, the Refseq mRNA sequence from Homo sapiens 
library for each gene was entered and parameters were adjusted to a product size of 80 – 
250bp with optimum primer melting temperature as 60°C (range 58 - 62°C) and 
maximum temp difference set at 1°C. Selection was done for primers spanning the exon-
exon junction for higher primer pair specificity for a given mRNA. Under advanced 
parameters, primer size was set at 20 nucleotides (range 18-25) and GC content was 
within the range of 40 – 65% with rest of the parameters set to default values. The 
resultant primer pairs were shortlisted based on much lower melting temperatures of 
hairpin structures (≤ primer annealing Tm°C) and low free energy of heterodimers and 
homodimers (∆G > -6 kcal/mole).  
Primer Efficiency 
NHKc and D4DR c-DNA was diluted fivefold for a total of eight serial dilutions to 
create a standard curve of reaction efficiencies per primer pair. Briefly, each starting 
template was serially diluted into eight sterile microfuge tubes with nuclease-free water 
(USB Corp, 71786) and the resulting templates were run in triplicates/primer pair at 
respective annealing temperature (Tm), on a 96-well plate format. The sample standards 
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and the dilution series were entered in the MyiQ Optical software version1 (BIO-RAD) 
before starting the run and the primer efficiency was noted at the completion of the 
experiment.  
Outliers at the extreme end of the dilution curves were removed in few cases where 
Cq values were off the curve, as they indicated saturation of reaction or no amplification 
at that concentration. All the primer details are as summarized in Table 2.1 and 2.2. 
Primer efficiencies of only selected panel of reference genes were calculated (Table 2.2). 
Tumor DNA was used to calculate efficiencies for HPV primers where required (Table 
2.1). 
 
C) RT-qPCR Assays 
Single color RT-qPCR assays were performed in a 96 well format using Bio-Rad’s 
MyiQ Single Color Real-Time PCR Detection System. Bio-Rad’s iQ™ SYBR® Green 
Supermix was used as the reaction mix and the assay was carried out on iQ™ 96-Well 
PCR Plates (Catalog no.223-9441), sealed with Microseal® 'B' Adhesive Seals (Catalog 
no.MSB-1001). The results were interpreted through MyiQ Optical software version 1 
(BIO-RAD). Overall, three kinds of assays were conducted: gradient RT-qPCR to 
determine the ideal Tm for each primer pair, primer efficiency RT-qPCR to determine 
specific reaction efficiencies and differential gene expression RT-qPCR. For gradient 
RT-qPCR; reaction was done in duplicates with 200nm primer mix (2.5µm stock of 
Forward + Reverse primers), 1X SYBR® Green Supermix and nuclease-free water to 
make up the volume of 20µl, with 1ng NHKc /D4DR/tumor sample as template c-DNA 




Table 2.1: Primer list- Target genes 
 
Gene ID Refseq 
ID 


























TAT CAG GGT GAA GCA 
GCA TCT GG 
TAG AAG GCT GGC TCC 
CAT GC 














































103.1 56.1 105 NHKc IDT 
MET NM_000
245.2 
GAC TCC TAC AAC CCG 
AAT ACT G 
ATA GTG CTC CCC AAT 
GAA AGT AG 










































CAA AGG TAT GCC AAC 
GAA TC 
CCA ATG ACA GCA ATA 
CAC CA 




AGA GTG CCT GAA CAA 
CGG ATT 
CCA TTC GCC TTC TGC 
TCT T 
96.8 62.3 117 NHKc RTPrime













TCA ACA AGA TGT TTT 
GCC AAC TG 
ATG TGC TGT GAC TGC 
TTG TAG ATG 
96.0 64.6 118 NHKc RTPrime






CCG GAC AGA GCC CAT 
TAC AAT 
ACG TGT GTG CTT TGT 
ACG CAC 
91.6 64.5 83 D4DR 233 
HPV35 
E6/7 
M74117 GGT GGA CAG GTC GGT 
GTA TGT C 
GTT GCC TCG GGT TCC 
AAA TC 






X74481 GTT GGA CAG GGC GCT 
GTT C 
CCT CCT CAT CTG AGC 
TGT CAC C 






D90400 AGG GCG CTG TGC AGT 
GTG T 
CAT CCT CGT CTG AGC 
TGT CAC A 








TGG CCG CTC CAG CAA 
ATG GT 










Table 2.2: Primer List-Reference Genes 
 











ATP5B NM_001686.3 TGG TAT CAA GGT TGT 
CGA TCT G 
GGT ATA AAT CAT TGC 
CTT CAC GG 
97.7 63.9 188 21.7 IDT 
B2M NM_004048.2 GGC ATT CCT GAA GCT 
GAC AG 
GGA TGA AAC CCA GAC 
ACA TAG C 
94.7 63.9 188 20.57 IDT 
CYC1 NM_001916.3 TCC CAA AAC CAT 
ACC CCA AC 
AGT AGA GAC CTT CCC 
GCA G 
88.2 55.5 174 23.35 IDT 
EIF4A2 NM_001967.3 CCA CAT TTG CTA TTT 
CCA TCC TG 
CCA TAT AGT CTC CAA 
GTG CCA G 
98.5 58.9 132 22.6 IDT 
GAPDH NM_002046.3 CAA TGA CCC CTT CAT 
TGA CC 
GAC AAG CTT CCC GTT 
CTC AG 
99.8 55.5 106 21.8 IDT 
SDHA NM_004168.2 CCC TCC AAT TAA ACC 
AAA CGC 
GCT GAT TTT CCC ACA 
ACC TTC 
93.2 57.5 178 23.2 IDT 
TOP-1 NM_003286.2 AGT CCA AAG AGA 
TGA AAG TCC G 
TGG GTG TAG ATT GAT 
GTG CTC 
98.9 61.4 152 24.2 IDT 
UBE2D2 NM_003339.2 TTT CCC AAC AGA TTA 
CCC CTT C 
AAC AGA GAA CAG ATG 
GAC AAG AG 
95.1 58.9 165 22.2 IDT 
SCLY NM_016510.5 CCC TAT GCT ATT TGG 
AGG TGG 
TGA CCG AAT TCA GCT 
TCC AG 
N/A 64.4 180 28.5 IDT 
PRDM4 NM_012406.3 GCC TTC TGC TCT GTC 
TTT AAT G 
GTT AGG GTG GAT GTA 
CTG TGG 
N/A 55.4 193 26 IDT 
ENOX2-
Var1 
NM_006375.3 CTT CTG CCA CAT TCG 
CTT TG 
GTT TAC ACT CCC ACT 
CAT ACA GG 
N/A 64.4 164 27.5 IDT 
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The plate setup for gradient PCR was modulated in the MyiQ Optical software with 
range set from 54°C to 64°C (Increasing temperature from Row H - Row A). For primer 
efficiency assays, reactions were carried out with starting template concentrations of each 
dilution mix in triplicates at the respective annealing temperatures with 200nm primer 
mix and 1X SYBR® Green Supermix, in 25µl reaction volume. Finally, for differential 
gene expression assays, a sample maximization strategy 221 was employed, so that all the 
samples for a particular gene were run on one plate. Thus, for our analysis, c-DNA 
derived from 49 tumor samples was used at a standardized concentration of 560pg per 
reaction and assays were split into two 96-well plates per gene. The reactions were 
carried out in duplicates with same parameters as listed above and 25µl total volume. 
Two types of experimental controls were run per plate per gene, 1) NHKc and 
D4DR c-DNA used as the inter-run calibrators/gene and 2) NHKc c-DNA run with 
GAPDH primers/plate, to make sure that reaction efficiencies were constant in all wells 
and across different assays (A7, C2, C11, E7, F2, F11 and H7). To investigate the 
optimum number of reference genes for RT-qPCR normalization, eight candidate 
reference genes (B2M, ATP5B, CYC1, GPDH, SDHA, TOP1, EIF4A2 and UBE2D2) 
were shortlisted from a total batch of 11 genes, based on the similarities in expression 
levels in normal human keratinocytes. The assays were carried out as for differential 
expression of genes, keeping the experimental controls constant, throughout. Lastly, all 
the template c-DNA was derived from a common stock for each set of differential 
expression assays involving respective target and reference genes. Thus, each time a new 
batch of c-DNA was synthesized, an assay for reference genes was run along with the 
new set of target genes to maintain consistency in the post-run analysis by alleviating the 
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experimental errors introduced with each cycle of reverse transcription and c-DNA 
quantification. 
The cycling conditions for the RT-qPCR assays were kept constant in the MyiQ 
icycler software with an initial denaturation of template at 95°C for 3 min followed by 40 
cycles of denaturation at 95°C for 10 sec and primer annealing at respective temperature 
for 1 min. The characteristics of melt curve of the amplified products were assessed by 
initial denaturation at 95°C for 1 min, followed by cooling at 60°C for another min and 
80 cycles of 10 sec each from 60°C to 100°C with an increment of 0.5°C. 
 
D) Data Analysis 
The RT-qPCR data were analyzed by qbase+ software version 2.5, according to the 
instructions listed in the qbase+ manual (revised 2013-04-23). Qbase+ is an advanced, 
and proven model for previously defined qbase software221. It performs relative 
quantification that uses gene-specific amplification efficiencies and allows normalization 
with multiple reference genes. The analysis is as described below. 
 
Extraction of Cq Data 
In the ‘View Post-Run Data’ tab of MyiQ software, the analysis mode was set at 
PCR baseline subtracted curve fit option, to calculate the threshold cycle for each run. 
While the baseline cycles were auto-calculated, the threshold position was user defined 





A new project file, called MUSC-HNSCC, was created by clicking the + sign from 
the qbase+ toolbar. Under the project tab, a new experiment palm was created for a group 
of assays with same experimental parameters, i.e. constant batch of c-DNA and identical 
number of runs. Thus, differential expression results for the target and reference genes of 
all biological replicates of sample c-DNA were included in separate experiments to 
maintain consistency in post-run analysis. All the post-run Cq data files (.xls format) for 
each run were exported from MyiQ software and imported as new runs under a 
predefined experiment palm in the qbase+ toolbar. Once, the files were imported, 
samples and targets were annotated for each run by manually entering the sample Id’s 
and target gene names per plate. To minimize work, sample ID’s were copied onto 
different runs with identical plate format using the ‘apply run layout’ function. Also, 
custom sample properties were listed based on HPV status and Race, in the sample 
properties window of the Annotations section.  
 
Calculation Parameters 
Under the Settings node of each experiment in the project explorer tree, respective 
icons for Calculation parameters and Quality control were selected by double clicking. In 
the calculation parameters window, target specific amplification efficiencies were 
selected along with reference genes as the normalization strategy. Thearithmetic mean of 
each technical replicates per sample were calculated to give a mean Cq value. All the 
mean Cq values were then scaled to the normals (control group). For quality control 
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settings, exclusion parameters were set to 39 and above for Cq values such as all 
quantification cycle values above 39 were excluded from the analysis.  
Inter-Run Calibration 
The Inter-run calibration feature of qbase+ eliminates variations between runs post 
normalization of data. The basic concept behind this procedure is that identical sample(s) 
(preferably one or more) are run in each reaction plate along with the sample of interest 
for ‘n’ number of reaction plates per gene and a calibration factor is calculated based on 
the normalized quantity of these IRC’s. In our study, tumor derived c-DNA from 49 
samples were split into two 96 well plates with identical IRC’s (NHKc and D4DR as 
IRC1 and IRC2 respectively) repeated on both the plates per gene assay. All the IRC’s 
were annotated as IRC1, IRC1a and IRC2, IRC2a between two runs for same gene under 
the Inter-run Calibration tab within the intermediate results section. 
 
Normalization of RT-qPCR 
The most stable group of reference genes was selected by simultaneous analysis of 
the RT-qPCR data obtained from 49 oropharyngeal samples for a panel of eight reference 
genes. The software and tools used to analyze the data are as listed below: 
 
Normfinder 227 is freely available software which employs novel evaluation 
strategy, called the “model-based approach to estimation of expression variation.” The 
sample set should minimally contain 8 samples / group, and the number of candidates 
should be at least 3 for technical reasons, but 5–10 are recommended. This approach 
entails description of the expression values measured by RT-qPCR, separate analysis of 
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the sample subgroups, estimation of both the intra- and the intergroup expression 
variation, and calculation of a candidate gene “stability value.” Thus, we estimated the 
‘intergroup expression variations’ which allowed for selection of the best suited genes 
and the ‘intragroup variance’ which provided a natural way of identifying the number of 
genes to include. The optimal number of genes is reached when addition of a further gene 
leads to a negligible reduction in the average of the gene variance estimates. This tool 
allowed us to identify the two most stably expressed genes to use as internal reference 
genes across our samples. 
 
BestKeeper 219 is a password protected, freely available, excel based tool which is 
able to compare expression levels of up to ten housekeeping genes (HKGs) together with 
ten target genes (TGs), each in up to hundred biological samples. Descriptive statistics of 
the derived crossing points (CP or Ct) are computed for each HKG: the geometric mean 
(GM), arithmetic mean (AM), minimal (Min) and maximal (Max) value, standard 
deviation (SD), and coefficient of variance (CV). From the genes considered stably 
expressed, the BestKeeper Index specific for the respective sample is calculated as the 
geometric mean of its candidate HKGs CP values. To estimate inter-gene relations of all 
possible HKG pairs, numerous pair-wise correlation analyses were performed. Within 
each such correlation the Pearson correlation coefficient (r) and the probability p value 
were calculated and highly correlated HKGs were combined into an index. Then, 
correlation between each candidate HKG and the index was calculated, describing the 
relation between the index and the contributing candidate HKG by the Pearson 
correlation coefficient (r), coefficient of determination (r2) and the p-value. Thus all the 
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reference genes were ranked based on their correlation coefficient values, with highest 
value signifying the most stably expressed gene. 
 
GeNorm 220 is the most popular algorithm to find the stable reference 
(housekeeping) genes from a set of tested candidate reference genes in a given 
experimental condition. From this, a gene expression normalization factor can be 
calculated for each sample, based on the geometric mean of a user-defined number of 
reference genes. GeNorm has been integrated in the qbase+ qPCR data-analysis software 
(Biogazelle) and provides fully automated calculations, handling of missing data and 
ranking of candidate reference genes up to the single most stable gene. Thus, GeNorm 
tool was used to shortlist top three candidate reference genes based on their M value and 
coefficient of variation (V).  
 
Quality Control & Results 
Target specific amplification efficiencies were calculated through primer efficiency 
RT-qPCR assays. These user defined values were entered by selecting the ‘target specific 
amplification efficiencies’ option in the Calculation parameters window of the software. 
Failed replicates were excluded by deselecting the particular well for a given sample. For 
multiple reference gene normalization experiment, reference target stability was 
determined by the software, which listed genes based on their stable expression across the 
given dataset. The threshold values for parameters like coefficient of variation (> 0.2) and 
geNorm M value (> 0.75) were adjusted, such as genes with values above the threshold 
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were considered less stable. Sample specific normalization factors indicated towards 
differential expression of reference genes per sample.  
The final analysis flowchart is as listed: all the relative quantities per sample/gene 
pair were calculated scaled to the control group by following the delta Cq method. These 
relative quantities were converted into normalized relative quantities with the help of 
sample specific normalization factor, leading to normalized relative quantities per 
sample-gene pair. The calibration factor calculated through inter-run calibration finally 
converts the normalized relative quantities into cumulative normalized relative quantities. 
Statistics 
All the statistical analysis was as defined by the Stat wizard function in the project 
explorer tree in Qbase+. The goal of the analysis was selected as Mean comparison and 
the software then compared all the samples based on HPV status through one way 
ANOVA. The calculated CNRQ values were extracted as excel sheet from the software 
and statistical analysis was performed on selected datasets. Similar analysis was done 
based on racial distribution of samples with respect to HPV status by manually entering 
the calculated CNRQ values from the software into Graphpad Prism (version6).  
Figure 2.2 describes the overall schemata of methods applied. The detailed 







Figure 2.2: Flowchart of methods.  
Clockwise from left to right: Overall sample distribution for microarray analysis. Sample processing through cryogrinder and 
isolation of nucleic acids. HPV typing through DNA (INNO-LiPA) and RNA (RT-qPCR) followed by gene expression analysis 
through Agilent 8x60k arrays. The validation of microarrays was done by RT-qPCR using qbase+ software. 
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CHAPTER 3: NORMALIZATION of RT-qPCR – A QUEST for 
OPTIMAL REFERENCE GENES 
3.1. Introduction  
Several advancements in Real Time-quantitative Polymerase Chain Reaction have 
been made in pursuit of accurate normalization219–221,227 and uniformity in reporting 
results and experimental parameters212,214,215,234. One critical aspect of all differential 
gene expression studies is normalization of data to the most stably expressed reference 
gene/s which is specific to the respective tissues/cell lines224,235–239. The most popular 
analysis tools for identifying best candidate reference genes have been- GeNorm220, 
Normfinder227, BestKeeper219, Delta Ct method239 and more recently a web based tool 
(refFinder)235,240 which gives a cumulative result utilizing the former tools. With respect 
to HNSCC, only one study so far has addressed the issue by comparing results from 
Normfinder and GeNorm225. 
We aimed to study a panel of commonly used reference genes and shortlist the best 
candidates to be used for efficient normalization of RT-qPCR assays for OPSCC tumors. 
For this purpose, we designed primers for eleven reference genes (B2M, ATP5B, CYC1, 
GAPDH, SDHA, TOP1, EIF4A2, UBE2D2, SCLY, PRDM4, ENOX2-var1) and 
conducted a preliminary expression analysis with NHKC c-DNA to assess normal 
expression levels of each gene.  
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3.2 Results 
Eight genes (B2M, ATP5B, CYC1, GAPDH, SDHA, TOP1, EIF4A2, UBE2D2) 
were selected with an average Cq of 22.4 (range 20.57 – 24.2) eliminating the ones with 
lower expression levels. We analyzed these 8 genes by RT-qPCR with c-DNA obtained 
from 44 OPSCC and 4 normal tonsil/uvula tissue samples. Our study was in compliance 
with the recent MIQE guidelines for optimum sharing of RT-qPCR data214. A flowchart 
describing the overall methodology is given in Figure 3.1. Raw Cq values of selected 8 
genes were plotted to see an overall variation in expression values (Figure 3.2). We then 
compared the expression levels of 8 reference genes through BestKeeper, Normfinder, 
GeNorm/qbase+ and compared the ranking of genes between all the five tools.  
The first analysis was conducted with excel-based analysis tool- BestKeeper. The 
Cq values were referred to as, crossing points (CP) and the overall trend of raw CP values 
is as given in Figure 3.3. The inter-gene relationships of all the reference 
genes/housekeeping genes (HKG) were analyzed by repeated pair-wise correlation and 
their respective coefficients (r) and p values were determined (Table 3.1). Figure 3.4 (A 
& B) gives geometric means and standard deviation (SD) of each gene across 48 samples. 
Respective values of SD were plotted to represent the stability of all HKG’s, where 
stability increases from left to right, in Figure 3.3 (C). A standard deviation of more than 
1 makes a gene unsuitable as a reference gene for analysis, which in our data was 




Figure 3.1: Flowchart of reference gene selection
commonly used reference genes were assessed 
candidate reference genes with a closer range of raw Cq values were analyzed 
for their stability through three software
qbase+. Final candidates were selected as per geNorm
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. Expression levels of 11 
through NHKC c-DNA. Eight 










Figure 3.2: Reference gene expression of 8 genes in samples of the oral cavity 
and oropharynx. Raw Cq values are represented as box-whisker plot based on 
individual expression values in 44 tumor and 4 control samples. The range of Cq 























































Table 3.1: Descriptive statistics of pair-wise correlation (Pearson’s correlation, r) 
 
GAPDH ATP5B EIF4A2 TOP1 SDHA CYC1 UBE2D2 B2M 
vs. HKG 1 HKG 2 HKG 3 HKG 4 HKG 5 HKG 6 HKG 7 HKG 8 
HKG 2 0.849 - - - - - - - 
p-
value 
0.001 - - - - - - - 
HKG 3 0.633 0.785 - - - - - - 
p-
value 
0.001 0.001 - - - - - - 
HKG 4 0.848 0.911 0.799 - - - - - 
p-
value 
0.001 0.001 0.001 - - - - - 






0.001 0.001 - - - - 
HKG 6 0.844 0.92 0.751 0.861 0.882 - - - 
p-
value 
0.001 0.001 0.001 0.001 0.001 - - - 
HKG 7 0.592 0.776 0.681 0.751 0.76 0.695 - - 
p-
value 
0.001 0.001 0.001 0.001 0.001 0.001 - - 
HKG 8 0.375 0.533 0.489 0.506 0.526 0.556 0.66 - 
p-
value 
0.009487 0.001 0.001 0.001 0.001 0.001 0.001 - 
Bestkeeper correlates each gene to the other by pearson’s pairwise correlation analysis 
and the respective pearson’s coefficient (r) along with its p value is given for each 






Figure 3.3: BestKeeper Analysis- CP of Housekeeping Genes  
Raw threshold cycle numbers are represented as crossing points (CP) in BestKeeper 
analysis and the graph show the overall distribution of CP per sample per gene across 





Figure 3.4: BestKeeper Analysis- Housekeeping Gene stability 
A) Geometric means of all CP values per gene are given with their 
respective standard errors. B) Overall standard deviation of gene 
expression/gene. The lower the standard deviation across the 
sample set, more stably expressed is the reference gene. 
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Normfinder algorithm227, an excel add-in, returns a stability value for each 
reference gene and thus ranks them based on their variation of expression across a given 
sample set. Figure 3.5 (A) depicts the inter-group variation of each gene, whereby the 
samples were grouped as HPV-active, -inactive, -negative and controls. The intra-group 
variations are as depicted by the error bars of each gene. The most stably expressed gene 
was CYC1 with a stability value of 0.140 and top two candidate reference genes with a 
cumulative stability value of 0.111 were, CYC1 and SDHA. The stability values of all 
genes are as given in Figure 3.5 (B) with the two best candidate genes highlighted in a 
square. The stability increases from left to right in Figure 3.5 (B).  
GeNorm is now available in combination with the RT-qPCR analysis software 
qbase+ and we conducted our gene expression analysis on the same platform. One novel 
feature of GeNorm which was utilized in assessing the expression variations was the 
introduction of Inter-run calibration. Two samples were consistently used as IRC’s and 
the calibration factors were calculated as a geometric mean of these two IRC’s per plate 
per gene (Figure 3.6 (A)). The closer the values of calibration factors per gene, the less 
are the inter-run variations. GeNorm also ranked the given set of genes based on their 
stability values (M value) which is given in Figure 3.6 (B). The Stability Values of 
Reference genes ranged from 0.8327 – 1.8016, which is higher than the set threshold of 
0.75. Figure 3.6 (C) depicts the stability values of different number of reference genes 
when considered together. This geNorm V values suggested that optimum number of 




Figure 3.5: Normfinder Analysis
A) The intergroup variation of 8 reference genes across 4 
major groups: HPV
Controls. The error bars indicate intra
B) The overall ranking of genes based on stability value. The 
genes are represented in the increasing order of stability from 




-active, HPV-inactive, HPV-negative and 
-group variation.  
 
 Figure 3.6: GeNorm Analysis
A) The stability values (M), coefficient of variation across the sample set and the 
inert-run calibration factors per plate are given for each gene, respectively. The values 
are as calculated by the qbase+ software. 
B) Increasing order of stability of ref
respective M values. 
C) GeNorm returned V values for determining the optimum number of reference 
genes. The horizontal grey line indicates the threshold cutoff for maximum stability of 
reference genes. GeNorm sugges




erence genes from left to right based on 






In view of the recently reported refFinder and Delta Ct method for evaluating most 
stable reference genes, we analyzed our data set through web-based tool refFinder and 
compared the gene ranking as given in Table 3.2. The RefFinder tool calculates stability 
values for each analysis tool (BestKeeper, Normfinder, GeNorm and Delta Ct) and 
returns a comprehensive ranking list of genes. The refFinder’s stability values and the 
ranking of reference genes for GeNorm and Normfinder tools were inaccurate when 
compared to our previously calculated values. The Delta Ct stability values are as given 
by the refFinder. The genes given in bold were final candidates for normalization and 
depict variation in their rankings.  
3.3 Discussion 
There is a growing emphasis on use of multiple reference genes for efficient 
normalization which is a modified Pfaffl’s equation and utilizes the geometric mean of 
the given reference genes as a normalization factor220. We attempted to compare the 
stability of a panel of 8 reference genes across 44 OPSCC tumor and 4 normal samples in 
pursuit of identifying the top candidates suited for normalization of our gene expression 
dataset. All three analysis tools indicated comparable but different results with respect to 
reference gene stability. While these tools utilize similar algorithms to calculate gene 
stability, differences might have risen due to no consideration of reaction efficiencies (in 
both BestKeeper and Normfinder), or inter-run variations (BestKeeper and Normfinder), 
or intergroup variations (Bestkeeper). GeNorm/qbase+ is an advanced algorithm which 
takes into account the reaction efficiencies and discrepancies involved with expression of 
genes measured across multiple runs. Also one additional advantage with using qbase+ 
over other tools is the choice of multiple reference genes for normalization.  
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1 UBE2D2 CYC-1 ATP-5B ATP5B ATP5B 
2 CYC1 SDHA TOP-1 TOP1 CYC1 
3 TOP1 TOP-1 SDHA CYC1 TOP1 
4 ATP5B ATP-5B CYC-1 SDHA UBE2D2 
5 SDHA EIF4A2 EIF4A2 UBE2D2 SDHA 
6 B2M UBE2D2 UBE2D2 EIF4A2 EIF4A2 
7 EIF4A2 B2M GAPDH GAPDH GAPDH 
8 GAPDH GAPDH B2M B2M B2M 
Comparative analysis of reference genes as given by the web based tool- refFinder. It 
ranks the genes based on BestKeeper, Normfinder, GeNorm and Delta Ct algorithm and 
finally returns a cumulative ranking based on these 4 algorithms. 
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Thus, we accepted the gene ranking as given by GeNorm/qbase+ for further 
analysis. Also, we observed medium reference target stability (M value 0.83 – 1.80) over 
our sample set which is common with heterogeneous samples arising from tumors or 
cancer cell lines. More homogenous samples such as primary cell lines yield a higher 
stability of reference genes with M values below 0.75 (inbuilt threshold for GeNorm).  
Relative quantities of genes can vary due to technical errors like different starting 
quantity or run-dependent differences besides inherent differential expression. We 
introduced the novel practice of quantifying our starting c-DNA template with ribogreen 
assay in addition to using constant amount of starting RNA for in-vitro transcription. 
Based on the Ribogreen assay, which quantifies single stranded c-DNA molecules, a 
constant amount of 560pg of cDNA was used in each reaction. 
To tackle the problems of run-to-run variations in gene expression, qbase+ has 
incorporated a special feature of inter-run calibration. This algorithm calculates a 
correction factor which is employed post normalization of data and corrects the 
normalized relative quantities for any technical errors that might affect the final 
expression values. An experiment can be setup in three ways, 1) All samples on one 
plate, 2) All genes on one plate or 3) maximum number of samples and genes on one 
plate. We used the third design due to the number of samples being analyzed and thus 
carefully assessed inter-run calibration accordingly. Two IRC’s were used per run and 
both the IRC’s measured technical variation to the same extent in all genes with an 
exception of one gene where IRC could not be calculated owing to variation in number of 
runs. Overall, quality control of the IRC’s indicated reliability of our gene expression 
data.  
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The optimum number of reference genes for our study was 3 or 4 genes and we 
normalized our data with geometric means of ATP5B, SDHA and TOP1 using the 
qbase+ software. 
3.4 Conclusion 
Our comparison of three major reference gene selection tools revealed 
discrepancies in stability of a panel of genes with very few similarities. The use of 
multiple tools for shortlisting reference genes might corroborate the choice of reference 
genes and we need to be careful in considering technical factors like reaction efficiencies, 
run-run errors and differences in starting concentration in our assessment. This critical 
observation might explain variations in gene expression studies arising from the use of 
different candidate reference genes. One way to minimize this error is by the use of 
multiple reference genes which considers the inherent differences in gene expression 
arising from a heterogeneous population, e.g. epithelial cancer models and cell lines. 
Thus, our study confirms the need of tissue and disease model specific array of reference 




CHAPTER 4: DIFFERENTIAL GENE EXPRESSION PATTERNS in  




4.1.1 Patient demographics and HPV prevalence and activity in OPSCC samples 
The demographic characteristics of tumor and normal samples and their respective 
HPV status are presented in Tables 4.1-3. Once the samples were analyzed for HPV, we 
classified them into three categories based on whether HPV DNA was present and 
transcribed (HPV-active), HPV DNA was present but not transcribed (HPV-inactive) or 
HPV DNA was not detected (HPV-negative). The prevalence of HPV, based on presence 
of HPV DNA, was 59% overall (Table 4.1). The RXC table confirmed the distribution of 
HPV-active, HPV-inactive and HPV-negative samples to be statistically significant (p 
value = 0.0393) by race. However, only a fraction of those (48% of the samples positive 
for HPV by INNO-LiPA) expressed the HPV E7 oncogene mRNA (Table 4.1). Only one 
of the 9 normal tissue samples was positive for HPV by INNO-LiPA (Table 4.2). HPV 
typing revealed the presence of HR-HPV types only, and among them HPV16 was 
present in about 83% of the OPSCC samples positive by INNO-LiPA (Figure 4.1 A). 
Other HPV types detected were HPV66, 35, 52 and 58 (Figure 4.1).  
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n (%) n (%) n (%) N (%) 
 AA All 20 12 (60) 2 (10) 6 (30) 8 (40) 61 
M 11 6 (54) 1 (10) 4 (36) 5 (45) 58 
F 9 6 (66) 1 (11) 2 (22) 3 (33) 61 
EA All 36 11 (30.5) 14 (39) 11 (30.5) 25 (69.5) 60 
M 29 8 (28) 14 (48) 7 (24) 21 (72) 57 
F 7 3 (43) 0 4 (57) 4 (57) 63 
Total All 56 23 (41) 16 (29) 17 (30) 33 (59) 60 
M 40 14 (35) 15 (38) 11 (27) 26 (65) 57 
F 16 9 (56) 1 (6.3) 6 (37) 7 (44) 63 
Total number of samples distributed by race and gender is given in the first two columns. 
This is followed by respective number of samples with HPV-negative, HPV-active and 
HPV-inactive status and the overall fraction of samples having HPV-positive infection by 
DNA. Last column depicts the group median age. 
 
Table 4.2: Characteristics of normal tissue samples 




49 EA M benign uvula NEG  
45 EA M benign uvula, tonsil NEG  
31 EA M benign uvula, tonsil NEG  
49 EA M benign uvula, tonsil NEG  
42 EA M tonsillitis, tonsil hypertrophy, 
benign uvula  
POS* 16 
32 EA F normal tonsil NEG  
61 EA M normal tonsil NEG  
34 EA M normal tonsil NEG  
30 AA F benign uvula, normal tonsil NEG  
Normal tissue samples included benign uvula and tonsil samples and all but one tested 
negative for HPV expression. (*) Positive for HPV16 by INNO-LiPA and could not be 






Figure 4.1: HPV type distribution in tumor samples. A) Graphical representation 
of different HPV types in our study population by race and gender. HPV16 was the 
most prominent type. 
B) Number of samples expressing respective HPV type by race and gender. Overall 
HPV-active and HPV-Inactive samples are given in the last two rows. 
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4.1.2 HPV type distribution and prevalence by race 
Forty percent of the samples from AA patients tested positive for HPV DNA by 
INNO-LiPA. However, only 10% of these expressed E7 mRNA. These numbers were 
much greater in samples from EA patients, 69% of which were positive for HPV DNA, 
with 39% of total EA patients exhibiting HPV-active infection (Figure 4.2A).  
Therefore, AA patients were more likely to present with HPV negative tumors as 
compared to EA patients (Figure 4.2A): the odds of having a HPV-positive tumor in EA 
OPSCC patients in comparison with AA patients were 3.4, with a 95% confidence 
interval of 1.08-10.7, p=0.035. The odds of presenting with an HPV-active tumor among 
EA OPSCC patients in comparison with AA patients were 5.7, with 95% confidence 
interval 1.15-28.6, p=0.033 (Figure 4.2A).  
When sample mean ages were compared by HPV status, race and gender, we 
observed HPV-active patients were considerably younger than HPV-negative patients 
(Figure 4.2B).  
When compared within EA population, HPV-active patients were younger than 
HPV-negative patients and similar analysis could not be done within AA population as 
only 2 HPV-active AA patients were available and thus no statistical significance could 





Figure 4.2: HPV prevalence in orapharyngeal cancer samples from EA and AA 
patients and overall incidence by age. A) HPV prevalence in EA and AA patients 
with higher rates in former when compared to latter. *Odds ratio for HPV DNA 
positivity in oropharyngeal cancer from EA vs AA patients: 3.4; 95% confidence 
interval:  1.08-10.7; p=0.035. ** Odds ratio for active HPV in oropharyngeal cancer 
from EA vs AA patients: 5.7; 95% confidence interval: 1.15-28.6; p=0.033 
 
B) Mean age of HPV-active, HPV-inactive and HPV-negative patients segregated by 
race and gender. The distribution of EA HPV-active males v/s EA HPV-negative 
males was found to be statistically significant with p = 0.0003. Also, within HPV-
negative patients, AA men were considerably younger than EA men (p = 0.0023) 
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4.1.3 Gene expression profiling of HPV-active, HPV-inactive and HPV-negative 
OPSCC samples: Lists of differentially-expressed genes 
Forty RNA samples, (36 tumor and 4 normal tissue samples) of RIN > 6.5 were 
included in the analysis, conducted on 8x60 K Human microarrays (Agilent 
Technologies). Analysis of the microarray data was conducted as described in Materials 
and Methods. The complete lists of differentially expressed genes obtained from seven 
analyses are given in Tables A.1-G.1. All the significantly altered genes with fold change 
of 2 and above were listed. The p value cutoff for all but the analysis in Tables G.1 was 
0.02, and the latter had p value cutoff of 0.05. Corrections applied for false discovery 
rates (FDR) have been listed where applicable. FDR is directly proportional to the 
number of samples and hence it could be applied for only one analysis which contained 
all 36 tumors, while the rest could not be corrected for FDR due to smaller sample size. 
Briefly, Benjamini-Hochberg correction was applied for gene list in Table A.1, and no 
correction for the rest. Non-parametric tests were conducted overall with Kruskal-Wallis 
test for comparisons involving more than two groups and Mann-Whitney test for 
comparison between two groups only. 
Table A.1 lists differentially expressed genes from multiple comparison of all 
HPV-active, -inactive and –negative tumors. The respective DEGs within total population 
were as follows: 692 down /1273 up in HPV-active vs HPV-inactive, 705 down /1260 up 
in HPV-active vs HPV-negative and 1127 down /838 up in HPV-inactive vs HPV-
negative tumors. This comparison was also conducted within the EA population and a 
total of 1657 DEGs were observed with 752 down/ 905 up in HPV-active vs HPV-
inactive,  673 down / 984 up in HPV-active vs HPV-negative and  896 down / 761 up in 
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HPV-inactive vs HPV-negative tumors (Table B.1). We also conducted a multiple 
comparison of HPV-inactive and HPV-negative tumors from both the races (Table C.1) 
which yielded a total of 367 DEGs. Additionally, HPV-inactive tumors from both AA 
and EA population were compared by race (Table G.1) and to the HPV-negative tumors 
(Table D.1 & E.1 respectively). On the other hand, within the AA population, 74 genes 
were upregulated and 96 downregulated in HPV-inactive vs HPV-negative tumors (Table 
D.1) and the number of differentially expressed genes within EA population were a little 
higher with 286 upregulated and 170 downregulated genes (Table E.1).  
When compared by race, both HPV-inactive and HPV-negative tumors appeared to 
express differential patterns with a total of 1347 genes differentially regulated in HPV-
inactive tumors from EA patients when compared to that of AA patients. Out of these, 
985 were upregulated and 362 were downregulated (Table G.1). HPV-negative tumors 
from AA patients had 191 downregulated and 72 upregulated genes in comparison to that 
from EA patients (Table F.1).  
 
4.1.4 Gene expression profiling of HPV-active, HPV-inactive and HPV-negative 
OPSCC samples: Unsupervised cluster analysis 
Unsupervised hierarchical clustering of differentially expressed genes (DEGs) 
between different groups of HPV-active, -inactive and -negative samples across the two 
racial groups allowed for a series of observations. 1) HPV-active tumor samples, 
irrespective of race, segregated very clearly from the HPV-negative and HPV-inactive 
tumors (Figure 4.3).  
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2) When analyzed within the EA population, HPV-inactive tumors clustered with 
the HPV-negative tumors, with the exception of one tumor sample that clustered with the 
HPV-active tumors (Figure 4.4). 
When HPV-negative and HPV-inactive tumors were compared to each other, they 
clearly separated by race and HPV status in an unsupervised cluster analysis, with HPV-
inactive and HPV-negative tumors exhibiting distinct and separable gene expression 
profiles within each racial group (Figure 4.5).  
Additionally, the biomarker tool of Ingenuity Pathway Analysis (IPA, Ingenuity 
Systems, Inc. 2000-2013) highlighted three major genes (ADAM12, IL1B, MMP14) as 
plausible markers for differences in HPV-negative OPSCC tumors between AA and EA 
patients (Table 4.3). When the data were sorted with p value 0.02 and FC 2, ADAM12 
emerged as the only significant biomarker. Highlighted genes in Table 4.3 were selected 
for RT-qPCR based validation.  
4.1.4 Gene Ontology and Ingenuity Pathway Analysis of microarray results 
Gene Ontology (GO) profiles indicated that in HPV-active OPSCC samples that 
express E7, gene expression patterns show distinct alterations of biological processes 
including cell proliferation, cell cycle checkpoints and mitosis, with relatively little 
involvement of pathways of EMT, invasion and angiogenesis (see Figure 4.6 for 
representative processes). HPV-negative OPSCC samples presented the opposite picture, 
with alterations of gene expression pathways indicative of EMT, angiogenesis, 
chemotaxis and cell motility, all pointing to possible invasive behavior and metastatic 




Figure 4.3: Unsupervised Hierarchical Clustering of 36 tumor samples, 
including HPV Active - HPV Inactive - HPV Negative tumors. Non-parametric 
test (Kruskal-Wallis one way anova) was used with p value and fold change cutoff 
0.02 & 2, respectively. False discovery rate correction applied was Benjamini-




Figure 4.4: Unsupervised Hierarchical clustering of HPV Active, Inactive and 
Negative in European American population only. Non-parametric test 
(Kruskal-Wallis one way anova) was used with p value and fold change cutoff 
0.02 & 2, respectively. No false discovery rate could be applied here. Clustering 




Figure 4.5: Unsupervised Hierarchical clustering of HPV Inactive v/s HPV 
Negative in African American and European American patients. Non-
parametric test (Kruskal-Wallis one way anova) was used with p value and fold 
change cutoff 0.02 & 2, respectively. No false discovery rate could be applied 
here. Clustering conditions were Euclidean distances and Ward’s variances. 
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In addition, a direct comparison of gene ontology biological processes between 
HPV-active, HPV-inactive and HPV-negative tumors from EA patients revealed that 
HPV-inactive tumors present with an intermediate profile which resembles, but does not 
completely overlap with the HPV-negative or –active tumors (Figure 4.7 and 4.8). The 
pathway analysis tool of genespring (Cutoff: p value 0.05, Fold Change 2) on 
differentially expressed genes between AA vs EA HPV-negative tumors, significantly 
represented TP63 transcriptional factor networks and cytokine-cytokine receptor 
interactions among 40 other pathways. 
 
4.1.5 RT-qPCR analysis of selected genes in an expanded sample set 
RT-qPCR assays confirmed the expression profiles of 18 selected DEGs (Figure 
4.9, 4.10 and 4.11) within HPV-active, HPV-inactive and HPV-negative tumors in the 36 
tumor samples used for microarray analysis and in an additional set of 13 samples, for a 
total of 49 samples, including 5 normal and 44 tumor samples. The mRNA expression 
data for genes that were significantly differentially expressed in this sample set are shown 
in Figures 4.8, 4.9 and 4.10. As expected, HPV-active cancers expressed significantly 
higher levels of CDKN2A mRNA than that of HPV-negative tumors (Figure 4.9). We 
detected overexpression of BRCA1 and KRT15 in HPV-active in comparison with HPV-
negative tumors; MMP10 expression was lower in HPV-active tumors and there was a 
significant difference in the expression of MMP13 between HPV-inactive and -active 





Figure 4.6: Comparison of Gene Ontology profiles of HPV Active and HPV 
Negative tumors. The GO profiles were generated by Genespring such as, HPV-
active tumors were compared to the controls and similarly HPV-negative tumors were 
compared to the same control group. Absolute Log converted P (AbsLogP) values 
were calculated for the combined ontologies and similar relationships in both the 





Figure 4.7: Comparison of Gene Ontology profiles from HPV Negative and HPV 
Inactive tumors from European American (EA) patients. The GO profiles were 
generated by Genespring such as, EA HPV-negative tumors were compared to EA-
controls and similarly EA HPV-inactive tumors were compared to the same control 
group. Absolute Log converted P (AbsLogP) values were calculated for the combined 
ontologies and similar relationships in both the analysis were identified. The most 





Figure 4.8: Comparison of Gene Ontology profiles from HPV-Active and HPV-
Inactive tumors from European American (EA) patients. The GO profiles were 
generated by Genespring such as, EA HPV-active tumors were compared to EA-
controls and similarly EA HPV-inactive tumors were compared to the same control 
group. Absolute Log converted P (AbsLogP) values were calculated for the combined 
ontologies and similar relationships in both the analysis were identified. The most 
significantly represented ontologies were shortlisted. 
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Table 4.3: Ingenuity Pathway Analysis: Biomarker analysis for HPV negative tumors- AA vs. EA patients 













type 1 motif, 10 
Extracellular 
Space 
peptidase   -2.028 diagnosis 
GJA1 gap junction 











other   -3.025 diagnosis, disease progression, 
efficacy, prognosis, response to 
therapy, safety 




cytokine IL-1 trap, 
canakinumab 








peptidase marimastat -2.136 diagnosis, prognosis, unspecified 
application 
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TP53 was overexpressed in HPV-active vs -inactive tumors, and c-MET and 
MCM2 were overexpressed in all tumor samples with respect to controls, with a trend for 
the highest levels of c-MET expression in HPV-negative tumors (Figure 4.10 and 4.11). 
A similar behavior was observed for ADAM12, IL1, TGF-β2 and IGFBP3 (Figure 
4.9 and 4.11). HPV-active tumors had minimum levels of MAL as compared to HPV-
negative and inactive tumors, while all the tumors showed downregulation of MAL as 
compared to controls (Figure 4.10). Figure 4.12 and 4.13 show the results of RT-qPCR 
for each of the selected DEGs, separated by HPV status and by race. c-MET was 
overexpressed in HPV-negative tumors in comparison with HPV-active tumors from EA 
patients (Figure 4.11). HPV-inactive and HPV-negative tumors in AA patients exhibited 
lover levels of c-MET RNA (Figure 4.12). A similar trend was observed for TGF-β2, 
with the highest levels of expression in HPV-negative tumors from EA patients (Figure 
4.13). TP53 mRNA levels were high in HPV-active tumors (all of them from EA 
patients) and similar to normal tissue in all other HPV-status categories (Figure 4.11). 
Similarly, we observed significant up-regulation of RNA for the BRCA1 tumor 
suppressor gene in HPV-active tumors from EA patients, as compared to the HPV-
negative and inactive tumors from both racial groups. In addition, expression levels of 
IL1B and MAL were significantly lower in HPV-negative tumors from EA patients than 
in HPV-negative tumors from AA patients (Figure 4.12). Summary of statistical analyses 
conducted on all the DEG’s is given in Table 4.4 (differences by race and HPV status) 
and Table 4.5 (differences by HPV status alone). 
Overall, the RT-qPCR results confirmed the microarray data as well as the IPA 
biomarker profile, and pointed to differences in gene expression between HPV-active and 
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HPV-negative tumors within each racial group. The concordance rate of gene regulation 
as observed by RT-qPCR and microarray was 95.8% for MCM2, TP53, MAL, KRT15, 
NOTCH1, TP53, CDKN2A, TLR10 in total tumor population, 83.3% for BRCA1, MAL, 
CDKN2A, NOTCH1, TP53, MMP13, MMP10, TGFB2, MET, TLR10, MCM2, KRT15 
within EA population and 71.4% for IGFBP3, IL1B, ADAM12, MMP14, MMP7, MAL, 
MMP10 within HPV-negative tumors from AA and EA population. These data also 
suggest more subtle differences between HPV-negative and HPV-inactive tumors, and 
possibly in tumors derived from EA and AA patients. All the gene expression values 




4.2.1 Markers and indicators of HPV-driven tumorigenesis in HNC 
Human Papillomavirus is an established independent risk factor for the 
development of OPSCC and its detection in squamous cell carcinoma of the oral cavity 
has truly come of age with the advent of RNA based assays to test HPV activity. In 
surgical pathology, immunohistochemistry for p16(INK4a) is a well-known surrogate 
marker for HPV expression in cervical cancers46,47 and HNSCC52. However, the 
sensitivity and specificity of this protein as a biomarker for HPV-driven HNSCC is 
highly debated53. This biomarker’s potential to characterize biologically active HPV 





Figure 4.9: Differential expression levels of ADAM12, BRCA1, CDKN2A, 
IGFBP3, IL1 and KRT15. Log10 CNRQs calculated by normalizing data to three 
reference genes using qbase+. Significant relationships determined by ANOVA and 
tukey’s multiple testing: (***) Active/Control, Active/Inactive and Active/Negative; 
(*#) Active/Negative; (#) Negative/Control. 
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Figure 4.10: Differential expression levels of MAL, MCM2, MET, MMP7, 
MMP10 and MMP13.  Log10 CNRQs calculated by normalizing data to three 
reference genes using qbase+. Significant relationships determined by ANOVA and 
tukey’s multiple testing: (**) Active/Inactive; (*) Inactive/Control; (*#) 
Active/Negative; (#) Negative/Control, (##) Active/Control 
                       MMP10 
                    *#              *                   
                       MMP13 
                    **              *                   
  
Figure 4.11: Differential expression levels of MMP14, NOTCH1, SIX1, TGF
TP53 and TLR10. Log10 CNRQs calculated by normalizing data to three reference 
genes using qbase+. Significant relationships determined by ANOVA and tukey’s 






 Figure 4.12: Differential expression levels of ADAM12, BRCA1, IL1, MAL, 
MCM2 and MET by HPV status and Race.
normalizing data to three reference genes using qbase+. Significant relationships 
determined by ANOVA and tukey’s multiple testing
Active, EA-N: European American Negative, EA
C: European American Control. AA
American Inactive, (*) EA
AA-I; (*#) EA-N / AA-N. 
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 Log10 CNRQs calculated by 
. EA-A: European American 
-I European American Inactive, EA
-N: African American Negative, AA






 Figure 4.13: Differential expression levels of MMP7, MMP10, MMP13, NOTCH1 
and TGFβ2 by HPV status and Race.
to three reference genes using qbase+. Significant relationships determined by 
ANOVA and tukey’s multipl
European American Negative, EA
American Control. AA-N: African American Negative, AA
Inactive, (**) EA-I/EA-C; (***) EA
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 Log10 CNRQs calculated by normalizing data 
e testing. EA-A: European American Active, EA
-I European American Inactive, EA-C: European 







Table 4.4: ANOVA Summary-by HPV status 
Target 
Gene 















                    
  
    ACTIVE/ 
CONTROL 
22.6 1.5 345.2 Yes ACTIVE 22.6 17.1 30.0 14 
  
    ACTIVE/ 
INACTIVE 
39.9 5.8 276.5 Yes CONTROL 1.0 0.3 3.9 4 
  
    ACTIVE/ NEG 15.8 2.9 85.6 Yes INACTIVE 0.6 0.1 2.7 11 
  
    INACTIVE/ 
CONTROL 
0.6 0.0 9.4 No NEG 1.4 0.5 4.0 19 
  
    NEG/ 
CONTROL 
1.4 0.1 20.2 No           
  
    NEG/ 
INACTIVE 





                    
  
    ACTIVE/ 
CONTROL 
28.9 0.5 1723.1 No ACTIVE 28.9 10.3 81.2 13 
  
    ACTIVE/ 
INACTIVE 
0.0 0.0 0.7 Yes CONTROL 1.0 0.1 8.0 3 
  
    ACTIVE/ NEG 0.1 0.0 0.7 Yes INACTIVE 579.0 98.8 3393.9 10 
  




Yes NEG 407.6 105.5 1574.1 19 
  




Yes           
  
    NEG/ 
INACTIVE 








                    
  
    ACTIVE/ 
CONTROL 
18.4 0.8 436.7 No ACTIVE 18.4 8.5 39.9 14 
  
    ACTIVE/ 
INACTIVE 
0.4 0.0 4.0 No CONTROL 1.0 0.1 11.1 4 
  
    ACTIVE/ NEG 0.1 0.0 0.9 Yes INACTIVE 43.4 5.5 342.1 11 
  
    INACTIVE/ 
CONTROL 
43.4 1.7 1129.8 Yes NEG 150.9 59.2 384.4 19 
  
    NEG/ 
CONTROL 
150.9 7.0 3253.3 Yes           
  
    NEG/ 
INACTIVE 





                    
  
    ACTIVE/ 
CONTROL 
0.1 0.0 1.7 No ACTIVE 0.1 0.0 0.2 14 
  
    ACTIVE/ 
INACTIVE 
8.8 0.9 87.7 No CONTROL 1.0 0.2 5.2 4 
  
    ACTIVE/ NEG 4.1 0.5 30.3 No INACTIVE 0.0 0.0 0.0 11 
  
    INACTIVE/ 
CONTROL 
0.0 0.0 0.2 Yes NEG 0.0 0.0 0.1 19 
  
    NEG/ 
CONTROL 
0.0 0.0 0.4 Yes           
  
    NEG/ 
INACTIVE 





                    
  
    ACTIVE/ 
CONTROL 
4.1 1.4 12.4 Yes ACTIVE 4.1 2.9 5.8 14 
  
    ACTIVE/ 
INACTIVE 





    ACTIVE/ NEG 1.5 0.7 3.2 No INACTIVE 3.6 2.1 6.2 11 
  
    INACTIVE/ 
CONTROL 
3.6 1.1 11.2 Yes NEG 2.7 1.7 4.3 19 
  
    NEG/ 
CONTROL 
2.7 0.9 7.9 No           
  
    NEG/ 
INACTIVE 





                    
  
    ACTIVE/ 
CONTROL 
4.8 0.9 25.9 No ACTIVE 4.8 2.5 9.1 12 
  
    ACTIVE/ 
INACTIVE 
1.8 0.2 20.3 No CONTROL 1.0 0.2 6.3 5 
  
    ACTIVE/ NEG 0.3 0.0 2.0 No INACTIVE 2.7 0.0 2083.3 2 
  
    INACTIVE/ 
CONTROL 
2.7 0.2 37.9 No NEG 18.8 1.4 249.5 3 
  
    NEG/ 
CONTROL 
18.8 1.8 190.3 Yes           
  
    NEG/ 
INACTIVE 





                    
  
    ACTIVE/ 
CONTROL 
2.9 0.4 19.5 No ACTIVE 2.9 1.6 5.2 14 
  
    ACTIVE/ 
INACTIVE 
3.7 0.9 14.6 No CONTROL 1.0 0.2 5.6 4 
  
    ACTIVE/ NEG 4.1 1.3 13.4 Yes INACTIVE 0.8 0.3 2.6 10 
  
    INACTIVE/ 
CONTROL 
0.8 0.1 5.8 No NEG 0.7 0.4 1.3 19 
  
    NEG/ 
CONTROL 
0.7 0.1 4.5 No           
  









                    
  
    ACTIVE/ 
CONTROL 
6.3 0.8 48.7 No ACTIVE 6.3 3.4 11.5 14 
  
    ACTIVE/ 
INACTIVE 
1.8 0.4 8.8 No CONTROL 1.0 0.2 4.8 5 
  
    ACTIVE/ NEG 0.8 0.2 3.0 No INACTIVE 3.5 1.1 10.9 11 
  
    INACTIVE/ 
CONTROL 
3.5 0.4 29.1 No NEG 8.3 3.8 18.3 19 
  
    NEG/ 
CONTROL 
8.3 1.1 59.7 Yes           
  
    NEG/ 
INACTIVE 





                    
  
    ACTIVE/ 
CONTROL 
2.5 0.7 9.3 No ACTIVE 2.5 1.7 3.6 14 
  
    ACTIVE/ 
INACTIVE 
0.9 0.3 2.6 No CONTROL 1.0 0.8 1.3 5 
  
    ACTIVE/ NEG 0.7 0.3 1.7 No INACTIVE 2.7 1.6 4.6 11 
  
    INACTIVE/ 
CONTROL 
2.7 0.7 10.6 No NEG 3.6 1.9 6.6 19 
  
    NEG/ 
CONTROL 
3.6 1.0 12.8 Yes           
  
    NEG/ 
INACTIVE 





                    
  
    ACTIVE/ 
CONTROL 
0.3 0.0 3.2 No ACTIVE 0.3 0.1 0.7 12 
  






    ACTIVE/ NEG 5.5 0.4 78.2 No INACTIVE 0.2 0.0 62.6 2 
  
    INACTIVE/ 
CONTROL 
0.2 0.0 8.3 No NEG 0.1 0.0 0.1 3 
  
    NEG/ 
CONTROL 
0.1 0.0 1.3 No           
  
    NEG/ 
INACTIVE 





                    
  
    ACTIVE/ 
CONTROL 
3.2 0.6 18.3 No ACTIVE 3.2 2.2 4.7 14 
  
    ACTIVE/ 
INACTIVE 
0.9 0.2 3.6 No CONTROL 1.0 0.7 1.3 5 
  
    ACTIVE/ NEG 0.9 0.3 2.8 No INACTIVE 3.4 1.8 6.7 11 
  
    INACTIVE/ 
CONTROL 
3.4 0.6 20.6 No NEG 3.8 1.6 8.7 19 
  
    NEG/ 
CONTROL 
3.8 0.7 20.1 No           
  
    NEG/ 
INACTIVE 





                    
  
    ACTIVE/ 
CONTROL 
2.3 0.7 7.7 No ACTIVE 2.3 1.6 3.4 14 
  
    ACTIVE/ 
INACTIVE 
1.3 0.6 3.1 No CONTROL 1.0 0.5 1.9 4 
  
    ACTIVE/ NEG 1.2 0.6 2.5 No INACTIVE 1.7 1.0 3.0 11 
  
    INACTIVE/ 
CONTROL 
1.7 0.5 6.0 No NEG 2.0 1.3 3.1 19 
  
    NEG/ 
CONTROL 





    NEG/ 
INACTIVE 





                    
  
    ACTIVE/ 
CONTROL 
1.1 0.0 49.7 No ACTIVE 1.1 0.4 3.3 14 
  
    ACTIVE/ 
INACTIVE 
1.3 0.1 14.5 No CONTROL 1.0 0.2 5.6 3 
  
    ACTIVE/ NEG 1.7 0.2 13.9 No INACTIVE 0.9 0.1 4.9 11 
  
    INACTIVE/ 
CONTROL 
0.9 0.0 41.2 No NEG 0.7 0.2 2.1 19 
  
    NEG/ 
CONTROL 
0.7 0.0 26.5 No           
  
    NEG/ 
INACTIVE 





                    
  
    ACTIVE/ 
CONTROL 
2.1 1.1 4.0 Yes ACTIVE 2.1 1.7 2.7 14.0000 
  
    ACTIVE/ 
INACTIVE 
1.6 1.0 2.5 Yes CONTROL 1.0 0.5 1.9 4.0000 
  
    ACTIVE/ NEG 1.7 1.1 2.5 Yes INACTIVE 1.3 1.0 1.8 11.0000 
  
    INACTIVE/ 
CONTROL 
1.3 0.7 2.6 No NEG 1.3 1.1 1.6 19.0000 
  
    NEG/ 
CONTROL 
1.3 0.7 2.4 No           
  
    NEG/ 
INACTIVE 





                    
  
    ACTIVE/ 
CONTROL 





    ACTIVE/ 
INACTIVE 
1.1 0.5 2.3 No CONTROL 1.0 0.3 3.2 4.0000 
  
    ACTIVE/ NEG 0.6 0.3 1.3 No INACTIVE 2.4 1.5 3.9 11.0000 
  
    INACTIVE/ 
CONTROL 
2.4 0.8 7.3 No NEG 4.1 2.8 6.0 19.0000 
  
    NEG/ 
CONTROL 
4.1 1.4 11.6 Yes           
  
    NEG/ 
INACTIVE 





                    
  
    ACTIVE/ 
CONTROL 
1.4 0.5 3.9 No ACTIVE 1.4 1.0 1.9 14.0000 
  
    ACTIVE/ 
INACTIVE 
2.3 1.1 4.8 Yes CONTROL 1.0 0.5 1.9 4.0000 
  
    ACTIVE/ NEG 1.8 1.0 3.5 No INACTIVE 0.6 0.3 1.1 11.0000 
  
    INACTIVE/ 
CONTROL 
0.6 0.2 1.8 No NEG 0.7 0.5 1.0 19.0000 
  
    NEG/ 
CONTROL 
0.7 0.3 2.1 No           
  
    NEG/ 
INACTIVE 





                    
  
    ACTIVE/ 
CONTROL 
1.8 0.5 5.7 No ACTIVE 1.8 1.1 2.7 14.0000 
  
    ACTIVE/ 
INACTIVE 
0.9 0.4 2.1 No CONTROL 1.0 0.3 3.6 4.0000 
  
    ACTIVE/ NEG 0.6 0.3 1.2 No INACTIVE 2.0 1.2 3.4 11.0000 
  
    INACTIVE/ 
CONTROL 
2.0 0.6 6.6 No NEG 2.9 2.0 4.2 19.0000 
  






    NEG/ 
INACTIVE 





                    
  
    ACTIVE/ 
CONTROL 
2.1 0.6 8.0 No ACTIVE 2.1 1.5 2.9 12.0000 
  
    ACTIVE/ 
INACTIVE 
2.2 0.4 12.8 No CONTROL 1.0 0.1 13.1 4.0000 
  
    ACTIVE/ NEG 0.9 0.2 4.0 No INACTIVE 0.9 0.1 7.6 2.0000 
  
    INACTIVE/ 
CONTROL 
0.9 0.1 6.9 No NEG 2.3 1.0 5.4 3.0000 
  
    NEG/ 
CONTROL 
2.3 0.4 13.2 No           
  
    NEG/ 
INACTIVE 





Table 4.5: ANOVA Summary-by HPV status and Race 
ADAM-12 
F 6.985 Tukey's multiple comparisons test Mean 
Diff. 
95% CI of diff. Significant? Summary 
P value 0.0005 EA-Control vs. EA-NEGATIVE -1.49 -2.346 to -0.6330 Yes *** 
P value 
summary 
*** EA-Control vs. AA-NEGATIVE -1.125 -1.953 to -0.2975 Yes ** 
 (P < 0.05) Yes EA-Control vs. EA-INACTIVE -1.278 -2.217 to -0.3400 Yes ** 
R square 0.4995 EA-Control vs. AA-INACTIVE -1.307 -2.210 to -0.4042 Yes ** 
BRCA-1 
F 4.222           
P value 0.0035           
P value 
summary 
** Tukey's multiple comparisons test Mean 
Diff. 
95% CI of diff. Significant? Summary 
 (P < 0.05) Yes EA-Active vs. AA-Negative 0.2886 0.05908 to 
0.5182 
Yes ** 




F 2.557           
P value 0.0424           
P value 
summary 
*           
 (P < 0.05) Yes           
R square 0.2422           
MAL 
F 8.024 Tukey's multiple comparisons test Mean 
Diff. 




P value 0.0002 EA-Control vs. EA-NEGATIVE 2.396 0.9258 to 3.866 Yes *** 
P value 
summary 
*** EA-Control vs. AA-INACTIVE 2.585 1.006 to 4.165 Yes *** 
 (P < 0.05) Yes EA-NEGATIVE vs. AA-NEGATIVE -1.148 -2.272 to -
0.02354 
Yes * 
R square 0.5253 AA-NEGATIVE vs. AA-INACTIVE 1.337 0.07383 to 2.600 Yes * 
IL-1 
F 4.25           
P value 0.0079 Tukey's multiple comparisons test Mean 
Diff. 
95% CI of diff. Significant? Summary 
P value 
summary 
** EA-Control vs. AA-NEGATIVE -1.218 -2.297 to -0.1398 Yes * 
 (P < 0.05) Yes EA-NEGATIVE vs. AA-NEGATIVE -0.8625 -1.700 to -
0.02481 
Yes * 
R square 0.3695 AA-NEGATIVE vs. AA-INACTIVE 0.9947 0.05324 to 1.936 Yes * 
MCM2 
F 2.845           
P value 0.0419           
P value 
summary 
*           
 (P < 0.05) Yes           
R square 0.2818           
MET 
F 3.953           
P value 0.0051           
P value 
summary 
**           
 (P < 0.05) Yes Tukey's multiple comparisons test Mean 
Diff. 
95% CI of diff. Significant? Summary 
R square 0.3253 EA-Control vs. EA-NEGATIVE -0.7404 -1.274 to -0.2068 Yes ** 
MMP-10 
F 4.812           







** EA-Control vs. EA-NEGATIVE -2.599 -4.338 to -0.8611 Yes ** 
 (P < 0.05) Yes EA-Control vs. AA-NEGATIVE -1.8 -3.511 to -
0.08888 
Yes * 
R square 0.3989           
MMP-13 
F 4.641 Tukey's multiple comparisons test Mean 
Diff. 
95% CI of diff. Significant? Summary 
P value 0.0056 NaN vs. EA-NEGATIVE -3.048 -5.221 to -0.8748 Yes ** 
P value 
summary 
** NaN vs. AA-NEGATIVE -2.216 -4.362 to -
0.07065 
Yes * 
 (P < 0.05) Yes NaN vs. EA-INACTIVE -3.013 -5.503 to -0.5237 Yes * 
R square 0.4074 NaN vs. AA-INACTIVE -2.596 -4.900 to -0.2908 Yes * 
TGFB2 
F 2.855           
P value 0.0266           
P value 
summary 
*           
 (P < 0.05) Yes Tukey's multiple comparisons test Mean 
Diff. 
95% CI of diff. Significant? Summary 




RNA expression patterns characteristic of cervical carcinomas 
(CxCaRNA)49,53,56,62,63 are also being explored as markers of active HPV infection in 
OPSCC49,53,62. HPV status in formalin fixed paraffin embedded (FFPE) OPSCC 
specimens was recently assayed by immunohistochemical analysis of HPV linked genes 
such as p16INK4A, pRb, Cyclin D1 and p53. These studies determined that high 
p16INK4a combined with low pRb provided a reliable marker for active HPV16 
infection56. Another study on FFPE OPSCC specimens employed a novel combinatorial 
strategy utilizing viral mRNA expression and in-situ hybridization for HPV DNA and 
mRNA, along with RT-qPCR for five genes functionally related to HPV (p53, Myc, Rb, 
p16 and p21). In this study, RT-qPCR and RNA in-situ hybridization for viral genes were 
found to be 100% concordant in assessing HPV status64.  
We categorized our OPSCC sample set for HPV status based on dual markers of 
viral DNA presence and viral RNA expression. 
A recent study classified OPSCC tumors into HPV Active (DNA+RNA+), Inactive 
(DNA+RNA-) and Negative (DNA-RNA-) based on multiplex nested PCR for HPV E6 
DNA and E6I/E1^E4 RNA129. Our algorithm involved INNO-LiPA based HPV DNA 
detection and determination of E7-E6/7 expression through RT-qPCR. Thus, tumors 
positive for both INNO-LiPA and E7-E6/7 RT-qPCR were classified as HPV Active, 
INNO-LiPA positive but E7-E6/7 RT-qPCR negative were classified as HPV Inactive 
and the ones which tested negative for both were classified as HPV Negative. Amongst 
the tumor samples that tested negative for HPV DNA by INNO-LiPA, one sample 
expressed HPV16 E7 mRNA and hence was categorized as HPV Active. We presume 
that the negative DNA result in this sample may be due to loss of the L1 ORF, perhaps a 
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consequence of integration events. Our HPV typing and gene expression results led to 
two major conclusions that are concordant with recent trends: (1) the HPV status of a 
HNC cannot be defined solely by the presence of HPV DNA or by p16 expression 
patterns, rather a combination of several different markers is needed53,5649,62; (2) the 
presence of HPV DNA alone, in the absence of HPV gene expression, does not indicate a 
HPV-driven pathogenesis in OPSCC94,129,204. 
4.2.2 Prevalence of active HPV in OPSCC from European American and African 
American patients 
The prevalence of HPV in our set of 56 OPSCC tumors was in agreement with 
previously reported trends: AA patients exhibited more HPV negative tumors as 
compared to EA patients99,203–205. HPV prevalence in African American patients has been 
previously studied using a variety of methods to assess HPV positivity, including the 
presence of HPV DNA205, HPV DNA and p16INK4A expression204, in-situ hybridization 
for HR-HPV99 and more recently HPV16 DNA copy number203. However, to the best of 
our knowledge, no study has so far assessed the rate of HPV prevalence in AA and EA 
patients based on the combined presence of HPV DNA and expression of viral 
oncogenes. While prevalence measured by HPV DNA (INNO-LiPA) was a little less than 
twice in EA as compared to AA patients, the prevalence of active HPV by RNA (E7, 
E6/7 RT-qPCR) was four times higher in EA than in AA patients. Overall, the odds of 
EA patients having an HPV active cancer were 5.7 times higher than for AA patients. 
HPV16 was the dominant HR-HPV type detected overall, with HPV types of the alpha 9 
genus (16, 35, 52 and 58) common in tumors from EA patients, and alpha 9 and alpha 10 
genera (16 and 66) in AA patients. The observed trends in HPV prevalence and 
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differential HPV type representation might derive from differences in lifestyle, sexual 
practices and possibly also genetic makeup of an individual which renders EA patients 
more susceptible to HPV infection.  
4.2.3 Gene expression profiles of HPV-active, -inactive and –negative tumors in 
European American and African American patients  
We further investigated the molecular differences among HPV-active, HPV-
inactive and HPV-negative tumors from AA and EA patients by conducting differential 
gene expression analysis in 40 samples, 36 cancer and 4 normal. We had only one AA 
patient with an HPV-active tumor, and thus the analysis involving HPV active AA 
population was not performed.  
Data are now available from landmark studies conducted to investigate the role of 
HPV in OPSCC with respect to gene expression patterns82,89,147,187,192,241, genetic and 
epigenetic profiles129,192,196,242,243, mutational landscape109,112 and more recently a 
comprehensive study on a small set of samples targeting the four-omics: methylation, 
transcription, miRNA and genomic based analysis192. The molecular mechanisms 
governing HPV mediated OPSCC are better understood in view of these studies. The 
global CpG island differential methylation profile studied in HPV-active (DNA+/RNA+), 
HPV-inactive (DNA+/RNA-) and HPV-negative (DNA-/RNA-) OPSCC tumors 
categorized HPV-inactive group much more closer to the HPV-negatives129 which is 
similar to our findings. Additionally, we could detect two (homeobox A6 (HOXA6) and 
Homo sapiens paired box 9 (PAX9)) of the 11 genes shortlisted from non-HPV driven 
tumors for massARRAY, in our DEG lists. We observed overexpression of HOXA6 and 
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PAX9 in HPV-active tumors when compared to HPV-negative and –inactive tumors, 
where HPV-inactive tumors exhibited an intermediate profile. These expression patterns 
can be directly related to hypermethylation of the respective gene promoters in HPV-
negative tumors as listed in the previous study. 
The novelty of our results lies in listing the differential expression patterns of 
OPSCC (HPV related and unrelated) arising in AA and EA patients. We observed that 
HPV-active OPSCC’s segregated clearly from the HPV-inactive and HPV-negative 
group in the overall population. Further investigation of HPV-negative and -inactive 
tumors revealed clear differences between the two kinds of tumors within AA and EA 
patients. These observations support our hypothesis that differential patterns of gene 
expression distinguish not only HPV-inactive and HPV-negative tumors, but also tumors 
from AA and EA patients. 
Hence, we can begin to define a new class of OPSCC tumors as those that harbor 
HPV DNA but lack expression of viral oncogenes. These HPV Inactive tumors were 
analyzed in comparison to HPV negative tumors within AA population, HPV negative 
and Active tumors within EA population and overall. Even though the HPV inactive 
OPSCC comprised only four tumor samples, the unsupervised hierarchical clustering of 
samples clustered them as a separate entity from the HPV actives entirely and somewhat 
from HPV negatives. We propose that such profiles indicate that HPV-inactive tumors 
might have originated as HPV-active, and have lost dependence on HPV during disease 
progression. With respect to HPV methylation studies244, no clear understanding of the 
molecular and pathogenetic nuances of an “inactive” virus state is available so far.  
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4.2.4 Individual differentially-expressed genes that characterize HPV-active, -
inactive and –negative tumors and may have relevance to pathogenesis 
Recent studies have highlighted the relevance of tumor degradome components like 
matrix metalloproteinases (MMP’s)143,245–248 and a disintegrin and metalloproteinase 
domain 12 (ADAM12)138,139 in the tumor progression of HPV negative OPSCC’s. Our 
Microarray studies detected about 25 fold up-regulation for MMP10 and 23 fold for 
MMP13 in HPV-negative tumors as compared to the HPV-active tumors from EA 
patients while such differences were not observed in the total tumor pool, indicating that 
MMP’s might act as a EA specific biomarker for EMT mediated disease progression in 
HPV negative tumors. Of note, are the differential expression profiles of MMP10246,249,250 
and MMP13 as the potential tumor and salivary biomarkers of disease progression in 
OSCC 246,248. These studies emphasized that detection of MMP profile from saliva of 
OPSCC patients will provide us with a less invasive method to detect and monitor the 
growth of oral malignancies.  
Within the subgroup of HPV negative tumors arising from two racial groups, we 
observed upregulation of ADAM12, MMP10 and MMP13, through microarray and RT-
qPCR, in EA patients as compared to AA patients. We further confirmed the expression 
of three biomarkers (ADAM12, IL1B, MMP14), as given by IPA, through RT-qPCR. 
Other degradome components validated through RT-qPCR included- MMP7 and 
MMP14. Keratin15 was found reported as downregulated in all HNC and cervical 
cancers as compared to controls in a recent study187 and our results showed similar levels 
of KRT15 in HPV-negative and HPV-inactive tumors as to that of controls, while an 
overexpression of the same was visible in HPV-active tumors. 
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We also assessed the expression levels of Notch1, a gene that has recently received 
considerable attention as an important determinant in HN carcinogenesis109,112. Notch1 
functions as an oncogene in acute lymphoblastic leukemia251 and tumor suppressor in 
HNSCC112,161. Notch1 dysregulation has been reported primarily due to activating point 
mutations of the same and differential expression patterns with respect to HNSCC 
haven’t been reported. In a recent study, HPV16 E6 involvement overexpresses Notch1 
in human keratinocytes252. Also, Notch1 has been implicated in proliferation and self-
renewal of dental follical cells253. We could not observe any significant differential 
expression patterns for Notch1 between HPV-active and –negative tumors. However, 
Notch1 was found to be overexpressed in all tumors when compared to controls, while a 
trend of overexpression in HPV-active when compared to HPV-inactive and –negative 
could be faintly observed.  
One interesting finding in our study samples was the significant overexpression of 
BRCA1 in HPV-active tumors as compared to the controls and HPV-negative tumors. A 
genome wide profiling of OSCC tumors revealed frequent alterations including gene 
amplifications within fanconi anemia related DNA damage response pathway including 
BRCA1254. BRCA1 has been reported to interact with zinc finger domain of E6 and E7 
proteins in vitro without any proteolytic degradation of the former255. Thus, the 
overexpression of BRCA1 in HPV-active tumors when compared to HPV-negatives 
might explain a compensatory mechanism for E6-E7 binding of BRCA1 in the former. 
The cytokine Interleukin 1-beta (IL1B) has been reported to convert normal 
periodontal ligament fibroblasts to tumor associated fibroblasts and further cause EMT in 
SCC-25 co-cultures256 and was recently proposed as a biomarker for OSCC in 
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unstimulated whole saliva from pre and post operation patients257. Overexpression of 
IL1B was observed in AA HPV-negative tumors in comparison to EA population, 
indicating a possible role of IL1B as a biomarker for HPV negative OPSCC’s specific to 
tumors in AA patients. Myelin and lymphocyte-associated protein (MAL) is found to be 
down-regulated in HNSCC258 and similar trend was observed in our set of samples with 
maximum down-regulation in EA HPV negative tumors as compared to AA HPV 
negative and EA HPV active tumors. We also validated the expression levels of an innate 
immunity linked gene- Toll-like Receptor 10 (TLR10) which plays a significant role in 
pathogen recognition and thus provides primary defense from invading pathogens. 
Downregulation of TLR10 was observed in HPV-active, -inactive and -negative tumors 
as opposed to the controls. While TP63 network and transcriptional targets of ∆Np63 
isoforms were well represented in HPV negative tumors from both racial groups, the 
differential gene expression analysis revealed an emphasis on tumor degradome profile 
for OPSCC’s arising from EA patients (MMP10, MMP13, ADAM12) as compared to 
tumor suppressor and cytokine based proliferation in AA patients (TGFβ2, IL1).  
Another important biomarker considered in our analysis was c-MET oncogene. The 
c-MET/HGF pathway has been well studied in HNSCC with c-MET overexpression 
patterns are reported in 80% of cases182,259,260 with its recent role as a potential cancer 
stem cell marker136. However, c-MET’s role with respect to HPV has not yet been 
reported134.  
Our study indicates differential expression patterns of c-MET, with HPV negative 
tumors exhibiting maximum overexpression as compared to inactive and active tumors 
both in the general sample set and within the EA population. Additionally, HPV negative 
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tumors arising from EA patients expressed higher levels of c-MET when compared to 
those of AA patients. This difference confirms the epithelial-mesenchymal transition and 
proliferative nature of HPV negative tumors, and also indicates that HPV negative tumors 
from EA patients may be driven by c-MET to a larger extent than those in AA patients. 
Therefore, we propose a novel profile of differentially expressed biomarkers 
(ADAM12hi, MMP10hi, MMP13hi, c-METhi, IL1low, MALlow and TGFβ2hi) for HPV 
negative tumors arising from European American vs African American patients. These 
biomarkers deserve further investigation as possible markers of particularly invasive, 
EMT-based tumor phenotypes amenable to differential therapeutic interventions.  
 
4.3 Conclusion 
In summary, our study allowed us to determine that HPV types other than HPV16 
do not play an important role in OPSCC in EA or AA patients, and began dissecting the 
gene expression profiles of OPSCC in tumors from EA and AA patients, uncovering 
subtle but potentially important differences. In addition, the differential gene expression 
analysis of OPSCC samples revealed that HPV-negative and HPV-inactive tumors do not 
completely overlap in terms of gene expression profiles, suggesting that the HPV-inactive 
tumors may have arisen by yet a separate mechanism from both HPV-active and HPV-
negative cancers. Further studies are needed, however, to fully explore this concept.  
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Our working hypothesis is that HPV-inactive tumors may begin as HPV-active 
lesions, and that in the course of tumor progression mutational events and/or epigenetic 
changes may re-direct the tumor development process along lines more similar to those 
of HPV-negative tumors. It will be of interest to assess how risk factors such as smoking 





CHAPTER 5- OVERALL DISCUSSION and FUTURE DIRECTIONS 
5.1 Overall Discussion 
Differential gene expression analysis of 36 OPSCC samples revealed that HPV-
negative and HPV-inactive tumors clearly segregate from HPV-active OPSCC in terms 
of GO and DEGs (both within a Race and in the combined population). The significance 
of presence of viral DNA as sole criteria for HPV mediated tumorigenesis in OPSCC has 
been greatly subverted by growing emphasis on expression of viral oncogenes and its 
downstream regulators. This method of characterization results in more conclusive 
segregation of HPV driven tumors and our methodology for determining HPV status was 
in agreement with current norms.  
We attempted to address a new group of HPV related OPSCC called HPV-inactive 
tumors with distinctive gene expression profiles within race and a somewhat intermediate 
ontology when compared to HPV-active and HPV-negative OPSCC’s. These findings led 
us to hypothesize their probable origin as HPV-active tumors and a loss of dependence on 
HPV driven pathogenesis during later stages. Our results are in line with recent 
differential methylation profile of HPV-active, -inactive and negative tumors, with HPV-
inactive tumors representing a more HPV-negative like profile with respect to 
methylation patterns. This segregation of HPV-related tumors into HPV-active and HPV-
inactive will be beneficial in efficiently diagnosis and prognosis of the concerned 
malignancies. 
 117 
5.2 Future Directions 
The results from our study have opened various avenues of research and 
therapeutics for a novel subgroup of HPV-positive OPSCC, referred to as HPV-inactive 
tumors and highlighted the importance of HPV as a racially linked marker. In addition, 
specific molecular markers of malignancies within OPSCC tumors arising from AA and 
EA patients will help in addressing the issue of targeted therapeutics. The new age cancer 
therapeutics relies on the fundamentals of developing patient specific treatment which in 
turn depends on genetic, epigenetic and transcriptional profile of these tumors. Thus our 
study is a significant drop in the ocean of designing a definite cure for malignancies like 
OPSCC. 
5.2.1 EGFR-MET crosstalk and p16INK4A status 
EGFR overexpression and mutation patterns have been described in HNSCC134, 
where constitutive activation of EGFR is well established in HPV-negative tumors132. It 
is known that a possible reason for failure of EGFR targeted therapeutics in HNSCC 
might be the crosstalk between MET and EGFR proteins which possibly substitutes for 
EGFR activity in these tumors135. A recent study on the association between EGFR 
variant III, HPV DNA, p16, c-MET, EGFR gene copy number and response to EGFR 
inhibitors in patients with recurrent or metastatic HNSCC detected 40% EGFR variant III 
mutation rate261. However, no clear association between role of active HPV infection and 
EGFR-MET expression was made as viral mRNA levels were not studied.  
It would be of interest to study this profile in the given sample set, in view of c-
MET expression patterns and racial distribution. Additionally, the relevance of 
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p16INK4A as a surrogate biomarker for HPV positivity can be determined by comparing 
the viral oncogene expression levels to immunohistochemical analysis of the same.  
5.2.2 Mutational profile of OPSCC by Race and HPV status 
It would be informative to conduct a mutational analysis of 40 most commonly 
mutated genes in HNSCC, including MET, TP53, NOTCH1, EGFR, in these OPSCC 
samples and to attempt correlating mutation profiles with HPV status and gene 
expression profiles. This study would be done in view of currently published differential 
mutation profiles between HPV-positive and HPV-negative tumors from whole exome 
sequencing of 75 tumor-normal pairs109, where HPV-positive tumors exhibited less 
mutations than HPV-negative HNSCC.  
5.2.3 Host and Viral DNA methylation patterns 
In view of recent studies concerning differential host DNA and viral methylation 
patterns from HPV-driven OPSCC262,263, a comprehensive knowledge of methylation 
profile of viral DNA within the HPV–inactive tumors might help solve the puzzle as to 
why HPV becomes inactive in certain tumors and thus mediate HPV independent 
tumorigenesis. In addition, we may attempt to reproduce these mechanisms of “escape” 
from HPV in HPV-transformed human keratinocytes in vitro. We can answer the 
question of ‘How’ such HPV independence takes place in tumors by replicating these 
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APPENDIX A - DEG ALL TUMORS 





















4.90 up 10.37 up 2.11 up AACSP1 NR_024035 
2.09 up 1.65 up 1.26 down AACSP1 NR_024035 
1.52 down 2.06 down 1.36 down AATK NM_001080395 
5.72 up 5.05 up 1.13 down ABCA13 NM_152701 
6.57 up 11.55 up 1.76 up ABCA3 NM_001089 
1.96 down 2.16 down 1.10 down ABCC2 NM_000392 
3.51 down 2.13 down 1.65 up ABCC9 NM_005691 
2.17 up 1.87 up 1.16 down ABHD8 NM_024527 
2.14 up 1.68 up 1.27 down ABI2 NM_005759 
2.14 down 1.81 down 1.19 up ABL1 NM_007313 
1.74 down 2.67 down 1.53 down ABL2 NM_007314 
1.27 up 2.22 up 1.75 up ACACB NM_001093 
4.29 up 3.85 up 1.12 down ACBD7 NM_001039844 
1.98 down 2.71 down 1.37 down ACOT8 
 
2.46 up 2.66 up 1.08 up ACOXL NM_001142807 
2.42 up 2.69 up 1.11 up ACPL2 NM_152282 
2.74 up 3.37 up 1.23 up ACSS1 NM_032501 
2.46 down 3.55 down 1.44 down ACTG2 NM_001615 
1.47 down 2.56 down 1.74 down ACTN1 NM_001102 
1.60 down 2.62 down 1.64 down ACTN3 NM_001104 
2.25 up 2.08 up 1.08 down ACTR3C BX640643 
2.64 up 2.46 up 1.07 down ADAM1 NR_036636 
2.61 up 4.05 up 1.55 up ADAM22 NM_021721 
1.91 up 3.07 up 1.61 up ADAMTS17 NM_139057 
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2.06 down 2.74 down 1.33 down ADAMTSL4 NM_019032 
2.36 down 1.82 down 1.30 up ADAMTS
L4 NM_025008 
10.50 up 10.76 up 1.02 up ADARB2 NM_018702 
4.22 up 4.60 up 1.09 up ADARB2 NM_018702 
3.26 up 3.35 up 1.03 up ADARB2 NM_018702 
2.57 up 3.42 up 1.33 up ADCY5 NM_183357 
2.19 up 2.54 up 1.16 up ADCY6 NM_015270 
1.63 down 2.02 down 1.24 down AFAP1L1 NM_152406 
2.19 up 1.44 up 1.52 down AGAP1 NM_001037131 
1.33 down 2.23 down 1.68 down AGPAT4 NM_020133 
1.43 down 2.35 down 1.64 down AGPAT4 NM_020133 
1.80 down 4.12 down 2.28 down AGPAT4 NM_020133 
1.73 down 2.23 down 1.29 down AGPAT9 NM_032717 
2.01 up 1.98 up 1.01 down AHDC1 NM_001029882 
1.58 down 3.12 down 1.98 down AHNAK2 NM_138420 
1.63 down 3.10 down 1.90 down AHNAK2 NM_138420 
2.47 down 2.85 down 1.15 down AIG1 
 
2.04 up 1.70 up 1.20 down AKAP1 NM_003488 
6.20 down 6.49 down 1.05 down AKR1C3 NM_003739 
5.93 down 6.56 down 1.11 down AKR1C4 NM_001818 
1.78 up 2.79 up 1.57 up AKR1E2 NM_001040177 
6.79 up 8.64 up 1.27 up ALDH1L1 NM_012190 
1.91 up 2.36 up 1.23 up ALDH2 NM_000690 
2.28 up 1.02 down 2.32 down ALS2 NM_020919 
2.37 down 1.82 down 1.30 up AMFR NM_001144 
2.54 down 3.10 down 1.22 down AMIGO2 NM_181847 
2.60 up 4.83 up 1.86 up AMOT NM_133265 
6.76 up 8.31 up 1.23 up AMY1C NM_001008219 
6.40 up 6.87 up 1.07 up AMY1C NM_001008219 
2.96 down 1.72 down 1.72 up ANGPT4 NM_015985 
3.09 up 2.84 up 1.09 down ANKRD10-IT1 XR_109155 




4.39 up 3.80 up 1.15 down ANKRD20A5P NR_040113 
3.62 up 3.36 up 1.08 down ANKRD20A5P NR_040113 
4.48 up 4.18 up 1.07 down ANKRD20A9P NR_027995 
4.78 up 3.20 up 1.49 down ANKRD33B 
NM_00116444
0 
2.32 up 2.75 up 1.18 up ANKRD36 
NM_00116431
5 
2.07 up 2.29 up 1.10 up ANKRD36 
NM_00116431
5 
1.31 up 2.12 up 1.62 up ANKRD36 
NM_00116431
5 
1.89 up 2.02 up 1.07 up ANKRD36B NM_025190 
1.87 up 2.14 up 1.14 up ANKRD36B NM_025190 
1.92 up 3.28 up 1.71 up ANKRD36BP2 BX648045 
1.80 up 2.46 up 1.37 up ANKRD36BP2 AK097649 
1.55 up 2.29 up 1.48 up ANKRD36BP2 NR_015424 
1.46 up 2.03 up 1.39 up ANKRD36BP2 NR_015424 
4.64 up 9.58 up 2.06 up ANKRD43 NM_175873 
1.74 up 2.15 up 1.24 up ANKRD6 NM_001242811 
2.31 up 3.03 up 1.31 up ANKRD65 
NM_00114521
0 
1.93 up 2.16 up 1.12 up ANO9 NM_001012302 
7.62 down 4.73 down 1.61 up ANXA10 NM_007193 
3.03 down 2.74 down 1.10 up ANXA13 NM_001003954 
2.28 up 1.77 down 4.03 down ANXA3 NM_005139 
3.65 up 5.68 up 1.56 up AP3B2 NM_004644 
1.64 down 2.37 down 1.44 down AP4S1 NM_007077 
1.72 down 2.57 down 1.49 down AP4S1 NM_001128126 
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3.17 up 2.40 up 1.32 down APOBEC3B NM_004900 
2.68 up 2.34 up 1.14 down APOBEC3C NM_014508 
2.58 up 2.64 up 1.02 up APOBEC3F NM_145298 
3.26 up 2.31 up 1.41 down APOBEC3G NM_021822 
2.80 down 7.49 down 2.68 down AREG NM_001657 
2.91 down 8.27 down 2.85 down AREG NM_001657 
4.22 up 2.84 up 1.49 down ARF3 
 
1.54 up 2.01 up 1.31 up ARHGAP24 AK130576 
3.31 up 3.35 up 1.01 up ARHGAP26 NM_015071 
2.57 up 2.46 up 1.04 down ARHGAP33 NM_052948 
1.91 up 3.57 up 1.87 up ARHGAP4 
NM_00116474
1 
4.51 up 2.18 up 2.07 down ARHGEF16 NM_014448 
3.51 up 2.09 up 1.68 down ARHGEF19 NM_153213 
3.39 up 2.79 up 1.21 down ARHGEF19 NM_153213 
3.00 up 3.94 up 1.31 up ARHGEF26 NM_015595 
2.21 up 1.38 up 1.61 down ARID1A NM_006015 
2.27 up 1.81 up 1.25 down ARL3 NM_004311 
3.67 down 4.09 down 1.12 down ARL4D NM_001661 
2.56 up 1.12 up 2.28 down ARL9 NM_206919 
5.70 up 7.55 up 1.32 up ARNT2 NM_014862 
1.78 down 2.42 down 1.36 down ARTN NM_057090 
5.50 up 6.59 up 1.20 up ASCL4 NM_203436 
2.42 up 1.96 up 1.23 down ASF1B NM_018154 
1.58 down 2.17 up 3.43 up ASPA NM_000049 
2.30 up 1.44 up 1.60 down ASPM NM_018136 
2.15 up 1.54 up 1.39 down ASPM NM_018136 
17.65 down 5.97 down 2.95 up ASPRV1 NM_152792 
1.93 up 2.21 up 1.15 up ASRGL1 NM_001083926 
2.47 up 1.81 up 1.36 down ATAT1 NM_024909 
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3.43 up 2.92 up 1.18 down ATF5 NM_012068 
2.91 up 1.28 up 2.28 down ATL2 NM_022374 
2.02 up 1.36 up 1.49 down ATL2 NM_022374 
1.56 down 2.14 down 1.37 down ATL3 NM_015459 
2.37 up 1.21 up 1.95 down ATP2B4 NM_001684 
2.03 up 1.08 down 2.19 down ATP2B4 NM_001001396 
2.77 up 2.05 up 1.35 down ATP2C1 NM_001199182 
2.01 up 1.52 up 1.33 down ATP5A1 NM_001001937 
4.44 up 1.46 up 3.04 down ATP5B NM_001686 
2.21 up 2.68 up 1.21 up ATP6V0E2 NM_145230 
2.28 up 1.88 up 1.21 down ATP7A AB208828 
13.79 down 4.60 down 3.00 up ATP8B3 NM_138813 
2.00 down 1.45 down 1.38 up AVP NM_000490 
2.96 up 1.43 up 2.07 down B3GALTL NM_194318 
4.20 down 4.17 down 1.01 up B4GALN
T1 NM_001478 
2.13 down 1.69 down 1.26 up BAALC 
 
1.56 down 2.36 down 1.52 down BAG2 NM_004282 
3.42 up 3.14 up 1.09 down BAI2 NM_001703 
1.74 up 2.27 up 1.31 up BAI2 NM_001703 
2.21 up 2.01 up 1.10 down BARD1 NM_000465 
1.54 down 2.24 down 1.46 down BBS5 NM_152384 
2.11 down 3.44 down 1.64 down BCAT1 NM_005504 
2.87 down 3.34 down 1.16 down BCAT1 NM_005504 
4.14 down 2.46 down 1.69 up BCHE NM_000055 
4.30 up 2.92 up 1.47 down BCL11A NM_022893 
2.71 up 3.62 up 1.33 up BCL11A NM_022893 
2.52 up 2.80 up 1.11 up BCL11A NM_018014 
2.21 up 2.59 up 1.17 up BCL11A NM_138559 
3.22 up 3.79 up 1.18 up BCL2 NM_000633 
2.24 up 2.55 up 1.14 up BCL2 NM_000657 
2.82 down 1.35 down 2.10 up BCO2 NM_031938 
2.21 up 1.95 up 1.13 down BCOR BC128456 
1.70 down 2.93 down 1.73 down BDKRB1 NM_000710 
1.62 up 2.36 up 1.46 up BDNF-AS1 NR_002832 
5.09 up 4.12 up 1.23 down BIRC3 NM_001165 
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3.59 up 4.52 up 1.26 up BK250D10.8 NR_024355 
1.49 down 3.06 down 2.05 down BNC1 NM_001717 
2.44 up 2.05 up 1.19 down BRCA2 NM_000059 
1.96 down 2.84 down 1.45 down BRI3 NM_001159491 
2.21 down 3.26 down 1.47 down BTBD11 NM_001018072 
3.66 down 3.09 down 1.19 up BTBD16 NM_144587 
6.26 up 14.72 up 2.35 up BTNL9 NM_152547 
2.38 up 4.38 up 1.84 up BZRAP1 NM_004758 
1.55 down 2.32 down 1.49 down BZW1 NM_001207068 
2.44 down 2.17 down 1.13 up C10orf114 NM_001010911 
2.99 up 1.06 up 2.81 down C10orf47 NM_153256 
2.12 down 2.01 down 1.06 up C10orf57 NM_025125 
2.22 down 1.67 down 1.32 up C11orf71 NM_019021 
3.78 up 3.68 up 1.03 down C11orf85 NM_001037225 
29.00 up 42.97 up 1.48 up C11orf92 NR_034154 
5.03 up 8.93 up 1.78 up C11orf93 NM_001136105 
2.43 down 1.93 down 1.26 up C11orf95 NM_001144936 
2.31 up 2.57 up 1.12 up C12orf34 NM_032829 
1.57 down 3.41 down 2.17 down C13orf16 NM_152324 
1.68 down 2.19 down 1.30 down C14orf109 NM_001098621 
1.48 down 2.15 down 1.45 down C14orf126 NM_080664 
2.23 up 2.00 up 1.12 down C14orf132 NR_023938 
1.98 down 3.15 down 1.59 down C14orf149 NM_144581 
3.28 down 4.37 down 1.33 down C14orf33 NR_027123 
3.31 down 4.68 down 1.41 down C14orf33 NR_027123 
3.38 down 4.41 down 1.30 down C14orf33 NR_027123 
3.20 down 7.06 down 2.21 down C14orf34 NR_026796 
3.01 down 2.21 down 1.36 up C14orf37 NM_001001872 
2.51 up 2.03 up 1.24 down C15orf2 NM_018958 
1.65 up 2.03 up 1.23 up C16orf5 NM_001199054 
1.96 down 3.22 down 1.64 down C16orf57 NM_00120491
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2.12 down 2.57 down 1.21 down C16orf74 NM_206967 
2.45 down 1.31 down 1.87 up C17orf105 NM_001136483 
1.04 up 2.04 up 1.96 up C17orf108 NM_001076680 
1.99 down 3.25 down 1.63 down C17orf51 NM_001113434 
2.00 down 1.98 down 1.01 up C17orf51 NM_001113434 
2.03 down 1.98 down 1.03 up C17orf51 NM_001113434 
2.07 down 1.91 down 1.09 up C17orf51 NM_001113434 
2.12 down 2.02 down 1.05 up C17orf51 NM_001113434 
2.36 up 1.60 up 1.48 down C17orf53 NM_024032 
3.28 up 2.90 up 1.13 down C17orf88 NR_026770 
2.07 up 2.17 up 1.05 up C19orf25 NM_152482 
1.03 down 2.73 down 2.65 down C19orf33 NM_033520 
2.94 up 3.47 up 1.18 up C19orf46 NM_001039876 
8.01 up 7.69 up 1.04 down C19orf57 NM_024323 
5.70 down 2.82 down 2.02 up C19orf81 NM_001195076 
2.27 down 2.09 down 1.09 up C1D NM_006333 
2.02 up 1.56 up 1.30 down C1orf112 NM_018186 
3.68 up 2.49 up 1.48 down C1orf213 NR_033690 
2.26 up 1.26 up 1.79 down C1orf213 NR_033691 
2.08 down 1.53 down 1.36 up C1orf229 NM_207401 
3.13 up 4.15 up 1.33 up C1orf51 NM_144697 
1.97 up 2.08 up 1.05 up C1orf63 NM_020317 
1.71 up 2.02 up 1.18 up C1orf93 NM_001195736 
4.00 up 3.71 up 1.08 down C21orf15 NR_026755 
2.14 down 1.69 down 1.27 up C21orf33 
 
1.75 up 2.07 up 1.18 up C21orf63 NM_058187 
1.73 up 2.11 up 1.22 up C21orf63 NM_058187 
1.62 up 2.13 up 1.32 up C21orf63 NM_058187 
3.23 up 3.22 up 1.00 down C21orf71 NR_024092 
2.18 up 3.85 up 1.76 up C21orf81 NR_027270 
5.25 up 5.23 up 1.00 down C22orf45 NR_028484 
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1.94 up 2.19 up 1.13 up C2CD2 NM_015500 
2.61 up 2.30 up 1.14 down C2CD4D NM_001136003 
4.53 up 2.78 up 1.63 down C2orf15 NM_144706 
8.47 up 4.51 up 1.88 down C2orf54 NM_024861 
6.71 up 5.09 up 1.32 down C2orf55 NM_207362 
2.93 up 3.11 up 1.06 up C2orf65 NM_138804 
2.21 up 1.86 up 1.19 down C3orf14 NM_020685 
2.22 up 1.91 up 1.16 down C3orf17 NM_015412 
2.72 down 2.17 down 1.26 up C3orf33 NM_173657 
6.64 down 7.58 down 1.14 down C3orf67 NM_198463 
2.10 up 1.76 up 1.19 down C4orf21 AK002193 
2.05 down 1.62 down 1.26 up C4orf32 NM_152400 
2.07 up 1.58 up 1.31 down C4orf46 NM_001008393 
57.41 up 131.36 up 2.29 up C4orf7 NM_152997 
3.55 up 4.49 up 1.27 up C5 NM_001735 
1.71 down 2.57 down 1.50 down C5AR1 NM_001736 
1.66 up 2.21 up 1.33 up C5orf25 AK299336 
2.29 down 1.33 down 1.72 up C5orf27 NR_026936 
2.33 up 1.93 up 1.21 down C5orf30 NM_033211 
2.88 up 2.80 up 1.03 down C5orf34 NM_198566 
2.00 up 2.05 up 1.02 up C5orf54 NM_022090 
3.84 up 4.02 up 1.05 up C5orf56 AK096941 
3.39 up 3.58 up 1.06 up C5orf56 AK025221 
2.63 up 2.68 up 1.02 up C5orf56 NR_045116 
1.39 down 2.02 down 1.45 down C6orf170 NM_152730 
8.62 up 4.18 up 2.06 down C7orf13 NR_026865 
2.95 up 2.47 up 1.19 down C7orf13 NR_026865 
2.35 up 2.77 up 1.18 up C7orf46 NM_001127364 
2.19 up 2.56 up 1.17 up C7orf46 NM_199136 
1.97 up 2.20 up 1.12 up C7orf46 NM_199136 
8.44 up 9.61 up 1.14 up C8G NM_000606 
3.66 up 4.73 up 1.29 up C8G NM_000606 
2.09 up 1.35 up 1.55 down C8orf39 NR_027259 
3.18 up 3.20 up 1.01 up C8orf45 NM_173518 
3.54 up 2.73 up 1.30 down C8orf51 NR_026785 
1.61 up 2.10 up 1.30 up C8orf80 NM_001010906 
2.08 up 2.68 up 1.29 up C9orf174 NM_020893 
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2.16 up 1.89 up 1.14 down C9orf3 NM_032823 
1.65 up 2.02 up 1.23 up C9orf91 NM_153045 
2.29 down 4.83 down 2.10 down CA12 NM_001218 
1.54 down 2.19 down 1.42 down CAB39 NM_001130849 
2.05 down 1.76 down 1.17 up CALCRL NM_005795 
1.38 down 2.05 down 1.49 down CAP1 NM_006367 
2.60 down 3.49 down 1.34 down CAP2 NM_006366 
5.42 up 7.24 up 1.34 up CAPN14 NM_001145122 
1.00 up 2.28 down 2.29 down CAPSL NM_144647 
2.21 down 1.93 down 1.14 up CARD6 NM_032587 
2.97 down 2.62 down 1.13 up CARD6 NM_032587 
3.29 up 1.59 up 2.07 down CASC2 NR_026939 
1.97 up 2.08 up 1.06 up CASP2 NM_032982 
3.66 up 2.39 up 1.53 down CATSPE
R2 NM_172097 
2.12 down 3.91 down 1.84 down CAV1 NM_001753 
2.17 down 3.65 down 1.68 down CAV1 NM_001753 
1.46 down 2.76 down 1.89 down CAV2 NM_001233 
2.63 down 4.34 down 1.65 down CAV3 NM_001234 
1.10 down 2.11 up 2.31 up CBFA2T3 NM_005187 
6.91 up 9.65 up 1.40 up CBLN2 NM_182511 
6.83 up 4.90 up 1.40 down CBS NM_000071 
2.36 up 2.95 up 1.25 up CBX5 NM_001127322 
2.39 up 2.40 up 1.00 up CBX6 NM_014292 
2.30 up 3.30 up 1.43 up CBX7 NM_175709 
2.33 up 2.34 up 1.00 up CCDC14 NM_022757 
3.13 up 2.32 up 1.35 down CCDC146 NM_020879 
1.36 down 3.11 down 2.28 down CCDC147 NM_001008723 
2.36 up 1.74 up 1.36 down CCDC150 NM_001080539 
2.83 up 1.58 up 1.79 down CCDC24 NM_152499 
2.42 up 2.48 up 1.02 up CCDC28
B 
NM_024296 
2.02 up 1.53 up 1.32 down CCDC34 NM_030771 
2.30 up 3.05 up 1.33 up CCDC74
B 
NM_207310 
2.13 up 1.78 up 1.20 down CCDC93 NM_019044 
7.16 up 5.62 up 1.27 down CCL20 NM_004591 
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2.78 down 3.31 down 1.19 down CCL26 NM_006072 
1.65 down 2.03 down 1.23 down CCNC NM_005190 
2.36 up 1.65 up 1.43 down CCNE2 NM_057749 
2.71 up 2.39 up 1.13 down CCNG2 NM_004354 
6.26 up 7.95 up 1.27 up CCNI2 NM_001039780 
3.82 up 2.53 up 1.51 down CCNJL NM_024565 
1.86 down 2.09 down 1.12 down CCNK NM_001099402 
3.87 up 3.05 up 1.27 down CCNO NM_021147 
1.21 down 2.00 down 1.65 down CCNYL1 NM_152523 
3.62 down 2.04 down 1.77 up CCRL1 NM_178445 
3.02 down 2.63 down 1.15 up CD209 NM_021155 
4.25 down 3.24 down 1.31 up CD209 NM_001144897 
12.26 down 1.93 down 6.36 up CD36 NM_001001547 
2.01 up 2.38 up 1.18 up CD40 NM_001250 
2.27 down 1.89 down 1.20 up CD55 NM_000574 
1.30 down 2.00 down 1.54 down CD68 NM_001251 
6.64 up 6.24 up 1.06 down CD8B NM_004931 
6.47 up 5.65 up 1.15 down CD8B NM_004931 
5.72 up 4.80 up 1.19 down CD8B NM_172102 
2.61 down 3.74 down 1.43 down CDA NM_001785 
2.02 up 1.44 up 1.40 down CDC25A NM_001789 
2.05 up 1.69 up 1.21 down CDC25C NM_001790 
3.73 up 2.94 up 1.27 down CDC42EP4 NM_012121 
2.25 up 2.18 up 1.03 down CDC7 NM_003503 
2.64 up 2.06 up 1.28 down CDCA7 NM_031942 
2.20 up 1.25 down 2.75 down CDCP1 NM_178181 
3.45 down 5.57 down 1.62 down CDH15 NM_004933 
2.84 down 1.96 down 1.45 up CDHR1 NM_033100 
4.11 up 2.17 up 1.90 down CDK1 NM_001170406 
3.66 up 2.12 up 1.73 down CDK18 NM_212503 
2.17 up 1.95 up 1.11 down CDK20 NM_001039803 
2.01 down 3.03 down 1.51 down CDK6 NM_001259 
31.15 up 24.37 up 1.28 down CDKN2A NM_000077 
12.93 up 13.10 up 1.01 up CDKN2A NM_058197 
5.12 up 4.27 up 1.20 down CDKN2B- NR_003529 
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4.51 up 4.41 up 1.02 down CDKN2B-AS NR_003529 
3.41 up 5.11 up 1.50 up CDKN2C NM_078626 
2.91 up 4.19 up 1.44 up CDON NM_016952 
15.88 down 25.99 down 1.64 down CDSN NM_001264 
4.99 up 3.44 up 1.45 down CEACAM1 NM_001712 
1.57 down 2.19 down 1.39 down CEBPE NM_001805 
5.19 up 5.12 up 1.01 down CECR7 NR_015352 
4.60 up 11.39 up 2.47 up CELF4 NM_020180 
2.65 up 3.52 up 1.33 up CELF4 NM_020180 
2.60 up 1.56 up 1.67 down CELSR2 NM_001408 
3.29 up 3.69 up 1.12 up CELSR3 NM_001407 
2.64 up 1.84 up 1.44 down CENPF NM_016343 
2.20 up 1.41 up 1.56 down CENPF NM_016343 
2.68 up 1.78 up 1.50 down CENPH NM_022909 
2.52 up 2.36 up 1.07 down CENPJ NM_018451 
2.97 up 2.32 up 1.28 down CENPK NM_022145 
2.36 up 2.47 up 1.05 up CENPM NM_001002876 
1.76 up 2.43 up 1.38 up CENPM NM_024053 
2.21 up 1.71 up 1.29 down CENPO NM_001199803 
2.15 down 2.13 down 1.01 up CEP112 NM_145036 
2.31 up 1.85 up 1.25 down CEP152 NM_014985 
1.82 up 2.18 up 1.19 up CEP68 BX648774 
2.37 up 3.98 up 1.68 up CGNL1 NM_032866 
1.98 up 3.41 up 1.73 up CHADL NM_138481 
2.28 up 2.03 up 1.12 down CHAF1A NM_005483 
2.11 up 2.26 up 1.07 up CHAF1A NM_005483 
2.34 up 2.62 up 1.12 up CHAF1B NM_005441 
8.45 up 9.20 up 1.09 up CHDH NM_018397 
2.60 up 2.90 up 1.11 up CHDH NM_018397 
2.06 down 1.97 down 1.05 up CHPF 
 
3.14 up 3.50 up 1.11 up CHPT1 NM_020244 
3.07 up 2.68 up 1.15 down CHRFAM7A NM_139320 
2.01 up 1.79 up 1.13 down CHRNA6 NM_004198 
1.33 down 2.08 down 1.56 down CHRNB1 NM_000747 
5.70 down 1.65 down 3.44 up CIDEA NM_001279 
2.44 up 2.01 up 1.22 down CIDEB NM_014430 
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2.29 up 2.14 up 1.07 down CIRBP NR_023312 
2.80 up 2.62 up 1.07 down CIT NM_007174 
1.57 down 4.26 down 2.71 down CLCA2 NM_006536 
2.05 down 3.25 down 1.59 down CLCF1 NM_013246 
4.32 up 3.27 up 1.32 down CLDN1 NM_021101 
70.03 up 38.41 up 1.82 down CLDN10 NM_182848 
9.51 up 9.57 up 1.01 up CLDN10 
 
1.36 up 1.68 down 2.28 down CLDN12 NM_012129 
12.76 up 30.52 up 2.39 up CLDN3 NM_001306 
5.58 up 2.64 up 2.11 down CLDN7 NM_001307 
2.37 up 2.04 up 1.16 down CLDN7 NM_001307 
2.65 down 1.68 up 4.46 up CLEC3B NM_003278 
4.44 down 2.10 down 2.11 up CLEC4G NM_198492 
11.46 up 8.77 up 1.31 down CLGN NM_004362 
1.40 down 2.15 down 1.53 down CLIC4 NM_013943 
1.77 down 2.19 down 1.23 down CLIP4 NM_024692 
1.89 down 2.55 down 1.35 down CLIP4 NM_024692 
1.62 up 2.06 up 1.27 up CLK4 NM_020666 
2.29 up 2.51 up 1.09 up CLMN NM_024734 
2.01 down 2.45 down 1.22 down CLMP NM_024769 
2.35 up 1.94 up 1.22 down CLTC-IT1 XM_003118745 
1.97 down 2.15 down 1.10 down CLTCL1 NM_007098 
2.09 up 1.50 up 1.40 down CNOT4 BC035590 
1.86 down 2.07 down 1.12 down CNST NM_001139459 
2.34 up 2.31 up 1.01 down CNTLN NM_017738 
2.45 down 1.84 down 1.33 up CNTNAP3B 
NM_00120138
0 
2.58 down 1.83 down 1.41 up CNTNAP3B AK054645 
2.58 up 2.53 up 1.02 down CNTRL AK097636 
22.02 up 4.91 up 4.48 down COL22A1 
 
12.09 up 3.97 up 3.04 down COL22A1 NM_152888 
3.05 up 5.34 up 1.75 up COL4A4 NM_000092 
12.35 down 12.16 down 1.02 up COL4A6 NM_033641 
4.70 up 5.16 up 1.10 up COL9A2 NM_001852 
2.37 down 1.77 down 1.34 up COPZ2 NM_016429 
2.93 up 2.03 up 1.44 down COQ4 AK301333 
2.13 up 1.90 up 1.12 down COX19 NM_001031617 
2.49 down 1.98 down 1.26 up COX7A1 NM_001864 
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1.90 up 3.92 up 2.07 up CPEB1 NM_030594 
3.05 up 11.32 up 3.72 up CR2 NM_001006658 
1.73 up 2.22 up 1.29 up CREB3L4 NM_130898 
1.73 down 2.76 down 1.60 down CREB5 NM_182898 
5.66 down 4.85 down 1.17 up CREG2 NM_153836 
1.73 up 2.72 up 1.57 up CRIP3 NM_206922 
2.34 up 2.23 up 1.05 down CRIPAK NM_175918 
1.53 up 2.08 up 1.36 up CRNDE NR_034105 
1.51 up 2.48 up 1.64 up CRNDE NR_034105 
2.14 up 1.87 up 1.15 down CRYGS NM_017541 
2.06 down 1.78 down 1.16 up CSGALNACT1 
NM_00113051
8 
1.82 up 2.22 up 1.22 up CTRC NM_007272 
1.25 down 2.08 down 1.67 down CTSL1 NM_001912 
1.34 down 2.25 down 1.68 down CTSL1P8 NR_033405 
1.61 down 2.71 down 1.69 down CTTN NM_001184740 
1.82 up 2.40 up 1.32 up CUL3 NM_003590 
2.37 up 2.60 up 1.10 up CUL9 NM_015089 
2.70 up 3.04 up 1.13 up CX3CL1 NM_002996 
1.22 up 2.46 up 2.02 up CX3CR1 NM_001337 
3.17 up 2.59 up 1.22 down CXADR NM_001338 
6.05 up 4.05 up 1.49 down CXCL10 NM_001565 
5.04 up 3.67 up 1.37 down CXCL10 NM_001565 
4.45 down 1.75 down 2.54 up CXCL12 NM_001033886 
6.05 down 5.02 down 1.20 up CXCL14 NM_004887 
2.74 down 2.32 down 1.18 up CXorf48 NM_001031705 
4.09 up 4.00 up 1.02 down CXXC4 NM_025212 
3.03 up 2.35 up 1.29 down CYB5R2 NM_016229 
2.40 down 1.22 down 1.97 up CYBRD1 NM_024843 
10.95 up 3.10 up 3.54 down CYP24A1 NM_000782 
7.59 up 2.48 up 3.07 down CYP24A1 NM_000782 
3.34 up 4.81 up 1.44 up CYP27A1 NM_000784 
2.36 up 1.95 up 1.21 down CYP2D6 NM_000106 
4.51 up 5.16 up 1.15 up CYP2E1 NM_000773 
4.96 up 3.00 up 1.65 down CYP2J2 NM_000775 
12.13 up 11.76 up 1.03 down CYP4X1 NM_178033 
9.19 up 6.60 up 1.39 down CYP4Z1 NM_178134 
7.53 up 6.17 up 1.22 down CYP4Z1 NM_178134 
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5.81 up 5.34 up 1.09 down CYP4Z1 NM_178134 
1.63 up 2.06 up 1.26 up D2HGDH NM_152783 
1.99 down 3.30 down 1.66 down DAAM1 NM_014992 
1.87 down 2.20 down 1.18 down DAAM2 BC078153 
3.42 up 1.98 up 1.73 down DAGLA NM_006133 
1.88 up 2.19 up 1.17 up DBP NM_001352 
1.58 down 2.07 down 1.31 down DCBLD1 NM_173674 
1.84 down 2.03 down 1.10 down DCUN1D3 NM_173475 
1.97 down 2.77 down 1.41 down DCUN1D5 NM_032299 
1.69 up 2.17 up 1.28 up DDB2 NM_000107 
3.19 up 2.01 up 1.59 down DDX11 NM_152438 
2.69 up 2.20 up 1.22 down DDX11 NM_030653 
2.55 up 2.18 up 1.17 down DDX11 NM_030653 
1.68 up 2.18 up 1.30 up DDX17 NM_006386 
2.48 up 2.56 up 1.03 up DDX26B NM_182540 
2.15 up 2.39 up 1.11 up DDX26B NM_182540 
113.3
0 up 8.01 up 14.15 down DDX3Y 
NM_00112266
5 
3.74 up 1.66 up 2.25 down DDX3Y NM_004660 
2.02 up 1.41 up 1.43 down DEM1 NM_022774 
1.44 up 2.18 up 1.51 up DENND2D NM_024901 
2.12 up 1.55 up 1.37 down DENR NM_003677 
3.40 up 4.62 up 1.36 up DERL3 NM_198440 
1.71 down 2.72 down 1.59 down DFNA5 NM_004403 
2.70 up 2.78 up 1.03 up DHFR NM_000791 
1.72 up 2.49 up 1.44 up DHRS3 NM_004753 
2.14 up 1.10 up 1.94 down DHX34 NM_014681 
2.03 up 2.13 up 1.05 up DIDO1 NM_080797 
5.70 down 2.47 down 2.31 up DIRAS1 NM_145173 
2.03 up 2.01 up 1.01 down DKFZp547G183 AL359570 
4.17 down 2.98 down 1.40 up DKFZP586K1520 AL050153 
2.76 down 2.63 down 1.05 up DKFZp779M0652 NR_027134 
2.08 up 1.87 up 1.11 down DLG3 NM_021120 
2.18 down 4.17 down 1.91 down DLX1 NM_178120 
2.10 down 5.02 down 2.39 down DLX2 NM_004405 
3.74 up 3.02 up 1.24 down DMD NM_004010 
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2.91 up 1.97 up 1.47 down DMD NM_004021 
3.65 down 4.10 down 1.12 down DMKN NM_033317 
3.89 down 4.05 down 1.04 down DMKN NM_001035516 
21.02 up 23.04 up 1.10 up DMRTA2 NM_032110 
1.45 up 2.04 up 1.41 up DNHD1 NM_144666 
1.22 up 3.48 up 2.85 up DNM1P46 NR_003260 
1.17 up 3.77 up 3.22 up DNM1P46 NR_003260 
1.14 up 2.46 up 2.16 up DNM1P46 NR_003260 
2.08 up 1.77 up 1.18 down DNMT1 NM_001130823 
3.64 up 4.17 up 1.15 up DOC2B NM_003585 
2.34 up 2.78 up 1.19 up DOC2B NM_003585 
1.31 down 2.29 down 1.74 down DOCK5 NM_024940 
2.24 up 1.77 up 1.26 down DOT1L NM_032482 
1.06 down 2.53 up 2.68 up DPT NM_001937 
18.78 down 9.20 down 2.04 up DSC1 NM_004948 
5.11 up 6.64 up 1.30 up DSCR6 NM_018962 
3.47 down 10.15 down 2.93 down DSG1 NM_001942 
2.32 up 2.19 up 1.06 down DTL NM_016448 
2.72 up 2.06 up 1.32 down DTX2 NM_001102594 
2.69 up 1.97 up 1.36 down DTX2 NM_020892 
2.62 up 1.89 up 1.38 down DTX2 NM_020892 
2.30 up 1.79 up 1.28 down DTX2 NM_020892 
4.66 up 4.03 up 1.16 down DYDC2 NM_032372 
1.38 down 2.18 down 1.57 down DYNLT3 NM_006520 
2.16 down 1.94 down 1.11 up DYRK4 NM_003845 
3.64 up 2.46 up 1.48 down DZANK1 NM_001099407 
2.13 up 2.35 up 1.11 up E2F2 NM_004091 
3.40 up 2.29 up 1.49 down E2F7 NM_203394 
2.66 up 2.05 up 1.29 down E2F7 NM_203394 
2.46 up 2.19 up 1.13 down E2F8 NM_024680 
2.54 up 2.30 up 1.10 down EBF4 NM_001110514 
2.90 up 2.71 up 1.07 down ECE1 NM_001113347 
1.51 down 2.07 down 1.38 down ECHDC1 NM_018479 
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1.75 up 2.56 up 1.46 up ECHDC2 NM_018281 
2.14 down 1.30 down 1.65 up EDA NM_001005610 
2.10 up 1.36 up 1.54 down EDARADD NM_080738 
1.59 down 2.80 down 1.76 down EFNB3 NM_001406 
2.07 down 1.40 down 1.47 up EGFL7 NM_201446 
4.35 up 4.22 up 1.03 down EGOT NR_004428 
20.29 up 4.95 up 4.10 down EIF1AY NM_004681 
2.46 up 1.93 up 1.28 down EIF3D 
 
4.95 down 1.20 down 4.12 up EIF4G3 
 
2.01 down 2.63 down 1.31 down EML1 NM_001008707 
2.05 up 1.98 up 1.04 down EMP2 NM_001424 
2.14 up 1.32 up 1.62 down ENO1 NM_001428 
4.20 up 4.97 up 1.18 up ENPP5 NM_021572 
1.53 up 2.02 up 1.32 up EPB41L4A NM_022140 
2.49 up 1.98 up 1.26 down EPB41L5 NM_020909 
4.34 up 6.20 up 1.43 up EPHA10 NM_001099439 
2.62 up 4.39 up 1.68 up EPHX2 NM_001979 
3.11 up 2.41 up 1.29 down EPHX3 NM_024794 
2.73 up 2.34 up 1.16 down EPM2AIP1 NM_014805 
1.61 down 2.00 down 1.25 down EPT1 NM_033505 
1.65 down 2.11 down 1.28 down ERBB2 AB025286 
2.92 up 3.14 up 1.08 up ERO1LB NM_019891 
2.15 up 2.70 up 1.26 up ERVK13-1 NR_040023 
2.30 up 1.76 up 1.31 down ESPL1 NM_012291 
2.95 up 2.82 up 1.05 down ESPN NM_031475 
3.04 up 3.84 up 1.26 up ESR1 NM_000125 
1.60 down 2.52 down 1.58 down ETNK1 NM_001039481 
3.61 up 1.36 down 4.89 down ETV4 NM_001079675 
2.23 up 2.29 up 1.03 up ETV6 NM_001987 
4.52 up 9.08 up 2.01 up EXOC3L4 NM_001077594 
1.39 down 2.92 down 2.09 down EXOC6B NM_015189 
2.29 up 2.04 up 1.12 down EXOC7 AK022397 
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2.39 up 4.60 up 1.92 up EYA2 NM_005244 
1.75 up 3.09 up 1.77 up EZH1 NM_001991 
2.03 up 2.27 up 1.11 up EZH2 NM_004456 
7.38 down 10.67 down 1.45 down F2RL1 NM_005242 
1.01 down 3.02 down 3.00 down F3 NM_001993 
2.95 up 3.69 up 1.25 up FAAH2 NM_174912 
46.59 down 3.98 down 11.70 up FABP4 NM_001442 
2.88 up 3.73 up 1.29 up FADS2 NM_004265 
2.48 up 2.55 up 1.03 up FAM106CP NR_026810 
2.15 up 1.57 up 1.37 down FAM108A1 AK090438 
1.96 down 2.67 down 1.36 down FAM110C NM_001077710 
2.02 down 2.54 down 1.26 down FAM110C NM_001077710 
2.42 up 2.81 up 1.16 up FAM111B NM_198947 
1.70 up 2.48 up 1.46 up FAM117A NM_030802 
2.05 down 2.49 down 1.21 down FAM126A NM_032581 
2.22 down 2.53 down 1.14 down FAM126A NM_032581 
3.04 down 3.53 down 1.16 down FAM126A  
1.76 up 2.56 up 1.45 up FAM149A NM_015398 
6.16 up 6.15 up 1.00 down FAM150B NM_001002919 
5.89 up 6.16 up 1.05 up FAM150B NM_001002919 
2.86 up 1.72 up 1.66 down FAM161A NM_032180 
2.59 up 1.58 up 1.64 down FAM161A NM_032180 
2.10 up 2.67 up 1.27 up FAM164A NM_016010 
1.72 up 3.23 up 1.87 up FAM164A NM_016010 
2.05 up 2.76 up 1.35 up FAM171A1 
NM_00101092
4 
1.03 down 3.31 down 3.21 down FAM176 NM_00113503
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A 2 
3.43 up 4.26 up 1.24 up FAM189A2 NM_004816 
3.04 up 7.51 up 2.47 up FAM189A2 NM_004816 
2.96 up 1.56 up 1.89 down FAM24B NM_152644 
3.19 up 2.54 up 1.26 down FAM27E3 XM_001720463 
18.03 up 17.87 up 1.01 down FAM3B NM_058186 
2.72 up 2.18 up 1.24 down FAM65C NM_080829 
4.65 up 3.75 up 1.24 down FAM81A NM_152450 
1.44 down 5.15 down 3.57 down FAM83A NM_207006 
1.47 down 4.38 down 2.97 down FAM83A NM_032899 
1.07 up 2.10 down 2.23 down FAM83B NM_001010872 
3.27 down 3.27 down 1.00 down FAM89A NM_198552 
1.43 down 2.48 down 1.73 down FAM91A1 NM_144963 
2.35 up 1.93 up 1.22 down FANCA NM_001018112 
2.09 up 1.64 up 1.28 down FANCB NM_001018113 
2.43 up 2.79 up 1.15 up FANCC NM_000136 
2.32 up 1.71 up 1.36 down FANCD2 NM_001018115 
2.18 up 1.73 up 1.26 down FANCG NM_004629 
2.45 up 2.36 up 1.04 down FANCL NM_018062 
2.41 up 2.19 up 1.10 down FANCL NM_001114636 
2.28 up 1.65 up 1.38 down FAR1 NM_032228 
2.11 up 2.04 up 1.03 down FAT2 NM_001447 
1.65 up 2.10 up 1.27 up FAT3 NM_001008781 
2.09 up 2.21 up 1.05 up FBF1 NM_001080542 
1.73 down 2.54 down 1.47 down FBLIM1 NM_017556 
1.87 down 2.88 down 1.54 down FBLIM1 NM_001024215 
1.35 down 2.00 down 1.48 down FBXO3 NM_033406 
3.57 up 3.91 up 1.10 up FBXO43 NM_001029860 
2.67 up 3.83 up 1.44 up FCGBP NM_003890 
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2.24 down 3.38 down 1.51 down FERMT2 NM_001135000 
2.53 down 2.39 down 1.06 up FERMT2 NM_001134999 
1.83 down 2.29 down 1.25 down FEZ1 NM_005103 
3.38 down 3.08 down 1.10 up FFAR3 NM_005304 
4.47 up 3.95 up 1.13 down FHAD1 NM_052929 
1.73 up 2.38 up 1.38 up FICD NM_007076 
2.39 up 1.91 up 1.25 down FIGNL1 NM_001042762 
2.77 up 2.96 up 1.07 up FLJ11710 AK021772 
6.62 down 13.13 down 1.98 down FLJ13744 AK023806 
2.17 up 1.81 up 1.20 down FLJ14186 NR_037596 
2.03 up 2.07 up 1.02 up FLJ14186 NR_037596 
2.33 down 2.21 down 1.05 up FLJ16779 NR_024389 
4.04 down 6.01 down 1.49 down FLJ22447 NR_039985 
2.20 up 2.07 up 1.06 down FLJ25694 AK127969 
1.75 down 2.45 down 1.40 down FLJ30838 NR_033873 
2.73 down 2.21 down 1.24 up FLJ31713 AK056275 
5.02 up 1.72 up 2.91 down FLJ35024 NR_015375 
4.49 up 1.83 up 2.45 down FLJ35024 NR_015375 
4.15 up 3.75 up 1.11 down FLJ35024 BC090887 
2.62 up 1.44 up 1.82 down FLJ35024 NR_015375 
5.96 up 4.30 up 1.39 down FLJ37638 AK127565 
5.32 up 3.20 up 1.66 down FLJ37638 AK094957 
4.98 up 4.42 up 1.13 down FLJ37638 AK127565 
2.50 down 3.95 down 1.58 down FLJ37786 XR_108343 
2.14 up 3.13 up 1.47 up FLJ38109 AK095428 
2.63 up 3.40 up 1.29 up FLJ38717 XR_108650 
1.98 up 2.40 up 1.21 up FLJ39653 BC132927 
4.21 up 3.69 up 1.14 down FLJ40852 NR_015392 
4.98 down 4.24 down 1.17 up FLJ41200 NR_033863 
2.00 up 2.03 up 1.02 up FLJ42289 NR_028139 
2.83 down 2.69 down 1.05 up FLJ45248 AK127183 
3.03 down 2.71 down 1.12 up FLJ45248 AK127183 
2.37 up 2.06 up 1.15 down FLJ45340 NR_024368 
10.67 up 5.96 up 1.79 down FLJ45482 AK127393 
7.01 up 4.98 up 1.41 down FLJ45482 AK127393 
1.51 down 2.12 down 1.41 down FLJ46906 NR_033896 
2.03 up 1.82 up 1.12 down FLNA AK125630 
1.64 down 3.03 down 1.85 down FLRT2 NM_013231 
1.93 down 5.93 down 3.07 down FLRT3 NM_198391 
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2.23 up 2.26 up 1.02 up FMNL3 NM_175736 
5.65 down 2.84 down 1.99 up FNDC1 NM_032532 
5.27 down 3.43 down 1.54 up FONG NR_034096 
1.18 down 3.21 down 2.72 down FOSL1 NM_005438 
7.80 up 5.61 up 1.39 down FOXA1 NM_004496 
6.68 up 7.62 up 1.14 up FOXD3 NM_012183 
3.17 up 2.54 up 1.25 down FOXD4 NM_207305 
1.60 down 2.22 down 1.39 down FOXF2 NM_001452 
1.65 down 2.31 down 1.40 down FOXP1 NM_001244808 
2.17 up 1.64 up 1.32 down FOXP4 NM_001012426 
4.27 up 3.60 up 1.19 down FOXRED2 NM_024955 
2.57 up 2.40 up 1.07 down FOXRED2 NM_024955 
2.14 up 1.75 up 1.22 down FRA10AC1 NM_145246 
2.85 up 3.14 up 1.10 up FRMD4A AK001072 
2.44 up 1.99 up 1.23 down FRMD4A NM_018027 
1.22 down 2.23 down 1.83 down FSD1L NM_031919 
1.89 up 1.95 down 3.68 down FST NM_013409 
2.28 down 2.85 down 1.25 down FSTL3 NM_005860 
3.35 up 2.83 up 1.18 down FXYD3 NM_001136008 
2.19 up 2.63 up 1.20 up FXYD6 NM_022003 
1.46 up 2.38 up 1.63 up FZD8 NM_031866 
43.03 up 22.78 up 1.89 down GABRP NM_014211 
10.88 up 8.27 up 1.32 down GAD1 NM_000817 
4.35 down 6.06 down 1.39 down GAL NM_015973 
2.04 down 1.69 down 1.21 up GALNT1 NM_020474 
2.45 down 2.89 down 1.18 down GALNT6 NM_007210 
5.21 down 3.94 down 1.32 up GALNTL2 NM_054110 
3.82 down 4.09 down 1.07 down GAST NM_000805 
2.36 up 3.49 up 1.48 up GATM NM_001482 
2.42 up 2.72 up 1.13 up GBP4 NM_052941 
3.98 up 4.76 up 1.20 up GCET2 NM_001190259 
2.40 up 2.72 up 1.13 up GCET2 NM_001190259 
2.10 up 2.49 up 1.18 up GCHFR NM_005258 
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2.01 up 2.17 up 1.08 up GGA2 NM_015044 
2.06 up 1.63 up 1.27 down GGT7 NM_178026 
2.32 up 2.24 up 1.04 down GHRLOS NR_004431 
2.22 up 1.72 up 1.29 down GINS1 NM_021067 
2.60 up 2.29 up 1.14 down GINS4 NM_032336 
2.26 down 2.74 down 1.21 down GJA1 NM_000165 
1.59 down 1.32 up 2.11 up GJA4 NM_002060 
1.91 down 4.10 down 2.14 down GJB2 NM_004004 
5.67 up 1.75 up 3.24 down GJB4 NM_153212 
7.49 down 13.62 down 1.82 down GJB6 NM_006783 
1.73 up 2.20 up 1.28 up GKAP1 NM_025211 
3.39 up 3.77 up 1.11 up GLB1L2 NM_138342 
10.43 up 10.96 up 1.05 up GLS2 NM_013267 
2.14 down 1.56 down 1.37 up GNG11 NM_004126 
3.48 down 4.59 down 1.32 down GNGT1 NM_021955 
2.04 up 1.83 up 1.11 down GNRH1 NM_000825 
1.94 up 2.40 up 1.24 up GOLGA2P5 NR_024261 
2.41 down 1.38 down 1.74 up GOLGA6L7P XR_110303 




2.17 up 2.13 up 1.02 down GOLGA8A NR_027409 
6.39 up 6.93 up 1.08 up GOLT1A NM_198447 
3.05 up 2.85 up 1.07 down GPC2 NM_152742 
1.30 down 2.10 down 1.61 down GPM6B NM_001001996 
2.98 up 2.17 up 1.38 down GPR126 NM_020455 
2.11 up 1.52 up 1.39 down GPR137 NM_020155 
2.80 up 2.76 up 1.01 down GPR137C NM_001099652 
8.92 down 4.51 down 1.98 up GPR158 NM_020752 
2.84 up 4.70 up 1.66 up GPR64 NM_001079858 
2.45 up 5.38 up 2.20 up GPT NM_005309 
1.65 down 2.49 down 1.51 down GPX8 NM_001008397 
2.02 up 2.09 up 1.03 up GRAMD4 NM_015124 
7.88 up 13.33 up 1.69 up GRIN2C NM_000835 
1.97 up 2.24 up 1.14 up GRIN2C NM_000835 
1.34 down 2.40 down 1.78 down GRIN3B NM_138690 
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3.18 up 1.39 up 2.29 down GRM8 NM_000845 
2.08 down 5.36 down 2.58 down GSDMC NM_031415 
2.15 down 1.65 down 1.30 up GUCY2G
P 
NR_028134 
2.26 up 2.35 up 1.04 up GUSBP1 NR_027028 
2.03 up 2.14 up 1.06 up GUSBP1 NR_027028 
1.92 up 2.03 up 1.06 up GUSBP11 NR_024448 
3.73 up 2.66 up 1.40 down GUSBP3 AK124130 
2.48 down 1.80 down 1.38 up H2AFJ NM_177925 
2.17 up 1.63 up 1.33 down H2AFV NM_138635 
2.00 up 2.13 up 1.07 up H6PD NM_004285 
1.54 up 2.87 up 1.86 up HAAO NM_012205 
3.12 up 2.19 up 1.42 down HAUS3 NM_024511 
2.39 up 2.39 up 1.00 down HAUS5 NM_015302 
2.37 up 1.31 up 1.81 down HCFC1 NM_005334 
1.24 down 2.04 down 1.65 down HCG18 NR_024052 
2.45 up 1.70 up 1.44 down HCG27 NR_026791 
2.95 up 2.29 up 1.29 down HCN3 NM_020897 
2.06 up 1.50 up 1.37 down HDAC10 NM_032019 
1.49 down 2.00 down 1.35 down HEATR5A BC062720 
2.00 down 2.31 down 1.15 down HEATR7A 
NM_00109928
0 
2.08 up 1.96 up 1.06 down HELLS NM_018063 
1.89 up 2.05 up 1.08 up HELLS NM_018063 
1.78 up 2.06 up 1.16 up HENMT1 NM_144584 
2.54 up 2.62 up 1.03 up HESX1 NM_003865 
1.88 down 2.34 down 1.25 down HIF1A NM_181054 
1.95 down 2.17 down 1.11 down HIF1A NM_181054 
2.89 down 2.19 down 1.32 up HIST2H2AA4 
NM_00104087
4 
2.06 up 1.72 up 1.20 down HIVEP1 NM_002114 
3.74 up 2.55 up 1.47 down HIVEP3 NM_024503 
2.71 up 1.85 up 1.46 down HIVEP3 NR_038260 
5.81 up 9.96 up 1.71 up HLF NM_002126 
2.23 up 2.39 up 1.07 up HLTF NM_003071 
1.37 down 4.13 down 3.01 down HMGA2 NM_003484 
1.96 up 2.11 up 1.08 up HMGB2 NM_002129 
2.10 up 2.51 up 1.19 up HMGN5 NM_030763 
1.91 down 2.48 down 1.30 down HMOX1 NM_002133 
3.11 up 2.94 up 1.06 down HMP19 AK098398 
4.11 up 5.71 up 1.39 up HMSD NM_00112336
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6 
1.55 up 2.04 up 1.32 up HNRNPU
-AS1 NR_026778 
3.15 down 3.66 down 1.16 down HOMER2 NM_199330 
1.25 down 2.06 down 1.65 down HOMER3 NM_001145722 
1.29 down 2.16 down 1.68 down HOMER3 NM_004838 
1.33 down 2.46 down 1.84 down HOMER3 NM_001145724 
2.43 up 1.61 up 1.51 down HOOK2 NM_013312 
1.39 up 2.31 up 1.66 up HOXA6 NM_024014 
1.32 down 5.67 up 7.46 up HOXA7 NM_006896 
23.59 up 49.45 up 2.10 up HOXB13 NM_006361 
2.30 down 1.67 down 1.38 up HOXB2 NM_002145 
4.24 down 4.94 down 1.17 down HOXC13 NM_017410 
3.14 up 4.62 up 1.47 up HOXC6 NM_153693 
3.03 down 2.07 down 1.46 up HOXD8 NM_019558 
1.66 up 2.06 up 1.25 up HP1BP3 NM_016287 
2.41 up 2.81 up 1.17 up HPCA NM_002143 
1.37 down 2.08 down 1.51 down HPSE NM_006665 
1.30 down 3.20 down 2.45 down HS1BP3 BC038847 
2.99 up 1.99 up 1.51 down HS3ST1 NM_005114 
6.83 up 15.30 up 2.24 up HS3ST4 NM_006040 
2.75 up 2.26 up 1.21 down HSD17B7 AK022929 
2.90 down 3.91 down 1.35 down HSPA12A NM_025015 
18.11 down 11.25 down 1.61 up HSPB3 NM_006308 
2.77 up 1.64 up 1.69 down HSPG2 NM_005529 
2.88 down 2.99 down 1.04 down HTR7 NM_019859 
2.12 down 2.00 down 1.06 up HTR7P1 NR_002774 
1.80 up 2.02 up 1.12 up HVCN1 NM_001040107 
1.62 up 2.10 up 1.29 up HVCN1 NM_001040107 
1.76 up 2.70 up 1.53 up ICA1 NM_004968 
1.65 up 2.51 up 1.53 up ICA1 NM_004968 
4.09 up 4.04 up 1.01 down ICAM4 NM_022377 
3.21 up 3.10 up 1.04 down ICOSLG 
 
1.80 up 2.04 up 1.13 up IFT122 NM_018262 
2.24 down 3.86 down 1.72 down IGF2BP2 NM_006548 
4.43 down 7.80 down 1.76 down IGF2BP2 NM_006548 
3.43 down 3.64 down 1.06 down IGFBP6 NM_002178 
1.96 up 2.06 up 1.05 up IGFBPL1 NM_00100756
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3 
6.39 down 8.70 down 1.36 down IGFL2 NM_001002915 
2.13 up 1.91 up 1.11 down IGLL1 NM_020070 
3.26 up 2.87 up 1.13 down IGSF9 NM_020789 
2.54 up 2.10 up 1.21 down IKBKE NM_014002 
3.56 up 2.81 up 1.27 down IKZF3 NM_012481 
1.40 up 3.79 down 5.33 down IL11 NM_000641 
1.77 up 2.25 up 1.27 up IL11RA NM_147162 
9.01 up 8.70 up 1.04 down IL17RB NM_018725 
2.08 up 2.53 down 5.25 down IL1A NM_000575 
1.69 down 2.48 down 1.47 down IL1RAP NM_134470 
1.57 down 5.16 down 3.29 down IL20 NM_018724 
3.82 up 3.44 up 1.11 down IL23A NM_016584 
1.31 down 8.06 down 6.17 down IL24 NM_001185156 
3.33 up 3.30 up 1.01 down IL27RA NM_004843 
3.67 up 2.34 up 1.57 down IL2RG NM_000206 
2.02 up 2.34 up 1.16 up IL2RG NM_000206 
1.54 up 2.18 up 1.41 up IL34 NM_152456 
2.56 up 2.60 up 1.01 up IL4I1 NM_172374 
2.01 up 2.13 up 1.06 up ILDR1 NM_175924 
2.70 down 3.59 down 1.33 down INHBB NM_002193 
3.04 up 3.50 up 1.15 up INPP1 NM_002194 
2.34 up 2.13 up 1.10 down INPP5F NM_014937 
1.86 up 2.11 up 1.13 up INPP5J NM_001002837 
2.94 up 1.25 up 2.34 down INTS4 NM_033547 
1.43 up 1.47 down 2.10 down INTS6 NM_012141 
2.42 down 3.88 down 1.60 down IRS1 NM_005544 
2.65 down 3.71 down 1.40 down IRS1 NM_005544 
1.94 up 2.12 up 1.10 up IRX3 NM_024336 
5.95 up 5.20 up 1.14 down IRX6 NM_024335 
11.21 up 9.93 up 1.13 down ISL1 NM_002202 
2.88 up 2.75 up 1.05 down ISYNA1 NM_016368 
2.72 up 2.93 up 1.08 up ISYNA1 NM_016368 
1.29 down 2.03 down 1.58 down ITGA5 NM_002205 
1.16 down 2.42 down 2.10 down ITGA6 NM_000210 
1.19 down 2.65 down 2.22 down ITGA6 NM_000210 
2.25 down 1.71 down 1.32 up ITGAD NM_005353 
1.36 down 2.03 down 1.49 down JKAMP NM_016475 
1.80 down 2.68 down 1.49 down JPH2 NM_020433 
 168 
5.13 up 4.82 up 1.06 down KATNAL2 NM_031303 
4.01 up 4.06 up 1.01 up KATNAL2 NM_031303 
10.81 up 11.15 up 1.03 up KCNA2 NM_001204269 
2.63 down 1.83 down 1.44 up KCNA6 NM_002235 
10.06 up 13.08 up 1.30 up KCNB2 NM_004770 
1.11 down 2.09 down 1.88 down KCNE1L NM_012282 
3.44 down 2.61 down 1.32 up KCNE4 NM_080671 
2.94 up 1.92 up 1.54 down KCNIP4 NM_001035003 
2.91 up 2.06 up 1.42 down KCNJ14 NM_170720 
1.62 down 2.46 down 1.52 down KCNJ15 NM_170736 
2.28 down 1.57 down 1.45 up KCNJ8 NM_004982 
1.13 down 2.17 up 2.45 up KCNK17 NM_031460 
2.31 down 1.33 down 1.74 up KCNQ4 NM_004700 
97.87 up 63.01 up 1.55 down KCNS1 NM_002251 
2.40 up 1.69 up 1.41 down KDM4C NM_001146694 
11.79 up 4.36 up 2.70 down KDM5D NM_004653 
9.73 up 13.35 up 1.37 up KEL NM_000420 
2.23 down 1.36 down 1.64 up KGFLP1 NR_003674 
2.49 up 2.83 up 1.14 up KHK NM_000221 
2.24 up 4.62 up 2.06 up KIAA0125 NR_026800 
2.72 up 1.53 up 1.78 down KIAA0319L AB058740 
3.28 up 2.47 up 1.33 down KIAA0368 
NM_00108039
8 
2.38 up 2.34 up 1.02 down KIAA0485 AB007954 
2.58 up 2.12 up 1.22 down KIAA1147 
NM_00108039
2 
2.14 up 2.11 up 1.02 down KIAA1147 
NM_00108039
2 
2.12 up 2.11 up 1.00 down KIAA1328 NM_020776 
1.91 up 2.32 up 1.22 up KIAA1407 NM_020817 
2.78 up 1.55 up 1.80 down KIAA1522 NM_020888 
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1.79 up 2.35 up 1.31 up KIAA1683 NM_025249 
3.18 up 6.04 up 1.90 up KIAA2022 
NM_00100853
7 
1.18 down 2.11 down 1.78 down KIF13A NM_022113 
2.41 up 1.70 up 1.42 down KIF15 NM_020242 
2.32 up 1.57 up 1.47 down KIF20A NM_005733 
3.00 up 2.21 up 1.36 down KIF24 NM_194313 
10.15 up 14.69 up 1.45 up KIF25 NM_030615 
2.13 up 1.34 up 1.58 down KIF2C NM_006845 
1.75 down 2.28 down 1.30 down KIRREL NM_018240 
2.12 down 2.24 down 1.06 down KIRREL AK090554 
2.14 up 2.39 up 1.12 up KITLG NM_000899 
1.43 down 3.02 down 2.11 down KLC3 NM_177417 
1.76 down 2.34 down 1.33 down KLF7 NM_003709 
3.62 up 3.46 up 1.05 down KLHDC7B NM_138433 
2.77 up 2.26 up 1.23 down KLHL23 NM_144711 
10.91 up 9.55 up 1.14 down KLHL35 NM_001039548 
2.94 down 5.16 down 1.76 down KLK10 NM_002776 
3.03 down 6.78 down 2.24 down KLK8 NM_144505 
5.67 down 5.84 down 1.03 down KLK9 NM_012315 
2.92 up 2.62 up 1.11 down KNTC1 NM_014708 
2.32 down 4.51 down 1.94 down KPNA7 NM_001145715 
2.76 down 4.47 down 1.62 down KPNA7 NM_001145715 
3.30 up 3.00 up 1.10 down KREMEN1 
NM_00103957
0 
8.30 up 4.83 up 1.72 down KREMEN2 NM_172229 
15.86 up 10.00 up 1.59 down KRT13 NM_002274 
1.22 up 3.41 down 4.16 down KRT14 NM_000526 
7.60 up 4.45 up 1.71 down KRT15 NM_002275 
1.11 up 3.36 down 3.73 down KRT17 NM_000422 
137.2
5 up 43.31 up 3.17 down KRT19 NM_002276 
84.61 up 33.18 up 2.55 down KRT19P2 NR_036685 
1.66 down 4.34 down 2.61 down KRT42P NR_033415 
7.39 down 4.59 down 1.61 up KRT42P NR_033415 
2.25 up 1.96 up 1.15 down KRT86 NM_002284 
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12.66 down 16.24 down 1.28 down KRTDAP NM_207392 
3.75 up 4.22 up 1.13 up L3MBTL1 NM_032107 
3.05 up 2.47 up 1.24 down L3MBTL1 NM_032107 
2.47 up 2.96 up 1.20 up L3MBTL1 XR_109604 
2.44 up 2.86 up 1.17 up L3MBTL1 XR_109604 
4.21 up 4.62 up 1.10 up L3MBTL4 NM_173464 
3.91 up 3.94 up 1.01 up L3MBTL4 NM_173464 
2.00 down 2.03 down 1.01 down LAMA4 NM_001105206 
2.24 down 1.66 down 1.35 up LAMA4 NM_001105209 
2.56 up 1.88 down 4.83 down LAMC2 NM_018891 
1.88 down 2.74 down 1.46 down LANCL3 NM_198511 
7.41 down 4.91 down 1.51 up LCE2A NM_178428 
5.64 down 7.09 down 1.26 down LCE3C NM_178434 
2.44 up 1.69 up 1.45 down LCORL NM_153686 
2.35 down 1.61 down 1.46 up LDB3 NM_001171610 
6.04 up 3.26 up 1.85 down LDHC NM_002301 
3.33 up 2.75 up 1.21 down LEAP2 NM_052971 
2.13 down 2.16 down 1.01 down LEPROT NM_001198683 
2.03 down 2.59 down 1.27 down LETM2 NM_144652 
1.49 down 1.55 up 2.31 up LGALS4 NM_006149 
2.39 up 1.89 up 1.27 down LGALS9 NM_009587 
2.26 up 2.14 up 1.05 down LGALS9C 
NM_00104007
8 
3.10 up 3.00 up 1.04 down LHFPL1 NM_178175 
3.48 down 8.44 down 2.43 down LHX1 NM_005568 
10.91 up 6.94 up 1.57 down LHX2 NM_004789 
3.37 up 3.35 up 1.01 down LIFR NM_002310 
2.70 up 2.56 up 1.05 down LIG1 NM_000234 





2.23 up 2.87 up 1.28 up LINC0002 NR_024358 
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8 
1.55 down 2.04 down 1.32 down LINC00152 NR_024204 
3.37 up 2.80 up 1.20 down LINC00173 NR_027346 
2.89 up 2.73 up 1.06 down LINC00173 NR_027345 
7.40 up 2.88 up 2.57 down LINC00230A NR_002161 
2.06 up 2.59 up 1.26 up LINC00240 NR_026775 
2.38 up 1.89 up 1.26 down LINC00263 NR_026762 
3.42 up 2.57 up 1.33 down LINC00319 NR_026960 
2.00 up 1.49 up 1.34 down LINC00472 NR_026807 
2.17 down 1.51 down 1.44 up LINC00487 NR_038369 
9.68 up 5.26 up 1.84 down LINGO2 NM_152570 
3.08 down 1.88 down 1.64 up LIPC NM_000236 
1.35 up 3.11 up 2.30 up LIPE NM_005357 
4.98 up 3.48 up 1.43 down LMO4 NM_006769 
4.93 up 3.37 up 1.46 down LMO4 NM_006769 
2.47 down 2.18 down 1.13 up LMOD1 NM_012134 
2.42 down 2.14 down 1.13 up LOC100127891 XR_108812 
4.06 up 4.23 up 1.04 up LOC100127909 XR_111781 
2.19 up 2.89 up 1.32 up LOC100128191 NR_027157 
4.28 up 5.24 up 1.22 up LOC100128252 NR_036522 
3.06 up 4.07 up 1.33 up LOC100128252 NR_036522 
2.06 up 1.68 up 1.22 down LOC100128361 NR_036505 
2.20 up 2.29 up 1.04 up LOC100128402 AK124574 
2.00 down 1.35 down 1.49 up LOC100128869 
XM_00171951
8 
1.73 down 2.83 down 1.64 down LOC1001 NR_036480 
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28881 
3.79 up 4.00 up 1.06 up LOC100129148 NR_033999 
1.66 up 2.11 up 1.27 up LOC100129196 NR_034182 
2.77 up 1.88 up 1.48 down LOC100129216 
NM_00124285
3 
2.79 up 2.15 up 1.30 down LOC100129387 NR_024490 
2.56 up 2.95 up 1.15 up LOC100129534 NR_024489 
2.11 down 4.21 down 2.00 down LOC100129781 XR_109259 
2.78 down 4.19 down 1.51 down LOC100129781 XR_109258 
2.04 up 1.98 up 1.03 down LOC100129917 NR_036511 
2.94 up 2.75 up 1.07 down LOC100130093 NR_024485 
2.00 up 1.65 up 1.21 down LOC100130463 AK124300 
2.27 up 2.53 up 1.11 up LOC100130930 AK126579 
2.35 down 3.67 down 1.57 down LOC100130938 XR_110148 
2.60 down 4.66 down 1.80 down LOC100130938 XR_110148 
3.02 down 4.11 down 1.36 down LOC100130938 XR_110148 
2.09 up 3.20 up 1.53 up LOC100131096 NR_040071 
1.99 down 2.09 down 1.05 down LOC100131242 AK124483 
1.97 up 2.99 up 1.52 up LOC100131355 AK124217 
1.84 up 2.62 up 1.42 up LOC100131564 NR_034089 
1.84 up 2.60 up 1.42 up LOC100131564 NR_034089 
5.16 up 5.47 up 1.06 up LOC100131654 AK124891 
3.14 up 2.33 up 1.35 down LOC1001 AK126439 
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31929 
3.43 up 2.99 up 1.15 down LOC100132111 NR_024237 
2.40 up 1.96 up 1.22 down LOC100132167 BC006438 
2.19 up 2.24 up 1.02 up LOC100132247 
NM_00113586
5 
2.21 up 1.82 up 1.22 down LOC100132287 NR_028322 
2.22 up 2.38 up 1.07 up LOC100132352 AK023536 
2.17 up 2.01 up 1.08 down LOC100132832 NR_028058 
2.03 up 1.79 up 1.13 down LOC100132832 NR_028058 
2.15 up 2.08 up 1.03 down LOC100133050 NR_027503 
2.68 up 2.41 up 1.11 down LOC100133315 NR_029192 
2.10 up 1.68 up 1.25 down LOC100133331 NR_028327 
2.44 up 2.23 up 1.10 down LOC100144603 BQ706985 
2.56 up 2.86 up 1.12 up LOC100170939 NR_024054 
2.20 up 3.48 up 1.58 up LOC100233156 AK126241 
3.65 up 2.17 up 1.68 down LOC100272216 NR_027439 
2.60 up 3.28 up 1.26 up LOC100287188 
XM_00311910
4 
1.65 down 2.57 down 1.56 down LOC100287314 NR_040245 
2.28 up 2.07 up 1.10 down LOC100288637 NR_038253 
2.12 down 1.87 down 1.13 up LOC100288911 NR_037631 
2.28 down 1.96 down 1.17 up LOC100288911 NR_037631 
1.80 up 2.19 up 1.22 up LOC100289097 
XM_00234389
1 
2.36 up 2.51 up 1.06 up LOC1002 NR_036530 
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89230 
1.55 up 2.34 up 1.50 up LOC100499466 NR_027418 
2.23 up 2.41 up 1.08 up LOC100505483 NR_038926 
2.31 up 1.76 up 1.32 down LOC100505648 AK125393 
2.11 up 1.86 up 1.14 down LOC100505666 NR_040772 
2.42 down 3.06 down 1.27 down LOC100505668 XR_112556 
2.11 down 1.54 down 1.37 up LOC100505679 
NM_00124353
1 
2.20 down 2.34 down 1.06 down LOC100505687 NR_038301 
1.39 up 2.61 up 1.88 up LOC100505719 XR_110561 
2.65 down 2.72 down 1.03 down LOC100505729 XR_108524 
1.41 up 3.27 up 2.32 up LOC100505799 XR_111953 
7.46 up 2.55 up 2.93 down LOC100505882 XR_110336 
1.68 up 2.06 up 1.23 up LOC100505960 XR_108741 
2.81 down 1.18 down 2.39 up LOC100505976 XR_110096 
6.13 up 3.89 up 1.58 down LOC100506003 XR_109785 
2.89 up 3.34 up 1.16 up LOC100506123 NR_040097 
2.66 up 3.45 up 1.30 up LOC100506123 NR_040097 
1.65 down 2.09 down 1.27 down LOC100506136 NR_038948 
3.17 up 2.07 up 1.54 down LOC100506255 
XM_00340363
6 
2.72 up 2.28 up 1.19 down LOC100506262 XR_109925 
3.47 up 1.93 up 1.80 down LOC100506314 NR_038920 
2.19 down 1.71 down 1.29 up LOC1005 XR_112081 
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06327 
15.22 up 2.12 up 7.19 down LOC100506328 AK055877 
7.42 up 1.61 up 4.62 down LOC100506328 AK055877 
5.82 up 1.45 up 4.03 down LOC100506328 AK055877 
2.05 up 2.15 up 1.05 up LOC100506342 XR_108862 
2.44 up 2.31 up 1.05 down LOC100506379 XR_108672 
2.39 up 2.16 up 1.11 down LOC100506472 NR_040535 
3.54 up 2.65 up 1.33 down LOC100506503 XR_109701 
3.98 up 4.02 up 1.01 up LOC100506538 XR_108868 
2.97 up 3.39 up 1.14 up LOC100506553 XR_109636 
3.75 up 2.57 up 1.46 down LOC100506660 NR_038927 
1.95 down 2.20 down 1.13 down LOC100506714 NR_038956 
2.81 down 4.61 down 1.64 down LOC100506718 XR_110230 
13.48 down 3.80 down 3.55 up LOC100506783 NR_038435 
2.17 up 2.35 up 1.08 up LOC100506821 XR_109474 
1.97 down 2.62 down 1.33 down LOC100506860 XR_108813 
2.34 down 2.26 down 1.03 up LOC100506870 XR_110520 
3.94 down 9.82 down 2.49 down LOC100506895 NR_038276 
2.05 up 2.36 up 1.15 up LOC100506930 AK090827 
2.00 up 1.88 up 1.07 down LOC100506930 AK090827 
2.83 up 2.29 up 1.23 down LOC100506934 XR_109940 
2.80 up 2.65 up 1.06 down LOC1005 XR_113296 
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06992 
8.94 up 4.94 up 1.81 down LOC100506994 NR_038281 
4.05 down 2.19 down 1.85 up LOC100506995 XR_108482 
2.27 up 2.45 up 1.08 up LOC100507018 XR_108884 
2.81 up 2.96 up 1.05 up LOC100507053 NR_037884 
3.67 up 3.32 up 1.11 down LOC100507094 XR_109558 
3.07 down 10.03 down 3.27 down LOC100507127 NR_038291 
2.75 up 1.98 up 1.39 down LOC100507128 XR_109038 
2.05 up 1.96 up 1.05 down LOC100507149 XR_132713 
2.38 up 2.31 up 1.03 down LOC100507153 XR_110384 
2.48 up 3.38 up 1.36 up LOC100507161 
XM_00311887
8 
1.97 up 2.47 up 1.25 up LOC100507266 NR_037888 
2.12 up 1.72 up 1.24 down LOC100507312 XR_113288 
3.92 up 3.78 up 1.04 down LOC100507404 XR_133567 
3.10 down 6.08 down 1.96 down LOC100507420 XR_110876 
7.95 up 9.39 up 1.18 up LOC100507421 
NM_00119527
8 
3.35 down 3.64 down 1.09 down LOC100507429 XR_110179 
3.48 down 3.51 down 1.01 down LOC100507429 XR_110179 
2.04 up 2.33 up 1.14 up LOC100507501 NR_039999 
3.12 down 1.91 down 1.64 up LOC100507554 XR_108428 
3.31 up 3.16 up 1.05 down LOC100507580 XR_109752 
1.80 down 2.35 down 1.31 down LOC1005 XR_110188 
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07624 
2.29 up 2.31 up 1.01 up LOC100507663 XR_132568 
2.71 up 1.57 up 1.72 down LOC100507760 XR_113110 
1.71 down 2.01 down 1.18 down LOC100508950 XR_112293 
2.07 up 2.55 up 1.23 up LOC100508995 XR_111214 
4.25 up 3.40 up 1.25 down LOC100509075 XR_111772 
3.32 up 4.10 up 1.24 up LOC100509075 XR_111771 
40.65 up 8.91 up 4.56 down LOC100509121 
XM_00312033
4 
2.48 up 2.66 up 1.07 up LOC100509263 
XM_00340344
3 
2.31 up 2.33 up 1.01 up LOC100527964 NR_037642 
3.15 up 2.04 up 1.54 down LOC100616668 NR_038258 
2.22 up 2.69 up 1.21 up LOC100652912 XR_132665 
2.49 up 3.55 up 1.42 up LOC100652917 XR_132741 
3.32 down 1.86 down 1.79 up LOC100652963 
XM_00340347
2 
3.52 up 2.33 up 1.51 down LOC100653030 XR_132913 
1.32 up 2.17 up 1.65 up LOC100653193 
XM_00340383
3 
1.60 up 2.08 up 1.29 up LOC100653329 XR_133136 
1.73 down 2.07 down 1.20 down LOC100653338 XR_133053 
2.64 up 2.74 up 1.04 up LOC115110 NR_026927 
1.90 up 2.35 up 1.23 up LOC115110 NR_026927 
1.59 up 2.10 up 1.32 up LOC143286 AL049428 
2.47 down 4.87 down 1.97 down LOC1497 NR_034147 
 178 
73 
3.53 down 4.89 down 1.38 down LOC149773 NR_034147 
1.69 up 2.53 up 1.50 up LOC151657 AK091114 
2.62 up 1.67 up 1.57 down LOC157860 AK025743 
1.89 up 2.39 up 1.26 up LOC202025 AL713660 
2.21 up 1.86 up 1.19 down LOC202181 NR_026921 
3.23 up 3.75 up 1.16 up LOC219731 NR_038222 
2.92 down 1.53 down 1.91 up LOC254057 AK024653 
8.03 up 11.72 up 1.46 up LOC254559 NR_015411 
5.39 up 8.50 up 1.58 up LOC254559 NR_015411 
5.08 up 9.66 up 1.90 up LOC255167 NR_024424 
2.20 down 1.58 down 1.39 up LOC255177 BC031230 
2.47 up 1.02 up 2.42 down LOC257396 BC041894 
7.90 up 10.04 up 1.27 up LOC283174 NR_024344 
7.83 up 8.83 up 1.13 up LOC283174 NR_024344 
7.15 up 7.91 up 1.11 up LOC283174 NR_024344 
3.58 up 3.70 up 1.03 up LOC283174 NR_024344 
2.26 down 1.62 down 1.40 up LOC283352 AK097496 
3.96 down 5.19 down 1.31 down LOC283404 NR_027358 
13.82 up 37.54 up 2.72 up LOC283485 AK093862 
2.10 up 3.08 up 1.47 up LOC283713 AK094982 
2.25 up 1.40 up 1.60 down LOC2840 NR_024349 
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23 
6.20 up 6.14 up 1.01 down LOC284630 AK096384 
2.93 up 3.45 up 1.17 up LOC284837 NR_026961 
1.93 up 2.04 up 1.05 up LOC284837 NR_026961 
1.81 up 2.90 up 1.60 up LOC284837 NR_026961 
66.28 up 83.68 up 1.26 up LOC285084 NR_038897 
33.88 up 48.47 up 1.43 up LOC285084 NR_038897 
1.87 up 2.47 up 1.32 up LOC285540 NR_037934 
2.21 down 1.90 down 1.16 up LOC285847 NR_027117 
2.06 up 2.75 up 1.33 up LOC286161 AK091672 
1.14 up 2.01 up 1.77 up LOC286367 NR_024011 
1.77 up 2.20 up 1.24 up LOC338799 NR_002809 
3.76 up 4.09 up 1.09 up LOC338817 NR_033890 
4.69 down 4.47 down 1.05 up LOC339240 NR_001443 
6.40 down 4.24 down 1.51 up LOC339240 NR_001443 
2.38 down 2.20 down 1.08 up LOC339807 NR_034023 
1.66 up 2.82 up 1.71 up LOC349196 NR_027000 
17.66 up 18.94 up 1.07 up LOC375196 NR_028386 
3.58 down 2.89 down 1.24 up LOC375295 NR_040001 
4.02 down 3.36 down 1.20 up LOC375295 NR_040001 
4.55 down 3.50 down 1.30 up LOC375295 NR_040001 
1.72 down 3.80 down 2.21 down LOC3887 XR_109642 
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80 
2.71 up 2.09 up 1.30 down LOC389602 XR_108709 
1.88 up 2.21 up 1.18 up LOC389641 NR_033928 
5.38 up 2.84 up 1.89 down LOC389831 
NM_00124248
0 
4.75 up 3.04 up 1.56 down LOC389831 AK123495 
4.68 up 3.18 up 1.47 down LOC389831 
NM_00124248
0 
2.36 up 3.29 up 1.40 up LOC389834 NR_027420 
2.16 up 3.41 up 1.58 up LOC389834 NR_027420 
2.11 up 4.56 up 2.16 up LOC389834 NR_027420 
1.69 up 2.35 up 1.39 up LOC389834 NR_027420 
2.31 up 1.77 up 1.31 down LOC399900 XR_111182 
1.79 up 2.31 up 1.29 up LOC401068 XR_110024 
4.81 up 5.45 up 1.13 up LOC401109 NR_034088 
2.43 up 2.71 up 1.12 up LOC401109 NR_034088 
2.71 up 5.74 up 2.12 up LOC401431 NR_027040 
3.56 up 4.86 up 1.36 up LOC401561 AY129027 
2.92 down 1.64 down 1.78 up LOC439990 NR_038464 
4.16 up 3.95 up 1.05 down LOC440792 AB051440 
2.86 up 3.61 up 1.26 up LOC441268 AK125166 
1.41 up 2.90 up 2.06 up LOC497257 BC030211 
1.53 down 2.02 down 1.32 down LOC541471 NR_024373 
14.82 up 10.38 up 1.43 down LOC5414 NR_003602 
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73 
2.27 up 2.23 up 1.02 down LOC553103 NR_037898 
6.21 up 7.36 up 1.19 up LOC642366 XR_108597 
2.09 up 2.25 up 1.08 up LOC644339 XR_132877 
2.09 up 2.20 up 1.05 up LOC644656 NR_036539 
2.20 down 2.12 down 1.04 up LOC645722 XR_132630 
1.11 down 2.53 down 2.27 down LOC646329 NR_034120 
3.09 up 2.32 up 1.33 down LOC646719 XR_112726 
2.45 up 3.01 up 1.23 up LOC646778 XR_132648 
4.25 up 2.82 up 1.51 down LOC647946 NR_024391 
4.14 up 2.90 up 1.43 down LOC647946 BC035184 
2.02 down 1.54 down 1.31 up LOC649294 AK091259 
2.87 up 1.50 up 1.91 down LOC653160 NR_037869 
2.03 down 1.16 down 1.76 up LOC653720 
XM_00234482
5 
2.57 up 3.02 up 1.18 up LOC728061 AK025151 
2.76 up 2.48 up 1.11 down LOC728147 AK096262 
2.12 down 1.63 down 1.30 up LOC728190 NR_024397 
3.04 up 4.56 up 1.50 up LOC728537 NR_038386 
1.96 up 3.45 up 1.76 up LOC728537 NR_038386 
4.95 up 5.33 up 1.08 up LOC728715 
XM_00311952
4 
3.04 down 1.53 down 1.99 up LOC729178 NR_034115 
2.44 up 2.45 up 1.01 up LOC7293 AK055581 
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24 
3.41 up 2.17 up 1.57 down LOC729558 AK096995 
2.59 up 3.46 up 1.34 up LOC729732 XR_132886 
2.32 down 1.61 down 1.44 up LOC729887 BC052334 
3.32 up 7.06 up 2.13 up LOC84856 NR_026827 
3.15 up 6.06 up 1.92 up LOC84856 NR_026827 
2.20 up 1.88 up 1.17 down LOC90784 NR_026984 
4.70 down 2.44 down 1.93 up LPL NM_000237 
1.34 down 2.06 down 1.54 down LPPR4 NM_014839 
1.64 down 2.29 down 1.39 down LRP11 NM_032832 
2.40 up 2.08 up 1.15 down LRPAP1 NM_002337 
2.20 up 1.18 up 1.86 down LRRC42 
 
3.20 up 3.85 up 1.20 up LRRC56 NM_198075 
2.13 up 1.93 up 1.10 down LRRC61 NM_001142928 
2.62 down 2.63 down 1.01 down LRRC69 NM_001129890 
2.99 down 2.71 down 1.10 up LRRC69 NM_001129890 
2.11 up 1.87 up 1.13 down LRRC8B NM_015350 
6.09 up 4.01 up 1.52 down LRRIQ1 NM_001079910 
5.31 up 3.96 up 1.34 down LRRN1 NM_020873 
2.11 up 1.35 up 1.56 down LSM14B NM_144703 
21.08 up 27.98 up 1.33 up LTF NM_002343 
2.54 up 2.19 up 1.16 down LTN1 BC031633 
5.12 up 3.84 up 1.33 down LY75 NM_002349 
2.16 up 1.96 up 1.10 down MACRO
D2 BC035876 
3.59 down 2.79 down 1.29 up MAGEA6 NM_175868 
2.39 up 1.84 up 1.30 down MAGI3 NM_152900 
3.69 up 1.79 up 2.06 down MAK NM_005906 
13.22 up 8.79 up 1.50 down MAL NM_002371 
3.30 up 2.88 up 1.14 down MAMDC4 NM_206920 
2.00 down 2.13 down 1.06 down MAP1LC NM_022818 
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1.65 down 2.11 down 1.28 down MAP2K4 NM_003010 
2.88 up 2.53 up 1.14 down MAP3K13 NM_004721 
2.64 up 3.19 up 1.21 up MAP3K14 NM_003954 
2.57 up 2.36 up 1.09 down MAP3K6 NM_004672 
1.88 down 2.43 down 1.30 down MAP7 NM_003980 
10.68 up 12.22 up 1.14 up MAP7D2 NM_152780 
2.24 up 2.42 up 1.08 up MAP7D2 NM_152780 
1.72 down 2.19 down 1.27 down MAP7D3 NM_024597 
2.62 up 4.73 up 1.80 up MAPK4 NM_002747 
2.02 up 1.50 up 1.35 down MAPK8 AB074280 
2.58 up 1.41 up 1.84 down MARVELD2 
NM_00103860
3 
2.45 up 1.68 up 1.46 down MARVELD2 AK055094 
2.23 up 1.89 up 1.18 down MAST4 NM_001164664 
2.49 up 4.55 up 1.82 up MAT1A NM_000429 
3.35 up 3.44 up 1.03 up MCF2L NM_024979 
2.41 up 3.09 up 1.28 up MCF2L NM_024979 
4.55 up 6.49 up 1.43 up MCF2L-AS1 NR_034002 
1.53 down 2.11 down 1.38 down MCFD2 NM_139279 
2.26 up 1.59 up 1.42 down MCM10 NM_182751 
3.45 up 3.38 up 1.02 down MCM2 NM_004526 
2.19 up 2.04 up 1.07 down MCM3 NM_002388 
2.01 up 1.50 up 1.34 down MCM4 NM_005914 
2.17 up 2.40 up 1.11 up MCM5 NM_006739 
2.20 up 2.57 up 1.16 up MCM5 NM_006739 
2.17 up 1.93 up 1.13 down MCM7 NM_182776 
2.59 up 2.60 up 1.00 up MCM8 NM_182802 
1.62 down 2.55 down 1.58 down MDFI NM_005586 
1.96 up 2.89 up 1.48 up MDK NM_001012334 
2.38 up 2.48 up 1.04 up MDM1 NM_017440 
2.42 up 2.69 up 1.11 up MDM2 NM_002392 
2.12 up 1.79 up 1.18 down MDM2 NM_002392 
2.78 down 3.44 down 1.24 down ME1 NM_002395 
2.54 up 3.64 up 1.43 up MECOM NM_005241 
2.08 up 3.05 up 1.47 up MECOM NM_00116400
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6.59 up 7.12 up 1.08 up MEI1 NM_152513 
2.51 up 2.75 up 1.10 up MEIS1 NM_002398 
1.87 up 2.88 up 1.54 up MESP1 NM_018670 
1.83 down 1.65 up 3.02 up METTL7A NM_014033 
2.52 up 1.69 up 1.49 down MFI2 NM_005929 
2.09 up 2.52 up 1.21 up MFI2-AS1 NR_038285 
1.31 down 2.61 down 1.99 down MFSD2A NM_001136493 
4.37 up 4.39 up 1.00 up MFSD4 NM_181644 
8.28 up 11.71 up 1.41 up MGAT3 NM_002409 
2.07 up 1.50 up 1.38 down MIB1 NM_020774 
2.81 up 2.92 up 1.04 up MICALL2 NM_182924 
2.00 up 2.05 up 1.02 up MID1 NM_001193278 
1.91 down 2.07 down 1.08 down MIR143HG NR_027180 
4.46 up 3.33 up 1.34 down MIR600HG NR_026677 
2.21 up 2.17 up 1.02 down MIRLET7
BHG NR_027033 
2.33 up 1.62 up 1.44 down MKI67 NM_002417 
2.62 up 2.36 up 1.11 down MLF1IP NM_024629 
1.69 up 2.01 up 1.19 up MLLT6 NM_005937 
1.61 up 2.24 up 1.39 up MLPH NM_024101 
2.15 up 2.84 up 1.32 up MMAA NM_172250 
2.23 down 1.66 down 1.34 up MME NM_007289 
3.71 down 3.52 down 1.05 up MME NM_007289 
1.66 down 2.89 down 1.74 down MMRN2 XR_111094 
1.72 up 1.75 down 3.01 down MNAT1 NM_002431 
3.85 up 2.27 up 1.69 down MNS1 NM_018365 
3.54 down 2.96 down 1.20 up MORN4 BC022054 
1.30 up 2.46 up 1.89 up MOSC2 NM_017898 
1.63 down 2.35 down 1.44 down MOSPD1 NM_019556 
2.55 up 4.00 up 1.57 up MOXD1 NM_015529 
1.53 down 2.43 down 1.58 down MPDU1 AK027742 
7.22 up 4.16 up 1.73 down MPP2 NM_005374 
4.04 up 2.24 up 1.80 down MPP2 NM_005374 
1.44 down 2.55 down 1.77 down MPP6 NM_016447 
4.09 down 5.64 down 1.38 down MPPED1 NM_00104437
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1.69 down 2.23 down 1.32 down MPZL3 NM_198275 
2.03 down 1.68 down 1.21 up MRGPRG NM_001164377 
2.06 up 1.75 up 1.17 down MSH2 NM_000251 
2.04 up 2.11 up 1.03 up MST1 NM_020998 
1.70 up 2.17 up 1.28 up MST1 NM_020998 
2.74 down 2.87 down 1.05 down MST1 BC044862 
4.60 up 2.67 up 1.72 down MST1R NM_002447 
4.70 down 4.36 down 1.08 up MSX2P1 NR_002307 
2.02 down 2.17 down 1.07 down MT1E NM_175617 
1.48 up 2.74 up 1.85 up MTERFD2 NR_028049 
1.55 down 2.06 down 1.33 down MTHFD1
L 
NM_015440 
1.97 down 2.28 down 1.15 down MTHFD1L NM_015440 
1.26 down 2.35 down 1.86 down MTSS1 NM_014751 
2.14 up 1.70 up 1.26 down MTX3 NM_001010891 
22.78 up 9.42 up 2.42 down MUC21 NM_001010909 
2.34 down 2.79 down 1.19 down MUSK NM_005592 
3.07 up 3.09 up 1.01 up MXD3 NM_001142935 
1.48 down 2.07 down 1.40 down MXRA7 NM_001008529 
5.04 up 5.36 up 1.06 up MYB NM_005375 
5.55 up 4.86 up 1.14 down MYCN NM_005378 
2.27 up 1.98 up 1.14 down MYEOV NM_138768 
2.11 up 2.81 up 1.33 up MYO15B AK074680 
1.41 down 2.17 down 1.54 down MYO1B NM_012223 
10.70 up 9.94 up 1.08 down MYO3A NM_017433 
7.21 up 8.41 up 1.17 up MYO3A BC036079 
2.77 down 2.90 down 1.05 down MYO5A NM_000259 
3.19 up 1.77 up 1.80 down MYO5B NM_001080467 
1.70 up 2.99 up 1.76 up MYO5C NM_018728 
1.89 up 2.17 up 1.15 up MZT2A BC017694 
5.91 down 3.01 down 1.96 up NAP1L2 NM_021963 
2.82 up 1.95 up 1.45 down NASP NM_002482 
1.86 down 2.28 down 1.22 down NAV1 NM_020443 
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1.85 down 4.30 down 2.33 down NAV3 NM_014903 
2.66 down 2.05 down 1.30 up NAV3 NM_014903 
2.02 up 1.79 up 1.13 down NBPF15 BX538005 
1.51 up 2.08 up 1.38 up NCK2 NM_001004722 
29.20 up 9.13 up 3.20 down NCRNA00185 NR_001544 
2.00 up 1.37 up 1.46 down NDC80 NM_006101 
1.52 down 2.17 down 1.43 down NDEL1 NM_030808 
2.61 down 2.26 down 1.15 up NDST2 BC018681 
6.97 down 4.51 down 1.54 up NEB NM_004543 
3.08 up 2.73 up 1.13 down NEDD1 NM_152905 
3.97 up 3.14 up 1.26 down NEDD4L NM_001144967 
3.39 up 3.14 up 1.08 down NEDD4L NM_015277 
2.07 up 2.65 up 1.28 up NEURL NM_004210 




13.00 up 6.64 up 1.96 down NEURL3 NR_026875 
3.25 down 3.10 down 1.05 up NEXN NM_144573 
2.57 down 2.22 down 1.16 up NFASC NM_001005388 
3.75 up 3.75 up 1.00 down NFE2L3 NM_004289 
2.93 up 2.54 up 1.15 down NFIB NM_005596 
2.28 up 1.93 up 1.18 down NFKB2 NM_001077493 
2.32 up 1.93 up 1.20 down NFKBID NM_139239 
1.50 up 3.56 down 5.32 down NGEF NM_019850 
6.71 up 2.85 up 2.36 down NGFR NM_002507 
3.00 up 2.86 up 1.05 down NINJ1 NM_004148 
2.42 up 2.44 up 1.01 up NINL NM_025176 
1.84 up 2.46 up 1.34 up NINL NM_025176 
1.23 down 2.59 down 2.11 down NIPAL1 NM_207330 
2.87 down 3.32 down 1.16 down NIPAL4 NM_001172292 
1.90 down 2.19 down 1.16 down NME4 NM_005009 
3.77 up 2.80 up 1.35 down NMU NM_006681 
3.82 down 2.69 down 1.42 up NNMT NM_006169 
3.41 up 8.91 up 2.61 up NOS2 NM_000625 
4.38 up 3.21 up 1.37 down NOTCH1 NM_017617 
1.04 up 3.02 up 2.91 up NOVA1 NM_002515 
3.26 up 3.92 up 1.20 up NPB NM_148896 
 187 
4.17 up 5.08 up 1.22 up NPPC NM_024409 
9.39 down 1.94 down 4.85 up NPTX1 NM_002522 
3.30 down 4.56 down 1.38 down NQO1 NM_000903 
3.96 up 6.73 up 1.70 up NR3C2 NM_000901 
1.16 down 3.38 down 2.91 down NRG1 AF176921 
1.33 down 4.11 down 3.10 down NRG1 NM_004495 
1.54 down 5.49 down 3.57 down NRG1 NM_004495 
2.78 up 3.76 up 1.35 up NRG2 NM_013982 
2.01 down 1.85 down 1.08 up NRP1 NM_001024629 
3.96 up 2.59 up 1.53 down NSUN7 NM_024677 
2.75 up 1.47 up 1.87 down NT5DC3 NM_001031701 
2.32 down 4.09 down 1.76 down NT5E NM_002526 
3.03 down 4.38 down 1.45 down NT5E NM_002526 
2.18 up 2.49 up 1.14 up NT5M NM_020201 
3.46 up 4.07 up 1.18 up NUP210 NM_024923 
2.02 up 1.72 up 1.18 down NUP62 NM_153719 
1.92 up 2.29 up 1.19 up NUP62CL NM_017681 
2.00 up 1.94 up 1.03 down NUSAP1 NM_016359 
2.06 down 1.35 down 1.52 up NXF5 NM_032946 
2.22 up 2.42 up 1.09 up NYNRIN NM_025081 
5.55 up 8.46 up 1.52 up OCA2 NM_000275 
5.16 up 9.89 up 1.92 up ODAM NM_017855 
1.41 up 2.01 up 1.43 up OGT NM_181672 
4.91 up 7.39 up 1.51 up OLFM1 NM_014279 
3.95 up 5.14 up 1.30 up OLFM1 NM_006334 
2.12 up 2.26 up 1.07 up ONECUT2 NM_004852 
2.18 down 1.46 down 1.49 up OR10G8 NM_001004464 
2.04 down 1.28 down 1.59 up OR1K1 NM_080859 
2.14 up 2.09 up 1.02 down OR7G1 NM_001005192 
2.26 up 1.56 up 1.45 down ORC1 NM_004153 
9.16 up 3.06 up 2.99 down OSTalpha NM_152672 
2.86 up 3.47 up 1.21 up OXER1 NM_148962 
3.88 down 12.92 down 3.33 down P01115 
 
2.53 up 1.97 up 1.28 down P39188 
 
1.44 down 2.82 down 1.96 down P39194 
 
2.16 up 2.52 up 1.17 up P39195 
 
2.33 up 2.13 up 1.09 down PABPC1L NM_00112475
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2.54 up 2.72 up 1.07 up PABPC4L NM_001114734 
2.89 up 1.57 up 1.84 down PACRGL NM_145048 
2.26 up 1.76 up 1.29 down PAFAH1B3 NM_002573 
1.84 up 2.91 up 1.58 up PAPLN NM_173462 
1.96 down 2.75 down 1.40 down PAPPA NM_002581 
1.91 down 3.65 down 1.91 down PAQR5 NM_001104554 
2.41 up 2.09 up 1.16 down PARD6A NM_016948 
2.82 up 2.17 up 1.30 down PARD6B NM_032521 
5.07 up 6.36 up 1.25 up PARM1 NM_015393 
1.40 up 2.70 up 1.93 up PASK NM_015148 
69.13 up 39.48 up 1.75 down PAX1 NM_006192 
4.02 up 8.41 up 2.09 up PAX6 NM_000280 
5.57 up 3.19 up 1.75 down PAX9 NM_006194 
2.02 up 2.34 up 1.16 up PBX1 NM_002585 
2.00 up 3.40 up 1.70 up PBX1 NM_002585 
3.90 up 3.15 up 1.24 down PBX4 NM_025245 
1.85 down 2.21 down 1.19 down PCDH18 NM_019035 
2.53 down 2.43 down 1.04 up PCDHB2 NM_018936 
2.61 down 2.05 down 1.28 up PCDHGB4 NM_032098 
3.75 up 2.89 up 1.30 down PCLO NM_014510 
2.50 up 2.16 up 1.16 down PCNA NM_002592 
2.33 up 2.13 up 1.09 down PCNA NM_002592 
2.28 up 2.14 up 1.06 down PCNA NM_002592 
1.51 up 2.00 up 1.33 up PCNA-AS1 NR_028370 
1.80 up 3.86 up 2.14 up PCOLCE2 NM_013363 
2.30 up 2.84 up 1.24 up PCP2 NM_174895 
4.53 down 5.99 down 1.32 down PCSK1 NM_000439 
3.25 down 2.70 down 1.20 up PCSK5 NM_006200 
3.66 down 2.37 down 1.55 up PCSK5 NM_006200 
2.33 down 1.22 down 1.91 up PDE1A NM_001003683 
2.63 down 1.80 down 1.46 up PDE2A NM_002599 
2.06 up 2.00 up 1.03 down PDE4DIP AK024906 
1.58 up 2.20 up 1.40 up PDE4DIP 
 
2.50 up 2.13 up 1.17 down PDE6B NM_000283 
3.00 down 1.47 down 2.04 up PDE7B NM_018945 
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2.91 up 3.07 up 1.05 up PDXK NM_003681 
6.24 down 1.51 down 4.13 up PEG3 NM_006210 
5.18 up 2.87 up 1.80 down PER3 NM_016831 
4.79 up 2.68 up 1.79 down PER3 NM_016831 
2.03 up 1.87 up 1.09 down PFN1P2 NR_003242 
1.48 down 2.09 down 1.41 down PGM3 NM_001199919 
1.62 down 2.03 down 1.25 down PGM3 NM_015599 
2.14 up 2.31 up 1.08 up PGPEP1 NM_017712 
2.04 up 1.54 up 1.32 down PHACTR4 BC068508 
1.91 down 2.95 down 1.54 down PHEX NM_000444 
1.85 up 2.01 up 1.09 up PHF17 NM_024900 
2.75 up 3.09 up 1.12 up PHGDH NM_006623 
1.61 down 4.00 down 2.49 down PHLDB2 NM_001134438 
2.42 down 4.98 down 2.06 down PI15 NM_015886 
2.08 up 2.76 up 1.33 up PIDD NM_145886 
1.46 down 2.09 down 1.43 down PIGL NM_004278 
2.06 up 2.46 up 1.19 up PIK3R3 NM_003629 
1.85 down 2.06 down 1.11 down PITPNM2 NM_020845 
5.19 up 2.73 up 1.90 down PITX1 NM_002653 
5.53 up 6.92 up 1.25 up PKDCC NM_138370 
5.03 up 5.73 up 1.14 up PKDCC NM_138370 
2.14 up 2.84 up 1.33 up PKIA NM_006823 
7.28 up 6.75 up 1.08 down PLAC8 NM_016619 
3.38 up 1.62 up 2.09 down PLAC8L1 NM_001029869 
2.65 down 3.87 down 1.46 down PLB1 BC065041 
2.69 down 1.88 down 1.43 up PLCB1 AX721082 
2.35 up 1.96 up 1.20 down PLCH2 NM_014638 
3.33 up 3.62 up 1.09 up PLEKHG4 NM_015432 
3.26 up 3.52 up 1.08 up PLEKHG4 NM_015432 
2.00 up 1.89 up 1.06 down PLEKHG6 NM_018173 
2.85 up 3.26 up 1.14 up PLGLB1 NM_001032392 
2.45 up 1.49 up 1.64 down PLK4 NM_014264 
1.20 down 2.01 down 1.67 down PLS3 NM_005032 
2.97 up 2.50 up 1.19 down PLXNA1 NM_032242 
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2.42 up 1.94 up 1.25 down PLXNB1 NM_002673 
1.34 down 2.15 down 1.60 down PMP22 
 
2.32 up 2.00 up 1.16 down PMS2L2 BC010535 
1.81 up 2.63 up 1.45 up PNMAL2 NM_020709 
5.38 up 6.30 up 1.17 up PODXL2 NM_015720 
4.20 up 5.79 up 1.38 up PODXL2 NM_015720 
2.62 up 2.37 up 1.11 down POGZ BC057773 
2.10 up 1.91 up 1.10 down POLA1 NM_016937 
2.02 up 1.67 up 1.21 down POLA2 NM_002689 
2.18 up 2.17 up 1.00 down POLD1 NM_002691 
2.93 up 1.48 up 1.98 down POLE NM_006231 
2.35 up 2.03 up 1.16 down POLE NM_006231 
2.76 up 2.80 up 1.02 up POLH NM_006502 
2.04 up 2.41 up 1.18 up POLH NM_006502 
2.27 up 1.89 up 1.20 down POLQ NM_199420 
2.12 down 7.40 down 3.50 down POPDC3 NM_022361 
6.24 up 5.87 up 1.06 down POU4F1 NM_006237 
3.21 up 2.98 up 1.08 down PP12719 XM_003403527 
1.91 up 2.08 up 1.09 up PPAP2B NM_003713 
2.77 down 1.87 down 1.48 up PPAPDC3 NM_032728 
3.30 down 2.52 down 1.31 up PPAPDC3 
 
1.58 down 2.01 down 1.27 down PPARD NM_006238 
3.18 up 2.84 up 1.12 down PPARGC1B NM_133263 
2.51 up 2.29 up 1.09 down PPARGC1B NM_133263 
4.01 up 2.61 up 1.54 down PPFIA4 NM_015053 
2.99 up 3.04 up 1.02 up PPFIBP2 NM_003621 
1.60 down 2.22 down 1.39 down PPIF NM_005729 
2.23 up 2.16 up 1.03 down PPM1N NM_001080401 
2.07 up 1.94 up 1.07 down PPM1N NM_001080401 
2.31 down 3.23 down 1.40 down PPP1R1C NM_001080545 
2.59 up 2.38 up 1.09 down PPP1R26 NM_014811 
5.42 down 2.73 down 1.99 up PPP1R27 NM_001007533 
1.58 up 2.27 up 1.44 up PPP1R3E NR_026862 
2.69 down 4.10 down 1.52 down PPP2R2C NM_181876 
2.79 up 3.16 up 1.13 up PPP2R3B- NR_027232 
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1.75 up 2.28 up 1.30 up PRC1 NM_003981 
2.89 up 2.89 up 1.00 up PRELID2 NM_138492 
2.11 down 1.88 down 1.12 up PRICKLE1 NM_153026 
6.35 up 6.91 up 1.09 up PRIMA1 NM_178013 
3.93 up 3.79 up 1.03 down PRINS NR_023388 
4.45 up 2.40 up 1.86 down PRKXP1 AI016765 
2.38 up 1.72 up 1.38 down PRKY NR_028062 
5.54 up 2.71 up 2.04 down PRLR NM_000949 
1.61 down 3.35 down 2.08 down PROC NM_000312 
2.64 down 3.24 down 1.23 down PROC NM_000312 
1.75 up 2.45 up 1.40 up PROCA1 NM_152465 
2.31 down 3.49 down 1.51 down PROCR NM_006404 
4.67 up 7.31 up 1.56 up PRODH NM_016335 
4.64 up 6.17 up 1.33 up PRODH NM_016335 
2.07 down 2.19 down 1.06 down PROS1 NM_000313 
1.91 up 2.13 up 1.11 up PRPF40A NM_017892 
2.59 up 2.38 up 1.09 down PRR19 NM_199285 
1.74 down 2.40 down 1.38 down PRRG1 NM_000950 
5.46 up 4.04 up 1.35 down PRSS12 NM_003619 
2.68 down 3.47 down 1.29 down PRUNE2 NM_015225 
2.08 up 2.60 up 1.25 up PSIP1 NM_033222 
1.71 up 2.52 up 1.48 up PSIP1 NM_021144 
2.77 up 1.98 up 1.40 down PSMC3IP NM_013290 
2.13 up 1.59 up 1.33 down PSMD5 AK001065 
2.03 up 1.33 up 1.53 down PTCD2 NM_024754 
3.30 down 1.76 down 1.88 up PTGER3 NM_198719 
5.40 down 18.45 down 3.42 down PTHLH NM_198965 
7.81 up 8.61 up 1.10 up PTN NM_002825 
1.48 down 2.13 down 1.43 down PTP4A1 NM_003463 
3.67 down 2.75 down 1.33 up PTPLA BC027709 
2.13 up 1.53 up 1.39 down PTPN13 NM_080685 
5.66 up 3.24 up 1.75 down PTPRF BC048416 
3.00 up 2.11 up 1.42 down PTPRF NM_002840 
2.06 down 1.12 up 2.31 up PTPRN2 NM_002847 
1.74 up 2.44 up 1.41 up PTPRS NM_002850 
2.00 down 1.83 down 1.10 up PTS NM_000317 
2.00 up 1.83 up 1.09 down PTTG1 NM_004219 
1.80 down 2.12 down 1.18 down PVT1 NR_003367 
1.91 down 2.06 down 1.08 down PVT1 NR_003367 
2.10 down 2.25 down 1.07 down PVT1 NR_003367 
 192 
2.42 down 3.76 down 1.55 down PYGL NM_002863 
1.97 down 3.84 down 1.94 down Q6P4E4 
 
3.51 down 6.93 down 1.97 down Q9RWL9 
 
2.00 up 2.10 up 1.05 up QRICH2 NM_032134 
1.35 down 2.07 down 1.54 down QSOX1 NM_001004128 
1.55 up 2.24 up 1.45 up RAB11FIP4 NM_032932 
2.70 up 4.04 up 1.50 up RAB26 NM_014353 
1.70 up 2.38 up 1.40 up RAB36 NM_004914 
2.01 down 3.78 down 1.88 down RAB38 NM_022337 
3.17 up 3.39 up 1.07 up RAB42 NM_152304 
2.24 down 1.40 down 1.61 up RAB44 AK125083 
2.01 up 1.49 up 1.35 down RAD54B NM_012415 
2.30 up 1.87 up 1.23 down RAD54L NM_003579 
5.88 up 4.31 up 1.36 down RALGPS1 NM_014636 
2.39 up 2.29 up 1.04 down RALGPS1 NM_014636 
11.04 up 9.32 up 1.18 down RANBP17 NM_022897 
1.73 up 2.72 down 4.70 down RAP1GA
P2 NM_015085 
2.43 up 2.25 up 1.08 down RARB NM_000965 
3.35 up 2.41 up 1.39 down RASEF AK056176 
2.58 up 4.83 up 1.87 up RASEF NM_152573 
2.98 up 2.47 up 1.21 down RASIP1 NM_017805 
2.50 up 1.63 up 1.53 down RBBP4 NM_005610 
2.13 up 1.39 up 1.53 down RBBP8 NM_002894 
2.19 up 1.66 up 1.32 down RBBP9 NM_006606 
1.39 up 2.02 up 1.45 up RBM10 NM_005676 
4.37 up 2.47 up 1.77 down RBM14 NM_006328 
2.11 up 1.83 up 1.16 down RBM15 NM_022768 
2.00 up 2.16 up 1.08 up RBM19 NM_001146699 
2.10 up 2.28 up 1.09 up RBM26-AS1 NR_038991 
2.22 down 2.46 down 1.11 down RBM44 NM_001080504 
1.40 up 3.39 up 2.42 up RBP5 NM_031491 
4.17 up 3.88 up 1.07 down RDM1 NM_001034836 
2.92 up 2.67 up 1.09 down REC8 NM_001048205 
3.25 down 2.40 down 1.35 up RECK NM_021111 
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2.24 up 1.85 up 1.21 down RECQL4 NM_004260 
2.13 up 2.08 up 1.02 down RELB NM_006509 
6.51 up 6.24 up 1.04 down REM1 NM_014012 
3.53 up 2.18 up 1.62 down REPS2 NM_004726 
2.17 down 2.03 down 1.07 up REREP3 NR_033735 
2.10 up 1.17 up 1.79 down RFC3 NM_181558 
2.16 up 2.57 up 1.19 up RFPL3-AS1 NR_001450 
2.26 down 1.59 down 1.42 up RFTN2 NM_144629 
1.91 up 2.06 up 1.08 up RFX5 NM_000449 
4.48 up 1.56 up 2.87 down RGNEF NM_001177693 
4.40 up 2.09 up 2.11 down RGNEF NM_001177693 
1.97 down 2.98 down 1.51 down RGPD1 NM_001024457 
2.77 down 7.63 down 2.76 down RGS20 NM_170587 
1.33 up 2.10 up 1.58 up RGS5 NM_003617 
8.94 up 8.46 up 1.06 down RHBDL3 NM_138328 
2.86 up 1.91 up 1.49 down RHEBL1 NM_144593 
2.10 down 2.13 down 1.01 down RHOB NM_004040 
2.50 down 2.05 down 1.22 up RHOB NM_004040 
1.69 down 4.25 down 2.51 down RHOD NM_014578 
4.49 up 4.90 up 1.09 up RHOXF1 NM_139282 
2.22 up 2.60 up 1.17 up RHPN1 NM_052924 
19.14 up 9.96 up 1.92 down RIBC2 NM_015653 
2.55 up 4.94 up 1.94 up RIC3 NM_024557 
2.31 up 1.36 up 1.70 down RIC8B NM_018157 
1.86 down 3.38 down 1.81 down RIMS3 NM_014747 
1.47 up 2.18 up 1.49 up RINL NM_001195833 
3.31 up 1.96 up 1.69 down RIPK4 NM_020639 
2.02 up 1.56 up 1.30 down RNASEH2A NM_006397 
2.32 down 2.39 down 1.03 down RNF112 NM_007148 
2.04 up 1.12 down 2.29 down RNF115 NM_014455 
4.74 up 4.82 up 1.02 up RNF150 NM_020724 
7.71 up 5.05 up 1.53 down RNF165 NM_152470 
5.50 up 4.88 up 1.13 down RNF207 BC119780 
4.63 up 5.73 up 1.24 up RNF207 NM_207396 
3.22 up 5.02 up 1.56 up RNF207 NM_207396 
14.63 up 16.31 up 1.11 up RNF212 NM_00113103
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12.23 up 11.52 up 1.06 down RNF212 NM_194439 
2.07 down 3.34 down 1.61 down RNF217 NM_152553 
6.30 up 5.71 up 1.10 down RNF32 NM_030936 
2.99 up 2.56 up 1.17 down RNF43 NM_017763 
1.85 up 2.02 up 1.09 up RNF44 NM_014901 
2.11 up 2.63 up 1.25 up RNPC3 AK289844 
1.85 up 2.25 up 1.22 up RNPC3 NM_017619 
2.18 down 1.95 down 1.12 up RNU12 NR_029422 
4.23 down 3.70 down 1.14 up RNU2-2 NR_002761 
2.24 up 2.32 up 1.03 up ROBO2 NM_002942 
2.48 up 2.30 up 1.08 down RPA2 NM_002946 
2.36 up 2.35 up 1.01 down RPA2 NM_002946 
1.46 down 2.01 down 1.38 down RPF2 NM_032194 
2.19 down 1.84 down 1.19 up RPL22L1 NM_001099645 
2.09 up 2.00 up 1.05 down RPL32P3 AK096589 
2.62 down 2.92 down 1.12 down RPL3L NM_005061 
2.22 up 1.85 up 1.20 down RPRD2 
 
2.36 up 1.87 up 1.26 down RPS15AP10 NR_026768 
2.20 up 2.44 up 1.11 up RPS23 NM_001025 
445.9
2 up 13.57 up 32.87 down RPS4Y1 NM_001008 
427.4
0 up 12.31 up 34.72 down RPS4Y2 
NM_00103956
7 
3.71 up 2.31 up 1.61 down RTKN2 NM_145307 
2.65 up 2.25 up 1.18 down RTKN2 BC025765 
50.71 up 16.42 up 3.09 down RTP3 NM_031440 
2.18 down 1.91 down 1.14 up RUNX2 NM_004348 
2.54 up 2.05 up 1.24 down RUNX3 NM_001031680 
2.52 up 1.82 up 1.39 down RUNX3 NM_001031680 
2.02 down 1.35 down 1.50 up S100A5 NM_002962 
2.10 up 2.16 up 1.03 up S1PR5 NM_030760 
2.27 up 2.65 up 1.17 up SAMD10 NM_080621 
1.68 down 2.46 down 1.46 down SAMD4A NM_015589 
1.81 down 2.41 down 1.33 down SAMD4A NM_015589 
1.92 down 2.29 down 1.19 down SAMD8 NM_144660 
2.13 up 2.09 up 1.02 down SAP18 NM_005870 
2.21 up 1.70 up 1.30 down SAP30 NM_003864 
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2.14 up 1.92 up 1.12 down SAP30L NM_024632 
2.07 up 1.54 up 1.34 down SASS6 NM_194292 
3.46 up 2.91 up 1.19 down SBK1 NM_001024401 
2.57 up 2.40 up 1.07 down SCAI NM_173690 
2.02 up 1.91 up 1.05 down SCAPER AB040887 
3.14 up 2.56 up 1.23 down SCARNA23 DW407923 
2.53 up 1.90 up 1.33 down SCD5 NM_001037582 
5.88 down 4.31 down 1.36 up SCG2 NM_003469 
1.96 down 3.88 down 1.98 down SCG5 NM_003020 
3.63 up 3.52 up 1.03 down SCML2 NM_006089 
2.31 down 1.93 down 1.20 up SCN3A NM_006922 
2.18 up 2.53 up 1.16 up SCPEP1 NM_021626 
3.71 up 1.54 up 2.41 down SDC4 NM_002999 
2.69 up 2.16 up 1.24 down SDHAP1 AK125217 
1.42 up 2.15 up 1.51 up SEC31B NM_015490 
2.04 down 3.04 down 1.49 down SEMA3C NM_006379 
2.48 up 2.18 up 1.13 down SEMA4C NM_017789 
1.28 down 1.93 up 2.47 up SEMA5B NM_001031702 
3.75 up 5.16 up 1.38 up SEMA6A NM_020796 
2.09 down 1.39 down 1.50 up SEMA6C NM_001178061 
4.48 up 3.74 up 1.20 down SEPT3 NM_145733 
2.19 down 2.27 down 1.04 down SEPX1 NM_016332 
1.33 down 2.53 down 1.89 down SERINC2 NM_178865 
1.57 up 2.25 down 3.53 down SERPINB5 NM_002639 
2.49 down 4.00 down 1.60 down SERPINE1 NM_000602 
3.14 down 2.37 down 1.32 up SESN3 NM_144665 
1.52 down 2.01 down 1.32 down SETD3 NM_199123 
2.20 up 1.75 up 1.26 down SETD5 NM_001080517 
1.69 up 2.22 up 1.32 up SFI1 NM_001007467 
3.97 down 2.00 down 1.98 up SGCA NM_000023 
3.25 up 3.16 up 1.03 down SGPP2 AK096323 
1.89 down 3.14 down 1.66 down SH2D5 NM_001103161 
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4.03 up 2.62 up 1.54 down SH3BP2 NM_001145855 
3.85 up 2.40 up 1.60 down SH3TC1 BC068094 
2.75 up 2.25 up 1.22 down SH3TC1 NM_018986 
1.43 up 2.29 up 1.60 up SHE NM_001010846 
3.39 up 1.89 up 1.79 down SHROOM3 NM_020859 
3.32 up 1.92 up 1.73 down SHROOM3 NM_020859 
1.80 up 2.14 up 1.19 up SIGIRR NM_021805 
9.99 up 13.09 up 1.31 up SIM2 NM_005069 
2.71 down 1.61 down 1.68 up SIRPB2 
 
5.44 up 1.98 up 2.75 down SIX4 NM_017420 
2.08 up 1.41 up 1.48 down SKA1 NM_001039535 
2.53 up 1.89 up 1.34 down SKA3 NM_145061 
1.91 down 2.40 down 1.26 down SLC10A6 NM_197965 
1.01 up 2.92 down 2.94 down SLC11A1 NM_000578 
3.12 up 5.12 up 1.64 up SLC12A7 NM_006598 
2.62 up 2.48 up 1.06 down SLC12A7 NM_006598 
1.05 down 3.21 down 3.05 down SLC16A10 NM_018593 
1.45 down 3.26 down 2.24 down SLC16A10 NM_018593 
5.96 up 5.54 up 1.07 down SLC16A8 NM_013356 
4.43 up 4.11 up 1.08 down SLC1A1 NM_004170 
2.22 down 2.52 down 1.14 down SLC22A23 NM_015482 
2.06 up 1.53 up 1.34 down SLC25A22 NM_024698 
2.56 up 3.23 up 1.26 up SLC25A23 NM_024103 
1.65 up 2.21 up 1.34 up SLC25A35 NM_201520 
2.00 up 1.74 up 1.15 down SLC26A5 NM_206883 
1.52 down 2.18 down 1.43 down SLC28A1 NM_004213 
1.84 down 2.07 down 1.12 down SLC2A14 BC060766 
1.33 down 2.37 down 1.79 down SLC2A3 NM_006931 
1.91 down 2.14 down 1.12 down SLC35D1 NM_015139 
2.79 up 2.43 up 1.15 down SLC35E2 NM_182838 
2.17 up 2.47 up 1.14 up SLC35E2 NM_182838 
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2.56 down 2.01 down 1.27 up SLC37A2 NM_198277 
2.02 down 1.55 down 1.31 up SLC38A1 DC378344 
2.06 up 1.56 up 1.32 down SLC45A4 NM_001080431 
5.06 down 5.38 down 1.06 down SLC47A2 NM_152908 
1.96 down 3.89 down 1.99 down SLC5A10 NM_152351 
2.43 up 1.76 up 1.39 down SLC5A6 NM_021095 
2.04 up 1.67 up 1.22 down SLC5A6 NM_021095 
1.49 up 2.06 up 1.38 up SLC6A16 NM_014037 
2.25 down 1.82 down 1.23 up SLC6A17 NM_001010898 
7.23 down 10.35 down 1.43 down SLC6A2 NM_001172501 
3.40 down 5.42 down 1.59 down SLC7A11 NM_014331 
2.13 down 3.97 down 1.86 down SLC7A5 NM_003486 
3.80 down 6.15 down 1.62 down SLC7A8 NM_182728 
4.02 down 7.10 down 1.77 down SLC7A8 NM_182728 
1.74 up 2.20 up 1.26 up SLC9A7 NM_032591 
1.55 up 2.31 up 1.49 up SLC9A7P1 NR_033801 
2.22 up 1.91 up 1.16 down SLC9A8 NM_015266 
2.33 down 1.68 down 1.38 up SLC9B2 NM_178833 
5.06 up 6.29 up 1.24 up SLFN13 NM_144682 
2.56 down 6.78 down 2.65 down SLITRK6 NM_032229 
2.43 up 3.36 up 1.38 up SMA4 NR_029426 
2.69 up 2.46 up 1.09 down SMARCA2 NM_139045 
1.96 up 2.16 up 1.10 up SMARCA2 NM_139045 
94.60 up 84.20 up 1.12 down SMC1B NM_148674 
2.11 up 1.98 up 1.07 down SMC5 NM_015110 
2.07 up 1.81 up 1.14 down SMG9 NM_019108 




1.64 down 2.44 down 1.49 down SMTN NM_134269 
1.75 down 2.29 down 1.31 down SNAI2 NM_003068 
2.26 down 1.58 down 1.43 up SNAR-I NR_024343 
2.37 down 1.61 down 1.46 up SNORA11 NR_002953 
2.09 down 1.54 down 1.36 up SNORA11D NR_003711 
2.23 down 2.30 down 1.03 down SNORA1 NR_002958 
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2.26 down 2.13 down 1.06 up SNORA19 NR_002917 
2.06 down 1.78 down 1.16 up SNORA21 NR_002576 
2.17 down 2.08 down 1.04 up SNORA23 NR_002962 
2.32 down 2.16 down 1.07 up SNORA27 NR_002575 
2.64 down 2.58 down 1.02 up SNORA28 NR_002964 
2.69 down 2.34 down 1.15 up SNORA3 NR_002580 
2.20 down 2.66 down 1.21 down SNORA43 NR_002975 
2.03 down 2.10 down 1.03 down SNORA52 NR_002585 
2.20 down 1.70 down 1.29 up SNORA5
B 
NR_002990 
2.56 down 2.34 down 1.10 up SNORA64 NR_002326 
2.09 down 2.18 down 1.04 down SNORA65 NR_002449 
1.98 down 2.21 down 1.12 down SNORA71A NR_002911 
2.27 down 2.33 down 1.03 down SNORA71B NR_002910 
2.13 down 2.25 down 1.06 down SNORA71C NR_003017 
2.06 down 1.91 down 1.08 up SNORA73A NR_002907 
2.09 down 1.92 down 1.09 up SNORD10 NR_002604 
6.04 down 5.09 down 1.19 up SNORD114-12 NR_003205 
2.56 down 2.74 down 1.07 down SNORD114-14 NR_003207 
4.30 down 5.51 down 1.28 down SNORD114-20 NR_003213 
3.10 down 2.86 down 1.08 up SNORD114-28 NR_003221 
3.79 down 3.62 down 1.05 up SNORD114-28 NR_003221 
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4.14 down 3.92 down 1.06 up SNORD114-9 NR_003201 
2.06 down 1.74 down 1.18 up SNORD12 NR_003030 
2.16 down 1.80 down 1.19 up SNORD12B NR_003695 
2.47 down 2.10 down 1.18 up SNORD16 NR_002440 
2.32 down 1.40 down 1.66 up SNORD17 NR_003045 
2.04 down 1.81 down 1.13 up SNORD24 NR_002447 
2.03 down 1.23 down 1.66 up SNORD34 NR_000019 
2.06 down 2.08 down 1.01 down SNORD37 NR_002602 
2.95 down 3.40 down 1.15 down SNORD3
B-1 NR_003271 
2.62 down 3.32 down 1.27 down SNORD42A NR_000014 
1.52 down 2.21 down 1.46 down SNORD45C NR_003042 
2.26 down 2.19 down 1.03 up SNORD46 NR_000024 
2.33 down 1.97 down 1.18 up SNORD6 NR_003036 
2.50 down 3.45 down 1.38 down SNORD65 NR_003054 
2.13 down 2.69 down 1.27 down SNORD82 NR_004398 
2.12 down 1.88 down 1.13 up SNORD83A NR_000027 
2.00 down 2.14 down 1.07 down SNORD92 NR_003074 
3.71 down 3.81 down 1.03 down SNORD93 NR_003075 
3.04 up 5.27 up 1.73 up SNX22 NM_024798 
5.71 up 5.61 up 1.02 down SNX31 NM_152628 
6.31 up 2.57 up 2.46 down SORBS2 NM_021069 
4.50 up 2.86 up 1.57 down SORBS2 NM_021069 
2.54 up 1.77 up 1.43 down SOX13 BC040649 
2.25 up 1.67 up 1.34 down SOX13 NM_005686 
1.78 down 5.08 down 2.85 down SOX15 NM_006942 
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2.20 down 1.21 down 1.82 up SOX17 NM_022454 
2.41 up 2.63 up 1.09 up SOX30 NM_178424 
3.38 up 5.01 up 1.48 up SOX8 NM_014587 
6.72 up 11.71 up 1.74 up SP5 NM_001003845 
10.01 up 19.05 up 1.90 up SP9 
 
2.52 up 2.64 up 1.05 up SPATA18 NM_145263 
2.55 up 1.66 up 1.54 down SPATA2 NM_006038 
3.15 up 1.75 up 1.81 down SPATA5 NM_145207 
1.67 down 2.82 down 1.69 down SPEG NM_001173476 
2.35 down 1.55 down 1.52 up SPEG 
 
9.14 up 15.23 up 1.67 up SPIB NM_003121 
1.87 up 2.42 up 1.29 up SPICE1 NM_144718 
16.93 down 19.50 down 1.15 down SPINK6 NM_205841 
3.09 up 3.42 up 1.10 up SPOCK2 NM_014767 
4.33 down 2.80 down 1.55 up SPON1 NM_006108 
14.14 down 21.77 down 1.54 down SPRR2G NM_001014291 
4.83 down 16.91 down 3.50 down SPRR4 NM_173080 
4.15 down 3.05 down 1.36 up SPTLC3 NM_018327 
2.06 down 2.04 down 1.01 up SPTSSA NM_138288 
4.94 up 5.24 up 1.06 up SRGAP3 NM_014850 
3.78 down 2.47 down 1.53 up SRRM3 NM_001110199 
1.70 down 2.16 down 1.27 down SSFA2 NM_006751 
2.13 down 2.03 down 1.05 up SSH2 BC011636 
2.94 up 2.71 up 1.08 down SSTR2 NM_001050 
2.20 up 2.64 up 1.20 up SSX2IP NM_014021 
2.31 up 1.78 up 1.30 down ST5 NM_005418 
23.15 up 37.41 up 1.62 up STAG3 NM_012447 
10.78 up 16.03 up 1.49 up STAG3 NM_012447 
5.57 up 9.22 up 1.66 up STAR NM_000349 
1.83 up 2.15 up 1.18 up STIM2 
 
2.53 up 1.88 up 1.35 down STMN1 NM_203401 
1.48 down 2.80 down 1.90 down STON2 NM_033104 
2.60 up 2.94 up 1.13 up STOX2 NM_020225 
1.36 down 2.06 down 1.51 down STRN3 NM_014574 
2.66 down 4.11 down 1.54 down SUN3 NM_001030019 
7.63 up 6.32 up 1.21 down SUSD4 NM_017982 
1.69 up 2.08 up 1.23 up SUV420H NM_032701 
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6.08 up 6.19 up 1.02 up SV2B NM_014848 
2.22 up 3.09 up 1.39 up SVIP NM_148893 
11.37 up 9.59 up 1.19 down SYCE2 NM_001105578 
23.50 up 30.23 up 1.29 up SYCP2 NM_014258 
1.42 up 2.55 up 1.79 up SYNGR1 NM_145731 
4.29 up 4.45 up 1.04 up SYNGR3 NM_004209 
2.51 up 2.92 up 1.17 up SYNGR3 NM_004209 
8.57 up 20.74 up 2.42 up SYNPO2 NM_133477 
9.48 up 11.09 up 1.17 up TAF7L NM_024885 
3.56 up 4.12 up 1.16 up TAL2 NM_005421 
2.25 up 1.66 up 1.36 down TBC1D24 NM_020705 
2.51 down 1.91 down 1.31 up TBX1 NM_080647 
6.84 down 4.27 down 1.60 up TBX18 NM_001080508 
66.60 up 113.10 up 1.70 up TCAM1P NR_002947 
17.76 up 17.63 up 1.01 down TCAM1P NR_002947 
2.41 up 3.50 up 1.45 up TCEA3 NM_003196 
2.43 down 2.23 down 1.09 up TCEAL7 NM_152278 
1.80 up 2.06 up 1.15 up TCF7 NM_003202 
2.20 up 1.91 up 1.15 down TCF7L1 NM_031283 
1.55 up 2.41 up 1.56 up TCL1B NM_004918 
19.53 up 28.83 up 1.48 up TCP11 NM_018679 
5.29 up 4.34 up 1.22 down TCP11 NM_018679 
2.22 down 2.25 down 1.02 down TCTEX1D4 
NM_00101363
2 
3.34 up 1.72 up 1.94 down TCTN2 NM_024809 
4.22 up 6.42 up 1.52 up TDRD10 NM_182499 
3.49 up 7.83 up 2.24 up TDRD10 NM_182499 
2.32 up 2.80 up 1.21 up TDRD10 NM_182499 
1.87 up 2.14 up 1.14 up TERT NM_198253 
2.36 down 1.59 down 1.49 up TFF1 NM_003225 
6.86 down 3.98 down 1.73 up TFPI2 NM_006528 
2.42 up 1.38 up 1.76 down TGIF2 NM_021809 
2.18 up 1.57 up 1.39 down THAP10 NM_020147 
2.83 up 2.55 up 1.11 down THAP2 NM_031435 
2.68 down 2.43 down 1.10 up THBS1 NM_003246 
3.03 down 2.59 down 1.17 up THBS1 NM_003246 
2.33 up 2.29 up 1.02 down THBS4 
 
2.44 down 2.86 down 1.17 down THSD1 NM_199263 
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2.87 up 2.73 up 1.05 down TIFA NM_052864 
2.19 up 2.25 up 1.03 up TIGD3 NM_145719 
2.58 up 2.51 up 1.03 down TIMELESS NM_003920 
6.50 up 7.65 up 1.18 up TJP3 NM_014428 
2.06 up 3.86 up 1.87 up TLR10 NM_030956 
2.65 up 2.31 up 1.14 down TLR5 NM_003268 
4.18 up 5.62 up 1.34 up TLX2 NM_016170 
14.76 up 20.76 up 1.41 up TLX3 NM_021025 
7.11 down 9.02 down 1.27 down TM4SF19 NM_138461 
7.88 down 10.75 down 1.36 down TM4SF19 NM_138461 
3.77 up 2.83 up 1.33 down TM7SF3 NM_016551 
2.64 up 2.46 up 1.07 down TM7SF3 NM_016551 
2.24 down 3.98 down 1.78 down TMC7 NM_024847 
1.91 up 3.08 up 1.61 up TMC8 NM_152468 
2.45 up 2.36 up 1.04 down TMCO4 NM_181719 
1.87 up 2.16 up 1.16 up TMCO4 NM_181719 
2.05 down 1.78 down 1.15 up TMCO7 NM_024562 
1.23 down 2.02 down 1.65 down TMEM105 NM_178520 
2.28 up 3.01 up 1.32 up TMEM150C 
NM_00108050
6 
2.76 up 1.52 up 1.81 down TMEM171 NM_173490 
2.36 up 2.22 up 1.06 down TMEM173 NM_198282 
2.76 up 2.17 up 1.27 down TMEM194A NM_015257 
2.53 up 2.14 up 1.18 down TMEM237 
NM_00104438
5 
2.06 up 1.45 up 1.42 down TMEM81 NM_203376 
1.47 up 3.14 up 2.13 up TMIE NM_147196 
2.23 up 1.86 up 1.20 down TMPO NM_003276 
20.58 up 16.07 up 1.28 down TMPRSS11B NM_182502 
3.58 up 2.82 up 1.27 down TMPRSS2 NM_005656 
4.15 up 3.67 up 1.13 down TMSB4Y NM_004202 
2.38 up 2.19 up 1.08 down TMTC2 NM_152588 
1.61 down 2.97 down 1.85 down TNC NM_002160 
3.98 up 3.53 up 1.13 down TNFAIP2 NM_006291 
2.18 up 2.00 up 1.09 down TNFRSF10B NM_003842 
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1.17 up 2.18 up 1.86 up TNFRSF11A NM_003839 
2.06 up 2.65 up 1.29 up TNFRSF14 NM_003820 
1.78 up 2.63 up 1.48 up TNFRSF9 NM_001561 
4.18 up 2.50 up 1.67 down TNFSF15 NM_005118 
1.67 down 2.08 down 1.24 down TNRC6C NM_001142640 
1.47 down 1.56 up 2.30 up TNXB NM_019105 
1.51 down 2.73 up 4.12 up TNXB NM_032470 
1.62 down 1.96 up 3.17 up TNXB NM_019105 
2.75 up 1.71 up 1.60 down TONSL NM_013432 
2.14 up 1.75 up 1.22 down TOPBP1 NM_007027 
3.53 up 1.77 up 1.99 down TP53 NM_000546 
2.50 up 1.86 up 1.34 down TP53 NM_000546 
2.71 up 3.00 up 1.11 up TP73-AS1 NR_033711 
2.63 up 2.55 up 1.03 down TPD52 NM_001025252 
1.55 down 2.11 down 1.36 down TPM4 NM_003290 
1.60 down 2.14 down 1.33 down TPM4 NM_003290 
5.20 up 4.85 up 1.07 down TRAF1 NM_005658 
3.76 up 2.53 up 1.49 down TRAF2 NM_021138 
2.92 up 2.76 up 1.06 down TRAF2 NM_021138 
5.46 down 3.41 down 1.60 up TREM1 NM_018643 
2.43 up 1.22 up 1.98 down TRIB2 NM_021643 
2.35 up 2.09 up 1.12 down TRIM2 NM_015271 
2.11 up 2.34 up 1.11 up TRIM45 NM_025188 
2.17 up 2.20 up 1.02 up TRIM47 NM_033452 
4.98 up 6.13 up 1.23 up TRIM50 NM_178125 
1.95 up 2.38 up 1.22 up TRIM66 NM_014818 
1.66 down 2.77 down 1.67 down TRMT12 NM_017956 
2.69 up 2.54 up 1.06 down TROAP NM_005480 
1.69 up 4.10 up 2.43 up TRPM6 NM_017662 
2.85 up 2.66 up 1.07 down TRPV4 NM_147204 
3.64 up 5.22 up 1.43 up TRPV6 NM_018646 
3.25 up 3.58 up 1.10 up TRPV6 NM_018646 
2.46 up 2.03 up 1.21 down TSC2 NM_000548 
5.20 down 1.88 down 2.76 up TSIX NR_003255 
7.31 down 1.78 down 4.11 up TSIX NR_003255 
1.39 up 1.55 down 2.16 down TTC26 NM_024926 
2.07 down 1.77 down 1.17 up TTC39B NM_152574 
2.93 down 3.32 down 1.13 down TTC7B NM_00101085
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4.08 up 2.51 up 1.63 down TTC9C AF289605 
3.18 up 2.70 up 1.18 down TTTY14 NR_001543 
42.58 up 6.20 up 6.87 down TTTY15 NR_001545 
15.88 up 4.18 up 3.80 down TTTY15 NR_001545 
1.52 down 2.10 down 1.37 down TUBA3C NM_006001 
1.83 down 2.40 down 1.31 down TUBA4A NM_006000 
1.90 down 2.66 down 1.40 down TUBA4A NM_006000 
1.96 down 2.65 down 1.35 down TUBA4A NM_006000 
2.09 down 1.41 down 1.48 up TUBA8 NM_018943 
1.80 down 2.48 down 1.37 down TUBB2A NM_001069 
2.40 down 2.76 down 1.15 down TUBB2A NM_001069 
2.91 down 4.19 down 1.44 down TUBB3 NM_006086 
1.25 down 2.02 down 1.62 down TUBB6 NM_032525 
2.17 down 3.01 down 1.38 down TWIST2 NM_057179 
34.70 up 8.16 up 4.25 down TXLNG2
P 
NR_045128 
23.34 up 5.42 up 4.31 down TXLNG2
P 
NR_045129 
22.75 up 6.69 up 3.40 down TXLNG2
P 
NR_045128 
2.01 up 1.65 up 1.22 down TYK2 NM_003331 
2.84 up 2.47 up 1.15 down TYMS NM_001071 
1.94 up 2.34 up 1.21 up UBA7 NM_003335 
7.76 up 6.78 up 1.14 down UBD NM_006398 
1.44 down 2.17 down 1.50 down UBE2H NM_003344 
2.56 down 2.04 down 1.26 up UBE2Q2 NM_173469 
2.46 down 1.92 down 1.28 up UBE2Q2P1 NR_003661 
2.95 down 2.11 down 1.40 up UBE2Q2P1 NR_003661 
1.56 up 1.40 down 2.18 down UBQLN1 NM_013438 
2.97 up 1.91 up 1.55 down UBXN11 NM_183008 
1.95 up 2.24 down 4.36 down UCA1 NR_015379 
2.49 up 2.08 up 1.20 down UNC119B NM_001080533 
2.12 up 1.79 up 1.18 down UNC13B NM_006377 
2.18 down 1.76 down 1.24 up UNCX NM_001080461 
2.10 up 1.87 up 1.12 down UNG NM_003362 
6.67 up 5.58 up 1.19 down UPB1 NM_016327 
1.86 down 3.26 down 1.75 down UPP1 NM_181597 
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2.05 down 3.19 down 1.55 down UPP1 BC047030 
2.00 up 2.29 up 1.15 up URB1 NM_014825 
2.57 up 1.82 up 1.41 down USP18 NM_017414 
46.53 up 6.45 up 7.22 down USP9Y NM_004654 
6.56 up 3.08 up 2.13 down USP9Y NM_004654 
1.61 down 2.05 down 1.28 down UST NM_005715 
18.95 up 5.55 up 3.41 down UTY BC012581 
13.36 up 4.48 up 2.99 down UTY NM_182660 
5.32 up 3.88 up 1.37 down UTY NM_007125 
4.75 down 3.68 down 1.29 up VAX1 NM_001112704 
6.30 up 7.98 up 1.27 up VCAM1 NM_001078 
2.10 down 2.03 down 1.04 up VCX2 NM_016378 
2.25 down 2.92 down 1.30 down VEGFC NM_005429 
3.36 down 2.03 down 1.66 up VGLL3 NM_016206 
1.74 up 2.04 up 1.17 up VHL NM_000551 
2.03 down 1.38 down 1.47 up VMAC NM_001017921 
2.49 down 2.01 down 1.24 up VPS37D NM_001077621 
1.41 down 3.45 down 2.44 down VSIG1 NM_182607 
1.67 up 2.02 up 1.21 up VSIG10 NM_019086 
2.90 down 1.83 down 1.58 up VTRNA1-2 NR_026704 
4.99 up 3.63 up 1.37 down VWDE NM_001135924 
2.47 down 1.82 down 1.36 up WASF3 NM_006646 
1.56 up 2.06 up 1.32 up WDR33 NM_001006623 
2.21 up 2.07 up 1.07 down WDR34 NM_052844 
2.71 up 2.68 up 1.01 down WDR52 NM_018338 
4.91 down 7.45 down 1.52 down WDR66 NM_144668 
2.16 up 1.84 up 1.17 down WDR76 NM_024908 
2.20 up 1.82 up 1.20 down WEE1 NM_003390 
29.77 up 10.74 up 2.77 down WFDC2 NM_006103 
24.53 up 7.73 up 3.17 down WFDC2 NM_006103 
2.82 up 2.40 up 1.17 down WHSC1 NM_133330 
2.12 up 1.90 up 1.12 down WHSC1 NM_007331 
2.02 up 1.51 up 1.34 down WHSC1 NM_133330 
3.65 up 5.09 up 1.39 up WIPF3 AK094250 
2.81 up 2.80 up 1.00 down WIPF3 BC156551 
27.26 up 29.32 up 1.08 up WNK2 NM_006648 
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6.03 up 8.34 up 1.38 up WNK2 NM_006648 
4.72 up 5.71 up 1.21 up WNK2 AB051547 
1.09 down 2.98 down 2.72 down WNT7A NM_004625 
1.10 down 2.05 down 1.85 down WNT7B NM_058238 
2.11 up 1.68 up 1.25 down WRAP73 NM_017818 
3.27 down 1.49 down 2.20 up XIST NR_001564 
95.21 down 5.26 down 18.11 up XIST NR_001564 
180.5
3 down 7.09 down 25.46 up XIST NR_001564 
289.2
1 down 7.42 down 38.98 up XIST NR_001564 
337.7
5 down 12.65 down 26.69 up XIST NR_001564 
346.5
7 down 8.31 down 41.71 up XIST NR_001564 
8.99 up 13.74 up 1.53 up XKR4 NM_052898 
2.81 up 2.40 up 1.17 down XLOC_000153 
3.01 up 4.42 up 1.47 up XLOC_000190 
1.82 up 2.04 up 1.12 up XLOC_000350 AK125443 
4.08 up 3.66 up 1.12 down XLOC_000363 
2.26 up 3.64 up 1.61 up XLOC_000377 
2.05 up 1.85 up 1.11 down XLOC_000390 AW963279 
3.09 up 3.06 up 1.01 down XLOC_000441 AK023394 
2.90 up 1.24 up 2.33 down XLOC_000490 
1.60 down 2.05 down 1.28 down XLOC_000505 
1.91 down 2.71 down 1.42 down XLOC_000527 XR_108329 
2.37 down 2.87 down 1.21 down XLOC_000527 XR_108330 
2.75 down 5.37 down 1.95 down XLOC_000587 AK124056 
3.27 down 6.25 down 1.91 down XLOC_000587 
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1.57 up 2.13 up 1.36 up XLOC_000746 
3.24 down 6.18 down 1.91 down XLOC_000778 
1.69 up 2.07 up 1.23 up XLOC_000889 
2.54 up 2.76 up 1.09 up XLOC_000939 
4.59 up 4.61 up 1.00 up XLOC_000956 BX089534 
2.16 down 1.51 down 1.43 up XLOC_001265 
2.41 up 4.61 up 1.91 up XLOC_001286 
1.77 up 2.89 up 1.63 up XLOC_001341 
2.55 up 2.61 up 1.02 up XLOC_001576 BG219825 
5.86 up 1.66 up 3.52 down XLOC_001595 
2.30 down 2.15 down 1.07 up XLOC_001784 
1.53 down 2.36 down 1.55 down XLOC_001826 
1.55 down 4.70 down 3.04 down XLOC_001826 
1.56 down 2.51 down 1.61 down XLOC_001826 
1.72 down 3.26 down 1.89 down XLOC_001856 
1.46 down 2.50 down 1.71 down XLOC_001869 
2.43 down 1.60 down 1.52 up XLOC_001910 
2.02 down 1.24 down 1.63 up XLOC_001931 
2.12 down 2.22 down 1.04 down XLOC_002484 AK307257 
1.45 down 2.22 down 1.53 down XLOC_002515 
2.19 down 1.83 down 1.20 up XLOC_002560 
 208 
24.31 down 8.47 down 2.87 up XLOC_002603 
36.03 down 11.62 down 3.10 up XLOC_002603 
2.18 down 1.65 down 1.32 up XLOC_002770 
3.41 up 3.33 up 1.02 down XLOC_002779 BC035247 
7.05 up 5.67 up 1.24 down XLOC_002830 
1.86 down 2.25 down 1.21 down XLOC_003077 
2.01 up 1.54 up 1.30 down XLOC_003221 BC030754 
2.11 down 1.69 down 1.24 up XLOC_003422 
1.94 up 2.61 up 1.34 up XLOC_003498 
1.25 up 2.20 up 1.76 up XLOC_003878 
5.34 down 1.97 down 2.71 up XLOC_003986 
2.51 down 2.07 down 1.22 up XLOC_004108 
2.44 up 1.66 up 1.47 down XLOC_004144 
1.28 up 2.16 up 1.69 up XLOC_004165 
2.47 down 5.66 down 2.29 down XLOC_004198 
3.75 up 2.21 up 1.70 down XLOC_004456 
3.02 up 2.18 up 1.38 down XLOC_004456 
2.07 up 2.56 up 1.24 up XLOC_004467 
1.62 down 4.16 down 2.57 down XLOC_005105 BX096383 
2.23 up 2.56 up 1.15 up XLOC_005244 
2.37 down 3.83 down 1.62 down XLOC_005369 
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8.04 down 1.66 down 4.85 up XLOC_005471 BY994446 
2.00 up 1.10 down 2.19 down XLOC_005514 
1.87 down 2.20 down 1.18 down XLOC_005748 
2.22 down 3.42 down 1.54 down XLOC_005748 
4.08 up 6.58 up 1.61 up XLOC_005764 
2.10 down 1.23 down 1.70 up XLOC_005809 
2.59 down 2.46 down 1.06 up XLOC_005810 
2.65 down 2.74 down 1.03 down XLOC_005810 
3.23 down 5.82 down 1.80 down XLOC_005935 CB123670 
3.97 down 8.01 down 2.02 down XLOC_005935 CB123670 
3.12 up 2.01 up 1.55 down XLOC_006153 
3.74 down 11.41 down 3.05 down XLOC_006200 BC040593 
1.52 up 2.45 up 1.61 up XLOC_006291 
1.85 up 2.18 up 1.18 up XLOC_006588 
3.34 down 2.35 down 1.42 up XLOC_006593 BG185100 
2.01 down 1.39 down 1.45 up XLOC_006688 
2.39 down 2.01 down 1.19 up XLOC_006915 DA998032 
2.16 down 1.57 down 1.38 up XLOC_007254 
1.63 up 3.06 up 1.88 up XLOC_007467 
1.18 down 2.69 down 2.28 down XLOC_007531 
2.27 up 1.82 up 1.25 down XLOC_007556 
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7.47 down 1.83 down 4.08 up XLOC_007697 
12.35 up 4.38 up 2.82 down XLOC_007734 BC043560 
2.08 down 1.48 down 1.41 up XLOC_007857 
2.11 down 2.30 down 1.09 down XLOC_007992 
3.30 down 1.67 down 1.97 up XLOC_008015 
27.69 down 4.33 down 6.40 up XLOC_008015 
1.93 down 2.14 down 1.11 down XLOC_008079 
2.10 down 1.87 down 1.12 up XLOC_008088 BC030106 
1.13 down 3.02 down 2.67 down XLOC_008151 BC015977 
1.62 down 3.60 down 2.22 down XLOC_008151 BC015977 
1.79 up 2.62 up 1.46 up XLOC_008152 
3.24 up 1.83 up 1.77 down XLOC_008276 
3.05 up 2.33 up 1.31 down XLOC_008276 
7.67 up 3.49 up 2.20 down XLOC_008323 
2.02 down 1.74 down 1.16 up XLOC_008542 
2.04 up 3.85 up 1.89 up XLOC_008666 AK056146 
3.87 down 6.89 down 1.78 down XLOC_008700 
2.07 down 2.08 down 1.01 down XLOC_008703 
2.26 down 7.45 down 3.29 down XLOC_008711 
1.67 down 2.43 down 1.45 down XLOC_008802 
4.59 down 4.65 down 1.01 down XLOC_009152 
 211 
2.36 up 1.95 up 1.21 down XLOC_009181 AK091996 
1.36 down 2.71 down 1.99 down XLOC_009378 
2.59 up 2.52 up 1.03 down XLOC_009494 
4.84 up 4.50 up 1.08 down XLOC_009507 AK054718 
3.44 down 1.65 down 2.08 up XLOC_009549 
2.32 up 1.86 up 1.24 down XLOC_009681 
1.52 down 3.09 down 2.04 down XLOC_009788 
2.38 down 2.21 down 1.08 up XLOC_009790 
1.59 down 2.80 down 1.76 down XLOC_009810 
1.71 down 2.32 down 1.36 down XLOC_009994 
2.12 up 2.53 up 1.20 up XLOC_010117 
2.87 up 2.07 up 1.39 down XLOC_010244 
4.99 up 3.91 up 1.28 down XLOC_010245 
1.53 down 2.25 down 1.47 down XLOC_010321 
2.52 down 2.55 down 1.01 down XLOC_010390 AJ412054 
2.10 up 2.58 up 1.23 up XLOC_010556 
3.42 up 2.27 up 1.51 down XLOC_010591 
2.14 down 1.47 down 1.45 up XLOC_010719 
2.48 down 1.69 down 1.47 up XLOC_010743 AK092053 
1.61 down 3.40 down 2.11 down XLOC_010881 
3.37 down 4.01 down 1.19 down XLOC_010933 
 212 
2.57 up 4.67 up 1.81 up XLOC_010942 
2.24 down 1.20 down 1.86 up XLOC_011107 
2.12 up 2.46 up 1.16 up XLOC_011248 BC035091 
2.01 up 2.06 up 1.03 up XLOC_011309 
2.06 down 1.32 down 1.56 up XLOC_011408 
4.65 up 7.33 up 1.58 up XLOC_011545 
2.41 up 3.05 up 1.27 up XLOC_011545 
4.68 up 7.69 up 1.64 up XLOC_011546 
2.66 up 2.12 up 1.26 down XLOC_011837 BC035173 
2.39 up 2.98 up 1.25 up XLOC_011872 
4.18 up 2.77 up 1.51 down XLOC_012079 
2.10 down 1.53 down 1.37 up XLOC_012304 
2.33 down 11.21 down 4.82 down XLOC_012452 BC084573 
2.60 up 2.91 up 1.12 up XLOC_012530 
4.07 up 3.74 up 1.09 down XLOC_012641 
3.85 up 3.55 up 1.08 down XLOC_012895 
2.19 down 1.95 down 1.12 up XLOC_013093 
2.61 down 3.49 down 1.34 down XLOC_013364 
1.60 down 2.60 down 1.63 down XLOC_013461 
1.72 down 2.76 down 1.61 down XLOC_013461 
8.11 up 7.43 up 1.09 down XLOC_013483 
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2.79 down 4.62 down 1.66 down XLOC_013541 BX116929 
2.80 down 5.00 down 1.79 down XLOC_013542 
2.23 down 2.25 down 1.01 down XLOC_013770 
3.92 down 3.66 down 1.07 up XLOC_013832 
1.17 up 2.90 up 2.47 up XLOC_013868 
1.57 down 2.58 down 1.64 down XLOC_013940 
2.47 up 2.18 up 1.13 down XLOC_013973 
2.84 up 2.61 up 1.09 down XLOC_013981 BX105611 
2.15 down 1.93 down 1.11 up XLOC_014102 
2.69 up 3.02 up 1.12 up XLOC_014107 
5.61 up 4.20 up 1.33 down XLOC_014111 DB312214 
4.33 up 3.16 up 1.37 down XLOC_014219 
2.42 down 1.59 down 1.52 up XLOC_014246 
6.89 up 4.94 up 1.39 down XLOC_014257 
3.09 up 3.24 up 1.05 up XLOC_014288 
2.58 up 3.09 up 1.19 up XLOC_014288 
1.52 up 2.17 up 1.43 up XLOC_014334 
6.79 up 3.87 up 1.75 down XLOC_014388 XR_109724 
1.27 down 2.75 down 2.16 down XLOC_014399 
5.92 up 3.73 up 1.59 down XLOC_014513 BC017979 
2.91 up 2.02 up 1.44 down XLOC_l2
_000010 
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2.25 up 2.36 up 1.05 up XLOC_l2
_000080 AK311553 
3.64 up 3.07 up 1.18 down XLOC_l2
_000101 
2.33 up 3.73 up 1.60 up XLOC_l2
_000417 
1.82 up 2.80 up 1.54 up XLOC_l2
_001091 
2.48 up 2.38 up 1.04 down XLOC_l2
_001332 
2.90 up 2.01 up 1.44 down XLOC_l2
_001953 AL832069 
1.62 down 2.66 down 1.65 down XLOC_l2
_002049 
2.67 down 2.19 down 1.22 up XLOC_l2
_002469 
2.28 down 3.27 down 1.43 down XLOC_l2
_002502 
7.37 up 5.87 up 1.26 down XLOC_l2
_003293 
















3.68 up 4.03 up 1.09 up XLOC_l2
_003881 
1.52 up 4.30 up 2.82 up XLOC_l2
_004315 
6.33 up 6.19 up 1.02 down XLOC_l2
_004317 CR620068 
3.73 up 3.22 up 1.16 down XLOC_l2
_004318 BI821606 
2.97 down 2.91 down 1.02 up XLOC_l2
_004562 
2.09 up 2.28 up 1.09 up XLOC_l2
_004611 
2.34 up 2.23 up 1.05 down XLOC_l2
_005179 
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1.73 down 2.41 down 1.39 down XLOC_l2
_005952 
1.65 down 4.13 down 2.50 down XLOC_l2
_006021 DB117598 
7.57 up 4.78 up 1.58 down XLOC_l2
_006152 
1.72 up 2.34 up 1.36 up XLOC_l2
_006152 AK311448 
3.57 up 3.35 up 1.06 down XLOC_l2
_006471 
2.11 down 2.06 down 1.03 up XLOC_l2
_006595 
2.65 up 2.50 up 1.06 down XLOC_l2
_006745 
1.90 down 3.28 down 1.73 down XLOC_l2
_006937 
2.10 down 1.48 down 1.42 up XLOC_l2
_007119 
2.06 up 2.30 up 1.12 up XLOC_l2
_007449 
2.04 down 1.40 down 1.45 up XLOC_l2
_007449 
5.15 up 4.40 up 1.17 down XLOC_l2
_007478 
3.28 up 3.27 up 1.00 down XLOC_l2
_007478 
2.02 down 1.92 down 1.05 up XLOC_l2
_007829 
1.73 up 2.95 up 1.71 up XLOC_l2
_007884 
1.81 down 2.14 down 1.18 down XLOC_l2
_007928 
2.53 up 2.15 up 1.18 down XLOC_l2
_008140 
2.51 up 3.41 up 1.36 up XLOC_l2
_008151 
2.04 up 2.92 up 1.43 up XLOC_l2
_008226 XR_109883 
2.08 down 1.38 down 1.51 up XLOC_l2
_008910 BC039367 
2.90 up 4.90 up 1.69 up XLOC_l2
_008991 
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3.05 up 3.05 up 1.00 down XLOC_l2
_009136 
2.46 down 2.37 down 1.04 up XLOC_l2
_009139 CR614803 
3.80 up 3.13 up 1.21 down XLOC_l2
_009273 AK127572 
2.52 up 2.66 up 1.05 up XLOC_l2
_009273 AK127572 
2.05 up 2.34 up 1.14 up XLOC_l2
_009285 
4.93 up 7.05 up 1.43 up XLOC_l2
_009301 
4.60 up 5.45 up 1.18 up XLOC_l2
_009316 
2.23 up 1.91 up 1.16 down XLOC_l2
_009571 
2.07 up 1.68 up 1.23 down XLOC_l2
_009571 
4.71 up 6.88 up 1.46 up XLOC_l2
_009668 
2.04 down 2.13 down 1.04 down XLOC_l2
_009888 
1.55 down 2.21 down 1.43 down XLOC_l2
_010139 
3.97 down 4.03 down 1.02 down XLOC_l2
_010141 DA697996 
2.11 down 1.45 down 1.45 up XLOC_l2
_010239 
2.48 down 2.23 down 1.11 up XLOC_l2
_010267 
3.46 up 2.52 up 1.38 down XLOC_l2
_010558 
2.53 up 2.47 up 1.03 down XLOC_l2
_010558 
3.43 down 2.84 down 1.21 up XLOC_l2
_010661 CD359603 
3.44 down 6.09 down 1.77 down XLOC_l2
_010751 
2.51 up 2.05 up 1.23 down XLOC_l2
_011011 BC036795 
17.72 up 6.12 up 2.89 down XLOC_l2
_011146 
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1.84 up 2.19 up 1.19 up XLOC_l2
_011265 BU852287 
2.73 up 2.67 up 1.02 down XLOC_l2
_011649 
1.83 up 2.32 up 1.27 up XLOC_l2
_011987 
2.06 up 2.43 up 1.18 up XLOC_l2
_012083 AL049987 
2.02 up 1.47 up 1.38 down XLOC_l2
_012836 
2.81 up 2.25 up 1.25 down XLOC_l2
_013001 DQ272581 
6.83 down 7.85 down 1.15 down XLOC_l2
_013124 AJ606328 
2.09 down 2.38 down 1.14 down XLOC_l2
_013125 AJ606331 
2.87 down 2.66 down 1.08 up XLOC_l2
_013293 BQ441651 
2.98 down 2.34 down 1.28 up XLOC_l2
_013293 BQ441651 
4.18 down 3.04 down 1.38 up XLOC_l2
_013293 
2.95 up 2.96 up 1.00 up XLOC_l2
_013301 XR_108746 
2.95 up 2.53 up 1.17 down XLOC_l2
_013301 XR_108746 
2.92 up 2.72 up 1.07 down XLOC_l2
_013301 XR_108746 
2.70 up 1.90 up 1.42 down XLOC_l2
_013485 
3.20 up 2.31 up 1.39 down XLOC_l2
_013734 
3.05 up 2.74 up 1.11 down XLOC_l2
_013873 
2.18 up 1.78 up 1.23 down XLOC_l2
_014048 
2.11 down 2.48 down 1.18 down XLOC_l2
_014697 XR_108927 




3.41 up 2.37 up 1.44 down XLOC_l2
_014802 AK311573 
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1.51 up 2.12 up 1.40 up XLOC_l2
_014830 
3.11 up 1.76 up 1.77 down XLOC_l2
_015121 
1.86 up 2.06 up 1.11 up XLOC_l2
_015441 
5.33 up 5.46 up 1.02 up XLOC_l2
_015849 BX111592 
5.76 up 3.94 up 1.46 down XLOC_l2
_015892 
2.96 down 2.09 down 1.42 up XLOC_l2
_015907 
2.86 up 2.07 up 1.38 down XLOC_l2
_015950 
2.38 down 2.03 down 1.17 up XPNPEP3 NM_001204827 
2.23 up 2.32 up 1.04 up XRCC1 NM_006297 
2.29 up 1.68 up 1.36 down XRCC2 NM_005431 
2.22 up 1.80 up 1.23 down XYLB NM_005108 
10.33 up 8.15 up 1.27 down YBX2 NM_015982 
1.79 down 3.30 down 1.85 down YIF1B NM_033557 
2.11 up 2.60 up 1.23 up YPEL1 NM_013313 
1.64 down 2.01 down 1.23 down YWHAE AK296555 
1.56 down 2.19 down 1.40 down YWHAZ NM_145690 
2.18 up 2.03 up 1.07 down ZADH2 NM_175907 
1.65 down 2.49 down 1.51 down ZAK NM_016653 
1.04 down 2.73 down 2.62 down ZBED2 NM_024508 
1.96 up 2.66 up 1.36 up ZBED3 NM_032367 
2.01 up 1.84 up 1.09 down ZBTB46 NM_025224 
2.01 up 1.83 up 1.09 down ZBTB5 NM_014872 
1.63 up 2.00 up 1.23 up ZC3H6 NM_198581 
2.47 down 1.81 down 1.37 up ZC4H2 NM_018684 
2.38 up 2.84 up 1.20 up ZCWPW1 NM_017984 
2.36 up 3.62 up 1.53 up ZCWPW1 NM_017984 
3.52 up 3.04 up 1.16 down ZDHHC23 NM_173570 
1.41 down 2.11 down 1.50 down ZDHHC9 NM_016032 
3.05 up 3.03 up 1.01 down ZFHX2 NM_033400 
3.02 up 3.33 up 1.10 up ZFP14 NM_020917 
2.07 up 2.25 up 1.09 up ZFP3 NM_153018 
1.70 up 2.02 up 1.19 up ZFP62 NM_152283 
1.64 up 2.04 up 1.25 up ZFP62 NM_152283 
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1.24 down 2.06 down 1.66 down ZFP64 NM_199427 
23.00 up 3.93 up 5.85 down ZFY NM_003411 
2.64 up 4.94 up 1.87 up ZMAT1 NM_001011657 
2.08 up 4.02 up 1.94 up ZMAT1 NM_001011657 
2.50 up 2.79 up 1.11 up ZMIZ2 NM_031449 
1.79 up 2.08 up 1.16 up ZNF10 NM_015394 
2.05 down 2.05 down 1.00 up ZNF134 NM_003435 
2.07 down 2.32 down 1.12 down ZNF134 NM_003435 
1.46 down 2.05 down 1.40 down ZNF165 NM_003447 
2.23 up 2.52 up 1.13 up ZNF239 NM_005674 
2.15 up 1.97 up 1.09 down ZNF248 NM_021045 
2.58 up 1.18 up 2.19 down ZNF284 NM_001037813 
2.77 up 2.26 up 1.23 down ZNF300 NM_052860 
2.31 up 1.82 up 1.27 down ZNF300 NM_001172831 
2.51 up 2.26 up 1.11 down ZNF311 NM_001010877 
2.19 up 1.81 up 1.21 down ZNF326 NM_182975 
3.64 up 2.84 up 1.28 down ZNF346 NM_012279 
2.82 up 2.62 up 1.08 down ZNF367 NM_153695 
2.20 up 2.36 up 1.07 up ZNF367 NM_153695 
2.05 up 1.70 up 1.21 down ZNF396 AF533251 
2.44 up 2.11 up 1.16 down ZNF397 NM_001135178 
2.19 up 1.49 up 1.47 down ZNF397 NM_032347 
2.42 up 2.57 up 1.07 up ZNF420 NM_144689 
2.49 up 1.47 up 1.69 down ZNF473 NM_015428 
2.87 up 2.39 up 1.20 down ZNF488 NM_153034 
2.30 up 2.21 up 1.04 down ZNF507 AB029007 
2.24 up 1.89 up 1.18 down ZNF512 NM_032434 
2.08 up 1.91 up 1.09 down ZNF514 NM_032788 
3.33 up 1.92 up 1.73 down ZNF519 NM_145287 
2.39 up 4.42 up 1.85 up ZNF540 NM_152606 
24.59 up 54.05 up 2.20 up ZNF541 NM_001101419 
2.14 up 1.89 up 1.13 down ZNF595 NM_182524 
1.77 up 2.11 up 1.20 up ZNF599 NM_001007248 
2.12 up 1.77 up 1.20 down ZNF605 NM_183238 
 220 
2.03 up 1.83 up 1.11 down ZNF605 NM_183238 
2.09 up 1.67 up 1.25 down ZNF641 NM_152320 
1.68 down 2.32 down 1.38 down ZNF655 NM_024061 
3.24 up 3.56 up 1.10 up ZNF667 NM_022103 
2.55 up 1.44 up 1.77 down ZNF713 NM_182633 
1.20 up 2.03 up 1.70 up ZNF714 NM_182515 
1.97 down 2.33 down 1.18 down ZNF726 BC046415 
4.06 down 1.56 down 2.61 up ZNF730 AK131472 
2.13 up 1.27 up 1.67 down ZNF77 NM_021217 
1.72 up 2.06 up 1.19 up ZNF783 NM_001195220 
2.50 down 2.02 down 1.24 up ZNF788 NR_027049 
2.21 down 1.66 down 1.33 up ZNF81 BC039609 
4.19 up 2.09 up 2.01 down ZNF827 NM_178835 
1.84 up 3.62 up 1.97 up ZNF862 NM_001099220 
2.75 up 2.41 up 1.14 down ZNF865 NM_001195605 
1.97 up 2.39 up 1.21 up ZNF879 NM_001136116 
2.00 up 2.26 up 1.13 up ZXDC NM_001040653 
24.72 up 8.79 up 2.81 down ZYG11A NM_001004339 
5.93 up 5.59 up 1.06 down ZYG11A NM_001004339 
12.36 up 9.86 up 1.25 down 
 
AF452715 
10.75 up 6.30 up 1.71 down 
 
XR_111273 
8.44 up 8.38 up 1.01 down 
 
AK094554 
8.32 up 8.44 up 1.01 up 
 
AK129565 




6.38 up 5.44 up 1.17 down 
 
AK027667 
5.71 up 3.69 up 1.55 down 
 
XR_109724 
5.29 up 3.16 up 1.67 down 
 
AF461897 
4.97 up 8.52 up 1.71 up 
 
AF289562 
4.67 up 3.01 up 1.55 down 
 
XR_110030 
4.38 up 4.20 up 1.04 down 
 
AL389942 
4.11 up 3.29 up 1.25 down 
 
BC119676 
3.99 up 4.89 up 1.22 up 
 
AK129520 





3.81 up 3.62 up 1.05 down 
 
XR_109883 
3.62 up 3.61 up 1.00 down 
 
AY129018 




3.47 up 4.60 up 1.33 up 
 
DA110513 




3.38 up 4.45 up 1.32 up 
 
BC069683 
3.34 up 4.70 up 1.41 up 
 
AF119797 
3.25 up 2.25 up 1.45 down 
 
AK098491 
3.13 up 2.35 up 1.33 down 
 
AK127966 
2.98 up 2.53 up 1.18 down 
 
AF068294 
2.84 up 2.52 up 1.13 down 
 
BG216262 
2.78 up 2.25 up 1.23 down 
 
AK127966 
2.78 up 2.26 up 1.23 down 
 
AK074492 
2.76 up 7.41 up 2.69 up 
 
AJ312026 
2.73 up 2.69 up 1.01 down 
 
AK024144 
2.72 up 2.03 up 1.34 down 
 
AK001057 
2.72 up 2.18 up 1.25 down 
 
AK091705 




2.59 up 1.81 up 1.43 down 
 
BC029479 
2.55 up 1.84 up 1.38 down 
 
AK130540 
2.48 up 1.99 up 1.25 down 
 
AK096917 
2.44 up 4.39 up 1.80 up 
 
BC034587 
2.40 up 2.24 up 1.08 down 
 
AY203941 
2.34 up 4.89 up 2.09 up 
 
AJ312027 
2.32 up 2.31 up 1.01 down 
 
DQ272581 
2.29 up 1.33 up 1.73 down 
 
AK309441 
2.28 up 2.04 up 1.12 down 
 
AK056419 
2.24 up 2.17 up 1.03 down 
 
AK096443 
2.17 up 1.52 up 1.43 down 
 
AK294208 
2.12 up 2.24 up 1.05 up 
 
CR737729 
2.11 up 1.91 up 1.11 down 
 
BC104430 
2.10 up 3.75 up 1.78 up 
 
BC044655 
2.09 up 1.10 up 1.90 down 
 
XR_109115 
2.08 up 2.02 up 1.03 down 
 
BC014063 
2.07 up 1.61 up 1.29 down 
 
AK097701 
2.05 up 1.85 up 1.11 down 
 
BC021857 
2.05 up 2.32 up 1.13 up 
 
AF264629 





1.90 up 3.02 up 1.58 up 
 
CR594811 
1.84 up 2.35 up 1.28 up 
 
AK126778 
1.79 up 2.14 up 1.20 up 
 
M15530 
1.73 up 2.00 up 1.16 up 
 
AK127601 
1.66 up 2.05 up 1.24 up 
 
BC022294 
1.61 up 2.30 up 1.42 up 
 
AK057820 
1.59 up 2.03 up 1.28 up 
 
AK026667 
1.40 up 2.06 up 1.46 up 
 
AF336885 
1.39 up 2.17 up 1.57 up 
 
X58736 
1.38 up 2.07 up 1.50 up 
 
AK129975 
1.36 up 3.97 up 2.92 up 
 
GQ232939 
1.05 down 3.81 down 3.62 down 
 
DR007925 
1.93 down 2.40 down 1.24 down 
 
AY927633 
2.02 down 1.62 down 1.24 up 
 
AF384996 




2.07 down 3.00 down 1.45 down 
 
AK130724 




2.23 down 2.39 down 1.07 down 
 
AF400227 
2.26 down 4.76 down 2.11 down 
 
BM457408 
2.33 down 3.00 down 1.29 down 
 
DR007930 
2.45 down 1.60 down 1.53 up 
 
DA734158 




2.65 down 1.96 down 1.35 up 
 
BX092453 
2.77 down 1.92 down 1.44 up 
 
BC104424 
2.91 down 2.19 down 1.33 up 
 
L19779 




4.19 down 4.64 down 1.11 down 
 
BC073826 
4.92 down 2.81 down 1.75 up 
 
BC034319 
4.99 down 2.78 down 1.79 up 
 
BC034319 







APPENDIX B - DEG EA POPULATION 


















of change  
10.16 up 9.18 up 1.11 down AACSP1 NR_024035 
1.41 down 2.70 down 1.92 down AATK NM_001080395 
3.25 up 9.62 up 2.96 up ABCA3 NM_001089 
2.42 up 1.56 up 1.55 down ABCB9 NM_019625 
2.41 down 1.93 down 1.25 up ABCC2 NM_000392 
4.91 down 2.33 down 2.11 up ABCC9 NM_005691 
2.70 down 2.18 down 1.24 up ABL1 NM_007313 
1.40 down 2.39 down 1.71 down ABL2 NM_007314 
1.53 down 3.47 down 2.28 down ABL2 NM_007314 
2.08 down 1.97 down 1.06 up ACOT8   
1.71 up 3.04 up 1.78 up ACOXL NM_001142807 
2.60 up 2.22 up 1.17 down ACPL2 NM_152282 
1.64 down 1.74 up 2.86 up ACSL5 NM_203380 
2.05 up 3.22 up 1.57 up ACSS1 NM_032501 
1.29 down 2.98 down 2.31 down ACTN1 NM_001102 
1.47 down 2.84 down 1.93 down ACTN3 NM_001104 
1.97 up 2.22 up 1.13 up ACTR3C BX640643 
2.08 up 2.53 up 1.22 up ADAM1 NR_036636 
1.22 down 3.55 down 2.90 down ADAM12 NM_021641 
1.22 down 1.67 up 2.03 up ADAM28 NM_021777 
1.48 down 2.78 up 4.10 up ADAMDEC1 NM_001145271 
1.15 up 3.03 up 2.63 up ADAMTS17 NM_139057 
2.41 down 5.40 down 2.24 down ADAMTS6 NM_197941 
2.68 up 3.64 up 1.36 up ADARB2 NM_018702 
8.66 up 7.64 up 1.13 down ADARB2 NM_018702 
2.20 down 1.04 up 2.29 up ADCY4 NM_139247 
2.13 up 2.08 up 1.03 down ADCY6 NM_015270 
6.75 down 1.10 up 7.42 up ADIPOQ NM_004797 
1.12 up 2.47 up 2.20 up ADORA2A NM_000675 
3.50 down 1.90 down 1.84 up ADPRHL1 NM_138430 
 224 
5.18 down 4.56 down 1.14 up AGMO NM_001004320 
1.35 down 2.54 down 1.88 down AGPAT4 NM_020133 
1.26 down 3.10 down 2.46 down AGPAT4 NM_020133 
2.07 down 5.17 down 2.50 down AGPAT4 NM_020133 
2.43 up 1.69 up 1.44 down AHDC1 NM_001029882 
1.17 up 4.12 down 4.81 down AHNAK2 NM_138420 
2.17 down 2.85 down 1.31 down AIG1   
2.27 up 2.80 up 1.23 up AKR1E2 NM_001040177 
1.64 up 2.04 up 1.24 up ALDH9A1 NM_000696 
1.24 down 1.77 up 2.18 up ALS2CR8 NM_024744 
2.85 down 1.62 up 4.62 up AMICA1 NM_153206 
2.59 down 3.99 down 1.54 down AMIGO2 NM_181847 
2.60 up 4.80 up 1.85 up AMY1C NM_001008219 
2.84 up 5.23 up 1.84 up AMY1C NM_001008219 
3.14 down 1.43 down 2.20 up ANK1 NM_000037 
1.43 down 1.68 up 2.40 up ANKAR NM_144708 
1.53 down 1.78 up 2.72 up ANKDD1A NM_182703 
2.89 up 1.10 up 2.62 down ANKRD13B NM_152345 
1.98 up 2.19 up 1.11 up ANKRD20A1 NM_032250 
4.05 up 4.03 up 1.00 down ANKRD20A5P NR_040113 
2.17 up 4.18 up 1.92 up ANKRD20A5P NR_040113 
3.74 up 6.99 up 1.87 up ANKRD20A9P NR_027995 
1.44 up 3.29 up 2.28 up ANKRD20A9P NR_027995 
2.40 up 2.32 up 1.03 down ANKRD24 NM_133475 
1.67 up 2.06 up 1.23 up ANKRD32 NM_032290 
3.45 up 11.98 up 3.47 up ANKRD43 NM_175873 
2.80 up 2.52 up 1.11 down ANKRD65 NM_001145210 
1.90 down 6.00 down 3.16 down ANO1-AS2 XR_110889 
4.20 down 1.32 up 5.54 up AOX1 NM_001159 
4.45 down 1.17 up 5.21 up AOX1 NM_001159 
1.05 up 1.98 down 2.07 down AP1S1 NM_001283 
4.49 up 5.12 up 1.14 up AP3B2 NM_004644 
1.92 down 2.02 up 3.88 up APBB1IP NM_019043 
1.52 down 2.12 down 1.39 down APBB2 NM_004307 
2.01 down 1.69 down 1.19 up APH1B NM_031301 
4.52 up 1.83 up 2.47 down APOBEC3B NM_004900 
2.19 up 2.16 up 1.01 down APOBEC3C NM_014508 
2.17 up 2.10 up 1.03 down APOBEC3F NM_145298 
 225 
1.45 down 1.89 up 2.73 up APOL3 NM_145641 
2.22 down 7.05 down 3.18 down AREG NM_001657 
2.02 down 6.47 down 3.20 down AREG NM_001657 
3.76 up 2.11 up 1.78 down ARF3   
1.19 down 1.69 up 2.02 up ARGLU1 NM_018011 
2.28 up 3.80 up 1.67 up ARHGAP26 NM_015071 
2.40 up 1.99 up 1.21 down ARHGAP33 NM_052948 
1.16 up 3.89 up 3.35 up ARHGAP4 NM_001164741 
1.67 up 1.37 down 2.29 down ARHGAP5 NM_001030055 
1.64 down 1.81 up 2.97 up ARHGAP9 NM_032496 
1.52 down 1.65 up 2.51 up ARHGDIB NM_001175 
7.01 up 2.60 up 2.70 down ARHGEF16 NM_014448 
4.44 up 2.20 up 2.01 down ARHGEF19 NM_153213 
5.13 up 1.91 up 2.68 down ARHGEF19 NM_153213 
2.29 up 1.96 up 1.17 down ARL3 NM_004311 
1.90 down 3.33 down 1.75 down ARL4D NM_001661 
5.93 up 6.39 up 1.08 up ARNT2 NM_014862 
1.14 up 3.52 down 4.03 down ARSJ NM_024590 
1.42 up 5.70 up 4.00 up ART4 NM_021071 
1.00 up 3.12 down 3.13 down ARTN NM_057090 
3.92 up 6.72 up 1.72 up ASCL4 NM_203436 
3.21 up 1.98 up 1.62 down ASF1B NM_018154 
3.24 down 2.03 up 6.58 up ASPA NM_000049 
2.75 up 2.58 up 1.07 down ATF5 NM_012068 
3.04 down 1.08 down 2.82 up ATOH8 NM_032827 
1.74 up 1.37 down 2.39 down ATP2B4 NM_001001396 
10.85 up 1.59 up 6.84 down ATP5B NM_001686 
1.64 up 3.28 up 2.00 up ATP6V0E2 NM_145230 
4.20 down 4.49 down 1.07 down ATP8B3 NM_138813 
1.78 down 3.51 down 1.97 down ATP9A NM_006045 
1.19 down 2.28 down 1.92 down ATXN1 NM_000332 
1.31 up 3.23 down 4.22 down B3GNT4 NM_030765 
1.08 down 3.36 down 3.10 down B4GALNT3 NM_173593 
4.03 up 2.04 up 1.98 down BAI2 NM_001703 
2.88 up 1.98 down 5.70 down BAIAP2L1 NM_018842 
2.48 up 1.96 up 1.27 down BARD1 NM_000465 
2.32 down 2.47 down 1.07 down BASP1 NM_006317 
1.87 down 2.24 down 1.19 down BBS5 NM_152384 
1.81 down 4.03 down 2.23 down BCAT1 NM_005504 
2.78 down 3.90 down 1.40 down BCAT1 NM_005504 
1.86 up 2.34 up 1.25 up BCL11A NM_018014 
2.18 up 3.62 up 1.66 up BCL11A NM_022893 
2.73 up 2.56 up 1.06 down BCL11A NM_022893 
1.76 up 2.38 up 1.36 up BCL11A NM_138559 
1.61 up 2.21 up 1.37 up BCOR BC128456 
 226 
1.96 up 2.25 up 1.15 up BDNF-AS1 NR_002832 
1.29 down 3.46 down 2.67 down BFSP1 NM_001195 
1.43 down 3.89 up 5.56 up BFSP2 NM_003571 
5.15 up 3.46 up 1.49 down BK250D10.8 NR_024355 
1.50 down 4.46 down 2.98 down BMPR1B NM_001203 
3.71 down 1.40 up 5.21 up BMX NM_001721 
1.19 down 2.16 down 1.81 down BNIP3 NM_004052 
1.11 up 1.86 down 2.06 down BOP1 NM_015201 
2.17 up 1.96 up 1.11 down BRCA1 NM_007300 
2.06 up 2.14 up 1.04 up BRCA2 NM_000059 
2.28 down 3.03 down 1.33 down BRI3 NM_001159491 
2.01 down 2.87 down 1.43 down BTBD16 NM_144587 
1.29 up 1.60 down 2.05 down BTBD7 NM_001002860 
1.45 down 2.05 down 1.41 down BTBD9 NM_052893 
6.46 up 10.01 up 1.55 up BTNL9 NM_152547 
1.51 up 5.03 up 3.33 up BZRAP1 NM_004758 
1.48 down 2.13 down 1.44 down BZW1 NM_001207068 
2.07 down 2.76 up 5.72 up C10orf105 NM_001164375 
1.56 down 3.20 down 2.05 down C10orf114 NM_001010911 
2.40 down 1.13 up 2.71 up C10orf128 NM_001010863 
2.06 down 1.27 down 1.61 up C10orf32 NM_144591 
2.25 down 1.70 down 1.33 up C11orf71 NM_019021 
3.78 up 4.46 up 1.18 up C11orf85 NM_001037225 
7.69 up 23.68 up 3.08 up C11orf92 NR_034154 
3.43 up 6.15 up 1.79 up C11orf93 NM_001136105 
2.05 down 2.08 down 1.02 down C11orf95 NM_001144936 
3.63 up 2.99 up 1.21 down C12orf34 NM_032829 
1.50 down 2.66 down 1.77 down C13orf16 NM_152324 
5.03 down 3.09 down 1.63 up C13orf33 NM_032849 
1.59 down 2.12 down 1.33 down C14orf109 NM_001098621 
1.36 up 2.05 down 2.78 down C14orf128 NR_027263 
1.48 up 2.01 down 2.98 down C14orf128 NR_027263 
2.38 down 3.05 down 1.28 down C14orf149 NM_144581 
1.93 down 1.50 up 2.90 up C14orf182 AK090420 
2.55 down 3.60 down 1.41 down C14orf33 NR_027123 
2.65 down 3.50 down 1.32 down C14orf33 NR_027123 
2.51 down 3.56 down 1.42 down C14orf33 NR_027123 
1.81 down 3.17 down 1.75 down C14orf37 NM_00100187
 227 
2 
3.14 up 1.77 up 1.77 down C15orf42 NM_152259 
2.31 down 3.69 down 1.60 down C16orf57 NM_001204911 
1.90 down 2.61 down 1.38 down C16orf74 NM_206967 
2.07 down 2.01 down 1.03 up C16orf87 NM_001001436 
1.44 down 3.12 down 2.17 down C17orf51 NM_001113434 
3.67 up 1.44 up 2.54 down C17orf53 NM_024032 
1.49 down 1.77 up 2.62 up C17orf67 NM_001085430 
1.33 up 2.11 up 1.59 up C17orf76 NM_207387 
1.50 up 1.36 down 2.04 down C18orf45 NM_032933 
2.02 up 1.93 up 1.05 down C19orf25 NM_152482 
11.87 up 6.47 up 1.83 down C19orf57 NM_024323 
2.08 up 1.58 up 1.31 down C1orf112 NM_018186 
2.66 up 1.39 up 1.91 down C1orf135 NM_024037 
5.16 up 1.65 up 3.13 down C1orf213 NR_033690 
2.24 down 2.31 down 1.03 down C1orf226 NM_001135240 
5.17 up 4.62 up 1.12 down C1orf51 NM_144697 
2.13 up 1.58 down 3.37 down C1orf74 NM_152485 
1.32 down 1.90 up 2.51 up C20orf160 NM_080625 
2.71 up 7.78 up 2.87 up C21orf15 NR_026755 
1.74 up 2.21 up 1.27 up C21orf63 NM_058187 
1.52 up 2.37 up 1.56 up C21orf63 NM_058187 
2.44 up 4.01 up 1.64 up C21orf71 NR_024092 
1.54 up 4.94 up 3.21 up C21orf81 NR_027270 
1.06 down 2.21 up 2.35 up C21orf81 BC036580 
1.75 up 2.13 up 1.22 up C2CD2 NM_015500 
2.65 down 1.66 down 1.60 up C2CD3 NM_015531 
3.29 up 2.21 up 1.48 down C2CD4D NM_001136003 
3.17 up 2.46 up 1.29 down C2orf15 NM_144706 
7.98 up 6.00 up 1.33 down C2orf54 NM_024861 
5.17 up 5.33 up 1.03 up C2orf55 NM_207362 
4.21 up 3.81 up 1.10 down C2orf65 NM_138804 
1.88 down 1.91 up 3.59 up C2orf89 NM_001080824 
2.57 up 2.26 up 1.14 down C3orf14 NM_020685 
2.47 down 7.47 down 3.02 down C3orf67 NM_198463 
2.25 up 1.85 up 1.21 down C4orf21 AK002193 
2.43 down 1.36 down 1.78 up C4orf32 NM_152400 
1.89 up 1.67 down 3.15 down C4orf47 NM_001114357 
22.46 up 120.95 up 5.39 up C4orf7 NM_152997 
 228 
2.84 up 3.31 up 1.17 up C5 NM_001735 
2.03 down 2.50 up 5.07 up C5orf20 NM_130848 
2.59 up 2.04 up 1.27 down C5orf30 NM_033211 
1.71 up 2.76 up 1.61 up C5orf34 NM_198566 
1.13 up 2.07 up 1.83 up C5orf45 NM_016175 
2.24 up 2.02 up 1.11 down C5orf54 NM_022090 
1.34 up 2.82 up 2.11 up C5orf56 NR_045116 
1.89 up 3.29 up 1.74 up C5orf56 AK025221 
1.79 down 2.40 down 1.34 down C6orf170 NM_152730 
1.58 down 2.15 down 1.36 down C6orf218 NR_027793 
2.10 down 1.77 down 1.19 up C6orf226 NM_001008739 
2.11 down 1.80 down 1.17 up C6orf226 NM_001008739 
6.47 up 2.67 up 2.42 down C7orf13 NR_026865 
2.88 up 2.14 up 1.34 down C7orf13 NR_026865 
1.53 up 2.51 up 1.64 up C7orf46 NM_199136 
2.91 up 3.84 up 1.32 up C8G NM_000606 
5.36 up 6.22 up 1.16 up C8G NM_000606 
2.21 up 1.62 up 1.37 down C9orf100 NM_032818 
1.79 down 2.64 down 1.47 down C9orf3 NM_001193329 
1.29 up 1.95 down 2.53 down C9orf30-TMEFF1 
NM_00119881
2 
1.39 down 6.35 down 4.58 down CA12 NM_001218 
20.13 up 1.29 up 15.57 down CA9 NM_001216 
1.37 down 2.04 down 1.49 down CAB39 NM_001130849 
1.10 down 2.77 up 3.04 up CACNB4 NM_001005747 
1.42 up 1.61 down 2.28 down CALU NM_001219 
7.72 up 10.95 up 1.42 up CAPN14 NM_001145122 
1.52 up 2.87 down 4.37 down CAPSL NM_144647 
1.03 down 2.09 down 2.04 down CARD10 NM_014550 
2.97 down 2.81 down 1.06 up CARD6 NM_032587 
1.15 down 1.97 up 2.27 up CARD9 NM_052813 
2.02 up 2.01 up 1.00 down CASP2 NM_032982 
2.03 down 1.60 down 1.27 up CASS4 NM_020356 
1.63 up 2.02 up 1.24 up CATSPER2 NM_172097 
2.36 down 3.60 down 1.53 down CAV1 NM_001753 
2.28 down 4.17 down 1.83 down CAV1 NM_001753 
1.32 down 2.82 down 2.14 down CAV2 NM_001233 
1.72 down 2.52 up 4.33 up CBFA2T3 NM_005187 
7.88 up 3.93 up 2.01 down CBS NM_000071 
2.75 up 2.71 up 1.01 down CBX5 NM_001127322 
1.10 up 2.78 up 2.52 up CBX7 NM_175709 
 229 
2.04 up 2.14 up 1.05 up CCDC14 NM_022757 
2.22 up 2.04 up 1.09 down CCDC146 NM_020879 
1.32 down 4.36 down 3.30 down CCDC147 NM_001008723 
2.74 up 1.59 up 1.72 down CCDC150 NM_001080539 
2.90 up 1.29 up 2.25 down CCDC24 NM_152499 
2.18 down 2.87 down 1.32 down CCDC3 NM_031455 
2.64 up 1.41 up 1.88 down CCDC34 NM_030771 
1.10 down 2.56 down 2.32 down CCDC40 NM_001243342 
2.09 down 1.53 up 3.20 up CCDC69 NM_015621 
6.49 down 1.64 up 10.63 up CCL14 NM_032963 
1.94 down 4.60 down 2.37 down CCL26 NM_006072 
2.60 up 1.74 up 1.49 down CCNB1 NM_031966 
3.02 up 1.94 up 1.55 down CCNE2 NM_057749 
2.81 up 2.28 up 1.23 down CCNE2 NM_057749 
6.46 up 14.50 up 2.25 up CCNI2 NM_001039780 
1.86 down 2.14 down 1.15 down CCNK NM_001099402 
5.74 up 2.94 up 1.95 down CCNO NM_021147 
1.09 up 2.11 up 1.93 up CCR10 NM_016602 
1.92 down 2.03 up 3.90 up CCR2 NM_001123041 
1.34 down 1.64 up 2.20 up CCR6 NM_031409 
2.65 down 2.16 up 5.72 up CD1C NM_001765 
2.99 down 2.88 up 8.62 up CD1E NM_001042583 
10.28 down 2.53 down 4.07 up CD209 NM_001144897 
8.50 down 2.18 down 3.90 up CD209 NM_021155 
4.31 down 1.60 down 2.69 up CD209 NM_021155 
10.39 down 1.50 down 6.95 up CD36 NM_001001547 
1.14 down 2.23 up 2.54 up CD74 NM_001025158 
3.59 up 6.73 up 1.88 up CD8B NM_004931 
3.51 up 5.74 up 1.64 up CD8B NM_172102 
3.19 up 6.03 up 1.89 up CD8B NM_004931 
2.12 down 1.45 down 1.46 up CD93 NM_012072 
2.27 up 1.72 up 1.32 down CDC25A NM_001789 
2.42 up 1.96 up 1.23 down CDC25C NM_001790 
3.31 up 2.06 up 1.61 down CDC42EP4 NM_012121 
1.60 down 1.64 up 2.62 up CDC42SE2 NM_020240 
2.49 up 1.74 up 1.43 down CDC45 NM_003504 
2.60 up 2.67 up 1.03 up CDC7 NM_003503 
2.52 up 1.36 up 1.85 down CDCA5 NM_080668 
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2.77 down 4.95 down 1.79 down CDH13 NM_001220491 
5.14 down 6.66 down 1.30 down CDH15 NM_004933 
2.35 up 1.53 up 1.53 down CDK2 NM_001798 
1.69 down 3.31 down 1.96 down CDK6 NM_001259 
14.90 up 11.57 up 1.29 down CDKN2A NM_058197 
45.21 up 23.38 up 1.93 down CDKN2A NM_000077 
3.22 up 3.79 up 1.18 up CDKN2B-AS NR_003529 
3.34 up 5.43 up 1.63 up CDKN2C NM_078626 
2.05 down 3.09 down 1.51 down CDR1 NM_004065 
1.39 down 2.17 down 1.56 down CDR2L NM_014603 
2.33 up 1.67 up 1.40 down CDT1 NM_030928 
3.60 up 4.59 up 1.27 up CEACAM1 NM_001712 
4.40 up 4.22 up 1.04 down CECR7 NR_015352 
1.99 up 4.33 up 2.17 up CELF4 NM_020180 
4.91 up 10.54 up 2.15 up CELF4 NM_020180 
2.83 up 1.46 up 1.94 down CENPF NM_016343 
2.50 up 2.15 up 1.17 down CENPH NM_022909 
2.29 up 2.46 up 1.08 up CENPJ NM_018451 
2.77 up 3.14 up 1.14 up CENPK NM_022145 
2.55 up 2.38 up 1.07 down CENPM NM_001002876 
2.04 up 2.39 up 1.17 up CENPM NM_024053 
2.36 up 1.56 up 1.51 down CENPO NM_001199803 
2.22 down 2.40 down 1.08 down CEP112 NM_145036 
2.39 up 1.53 up 1.56 down CEP72 NM_018140 
3.06 down 1.09 up 3.33 up CFI NM_000204 
2.68 down 2.01 up 5.39 up CFP NM_002621 
2.16 up 3.73 up 1.72 up CGNL1 NM_032866 
2.31 up 2.81 up 1.22 up CHADL NM_138481 
2.77 up 2.32 up 1.19 down CHAF1A NM_005483 
2.89 up 2.07 up 1.40 down CHAF1A NM_005483 
2.82 up 2.76 up 1.02 down CHAF1B NM_005441 
2.94 up 3.08 up 1.05 up CHDH NM_018397 
6.13 up 8.19 up 1.34 up CHDH NM_018397 
14.43 down 5.93 down 2.43 up CHGB NM_001819 
3.00 down 3.73 up 11.18 up CHI3L2 NM_001025199 
2.79 down 1.96 down 1.42 up CHN2 NM_004067 
2.26 up 2.76 up 1.22 up CHPT1 NM_020244 
8.44 down 1.58 down 5.34 up CIDEA NM_001279 
2.27 up 2.49 up 1.10 up CIDEB NM_014430 
3.31 up 2.28 up 1.45 down CIT NM_007174 
1.63 up 1.37 down 2.24 down CKAP4 NM_006825 
1.89 down 3.61 down 1.91 down CLCF1 NM_013246 
30.07 up 22.52 up 1.34 down CLDN10 NM_182848 
2.93 up 2.04 up 1.44 down CLDN7 NM_001307 
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4.15 down 1.69 up 7.00 up CLEC10A NM_182906 
3.55 down 1.93 up 6.85 up CLEC3B NM_003278 
13.77 down 1.49 down 9.23 up CLEC4G NM_198492 
38.78 down 1.96 down 19.79 up CLEC4G NM_198492 
12.20 down 1.45 down 8.44 up CLEC4GP1 NR_002931 
2.64 down 2.21 up 5.84 up CLECL1 NM_172004 
8.65 up 8.31 up 1.04 down CLGN NM_004362 
1.43 down 1.88 up 2.68 up CLIC2 NM_001289 
1.12 down 2.64 down 2.36 down CLIC4 NM_013943 
1.83 down 2.81 down 1.54 down CLIP4 NM_024692 
1.61 down 2.12 down 1.32 down CLIP4 NM_024692 
2.11 down 1.66 down 1.27 up CLIP4 NM_024692 
1.23 up 2.38 up 1.93 up CLK4 NM_020666 
2.56 down 2.83 down 1.10 down CLMP NM_024769 
2.15 up 1.21 up 1.78 down CLSPN NM_022111 
1.14 up 2.09 down 2.39 down CNTF NM_000614 
1.23 up 2.17 up 1.77 up CNTRL AK097636 
16.93 up 2.17 up 7.80 down COL22A1 NM_152888 
1.03 up 6.96 up 6.79 up COL4A4 NM_000092 
4.54 down 13.72 down 3.03 down COL4A6 NM_033641 
5.77 up 3.58 up 1.61 down COL9A2 NM_001852 
1.45 down 2.26 up 3.27 up CORO1A NM_007074 
1.25 down 5.13 down 4.11 down CPA4 NM_016352 
3.74 down 1.50 up 5.62 up CR1L NM_175710 
1.55 down 19.14 up 29.65 up CR2 NM_001006658 
1.50 up 2.01 up 1.34 up CREB3L4 NM_130898 
1.53 down 3.23 down 2.12 down CREB5 NM_182898 
2.54 down 9.96 down 3.93 down CREG2 NM_153836 
1.26 up 3.69 up 2.92 up CRIP3 NM_206922 
2.06 up 1.39 up 1.48 down CROCC NM_014675 
2.40 down 1.52 down 1.58 up CSGALNACT1 NM_018371 
2.47 down 2.00 down 1.23 up CSGALNACT1 
NM_00113051
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1.07 down 3.05 down 2.85 down CTTN NM_001184740 
1.20 down 3.24 up 3.87 up CUL3 NM_003590 
1.66 up 2.67 up 1.61 up CUL9 NM_015089 
1.18 down 3.04 up 3.59 up CX3CR1 NM_001337 
3.60 up 4.03 up 1.12 up CXCL10 NM_001565 
3.66 up 4.53 up 1.24 up CXCL10 NM_001565 
4.15 down 6.13 down 1.48 down CXCL14 NM_004887 
2.01 down 3.73 up 7.47 up CXCR5 NM_032966 
2.19 down 1.26 down 1.73 up CXorf36 NM_176819 
1.39 down 2.03 down 1.46 down CXorf48 NM_001031705 
5.05 up 3.65 up 1.38 down CXXC4 NM_025212 
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4.82 up 2.03 up 2.38 down CYB5R2 NM_016229 
4.98 up 2.01 up 2.48 down CYB5R2 NM_016229 
1.38 down 1.70 up 2.34 up CYBASC3 NM_153611 
1.26 down 2.01 up 2.54 up CYFIP2 NM_001037332 
1.43 down 2.91 up 4.16 up CYFIP2 NM_001037332 
3.97 up 2.26 up 1.75 down CYP2J2 NM_000775 
1.07 down 2.13 up 2.28 up CYP4V2 NM_207352 
5.84 up 10.73 up 1.84 up CYP4X1 NM_178033 
5.62 up 5.77 up 1.03 up CYP4Z1 NM_178134 
4.29 up 4.56 up 1.06 up CYP4Z1 NM_178134 
4.49 up 4.85 up 1.08 up CYP4Z1 NM_178134 
1.60 down 1.71 up 2.73 up CYSLTR1 NM_006639 
2.04 down 1.58 down 1.29 up CYYR1 NM_052954 
2.27 down 2.98 down 1.31 down DAAM1 NM_014992 
1.50 down 2.13 down 1.42 down DAAM2 BC078153 
3.23 down 1.87 up 6.03 up DARC NM_002036 
1.16 down 3.06 down 2.63 down DCBLD1 NM_173674 
1.17 down 3.09 down 2.64 down DCBLD1 NM_173674 
1.77 down 2.09 down 1.18 down DCUN1D3 NM_173475 
1.58 down 3.25 down 2.06 down DCUN1D5 NM_032299 
2.80 up 1.81 up 1.55 down DDX11 NM_030653 
2.60 up 1.80 up 1.45 down DDX11 NM_030653 
2.90 up 1.63 up 1.78 down DDX11 NM_152438 
1.34 up 2.43 up 1.81 up DDX26B NM_182540 
1.17 up 2.38 up 2.04 up DDX26B NM_182540 
1.51 down 2.03 up 3.07 up DENND1C NM_024898 
1.68 down 2.00 down 1.19 down DENND2A NM_015689 
1.05 up 2.53 up 2.42 up DENND2D NM_024901 
1.42 down 1.73 up 2.45 up DENND4A NM_001144823 
1.18 up 1.94 down 2.29 down DEPDC7 NM_139160 
1.73 down 3.60 down 2.09 down DFNA5 NM_004403 
2.24 up 1.47 up 1.52 down DGCR14 NM_022719 
2.69 up 3.11 up 1.16 up DHFR NM_000791 
4.66 down 2.31 down 2.02 up DIO3OS NR_002770 
6.39 down 2.85 down 2.25 up DIRAS1 NM_145173 
5.06 down 4.00 down 1.27 up DKFZP586K1520 AL050153 
1.30 down 2.10 down 1.62 down DKK3 NM_015881 
2.40 up 1.76 up 1.36 down DLG3 NM_021120 
92.23 up 32.77 up 2.81 down DMRTA2 NM_032110 
3.59 up 3.22 down 11.57 down DNAH17   
1.05 up 2.34 up 2.22 up DNHD1 NM_144666 
2.18 up 1.75 up 1.25 down DNMT1 NM_001130823 
1.22 down 3.23 down 2.65 down DNMT3B NM_175850 
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4.19 up 4.42 up 1.06 up DOC2B NM_003585 
2.44 up 2.82 up 1.15 up DOC2B NM_003585 
1.46 down 1.93 up 2.82 up DOCK10 NM_014689 
2.11 up 1.92 up 1.10 down DONSON NM_017613 
2.24 up 1.69 up 1.33 down DOT1L NM_032482 
2.81 down 1.02 up 2.88 up DPP4 NM_001935 
6.68 up 7.57 up 1.13 up DSCR6 NM_018962 
2.87 up 2.27 up 1.26 down DTL NM_016448 
2.25 up 1.68 up 1.34 down DTX2 NM_020892 
3.11 up 1.84 up 1.69 down DTX2 NM_020892 
2.75 up 1.81 up 1.52 down DTX2 NM_020892 
1.34 down 2.24 down 1.66 down DUSP18 NM_152511 
2.11 down 1.69 down 1.25 up DUSP6 NM_001946 
9.41 up 3.28 up 2.87 down DYDC2 NM_032372 
6.54 up 1.84 up 3.56 down E2F7 NM_203394 
3.40 up 1.80 up 1.90 down E2F7 NM_203394 
2.65 up 2.88 up 1.09 up E2F8 NM_024680 
3.26 up 1.79 up 1.82 down EBF4 NM_001110514 
2.07 down 1.11 down 1.86 up ECSCR NM_001077693 
1.53 up 1.96 down 2.99 down EFNB1 NM_004429 
3.01 up 2.84 up 1.06 down EGOT NR_004428 
1.82 down 1.39 up 2.53 up EGR1 NM_001964 
65.79 up 5.06 up 13.01 down EIF1AY NM_004681 
1.20 up 1.75 down 2.11 down EIF2C2 NM_012154 
3.06 up 1.82 up 1.68 down EIF3D   
1.63 up 1.92 down 3.14 down EIF4EBP1 NM_004095 
1.56 down 2.00 up 3.12 up ELANE NM_001972 
2.18 down 1.26 down 1.73 up ELTD1 NM_022159 
2.09 down 1.25 down 1.68 up ELTD1 NM_022159 
2.09 up 1.77 up 1.19 down EME1 NM_152463 
2.11 down 2.64 down 1.25 down EML1 NM_001008707 
1.60 down 2.11 down 1.32 down ENDOD1 NM_015036 
2.25 up 1.60 down 3.60 down ENKUR NM_145010 
3.23 up 1.68 up 1.92 down ENO2 NM_001975 
2.69 down 1.39 up 3.74 up ENPP3 NM_005021 
4.01 up 3.41 up 1.17 down ENPP5 NM_021572 
1.06 up 2.39 down 2.53 down ENTPD7 NM_020354 
1.29 up 2.40 up 1.86 up EPB41L4A NM_022140 
2.13 up 6.33 up 2.97 up EPHX2 NM_001979 
4.02 up 2.77 up 1.45 down EPHX3 NM_024794 
1.67 up 2.57 up 1.54 up EPM2AIP1 NM_014805 
1.32 down 2.02 down 1.53 down ERBB2 AB025286 
1.37 up 1.64 down 2.26 down ERC1 NM_178040 
2.75 down 1.89 down 1.46 up ERG NM_004449 
5.37 up 1.13 down 6.06 down ESM1 NM_007036 
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2.90 up 2.19 up 1.32 down ESPL1 NM_012291 
2.50 up 1.72 down 4.30 down ESRP1 NM_017697 
2.27 down 3.13 down 1.38 down ETNK1 NM_001039481 
2.09 up 1.78 up 1.17 down ETV6 NM_001987 
1.49 up 1.59 down 2.37 down EXD2 NM_018199 
2.74 up 1.52 up 1.81 down EXO1 NM_003686 
2.96 up 10.02 up 3.39 up EXOC3L4 NM_001077594 
1.04 up 1.95 down 2.03 down EXOC6B AK023791 
1.17 down 3.16 down 2.70 down EXOC6B NM_015189 
1.30 down 2.01 down 1.55 down EXOC6B AB384543 
1.47 down 2.01 down 1.37 down EXOC7 BC029432 
1.51 up 1.52 down 2.30 down EXT1 NM_000127 
1.35 down 2.05 down 1.52 down EXT2 NM_000401 
2.32 up 2.52 up 1.09 up EZH2 NM_004456 
2.16 up 1.11 up 1.94 down F11R NM_016946 
1.76 down 2.15 down 1.22 down F2R NM_001992 
5.03 down 9.77 down 1.94 down F2RL1 NM_005242 
2.96 up 2.31 up 1.28 down FAAH NM_001441 
2.47 up 3.82 up 1.55 up FAAH2 NM_174912 
34.98 down 3.34 down 10.48 up FABP4 NM_001442 
4.47 up 3.15 up 1.42 down FADS2 NM_004265 
2.05 down 1.69 up 3.46 up FAM107A NM_007177 
3.85 up 2.93 up 1.32 down FAM111B NM_198947 
1.32 up 1.83 down 2.41 down FAM114A1 NM_138389 
1.06 up 2.50 up 2.35 up FAM117A NM_030802 
2.76 down 3.49 down 1.26 down FAM126A   
2.19 down 2.32 down 1.06 down FAM126A NM_032581 
1.60 down 2.41 down 1.51 down FAM126A NM_032581 
5.06 down 2.08 down 2.43 up FAM134B NM_001034850 
1.38 up 2.87 up 2.08 up FAM151A NM_176782 
1.22 down 2.33 up 2.86 up FAM159A NM_001042693 
2.93 up 1.36 up 2.16 down FAM161A NM_032180 
1.03 up 4.70 down 4.86 down FAM176A NM_001135032 
2.10 up 1.44 up 1.45 down FAM200B NM_001145191 
3.21 up 1.77 up 1.82 down FAM27E3 XM_001720463 
8.73 up 21.85 up 2.50 up FAM3B NM_058186 
4.37 up 1.40 up 3.13 down FAM64A NM_001195228 
3.35 up 5.63 up 1.68 up FAM81A NM_152450 
2.70 up 2.10 down 5.66 down FAM83B NM_001010872 
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2.33 down 3.45 down 1.48 down FAM89A NM_198552 
1.11 down 2.68 down 2.42 down FAM91A1 NM_144963 
2.42 up 1.89 up 1.28 down FANCB NM_001018113 
2.46 up 1.48 up 1.66 down FANCC NM_001243744 
2.72 up 2.39 up 1.13 down FANCC NM_000136 
2.42 up 1.98 up 1.23 down FANCG NM_004629 
2.41 up 2.31 up 1.04 down FANCL NM_018062 
2.46 up 2.25 up 1.09 down FANCL NM_001114636 
1.56 up 2.06 up 1.31 up FAR1 NM_032228 
1.24 down 3.78 down 3.05 down FBLIM1 NM_001024215 
1.31 down 3.51 down 2.68 down FBLIM1 NM_017556 
1.34 up 2.38 up 1.77 up FBXL16 NM_153350 
1.39 down 2.15 down 1.54 down FBXO3 NM_033406 
3.62 up 3.60 up 1.01 down FBXO43 NM_001029860 
2.10 down 1.52 up 3.20 up FCGR2B NM_004001 
2.26 up 1.73 up 1.31 down FEN1 NM_004111 
2.08 down 3.71 down 1.79 down FERMT2 NM_001135000 
1.67 down 2.82 down 1.69 down FEZ1 NM_005103 
5.01 down 2.28 down 2.20 up FFAR3 NM_005304 
1.70 down 1.39 up 2.36 up FGD2 NM_173558 
1.88 down 1.69 up 3.17 up FGD3 NM_033086 
2.10 up 1.31 up 1.59 down FGD6 NM_018351 
2.10 up 2.31 up 1.10 up FIGNL1 NM_001042762 
1.39 down 2.22 down 1.60 down FKBP14 NM_017946 
1.01 up 2.35 down 2.37 down FKBP9 NM_007270 
3.48 down 23.35 down 6.71 down FLJ13744 AK023806 
2.85 down 4.34 down 1.52 down FLJ22447 NR_039985 
1.35 down 1.66 up 2.24 up FLJ33630 NR_015360 
4.71 up 1.99 up 2.36 down FLJ35024 NR_015375 
5.06 up 3.63 up 1.40 down FLJ35024 BC090887 
1.62 up 3.18 up 1.96 up FLJ38109 AK095428 
3.53 up 3.29 up 1.08 down FLJ40852 NR_015392 
6.83 down 2.86 down 2.39 up FLJ41200 NR_033863 
2.39 down 3.68 down 1.54 down FLJ45248 AK127183 
2.01 down 3.34 down 1.66 down FLJ45248 AK127183 
13.63 up 5.12 up 2.66 down FLJ45482 AK127393 
9.82 up 3.87 up 2.54 down FLJ45482 AK127393 
6.60 down 3.71 down 1.78 up FLJ45983 NR_024256 
1.20 down 2.19 down 1.83 down FLJ46906 NR_033896 
1.15 down 2.19 down 1.90 down FLJ46906 NR_033896 
1.18 down 2.22 down 1.88 down FLJ46906 NR_033896 
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1.33 down 2.15 down 1.62 down FLJ46906 NR_033896 
2.18 up 1.77 up 1.23 down FLNA AK125630 
1.95 down 4.78 down 2.46 down FLRT2 NM_013231 
2.65 down 13.57 down 5.12 down FLRT3 NM_198391 
1.17 up 2.00 up 1.71 up FLT3LG NM_001459 
2.43 up 1.40 up 1.73 down FMO6P NR_002601 
9.16 down 2.38 down 3.84 up FONG NR_034096 
1.45 up 3.13 down 4.55 down FOSL1 NM_005438 
10.44 up 9.12 up 1.14 down FOXD3 NM_012183 
1.01 down 2.31 down 2.29 down FOXF2 NM_001452 
2.64 up 1.44 up 1.83 down FOXP4 NM_001012426 
5.21 up 3.49 up 1.49 down FOXRED2 NM_024955 
2.52 up 2.40 up 1.05 down FOXRED2 NM_024955 
2.02 up 2.26 up 1.12 up FRA10AC1 NM_145246 
1.00 up 2.44 down 2.45 down FRMD6 NM_001042481 
1.20 down 2.44 up 2.93 up FRZB NM_001463 
1.02 down 2.26 down 2.23 down FSD1L NM_031919 
1.82 down 4.09 down 2.25 down FSTL3 NM_005860 
2.33 up 4.75 up 2.04 up FUT7 NM_004479 
1.40 up 2.12 up 1.52 up G3BP1   
1.08 down 2.14 down 1.98 down GABARAPL1 NM_031412 
36.74 up 14.72 up 2.50 down GABRP NM_014211 
21.34 up 5.96 up 3.58 down GAD1 NM_000817 
1.06 down 2.12 down 2.00 down GALNT3 NM_004482 
3.23 down 3.80 down 1.18 down GALNT6 NM_007210 
5.58 down 4.48 down 1.25 up GALNTL2 NM_054110 
1.57 down 2.54 up 3.97 up GAPT NM_152687 
1.70 down 4.80 down 2.82 down GAST NM_000805 
1.69 up 3.81 up 2.25 up GATM NM_001482 
1.44 up 2.41 up 1.68 up GBP4 NM_052941 
1.53 down 1.62 up 2.48 up GCA NM_012198 
2.56 up 6.74 up 2.63 up GCET2 NM_001190259 
1.85 up 3.41 up 1.84 up GCET2 NM_001190259 
1.58 down 1.75 up 2.77 up GCFC1-AS1 NR_038879 
2.27 up 2.95 up 1.30 up GCHFR NM_005258 
5.23 down 2.02 up 10.59 up GDF10 NM_004962 
3.82 down 1.08 down 3.54 up GFRA2 NM_001495 
1.21 up 2.02 up 1.67 up GGA2 NM_015044 
2.61 down 1.57 up 4.11 up GGTA1P NR_003191 
1.95 down 2.49 up 4.86 up GHRL NM_016362 
2.04 down 1.78 up 3.63 up GIMAP2 NM_015660 
1.65 up 2.18 up 1.32 up GIN1 NM_017676 
1.50 down 3.73 down 2.48 down GJA1 NM_000165 
1.74 down 1.49 up 2.59 up GJA4 NM_002060 
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1.11 up 2.40 up 2.15 up GKAP1 NM_025211 
4.10 up 4.08 up 1.00 down GLB1L2 NM_138342 
2.69 down 1.74 down 1.55 up GLIPR1 NM_006851 
1.15 down 2.95 down 2.57 down GLIS1 NM_147193 
13.21 up 15.05 up 1.14 up GLS2 NM_013267 
2.59 down 1.24 up 3.21 up GNA14 NM_004297 
2.41 down 1.45 down 1.66 up GNG11 NM_004126 
1.52 up 2.00 up 1.31 up GOLGA2P5 NR_024261 
3.96 down 14.21 down 3.59 down GOLGA7B NM_001010917 
1.31 up 2.05 up 1.56 up GOLGA8A NM_181077 
5.07 up 5.72 up 1.13 up GOLT1A NM_198447 
3.10 up 2.15 up 1.44 down GPC2 NM_152742 
2.04 down 1.05 down 1.95 up GPD1 NM_005276 
1.44 down 2.46 up 3.54 up GPR114 NM_153837 
2.17 up 2.37 up 1.09 up GPR126 NM_020455 
1.05 down 2.22 down 2.11 down GPR135 NM_022571 
2.11 up 1.33 up 1.59 down GPR137 NM_020155 
2.45 up 2.59 up 1.06 up GPR137C NM_001099652 
1.04 up 2.53 down 2.63 down GPR153 NM_207370 
2.85 up 1.02 down 2.92 down GPR161 NM_153832 
1.84 down 2.13 down 1.16 down GPSM1 NM_001145638 
8.30 up 13.49 up 1.62 up GRIN2C NM_000835 
2.73 up 2.58 up 1.06 down GRIN2C NM_000835 
2.37 up 2.94 down 6.98 down GRIN2D NM_000836 
1.51 down 2.52 down 1.67 down GRIN3B NM_138690 
2.28 up 1.35 up 1.68 down GTSE1 NM_016426 
1.41 down 2.97 down 2.10 down GUCY1A2 NM_000855 
1.48 down 1.70 up 2.51 up GYPC NM_002101 
2.88 down 1.69 down 1.71 up H2AFJ NM_177925 
1.55 down 1.62 up 2.50 up H3F3B NM_005324 
2.02 down 1.36 down 1.48 up HABP4 NM_014282 
1.44 up 3.89 down 5.59 down HAS3 NM_005329 
2.40 up 2.17 up 1.11 down HAUS3 NM_024511 
2.38 up 2.56 up 1.08 up HAUS5 NM_015302 
1.21 down 2.08 down 1.71 down HCG18 NR_024052 
1.87 down 4.41 down 2.36 down HCG4 NR_002139 
3.56 up 1.66 up 2.14 down HCN3 NM_020897 
2.35 down 1.26 up 2.97 up HDC NM_002112 
1.57 down 2.72 down 1.73 down HEATR7A NM_001099280 
2.54 up 2.20 up 1.15 down HELLS NM_018063 
2.28 up 2.11 up 1.08 down HELLS NM_018063 
1.26 down 1.64 up 2.06 up HERC2 NM_004667 
1.65 up 2.80 up 1.69 up HESX1 NM_003865 
1.53 down 2.63 down 1.72 down HEYL NM_014571 
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1.72 down 1.94 up 3.33 up HHEX NM_002729 
1.82 down 2.23 down 1.23 down HIF1A NM_181054 
1.61 down 2.38 down 1.47 down HIF1A NM_181054 
2.18 down 2.23 down 1.02 down HIST1H2AD NM_021065 
1.84 down 2.12 down 1.16 down HIST1H2AE NM_021052 
3.68 down 3.51 down 1.05 up HIST2H2AA4 NM_001040874 
1.53 down 1.69 up 2.59 up HLA-DMA NM_006120 
2.02 down 1.64 up 3.31 up HLA-DPB2 NR_001435 
1.07 down 3.12 up 3.35 up HLA-DQA2 NM_020056 
1.38 down 1.65 up 2.28 up HLA-DRB1 NM_002124 
1.44 down 2.25 up 3.24 up HLA-DRB4 NM_021983 
1.63 down 1.60 up 2.62 up HLA-DRB5 NM_002125 
2.65 up 12.50 up 4.71 up HLF NM_002126 
2.05 up 2.40 up 1.17 up HLTF NM_003071 
1.17 down 3.73 down 3.18 down HMGA2 NM_003484 
2.27 down 1.05 down 2.16 up HMGCLL1 NM_019036 
1.46 down 2.10 up 3.06 up HMHA1 NM_012292 
2.31 down 2.19 down 1.06 up HMOX1 NM_002133 
4.03 up 10.06 up 2.50 up HMSD NM_001123366 
1.04 down 2.91 down 2.79 down HOMER3 NM_004838 
1.02 down 3.20 down 3.14 down HOMER3 NM_001145724 
1.07 down 2.85 down 2.65 down HOMER3 NM_001145722 
2.78 up 1.22 up 2.28 down HOOK2 NM_013312 
21.67 up 42.46 up 1.96 up HOXB13 NM_006361 
1.63 down 4.88 down 2.98 down HOXB5 NM_002147 
1.42 down 3.23 up 4.58 up HPGD NM_000860 
3.63 down 4.63 down 1.27 down HSPA12A NM_025015 
3.02 down 3.42 down 1.13 down HTR7 NM_019859 
2.52 down 2.44 down 1.03 up HTR7P1 NR_002774 
1.18 down 2.34 up 2.77 up HVCN1 NM_001040107 
1.23 down 2.50 up 3.09 up HVCN1 NM_001040107 
1.04 up 2.44 up 2.35 up ICA1 NM_004968 
1.23 up 2.45 up 2.00 up ICA1 NM_004968 
1.32 down 2.00 up 2.63 up ICAM2 NM_000873 
1.36 down 1.97 up 2.67 up ICAM3 NM_002162 
4.10 up 2.92 up 1.41 down ICAM4 NM_022377 
2.53 up 2.55 up 1.01 up ICOSLG   
1.21 down 2.00 up 2.42 up ID2 NM_002166 
1.75 down 4.20 down 2.40 down IGF2BP2 NM_006548 
2.62 down 9.35 down 3.57 down IGF2BP2 NM_006548 
2.53 up 2.15 up 1.18 down IGFBPL1 NM_001007563 
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1.67 down 18.43 down 11.05 down IGFL3 NM_207393 
4.21 up 2.33 up 1.81 down IGSF9 NM_020789 
1.97 up 2.07 up 1.05 up IKBKE NM_014002 
1.15 up 2.40 up 2.08 up IL11RA NM_147162 
1.20 down 1.87 up 2.25 up IL17RA NM_014339 
7.96 up 11.01 up 1.38 up IL17RB NM_018725 
1.43 down 3.23 up 4.62 up IL22RA2 NM_052962 
1.07 down 2.57 up 2.73 up IL2RG NM_000206 
1.17 up 2.67 up 2.28 up IL2RG NM_000206 
1.06 up 2.15 up 2.04 up IL34 NM_152456 
1.79 up 2.47 up 1.38 up IL4I1 NM_172374 
1.22 down 1.92 up 2.34 up IL7 NM_000880 
4.62 up 3.29 up 1.41 down INA NM_032727 
2.44 up 1.36 up 1.80 down INADL NM_176877 
2.81 down 5.41 down 1.92 down INHBB NM_002193 
2.80 up 3.24 up 1.16 up INPP1 NM_002194 
2.21 down 2.30 down 1.04 down INPP4B NM_003866 
1.18 down 2.98 down 2.53 down INPP4B NM_003866 
1.61 down 2.13 up 3.43 up INPP5D NM_001017915 
2.23 up 1.77 up 1.26 down INPP5F NM_014937 
1.92 up 2.50 up 1.30 up INPP5J NM_001002837 
1.90 up 1.28 down 2.43 down IQCD NM_138451 
6.38 up 1.42 down 9.08 down IRF6 NM_006147 
1.82 up 1.20 down 2.18 down IRGQ NM_001007561 
2.60 down 4.82 down 1.85 down IRS1 NM_005544 
2.66 down 5.61 down 2.11 down IRS1 NM_005544 
5.36 up 4.16 up 1.29 down IRX6 NM_024335 
13.06 up 6.80 up 1.92 down ISL1 NM_002202 
1.92 up 2.53 up 1.31 up ISOC1 NM_016048 
3.50 up 2.39 up 1.47 down ISYNA1 NM_016368 
3.28 up 2.62 up 1.25 down ISYNA1 NM_016368 
1.15 down 2.34 down 2.03 down ITGA5 NM_002205 
1.02 down 3.14 down 3.09 down ITGA6 NM_000210 
1.09 down 2.78 down 2.55 down ITGA6 NM_000210 
1.16 up 2.25 down 2.60 down ITGB5 NM_002213 
1.32 down 1.96 up 2.59 up ITIH1 NM_002215 
2.48 down 1.73 up 4.29 up ITM2A NM_004867 
1.97 up 3.04 up 1.55 up IZUMO4 NM_001031735 
4.25 down 3.33 down 1.28 up JAKMIP2 NM_014790 
3.55 down 2.63 down 1.35 up JAKMIP2 NM_014790 
2.13 down 1.70 down 1.25 up JAM3 NM_032801 
1.82 down 2.02 down 1.11 down JPX NR_024582 
4.81 down 3.57 down 1.35 up KALRN NR_028136 
1.66 down 1.53 up 2.54 up KAT2B NM_003884 
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3.70 up 4.57 up 1.23 up KATNAL2 NM_031303 
2.79 up 3.57 up 1.28 up KATNAL2 NM_031303 
3.91 down 1.62 down 2.41 up KBTBD11 NM_014867 
8.87 up 10.27 up 1.16 up KCNB2 NM_004770 
5.52 up 3.59 up 1.54 down KCNG3 NM_133329 
2.31 up 1.86 up 1.24 down KCNJ14 NM_170720 
2.52 down 1.56 down 1.61 up KCNJ8 NM_004982 
100.2
4 up 35.60 up 2.82 down KCNS1 NM_002251 
1.32 down 2.27 down 1.72 down KDM5B NM_006618 
1.22 down 2.68 down 2.20 down KDM5B NM_006618 
16.71 up 3.28 up 5.09 down KDM5D NM_004653 
5.67 up 16.06 up 2.83 up KEL NM_000420 
2.26 up 3.67 up 1.62 up KHK NM_000221 
2.03 up 2.75 up 1.36 up KIAA0368 NM_001080398 
1.85 up 2.46 up 1.33 up KIAA0485 AB007954 
1.59 down 1.42 up 2.25 up KIAA1370 NM_019600 
2.25 up 1.33 down 2.98 down KIAA1671 NM_001145206 
2.13 down 1.51 down 1.41 up KIAA1919 NM_153369 
1.06 down 2.54 down 2.40 down KIF13A NM_022113 
2.42 up 1.97 up 1.23 down KIF15 NM_020242 
1.14 up 1.94 down 2.21 down KIF1B NM_183416 
2.98 up 1.81 up 1.65 down KIF20A NM_005733 
2.21 up 1.31 up 1.68 down KIF23 NM_138555 
3.27 up 2.62 up 1.25 down KIF24 NM_194313 
5.82 up 10.23 up 1.76 up KIF25 NM_030615 
1.43 down 4.29 down 3.00 down KIF26B NM_018012 
2.54 up 1.30 up 1.96 down KIF2C NM_006845 
1.02 up 2.02 down 2.05 down KIF3C NM_002254 
1.01 down 2.10 down 2.07 down KIF3C NM_002254 
2.52 up 1.07 up 2.36 down KIF4A NM_012310 
1.39 down 3.06 down 2.20 down KIRREL NM_018240 
1.63 down 3.28 down 2.01 down KIRREL AK090554 
2.37 up 2.34 up 1.01 down KITLG NM_000899 
1.19 up 3.84 down 4.55 down KLC3 NM_177417 
2.41 down 1.63 up 3.93 up KLF2 NM_016270 
1.22 down 3.23 down 2.65 down KLF7 NM_003709 
2.47 down 1.73 down 1.43 up KLF9 NM_001206 
14.05 up 9.21 up 1.53 down KLHL35 NM_001039548 
1.80 down 2.72 up 4.88 up KLRB1 NM_002258 
2.68 up 2.61 up 1.03 down KNTC1 NM_014708 
1.22 down 5.89 down 4.82 down KPNA7 NM_001145715 
1.05 up 5.43 down 5.72 down KPNA7 NM_001145715 
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4.69 up 2.37 up 1.98 down KREMEN1 NM_001039570 
26.58 up 19.48 up 1.36 down KRT13 NM_002274 
7.82 up 4.24 up 1.84 down KRT15 NM_002275 
5.15 up 3.61 down 18.60 down KRT17 NM_000422 
106.7
4 up 18.57 up 5.75 down KRT19 NM_002276 
83.83 up 15.09 up 5.56 down KRT19P2 NR_036685 
21.60 up 30.25 up 1.40 up KRT4 NM_002272 
2.92 up 4.64 down 13.56 down KRT42P NR_033415 
3.50 up 1.83 up 1.91 down KRT8 NM_002273 
2.84 up 1.64 up 1.74 down KRT86 NM_002284 
3.90 up 3.09 up 1.26 down L3MBTL1 NM_032107 
1.04 up 2.81 down 2.92 down LARP6 NM_197958 
7.50 down 3.86 down 1.94 up LCE2A NM_178428 
2.01 up 1.67 up 1.20 down LCORL NM_153686 
2.59 down 1.56 down 1.66 up LDB3 NM_001171610 
8.25 up 4.39 up 1.88 down LDHC NM_002301 
1.73 down 3.40 up 5.88 up LDLRAD2 NM_001013693 
2.14 up 3.75 up 1.75 up LEAP2 NM_052971 
1.52 down 2.23 down 1.47 down LEPROT NM_001198683 
1.90 up 2.18 up 1.14 up LGALS9 NM_009587 
1.42 up 2.14 up 1.51 up LGALS9C NM_001040078 
3.01 down 15.84 down 5.27 down LHX1 NM_005568 
18.86 up 6.71 up 2.81 down LHX2 NM_004789 
2.00 down 5.29 down 2.64 down LIF NM_002309 
2.42 up 2.37 up 1.02 down LIG1 NM_000234 
1.27 down 2.07 up 2.63 up LIMD2 NM_030576 
3.75 down 2.41 down 1.56 up LIMS3L NM_001205288 
2.15 up 2.91 up 1.35 up LINC00028 NR_024358 
1.44 down 2.01 down 1.40 down LINC00152 NR_024204 
1.25 up 2.10 down 2.61 down LINC00174 NR_026873 
3.07 up 1.89 up 1.62 down LINC00263 NR_026762 
6.42 up 1.64 up 3.92 down LINC00319 NR_026960 
1.07 up 2.77 up 2.60 up LIPE NM_005357 
4.06 up 2.87 up 1.42 down LMO4 NM_006769 
3.97 up 2.92 up 1.36 down LMO4 NM_006769 
3.65 up 1.22 up 3.00 down LMO7 AK092052 
2.60 down 2.39 down 1.09 up LOC100127891 XR_108812 
6.61 up 4.49 up 1.47 down LOC100127909 XR_111781 
2.76 up 2.36 up 1.17 down LOC1001281 NR_027157 
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1.46 up 2.19 up 1.50 up LOC100128429 AK123323 
1.44 up 3.33 down 4.80 down LOC100128881 NR_036480 
9.71 up 13.43 up 1.38 up LOC100128977 NR_024559 
5.84 up 4.25 up 1.38 down LOC100129148 NR_033999 
2.13 up 2.95 up 1.38 up LOC100129534 NR_024489 
3.24 down 4.99 down 1.54 down LOC100129781 XR_109258 
3.19 down 5.32 down 1.67 down LOC100129781 XR_109259 
2.49 up 2.22 up 1.12 down LOC100130093 NR_024485 
1.60 up 2.02 up 1.26 up LOC100130157 XR_109613 
2.19 up 1.55 up 1.41 down LOC100130275 NR_033910 
2.63 up 3.00 up 1.14 up LOC100130930 AK126579 
2.56 down 6.68 down 2.61 down LOC100130938 XR_110148 
2.22 down 5.75 down 2.59 down LOC100130938 XR_110148 
2.75 down 6.95 down 2.53 down LOC100130938 XR_110148 
1.19 up 3.21 up 2.70 up LOC100131096 NR_040071 
1.50 up 2.39 up 1.60 up LOC100131355 AK124217 
1.34 down 2.29 up 3.06 up LOC100131733 NR_038996 
2.65 up 2.49 up 1.07 down LOC100131929 AK126439 
1.47 up 2.08 up 1.41 up LOC100132352 AK023536 
1.76 up 2.10 up 1.19 up LOC100170939 NR_024054 
1.52 down 8.26 down 5.43 down LOC100216001 NR_024475 
1.38 down 5.22 down 3.78 down LOC100216001 NR_024475 
1.33 down 2.12 down 1.59 down LOC100270746 NR_026776 




2.83 down 2.34 down 1.21 up LOC100287216 NR_029193 
1.69 down 3.30 down 1.95 down LOC100287314 NR_040245 
1.17 down 4.61 down 3.95 down LOC100287314 NR_040245 
1.47 down 2.46 down 1.67 down LOC100288092 XR_108415 
2.33 up 2.46 up 1.06 up LOC100288637 NR_038253 
2.91 down 2.33 down 1.25 up LOC100288911 NR_037631 
2.73 down 2.23 down 1.22 up LOC100288911 NR_037631 
1.14 up 2.40 up 2.10 up LOC100289230 NR_036530 
1.44 up 2.70 up 1.88 up LOC100289230 NR_036530 
1.57 up 2.53 up 1.61 up LOC100505483 NR_038926 
1.62 down 3.62 down 2.23 down LOC100505668 XR_112556 
1.09 down 2.57 up 2.81 up LOC100505719 XR_110561 
2.65 down 2.19 down 1.21 up LOC100505729 XR_108524 
1.36 down 3.04 up 4.15 up LOC100505799 XR_111953 
13.11 up 2.34 up 5.61 down LOC100505882 XR_110336 
2.24 up 2.48 down 5.57 down LOC100505912 NR_037877 
2.77 up 1.68 up 1.65 down LOC100505920 XR_108534 
1.63 down 2.34 up 3.81 up LOC100505921 XR_108739 
1.58 up 2.01 up 1.27 up LOC100505960 XR_108741 
7.67 up 3.80 up 2.02 down LOC100506003 XR_109785 
2.17 up 2.22 up 1.02 up LOC100506123 NR_040097 
2.34 up 2.34 up 1.00 up LOC100506123 NR_040097 
1.57 down 2.02 down 1.29 down LOC100506136 NR_038948 
2.27 down 1.32 down 1.72 up LOC100506295 XR_109394 
4.31 down 1.02 up 4.39 up LOC1005063 XR_108932 
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2.42 down 1.82 down 1.33 up LOC100506327 XR_112081 
14.57 up 2.60 up 5.60 down LOC100506328 AK055877 
2.75 up 3.43 up 1.25 up LOC100506503 XR_109701 
2.39 up 3.86 up 1.61 up LOC100506538 XR_108868 
2.03 down 3.86 down 1.90 down LOC100506578 XR_132581 
3.58 up 2.31 up 1.55 down LOC100506660 NR_038927 
1.96 down 2.20 down 1.12 down LOC100506714 NR_038956 
3.03 down 8.93 down 2.95 down LOC100506718 XR_110230 
1.43 down 2.87 up 4.10 up LOC100506779 NR_038410 
1.59 down 2.02 up 3.21 up LOC100506802 XR_132718 
3.31 down 15.78 down 4.77 down LOC100506895 NR_038276 
2.02 up 2.42 up 1.20 up LOC100506930 AK090827 
1.93 up 2.89 up 1.50 up LOC100506992 XR_113296 
9.01 up 5.07 up 1.78 down LOC100506994 NR_038281 
2.50 down 3.49 down 1.40 down LOC100507025 XR_108687 
1.61 up 11.72 down 18.86 down LOC100507033 XR_110380 
2.57 up 1.84 up 1.40 down LOC100507053 NR_037884 
5.22 down 11.98 down 2.30 down LOC100507127 NR_038291 
2.86 down 9.34 down 3.26 down LOC100507127 NR_038291 
2.69 up 2.41 up 1.12 down LOC100507161 
XM_00311887
8 
2.08 down 1.70 down 1.22 up LOC100507241 XR_108695 
1.52 down 8.33 down 5.47 down LOC100507420 XR_110876 
5.15 up 7.41 up 1.44 up LOC100507421 
NM_00119527
8 
2.91 down 3.15 up 9.19 up LOC100507616 XR_110328 
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1.67 down 3.31 down 1.99 down LOC100507624 XR_110188 
5.67 down 2.10 down 2.70 up LOC100507632 NR_038236 
6.65 up 5.47 up 1.22 down LOC100507759 XR_111561 
1.53 up 3.73 up 2.44 up LOC100508995 XR_111214 
2.44 up 3.82 up 1.57 up LOC100509075 XR_111772 
2.21 up 4.07 up 1.84 up LOC100509075 XR_111771 
114.7





2.15 up 2.70 up 1.26 up LOC100616668 NR_038258 
2.26 down 1.04 up 2.35 up LOC100652740 
XM_00340346
2 
2.49 down 3.34 down 1.34 down LOC100652760 XR_132680 
1.80 down 2.13 down 1.19 down LOC100652766 
XM_00340343
8 
2.93 down 1.56 down 1.87 up LOC100652787 XR_132806 
1.65 up 2.67 up 1.62 up LOC100652912 XR_132665 
1.46 up 4.31 up 2.95 up LOC100652917 XR_132741 
2.18 down 1.20 up 2.61 up LOC145820 NR_027132 
3.81 down 6.33 down 1.66 down LOC149773 NR_034147 
1.26 down 4.38 down 3.48 down LOC152225 NR_026934 
1.12 up 2.54 up 2.27 up LOC202025 AL713660 
3.42 up 3.81 up 1.12 up LOC219731 NR_038222 
1.61 up 1.73 down 2.78 down LOC254128 NR_037857 
6.89 up 9.82 up 1.43 up LOC254559 NR_015411 
8.84 up 13.97 up 1.58 up LOC254559 NR_015411 
2.84 down 1.68 down 1.69 up LOC255177 BC031230 
5.76 up 9.44 up 1.64 up LOC283174 NR_024344 
5.58 up 10.62 up 1.90 up LOC283174 NR_024344 
3.19 up 3.89 up 1.22 up LOC283174 NR_024344 
4.61 up 8.46 up 1.84 up LOC283174 NR_024344 
1.80 down 6.13 down 3.40 down LOC283404 NR_027358 
7.51 up 33.07 up 4.40 up LOC283485 AK093862 
1.54 up 3.59 up 2.32 up LOC283713 AK094982 
4.42 up 1.57 up 2.82 down LOC284023 NR_024349 
1.50 up 2.21 up 1.47 up LOC284513 AK096098 
3.10 up 5.34 up 1.72 up LOC284630 AK096384 
47.36 up 38.74 up 1.22 down LOC285084 NR_038897 
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71.74 up 60.22 up 1.19 down LOC285084 NR_038897 
3.64 down 1.99 down 1.83 up LOC285419 NR_027105 
1.34 up 2.04 up 1.51 up LOC285540 NR_037934 
2.87 down 2.84 down 1.01 up LOC286068 BC015720 
1.78 up 1.27 down 2.27 down LOC286109 AK092172 
1.74 up 2.38 up 1.37 up LOC286161 AK091672 
2.20 down 5.81 down 2.63 down LOC339240 NR_001443 
13.74 up 17.03 up 1.24 up LOC375196 NR_028386 
3.81 down 3.87 down 1.02 down LOC375295 NR_040001 
1.26 down 1.83 up 2.32 up LOC386758 NR_037161 
6.63 up 4.09 up 1.62 down LOC389831 NM_001242480 
6.03 up 3.63 up 1.66 down LOC389831 AK123495 
5.83 up 3.38 up 1.73 down LOC389831 NM_001242480 
1.45 up 2.63 up 1.81 up LOC389834 NR_027420 
1.18 up 4.12 up 3.49 up LOC389834 NR_027420 
3.41 down 1.24 up 4.25 up LOC400456 NR_034095 
1.58 up 2.31 up 1.46 up LOC401068 XR_110024 
3.98 up 2.44 up 1.63 down LOC401109 NR_034088 
6.63 up 3.90 up 1.70 down LOC401109 NR_034088 
1.48 down 7.36 down 4.98 down LOC401164 NR_033869 
1.72 down 6.64 down 3.87 down LOC401164 NR_033869 
1.81 up 5.09 up 2.81 up LOC401431 NR_027040 
3.74 up 3.82 up 1.02 up LOC440792 AB051440 
2.01 up 3.24 up 1.61 up LOC441268 AK125166 
2.05 up 3.22 up 1.57 up LOC497257 BC030211 
1.41 down 2.03 down 1.44 down LOC541471 NR_024373 
16.89 up 10.20 up 1.65 down LOC541473 NR_003602 
7.39 up 5.15 up 1.44 down LOC642366 XR_108597 
1.69 down 1.87 up 3.16 up LOC643733 NR_034079 
1.52 up 2.55 up 1.68 up LOC644656 NR_036539 
2.10 down 1.54 down 1.37 up LOC645676 NR_027023 
1.54 down 2.68 down 1.74 down LOC646329 NR_034120 
2.14 down 1.42 down 1.51 up LOC646626 NR_045484 
1.54 up 3.03 up 1.97 up LOC728537 NR_038386 
1.22 up 2.57 up 2.10 up LOC728537 NR_038386 
3.97 up 4.33 up 1.09 up LOC728715 XM_003119524 
1.16 up 2.10 up 1.82 up LOC728743 NR_027237 
1.05 down 2.22 down 2.12 down LOC728975 XR_110914 
3.55 down 1.79 down 1.99 up LOC729178 NR_034115 
1.23 up 6.24 down 7.65 down LOC729444 NR_038388 
3.07 down 1.24 up 3.80 up LOC729468 BU567215 
2.34 up 3.57 up 1.52 up LOC729732 XR_132886 
2.64 down 2.20 down 1.20 up LOC729887 BC052334 
3.63 up 6.27 up 1.73 up LOC84856 NR_026827 
4.98 up 6.20 up 1.24 up LOC84856 NR_026827 
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1.07 down 2.04 down 1.90 down LOH12CR1 NM_058169 
2.11 down 1.25 down 1.69 up LPAR1 NM_057159 
2.17 up 2.28 down 4.96 down LPAR3 NM_012152 
1.24 down 2.31 down 1.86 down LPCAT2 NM_017839 
1.21 up 2.39 down 2.88 down LRP11   
1.66 down 1.58 up 2.62 up LRRC33 NM_198565 
2.60 up 3.18 up 1.23 up LRRC56 NM_198075 
1.87 up 2.60 up 1.39 up LRRC61 NM_001142928 
1.67 down 3.44 down 2.06 down LRRC69 NM_001129890 
1.96 down 3.80 down 1.94 down LRRC69 NM_001129890 
3.18 down 1.04 up 3.31 up LRRC70 NM_181506 
1.38 up 1.67 down 2.31 down LRRC8A NM_019594 
2.67 up 2.60 down 6.96 down LRRC8E NM_025061 
1.83 down 1.74 up 3.17 up LRRK2 NM_198578 
2.11 up 1.33 up 1.59 down LSM11 NM_173491 
2.07 up 1.04 down 2.14 down LSR NM_205834 
1.25 down 2.23 up 2.77 up LTA NM_000595 
1.50 down 2.57 down 1.71 down LTBP1 NM_206943 
1.25 up 1.79 down 2.24 down LTBR NM_002342 
6.38 up 30.14 up 4.72 up LTF NM_002343 
2.79 down 3.61 down 1.29 down LY6H NM_002347 
1.23 up 3.27 up 2.66 up LY75 NM_002349 
1.50 down 2.19 up 3.27 up LYL1 NM_005583 
1.41 down 1.76 up 2.49 up LYSMD2 NM_153374 
9.60 down 1.09 up 10.46 up LYVE1 NM_006691 
1.31 down 2.07 down 1.58 down MACF1 NM_012090 
9.17 down 36.18 down 3.94 down MAGEA12 NM_005367 
17.69 down 26.23 down 1.48 down MAGEA2B NM_153488 
28.64 down 27.63 down 1.04 up MAGEA4 NM_002362 
2.92 down 3.07 down 1.05 down MAGEA6 NM_175868 
18.44 down 104.17 down 5.65 down MAGEA6 NM_175868 
2.50 up 1.85 up 1.35 down MAGI3 NM_152900 
5.14 up 25.52 up 4.97 up MAL NM_002371 
2.31 down 1.15 down 2.01 up MALAT1 NR_002819 
2.49 down 1.26 down 1.98 up MALAT1 NR_002819 
2.91 up 2.73 up 1.06 down MAMDC4 NM_206920 
1.78 down 1.72 up 3.07 up MAN1C1 NM_020379 
1.89 down 1.60 up 3.03 up MAN1C1 NM_020379 
1.01 up 2.23 up 2.20 up MAN2A2 NM_006122 
3.50 up 1.86 up 1.88 down MAP3K13 NM_004721 
1.66 up 3.36 up 2.02 up MAP3K14 NM_003954 
2.26 up 1.72 up 1.31 down MAP3K6 NM_004672 
2.96 up 2.04 up 1.45 down MAP3K6 NM_004672 
2.50 down 1.24 down 2.02 up MAP3K8 AB209539 
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1.32 up 2.16 down 2.85 down MAP3K9 NM_033141 
1.18 up 2.60 down 3.07 down MAP7 NM_003980 
1.11 up 1.97 down 2.19 down MAP7 NM_003980 
2.70 up 2.42 up 1.12 down MAP7D2 NM_152780 
6.77 up 10.43 up 1.54 up MAP7D2 NM_152780 
2.09 down 2.07 down 1.01 up MAP7D3 NM_024597 
3.78 down 2.95 down 1.28 up MAP7D3 NM_001173517 
1.40 down 2.05 down 1.47 down MARK3 NM_001128918 
3.60 up 1.40 up 2.57 down MARVELD2 NM_001038603 
3.25 up 1.54 up 2.11 down MARVELD2 AK055094 
2.43 up 1.56 up 1.56 down MAST4 NM_001164664 
2.41 up 5.28 up 2.19 up MAT1A NM_000429 
2.95 up 3.24 up 1.10 up MCF2L NM_024979 
2.20 up 2.75 up 1.25 up MCF2L NM_024979 
3.07 up 1.74 up 1.77 down MCM10 NM_182751 
4.00 up 3.24 up 1.23 down MCM2 NM_004526 
2.34 up 2.25 up 1.04 down MCM3 NM_002388 
2.38 up 1.43 up 1.67 down MCM4 NM_005914 
2.15 up 2.24 up 1.04 up MCM5 NM_006739 
2.17 up 2.35 up 1.08 up MCM5 NM_006739 
2.08 up 2.18 up 1.05 up MCM6 NM_005915 
2.40 up 1.54 up 1.56 down MCM7 NM_005916 
2.56 up 2.12 up 1.21 down MCM8 NM_182802 
1.02 up 2.49 down 2.54 down MDFI NM_005586 
1.93 up 2.80 up 1.45 up MDM1 NM_017440 
2.06 up 1.67 up 1.23 down MDM2 NM_002392 
2.36 up 2.51 up 1.07 up MDM2 NM_002392 
2.12 up 7.39 up 3.48 up MEI1 NM_152513 
2.84 up 2.22 up 1.28 down MEIS1 NM_002398 
2.51 up 1.33 up 1.88 down MELK NM_014791 
3.24 down 2.44 up 7.90 up MEOX2 NM_005924 
1.20 down 2.61 down 2.17 down MET NM_000245 
2.06 down 1.66 up 3.43 up METTL7A NM_014033 
3.88 up 1.67 up 2.33 down MFI2 NM_005929 
1.78 down 1.73 up 3.08 up MFNG NM_002405 
3.28 up 9.69 up 2.95 up MGAT3 NM_002409 
1.10 down 2.64 down 2.39 down MICALCL NM_032867 
2.55 up 2.07 up 1.23 down MICALL2 NM_182924 
1.59 up 1.97 down 3.13 down MIPOL1 NM_138731 
1.79 up 1.73 down 3.11 down MIPOL1 NM_001195296 
1.83 down 2.63 down 1.44 down MIR143HG NR_027180 
2.58 up 3.85 up 1.49 up MIR600HG NR_026677 
2.26 up 1.66 up 1.36 down MIS18A NM_018944 
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2.99 up 2.52 up 1.19 down MLF1IP NM_024629 
1.53 down 3.92 down 2.56 down MLLT11 NM_006818 
1.37 up 2.03 up 1.48 up MLPH NM_024101 
2.01 up 2.26 up 1.12 up MMAA NM_172250 
5.45 down 3.19 down 1.71 up MME NM_007289 
1.19 up 25.03 down 29.78 down MMP10 NM_002425 
4.85 down 23.47 down 4.84 down MMP13 NM_002427 
4.79 down 3.47 up 16.65 up MMRN1 NM_007351 
1.34 down 3.28 down 2.45 down MMRN2 XR_111094 
1.11 up 3.32 down 3.67 down MN1 NM_002430 
3.54 up 1.70 down 6.01 down MNAT1 NM_002431 
3.53 up 3.23 up 1.10 down MNS1 NM_018365 
2.02 up 1.79 up 1.13 down MORC4 NM_024657 
1.64 down 3.00 down 1.83 down MORN4 BC022054 
1.03 down 2.18 down 2.12 down MPDU1 AK027742 
9.94 up 3.26 up 3.05 down MPP2 NM_005374 
2.44 down 5.77 down 2.37 down MPPED1 NM_001044370 
1.11 up 2.05 up 1.84 up MRPS25 NM_022497 
1.38 up 2.21 up 1.61 up MST1 NM_020998 
1.49 down 2.53 down 1.69 down MST1 BC044862 
1.74 up 2.17 up 1.25 up MST1 NM_020998 
5.40 up 2.53 up 2.13 down MST1R NM_002447 
4.58 down 3.75 down 1.22 up MSX2P1 NR_002307 
1.13 up 2.00 up 1.76 up MTERFD2 NR_028049 
1.52 down 2.06 down 1.35 down MTHFD1L NM_015440 
1.18 down 3.10 down 2.62 down MTSS1 NM_014751 
40.33 up 25.01 up 1.61 down MUC21 NM_001010909 
3.31 down 9.16 down 2.77 down MUM1L1 NM_152423 
2.72 up 3.75 up 1.38 up MXD3 NM_001142935 
1.38 down 2.41 down 1.75 down MXRA7 NM_001008529 
1.04 down 2.03 down 1.95 down MXRA7 NM_001008529 
1.57 down 2.17 down 1.38 down MXRA7 NM_001008528 
3.22 up 5.84 up 1.81 up MYB NM_005375 
1.57 down 1.31 up 2.05 up MYCBP2 NM_015057 
3.77 up 3.47 up 1.09 down MYCN NM_005378 
2.38 down 1.21 down 1.96 up MYCT1 NM_025107 
2.68 up 2.35 up 1.14 down MYEOV NM_138768 
1.90 up 1.20 down 2.28 down MYO19 NM_001033580 
2.08 up 1.38 up 1.51 down MYO19 NM_025109 
1.28 down 2.56 down 2.00 down MYO1B NM_012223 
1.06 down 2.80 down 2.63 down MYO1B NM_012223 
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1.82 down 1.24 up 2.26 up MYO1F NM_012335 
11.87 up 9.66 up 1.23 down MYO3A BC036079 
16.98 up 13.91 up 1.22 down MYO3A NM_017433 
2.85 down 3.19 down 1.12 down MYO5A NM_000259 
1.23 up 1.94 down 2.39 down MYOF NM_013451 
1.47 up 2.25 down 3.30 down MYOF NM_133337 
4.58 down 6.64 down 1.45 down MYOM3 NM_152372 
3.22 down 1.38 up 4.46 up MYRIP NM_015460 
1.17 down 3.56 up 4.14 up MYZAP NM_001018100 
2.66 up 2.28 up 1.17 down NASP NM_002482 
1.50 down 2.38 down 1.59 down NAV1 NM_020443 
2.74 down 4.51 down 1.65 down NAV3 NM_014903 
1.29 down 2.42 down 1.88 down NAV3 NM_014903 
2.05 up 1.62 up 1.26 down NCAPD3 NM_015261 
2.53 up 2.05 up 1.24 down NCAPG NM_022346 
1.43 down 2.18 up 3.10 up NCF1 NM_000265 
1.01 down 2.06 up 2.07 up NCF1 NM_000265 
1.22 down 2.42 up 2.96 up NCF1 NM_000265 
1.92 up 2.11 up 1.10 up NCK1 NM_006153 
2.07 down 2.03 up 4.20 up NCR3 NM_001145467 
104.5
2 up 5.37 up 19.48 down 
NCRNA0018
5 NR_001544 
2.36 down 1.91 down 1.23 up NDST2 BC018681 
15.31 down 7.84 down 1.95 up NEB NM_004543 
10.12 down 7.85 down 1.29 up NEB NM_001164507 
2.92 up 2.71 up 1.08 down NEDD1 NM_152905 
5.26 up 3.26 up 1.61 down NEDD4L NM_001144967 
5.26 up 2.69 up 1.95 down NEDD4L NM_015277 
3.28 up 2.71 up 1.21 down NEURL1B NM_001142651 
8.65 up 5.28 up 1.64 down NEURL3 NR_026875 
2.30 up 1.80 up 1.28 down NFKB2 NM_001077493 
1.29 up 2.83 up 2.19 up NFX1 NM_002504 
1.88 up 2.01 up 1.07 up NINJ1 NM_004148 
5.41 down 5.19 down 1.04 up NLGN4X NM_020742 
1.80 down 2.27 up 4.09 up NLRC3 NM_178844 
2.63 down 1.28 down 2.05 up NLRP3 NM_001079821 
2.40 down 1.27 down 1.90 up NLRP3 NM_001243133 
1.29 down 2.20 down 1.70 down NME4 NM_005009 
8.09 up 2.12 up 3.81 down NMU NM_006681 
2.17 up 6.60 up 3.04 up NOS2 NM_000625 
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2.31 down 1.13 up 2.61 up NOSTRIN NM_052946 
3.74 up 2.53 up 1.48 down NOTCH1 NM_017617 
3.31 up 6.59 up 1.99 up NPPC NM_024409 
1.09 up 5.61 down 6.12 down NPTX2 NM_002523 
1.59 down 1.31 up 2.09 up NR2F2 NM_021005 
1.44 up 7.50 up 5.21 up NR3C2 NM_000901 
1.45 up 4.18 down 6.07 down NRG1 AF176921 
1.11 up 7.06 down 7.86 down NRG1 NM_004495 
1.42 up 4.13 down 5.88 down NRG1 NM_004495 
1.24 up 4.59 up 3.70 up NRG2 NM_013982 
1.02 down 2.34 down 2.28 down NRP2 NM_201264 
1.31 up 2.08 down 2.72 down NRP2 NM_201266 
3.17 up 1.16 up 2.73 down NT5DC3 NM_001031701 
3.39 down 3.71 down 1.09 down NT5E NM_002526 
2.62 down 3.50 down 1.34 down NT5E NM_002526 
2.40 up 3.02 up 1.26 up NT5M NM_020201 
2.13 up 4.34 up 2.04 up NUP210 NM_024923 
2.45 up 2.11 up 1.16 down NUSAP1 NM_016359 
2.95 down 3.28 down 1.11 down OBSL1 NM_015311 
1.31 down 2.09 down 1.59 down ODF2 NM_153437 
1.89 up 1.55 down 2.93 down ODZ3 NM_001080477 
1.21 up 2.05 up 1.70 up OGG1 NM_016828 
4.26 up 7.51 up 1.76 up OLFM1 NM_014279 
2.03 up 2.18 up 1.07 up OLFM1   
1.09 up 2.15 down 2.35 down OLFM2 NM_058164 
2.07 up 2.55 up 1.23 up ONECUT2 NM_004852 
2.07 down 1.64 down 1.26 up OTUD1 NM_001145373 
1.79 up 1.17 down 2.09 down OTUD7B NM_020205 
2.22 up 3.00 up 1.35 up OXER1 NM_148962 
2.78 down 18.50 down 6.66 down P01115   
3.26 down 2.14 up 6.97 up P2RY12 NM_022788 
1.78 down 2.26 up 4.03 up P2RY13 NM_176894 
2.55 down 1.76 up 4.48 up P2RY14 NM_014879 
1.92 down 2.09 down 1.09 down P39193 AK056172 
1.98 down 2.06 down 1.04 down P39193 AK056172 
2.93 up 1.73 up 1.69 down PAFAH1B3 NM_002573 
2.17 down 3.13 down 1.44 down PAPPA NM_002581 
2.18 up 1.31 up 1.66 down PAQR4 NM_152341 
1.74 up 2.75 up 1.58 up PARD6A NM_016948 
2.90 up 2.04 up 1.42 down PARD6B NM_032521 
2.42 up 1.66 up 1.46 down PARS2 NM_152268 
1.18 down 2.81 up 3.31 up PASK NM_015148 
1.21 up 1.79 down 2.18 down PAWR NM_002583 
125.7
3 up 48.41 up 2.60 down PAX1 NM_006192 
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2.84 up 1.64 up 1.73 down PAX9 NM_006194 
8.84 up 3.43 up 2.58 down PAX9 NM_006194 
2.06 up 2.84 up 1.38 up PBX1 NM_002585 
2.12 up 2.81 up 1.33 up PBX4 NM_025245 
2.49 down 1.99 down 1.25 up PCDHB15 NM_018935 
2.44 down 3.26 down 1.34 down PCDHB16 NM_020957 
3.16 down 3.49 down 1.10 down PCDHGA3 NM_032011 
2.48 down 3.95 down 1.59 down PCDHGA5 NM_032054 
1.57 down 2.44 down 1.55 down PCDHGA8 NM_032088 
1.22 down 3.90 down 3.20 down PCDHGB1 NM_032095 
2.68 down 2.75 down 1.03 down PCDHGB4 NM_032098 
4.72 up 2.73 up 1.73 down PCLO NM_014510 
1.10 up 2.29 up 2.09 up PCM1 NM_006197 
2.17 up 2.07 up 1.05 down PCNA NM_002592 
2.25 up 2.09 up 1.08 down PCNA NM_002592 
2.14 up 2.06 up 1.04 down PCNA NM_002592 
1.40 up 2.11 up 1.51 up PCNA-AS1 NR_028370 
2.57 up 2.96 up 1.15 up PCP2 NM_174895 
3.81 down 6.35 down 1.67 down PCSK1 NM_000439 
3.37 down 2.93 down 1.15 up PCSK5 NM_006200 
3.56 down 2.49 down 1.43 up PCSK5 NM_006200 
3.29 down 2.00 down 1.64 up PDE1C NM_005020 
3.02 down 1.90 down 1.59 up PDE2A NM_002599 
2.89 down 1.56 down 1.85 up PDE7B NM_018945 
1.70 down 2.57 down 1.51 down PDGFC NM_016205 
5.89 down 1.41 down 4.19 up PDK4 NM_002612 
1.10 up 2.17 down 2.38 down PDLIM7 NM_005451 
2.72 up 2.52 up 1.08 down PDXK NM_003681 
2.20 down 1.44 down 1.53 up PDZK1 NM_002614 
1.60 down 1.33 up 2.13 up PECAM1 NM_000442 
2.20 up 2.27 up 1.03 up PER3 NM_016831 
2.33 up 1.68 up 1.39 down PER3 NM_016831 
1.37 down 2.01 down 1.47 down PEX13 NM_002618 
1.51 down 2.03 down 1.35 down PGM3 NM_015599 
1.34 down 2.13 down 1.59 down PGM3 NM_001199919 
3.76 down 1.63 up 6.13 up PGM5 NM_021965 
1.39 up 2.06 up 1.47 up PGPEP1 NM_017712 
2.16 down 1.36 down 1.59 up PHACTR2 NM_001100164 
2.38 down 3.87 down 1.63 down PHEX NM_000444 
1.39 up 2.15 up 1.55 up PHF17 NM_024900 
1.03 down 2.14 up 2.20 up PHF17 NM_199320 
2.98 up 2.27 up 1.31 down PHGDH NM_006623 
1.18 down 2.26 down 1.91 down PHLDA1 NM_007350 
1.41 down 4.73 down 3.35 down PHLDB2 NM_001134438 
3.03 down 7.25 down 2.40 down PI15 NM_015886 
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4.74 down 5.83 up 27.64 up PI16 NM_153370 
1.60 up 2.40 up 1.50 up PIDD NM_145886 
1.48 down 2.09 down 1.41 down PIGL NM_004278 
1.86 up 2.27 up 1.22 up PIK3R3 NM_003629 
1.93 down 2.25 down 1.17 down PITPNM2 NM_020845 
11.72 up 3.41 up 3.43 down PITX1 NM_002653 
6.53 up 3.18 up 2.05 down PITX1 NM_002653 
2.28 down 1.84 down 1.24 up PKIG NM_181805 
4.25 up 8.29 up 1.95 up PLAC8 NM_016619 
2.63 up 1.81 up 1.46 down PLAC8L1 NM_001029869 
1.05 down 3.16 down 3.02 down PLAU NM_001145031 
2.87 down 3.16 down 1.10 down PLB1 BC065041 
2.55 up 1.74 up 1.46 down PLCH2 NM_014638 
1.59 down 2.32 up 3.68 up PLD4 NM_138790 
1.22 up 1.88 down 2.29 down PLEC NM_201380 
1.36 down 2.20 down 1.62 down PLEC NM_201380 
1.10 down 3.40 up 3.72 up PLEK NM_002664 
3.26 up 3.72 up 1.14 up PLEKHG4 NM_015432 
3.39 up 3.74 up 1.10 up PLEKHG4 NM_015432 
1.10 up 2.45 up 2.22 up PLGLB1 NM_001032392 
1.07 up 2.04 down 2.18 down PLS3 NM_005032 
2.94 up 1.68 up 1.75 down PLXNA1 NM_032242 
2.58 up 2.08 up 1.24 down PMEL NM_006928 
2.05 up 1.62 up 1.27 down PML NM_033238 
2.37 up 1.97 up 1.20 down PMS2L2 BC010535 
8.37 up 3.67 up 2.28 down PODXL2 NM_015720 
5.81 up 3.87 up 1.50 down PODXL2 NM_015720 
2.06 up 2.03 up 1.02 down POLA1 NM_016937 
2.15 up 1.64 up 1.31 down POLA2 NM_002689 
2.10 up 2.23 up 1.06 up POLD1 NM_002691 
2.43 up 1.87 up 1.30 down POLE NM_006231 
3.27 up 1.08 up 3.03 down POLE NM_006231 
2.93 up 1.66 up 1.77 down POLE2 NM_002692 
3.37 up 2.84 up 1.19 down POLH NM_006502 
2.13 up 2.61 up 1.22 up POLH NM_006502 
1.81 up 1.18 down 2.13 down POLR1A NM_015425 
3.90 up 7.41 up 1.90 up POU4F1 NM_006237 
1.34 down 2.66 down 1.98 down POU6F2 NM_007252 
2.86 up 2.01 up 1.42 down PP12719 XM_003403527 
2.59 down 2.11 down 1.23 up PPAPDC3   
3.27 up 2.99 up 1.09 down PPARGC1B NM_133263 
2.69 up 2.95 up 1.09 up PPARGC1B NM_133263 
3.80 up 2.04 up 1.87 down PPFIA4 NM_015053 
1.03 down 2.06 down 1.99 down PPFIBP1 NM_003622 
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1.17 down 2.62 down 2.23 down PPFIBP1 NM_177444 
1.29 down 2.53 down 1.96 down PPFIBP1 NM_003622 
2.95 up 3.04 up 1.03 up PPFIBP2 NM_003621 
1.69 up 2.70 up 1.60 up PPM1N NM_001080401 
1.60 up 2.92 up 1.82 up PPM1N NM_001080401 
1.37 up 1.54 down 2.11 down PPP1R14B NM_138689 
1.53 down 4.88 down 3.18 down PPP1R1C NM_001080545 
2.75 up 2.26 up 1.22 down PPP1R26 NM_014811 
1.00 down 2.15 up 2.16 up PPP1R3E NR_026862 
1.63 down 7.35 down 4.51 down PPP2R2C NM_181876 
2.65 up 2.19 up 1.21 down PPP2R3B-AS1 NR_027232 
2.01 down 1.35 down 1.49 up PQLC3 NM_152391 
3.57 up 2.81 up 1.27 down PRELID2 NM_138492 
1.75 down 2.38 down 1.36 down PRICKLE1 NM_153026 
9.84 up 7.82 up 1.26 down PRIMA1 NM_178013 
4.48 up 2.48 up 1.80 down PRINS NR_023388 
1.46 down 2.20 up 3.21 up PRKAR2B NM_002736 
1.25 down 2.27 up 2.83 up PRKAR2B NM_002736 
2.21 down 2.30 up 5.07 up PRKCB NM_002738 
1.49 down 2.59 down 1.74 down PRKG1 NM_006258 
4.87 up 1.88 up 2.59 down PRKXP1 AI016765 
2.65 up 1.46 up 1.81 down PRKY NR_028062 
2.50 down 3.73 down 1.50 down PROC NM_000312 
2.18 down 2.83 down 1.30 down PROCR NM_006404 
5.11 up 8.27 up 1.62 up PRODH NM_016335 
4.42 up 5.83 up 1.32 up PRODH NM_016335 
2.59 down 1.11 up 2.87 up PRORSD1P NR_027258 
1.64 up 2.01 up 1.23 up PRPF40A NM_017892 
3.24 up 2.15 up 1.51 down PRR19 NM_199285 
7.62 down 4.00 down 1.90 up PRUNE2 NM_015225 
7.35 down 2.84 down 2.59 up PRUNE2 NM_015225 
1.47 up 2.68 up 1.82 up PSIP1 NM_021144 
1.35 up 3.12 up 2.32 up PSIP1 NM_033222 
4.15 up 1.95 up 2.12 down PSMC3IP NM_013290 
1.96 down 24.19 down 12.33 down PTHLH NM_198965 
1.37 up 2.29 down 3.14 down PTK7 NM_002821 
9.55 up 6.12 up 1.56 down PTN NM_002825 
1.23 down 2.24 down 1.82 down PTP4A1 NM_003463 
4.76 down 3.05 down 1.56 up PTPLA BC027709 
8.29 up 2.32 up 3.58 down PTPRF BC048416 
3.68 up 1.61 up 2.29 down PTPRF NM_002840 
2.49 down 1.53 up 3.80 up PTPRN2 NM_002847 
2.19 up 2.07 up 1.06 down PTTG1 NM_004219 
2.04 up 2.00 up 1.02 down PTTG3P NR_002734 
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1.15 up 1.88 down 2.16 down PVR NM_006505 
1.14 down 3.20 up 3.64 up PVRIG NM_024070 
1.73 down 2.07 down 1.20 down PVT1 NR_003367 
1.42 down 3.40 down 2.39 down PYGL NM_002863 
3.15 up 4.00 up 1.27 up Q8ZSP1   
1.52 down 9.72 down 6.40 down Q9RWL9   
3.02 up 1.96 up 1.54 down QRICH2 NM_032134 
1.29 down 2.11 down 1.63 down QSOX1 NM_001004128 
1.41 up 1.67 down 2.34 down RAB23 NM_016277 
2.25 up 4.36 up 1.94 up RAB26 NM_014353 
2.15 down 1.95 up 4.19 up RAB37 NM_175738 
1.46 down 4.43 down 3.04 down RAB38 NM_022337 
2.36 up 1.67 up 1.41 down RAD54B NM_012415 
3.21 up 1.80 up 1.79 down RAD54L NM_003579 
1.13 down 2.55 down 2.26 down RAET1K NR_024045 
1.33 down 2.16 down 1.62 down RAI1 AJ271790 
3.15 up 4.91 up 1.56 up RALGPS1 NM_014636 
11.15 up 8.36 up 1.33 down RANBP17 NM_022897 
1.26 down 1.76 up 2.23 up RAPGEF6 NM_016340 
1.03 up 2.08 down 2.14 down RASAL2 NM_170692 
1.00 up 2.24 down 2.25 down RASAL2 NM_170692 
2.36 down 2.41 down 1.02 down RASD1 NM_016084 
3.40 up 3.90 up 1.15 up RASEF NM_152573 
5.78 up 1.74 up 3.32 down RASEF AK056176 
1.52 down 2.28 up 3.47 up RASSF2 NM_014737 
1.25 down 1.70 up 2.12 up RASSF5 NM_182663 
2.10 down 1.64 down 1.28 up RBBP6 NM_032626 
1.36 up 2.12 down 2.89 down RBFOX2 NM_001031695 
2.70 up 2.13 up 1.27 down RBM14 NM_006328 
1.07 up 2.78 up 2.61 up RBM26-AS1 NR_038991 
2.27 up 1.08 up 2.10 down RCC2 NM_018715 
3.59 down 2.43 down 1.48 up RECK NM_021111 
2.74 up 1.71 up 1.60 down RECQL4 NM_004260 
1.42 down 2.06 down 1.45 down REEP3 NM_001001330 
4.80 up 7.76 up 1.62 up REM1 NM_014012 
1.57 up 2.07 up 1.32 up REXO1 NM_020695 
2.19 down 1.75 down 1.25 up RFTN2 NM_144629 
1.49 up 2.13 up 1.43 up RFX5 NM_000449 
1.79 down 2.14 down 1.20 down RFX8 NM_001145664 
5.54 up 1.94 up 2.86 down RGNEF NM_001177693 
3.70 down 3.11 down 1.19 up RGPD1 NM_001024457 
2.05 down 4.33 up 8.86 up RGS13 NM_002927 
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2.21 down 1.76 down 1.25 up RGS2 NM_002923 
1.31 down 6.16 down 4.70 down RGS20 NM_170587 
1.05 up 2.04 up 1.95 up RGS5 NM_003617 
13.32 up 5.60 up 2.38 down RHBDL3 NM_138328 
14.51 up 7.26 up 2.00 down RHCG NM_016321 
2.07 up 1.95 up 1.06 down RHEBL1 NM_144593 
1.81 down 2.21 down 1.22 down RHOB NM_004040 
2.14 down 3.08 down 1.44 down RHOB NM_004040 
1.73 down 2.05 down 1.19 down RHOBTB1 NM_001242359 
2.20 down 1.49 down 1.48 up RHOJ NM_020663 
2.49 down 1.69 down 1.47 up RHOQ NM_012249 
3.42 up 4.38 up 1.28 up RHOXF1 NM_139282 
1.72 up 2.76 up 1.61 up RHPN1 NM_052924 
11.40 up 8.65 up 1.32 down RIBC2 NM_015653 
1.20 up 5.64 up 4.71 up RIC3 NM_024557 
1.12 up 3.05 down 3.40 down RIMS3 NM_014747 
1.24 down 2.61 up 3.23 up RINL NM_001195833 
1.30 down 1.96 up 2.54 up RLTPR NM_001013838 
1.65 up 2.40 up 1.46 up RMND5B NM_022762 
2.72 up 1.41 up 1.92 down RNASEH2A NM_006397 
3.37 up 3.64 up 1.08 up RNF207 NM_207396 
6.16 up 3.23 up 1.91 down RNF207 BC119780 
4.35 up 3.55 up 1.22 down RNF207 NM_207396 
12.51 up 13.96 up 1.12 up RNF212 NM_001131034 
1.43 down 4.53 down 3.16 down RNF217 NM_152553 
7.73 up 7.12 up 1.09 down RNF32 NM_030936 
3.80 up 1.93 up 1.97 down RNF43 NM_017763 
1.72 up 2.33 up 1.36 up RNPC3 AK289844 
7.96 down 4.81 down 1.66 up RNU2-2 NR_002761 
2.72 down 1.15 up 3.13 up RNU4ATAC DW419002 
1.82 down 2.12 up 3.85 up RORC NM_005060 
2.00 up 2.42 up 1.21 up RPA2 NM_002946 
1.92 up 2.33 up 1.21 up RPA2 NM_002946 
2.62 down 3.12 down 1.19 down RPL3L NM_005061 
####
# up 7.60 up 
420.1
0 down RPS4Y2 
NM_00103956
7 
2.44 up 1.47 down 3.58 down RTKN NM_033046 
1.89 up 2.36 up 1.25 up RTKN2 NM_145307 
27.10 up 6.93 up 3.91 down RTP3 NM_031440 
1.12 up 2.04 down 2.28 down RUNX2 NM_001015051 
2.15 up 1.46 up 1.48 down SAC3D1 NM_013299 
2.08 up 1.00 up 2.08 down SAMD1 NM_138352 
1.83 up 3.08 up 1.68 up SAMD10 NM_080621 
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1.99 down 2.57 down 1.29 down SAMD4A NM_015589 
1.56 down 2.25 down 1.44 down SAMD4A NM_015589 
1.32 down 2.25 down 1.70 down SAMD8 NM_144660 
1.62 up 2.10 up 1.30 up SAP18 NM_005870 
2.23 up 1.64 up 1.36 down SAP30 NM_003864 
2.31 up 1.90 up 1.22 down SASS6 NM_194292 
1.68 up 2.52 up 1.50 up SCAI NM_173690 
1.22 down 1.81 up 2.21 up SCARNA14 NR_004388 
3.71 down 1.12 down 3.32 up SCARNA16 NR_003013 
3.63 down 1.17 down 3.11 up SCARNA16 NR_003013 
8.86 down 4.63 down 1.91 up SCG2 NM_003469 
1.67 down 4.82 down 2.89 down SCG5 NM_003020 
4.82 up 3.06 up 1.57 down SCIN NM_033128 
3.00 up 4.61 up 1.53 up SCML2 NM_006089 
3.35 down 1.64 down 2.05 up SCN3B NM_018400 
1.66 up 1.34 down 2.23 down SDAD1 NM_018115 
2.37 up 1.98 up 1.20 down SDHAP1 AK125217 
2.48 down 1.72 up 4.26 up SELP NM_003005 
2.77 down 2.08 up 5.77 up SELP NM_003005 
3.94 down 8.60 down 2.18 down SEMA3A NM_006080 
1.80 down 4.82 down 2.67 down SEMA3C NM_006379 
1.18 down 1.92 up 2.25 up SEMA4D NM_006378 
1.08 down 2.33 up 2.51 up SEMA4D NM_001142287 
1.26 down 1.99 up 2.50 up SEMA5B NM_001031702 
2.04 up 1.52 up 1.34 down SENP1 NM_014554 
7.92 up 3.04 up 2.60 down SEPT3 NM_145733 
2.09 down 2.30 down 1.10 down SEPX1 NM_016332 
1.03 down 3.74 down 3.62 down SERINC2 NM_178865 
2.45 down 5.47 down 2.23 down SERPINE1 NM_000602 
2.84 down 2.71 down 1.05 up SESN3 NM_144665 
1.20 up 2.07 up 1.72 up SFI1 NM_001007467 
1.06 down 2.71 down 2.56 down SGMS2 NM_152621 
1.40 down 1.76 up 2.46 up SH2D3C NM_170600 
1.47 down 2.74 down 1.87 down SH2D5 NM_001103161 
2.65 down 2.20 down 1.21 up SHC2 BC034544 
1.14 down 2.37 up 2.69 up SHE NM_001010846 
2.21 up 2.23 up 1.01 up SHMT1 NM_004169 
5.04 up 2.46 up 2.05 down SHROOM3 NM_020859 
6.58 up 1.92 up 3.42 down SHROOM3 NM_020859 
1.42 up 2.38 up 1.67 up SIGIRR NM_021805 
1.27 up 2.10 up 1.66 up SIGIRR AY358342 
10.90 up 9.90 up 1.10 down SIM2 NM_005069 
2.18 down 1.71 down 1.28 up SIRPB2   
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3.59 up 2.18 up 1.65 down SKA3 NM_145061 
1.82 down 3.63 down 2.00 down SLC16A10 NM_018593 
1.23 down 3.33 down 2.70 down SLC16A10 NM_018593 
2.25 down 1.03 up 2.31 up SLC16A7 NM_004731 
7.42 up 6.33 up 1.17 down SLC16A8 NM_013356 
2.64 up 3.59 up 1.36 up SLC1A1 NM_004170 
1.42 down 3.52 down 2.48 down SLC22A23 NM_015482 
2.77 up 3.35 up 1.21 up SLC25A23 NM_024103 
2.16 up 2.04 up 1.06 down SLC25A23 NM_024103 
2.78 down 2.05 down 1.36 up SLC2A14 BC060766 
2.56 down 2.34 down 1.09 up SLC2A3 NM_006931 
1.72 down 2.32 down 1.35 down SLC35D1 NM_015139 
2.12 up 1.09 up 1.94 down SLC35E1 NM_024881 
1.51 up 2.09 up 1.38 up SLC35E2 NM_182838 
2.12 down 2.09 down 1.01 up SLC37A2 NM_198277 
1.32 up 1.94 down 2.55 down SLC39A4 NM_017767 
1.31 down 2.39 down 1.82 down SLC3A2 NM_001012662 
1.29 down 2.86 down 2.22 down SLC4A3 NM_005070 
2.44 up 1.82 up 1.34 down SLC5A6 NM_021095 
1.54 down 5.30 down 3.44 down SLC6A15 NM_018057 
1.18 down 2.09 up 2.47 up SLC6A16 NM_014037 
6.75 down 15.34 down 2.27 down SLC6A2 NM_001172501 
1.67 down 4.29 down 2.57 down SLC7A5 NM_003486 
3.40 down 9.64 down 2.83 down SLC7A8 NM_182728 
3.04 down 7.43 down 2.45 down SLC7A8 NM_182728 
2.19 down 1.76 down 1.25 up SLC9B2 NM_178833 
2.51 up 6.73 up 2.68 up SLFN13 NM_144682 
1.26 down 4.09 down 3.24 down SLITRK6 NM_032229 
1.66 down 15.41 down 9.27 down SLITRK6 NM_032229 
1.64 up 2.16 up 1.32 up SMA4 NR_029426 
1.80 up 2.34 up 1.30 up SMARCA2 NM_139045 
74.30 up 100.65 up 1.35 up SMC1B NM_148674 
2.10 up 1.83 up 1.15 down SMC4 NM_005496 
3.73 up 3.86 up 1.04 up SMPDL3B NM_001009568 
1.11 down 2.87 down 2.60 down SMTN NM_134269 
1.20 up 1.89 down 2.27 down SMYD3 NM_022743 
1.00 up 2.59 down 2.60 down SNAI2 NM_003068 
2.66 down 1.94 up 5.16 up SNAP91 NM_014841 
3.04 down 1.40 up 4.26 up SNORA12 NR_002954 
2.14 down 1.77 down 1.21 up SNORA17 NR_002958 
2.04 down 1.91 down 1.07 up SNORA43 NR_002975 
2.00 down 1.20 down 1.67 up SNORA5B NR_002990 
5.50 down 4.26 down 1.29 up SNORD114-12 NR_003205 
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3.15 down 4.13 down 1.31 down SNORD114-20 NR_003213 
1.35 down 1.75 up 2.37 up SNORD59B NR_003046 
1.27 down 2.21 down 1.74 down SNORD72 NR_002583 
4.05 down 3.02 down 1.34 up SNORD93 NR_003075 
2.01 down 1.69 down 1.20 up SNTA1 NM_003098 
1.15 up 9.66 up 8.39 up SNX22 NM_024798 
2.31 down 1.69 down 1.37 up SOCS3 NM_003955 
1.01 down 4.07 down 4.04 down SOX15 NM_006942 
2.96 up 3.13 up 1.06 up SOX30 NM_178424 
2.79 up 1.01 down 2.81 down SOX4 NM_003107 
4.30 up 9.74 up 2.27 up SP5 NM_001003845 
37.14 up 11.58 up 3.21 down SP9   
2.26 up 1.72 up 1.31 down SPATA5 NM_145207 
1.56 down 2.70 down 1.73 down SPEG NM_001173476 
2.55 up 19.19 up 7.53 up SPIB NM_003121 
2.29 down 1.51 up 3.45 up SPNS3 NM_182538 
1.36 up 5.09 down 6.91 down SPOCD1 NM_144569 
1.24 up 3.54 up 2.87 up SPOCK2 NM_014767 
4.36 down 3.45 down 1.26 up SPON1 NM_006108 
1.73 down 3.54 down 2.05 down SPON2 NM_012445 
2.44 down 17.24 down 7.07 down SPRR4 NM_173080 
1.17 up 1.81 down 2.11 down SRGAP1 NM_020762 
3.40 up 4.64 up 1.36 up SRGAP3 NM_014850 
1.51 down 2.02 down 1.34 down SRPK2 NM_182691 
1.64 down 2.31 down 1.41 down SSFA2 NM_006751 
3.17 down 1.78 down 1.77 up SSH2 BC011636 
3.16 up 2.52 up 1.25 down SSX2IP NM_014021 
2.11 down 1.77 down 1.19 up ST3GAL5 NM_003896 
3.65 down 1.53 down 2.38 up ST6GALNAC3 
NM_00116001
1 
2.39 down 1.45 down 1.65 up ST6GALNAC3 NM_152996 
7.80 up 16.05 up 2.06 up STAG3 NM_012447 
10.25 up 30.56 up 2.98 up STAG3 NM_012447 
8.31 up 9.19 up 1.11 up STAR NM_000349 
1.16 down 1.77 up 2.05 up STAT5A NM_003152 
2.37 up 1.47 up 1.61 down STIL NM_001048166 
1.24 up 2.14 up 1.72 up STIM2   
2.47 up 1.69 up 1.46 down STMN1 NM_203401 
1.17 up 3.24 down 3.78 down STON2 NM_033104 
2.84 up 2.08 up 1.36 down STOX2 NM_020225 
1.17 down 2.30 down 1.97 down STRN3 NM_014574 
1.49 up 1.70 down 2.53 down STX1A NM_004603 
3.84 down 3.45 down 1.11 up SUN3 NM_00103001
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1.15 up 1.81 down 2.09 down SUPT3H NM_003599 
6.84 up 8.31 up 1.22 up SUSD4 NM_017982 
1.80 up 4.54 up 2.53 up SV2B NM_014848 
2.93 down 1.31 down 2.23 up SVEP1 NM_153366 
11.74 up 7.53 up 1.56 down SYCE2 NM_001105578 
29.71 up 18.56 up 1.60 down SYCP2 NM_014258 
4.50 up 4.37 up 1.03 down SYNGR3 NM_004209 
3.19 up 3.02 up 1.06 down SYNGR3 NM_004209 
3.78 up 13.71 up 3.63 up SYNPO2 NM_133477 
7.50 down 3.35 down 2.24 up SYPL2 NM_001040709 
1.61 up 3.36 up 2.09 up TAC3 NM_013251 
1.45 down 2.08 up 3.01 up TAGAP NM_054114 
1.37 up 1.81 down 2.47 down TANC2 NM_025185 
2.10 up 1.51 up 1.39 down TAS2R9 NM_023917 
1.48 down 2.26 down 1.52 down TBC1D16 NM_019020 
2.32 up 1.38 up 1.68 down TBC1D24 NM_020705 
1.44 down 1.73 up 2.49 up TBC1D4 NM_014832 
98.83 up 66.72 up 1.48 down TCAM1P NR_002947 
19.71 up 18.42 up 1.07 down TCAM1P NR_002947 
2.00 up 3.25 up 1.62 up TCEA3 NM_003196 
2.70 down 2.60 down 1.04 up TCEAL7 NM_152278 
2.02 up 1.73 up 1.16 down TCF19 NM_007109 
2.36 up 1.45 up 1.63 down TCF7L1 NM_031283 
2.14 down 7.77 down 3.63 down TCHH NM_007113 
1.02 up 2.36 up 2.31 up TCL1B NM_004918 
7.20 up 4.89 up 1.47 down TCP11 NM_018679 
24.22 up 24.65 up 1.02 up TCP11 NM_018679 
1.20 down 2.28 down 1.90 down TCP11L1 NM_018393 
2.13 down 2.66 down 1.25 down TCTEX1D4 NM_001013632 
3.46 up 1.21 up 2.87 down TCTN2 NM_024809 
3.22 up 7.32 up 2.27 up TDRD10 NM_182499 
1.81 up 3.02 up 1.67 up TDRD10 NM_182499 
2.60 up 6.46 up 2.48 up TDRD10 NM_182499 
2.21 up 1.22 up 1.80 down TEAD2 NM_003598 
2.17 up 1.43 up 1.52 down TECR NM_138501 
2.09 down 1.10 down 1.90 up TEK NM_000459 
2.37 down 2.05 down 1.15 up TET2 NM_017628 
1.06 up 3.12 down 3.29 down TFCP2L1 NM_014553 
3.38 down 2.05 down 1.65 up TFF1 NM_003225 
7.40 down 4.49 down 1.65 up TFPI2 NM_006528 
1.02 down 2.74 down 2.68 down TGFB2 NM_003238 
3.10 down 1.25 down 2.48 up TGFBR2 NM_001024847 
1.27 up 1.72 down 2.19 down TGIF1 NM_170695 
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2.41 up 1.74 up 1.38 down THAP10 NM_020147 
1.87 up 2.56 up 1.37 up THAP2 NM_031435 
2.35 up 1.55 up 1.52 down THAP3 NM_138350 
2.06 down 1.89 down 1.09 up THBD NM_000361 
3.33 down 2.10 down 1.59 up THBS1 NM_003246 
3.05 down 2.27 down 1.34 up THBS1 NM_003246 
2.35 up 2.83 up 1.21 up THBS4   
2.12 down 2.82 down 1.33 down THSD1 NM_199263 
2.37 down 1.89 down 1.25 up THSD1 NM_018676 
3.35 up 3.35 up 1.00 up TIFA NM_052864 
1.66 down 3.15 up 5.22 up TIFAB NM_001099221 
2.35 up 2.35 up 1.00 up TIGD3 NM_145719 
1.43 up 1.46 down 2.08 down TIGD5 NM_032862 
2.69 up 2.15 up 1.25 down TIMELESS NM_003920 
7.13 down 3.51 down 2.03 up TIMP4 NM_003256 
5.60 up 5.30 up 1.06 down TJP3 NM_014428 
2.17 down 5.94 up 12.87 up TLR10 NM_030956 
1.13 down 2.31 up 2.61 up TLR9 NM_017442 
3.27 up 5.03 up 1.54 up TLX2 NM_016170 
25.11 up 23.62 up 1.06 down TLX3 NM_021025 
3.01 down 8.89 down 2.96 down TM4SF19 NM_138461 
3.50 down 9.91 down 2.84 down TM4SF19 NM_138461 
4.77 up 2.52 up 1.89 down TM7SF3 NM_016551 
2.69 up 2.20 up 1.22 down TM7SF3 NM_016551 
1.80 down 2.00 up 3.60 up TMBIM4 NM_016056 
1.55 down 5.63 down 3.64 down TMC7 NM_024847 
1.06 up 2.41 up 2.29 up TMC8 NM_152468 
1.43 up 2.29 up 1.60 up TMCO4 NM_181719 
1.86 up 2.34 up 1.26 up TMCO4 NM_181719 
2.19 down 1.69 down 1.30 up TMCO7 NM_024562 
3.82 up 1.76 up 2.17 down TMEM171 NM_173490 
2.37 up 2.31 up 1.03 down TMEM194A NM_015257 
1.43 down 2.26 down 1.58 down TMEM2 NM_013390 
2.97 down 2.85 down 1.04 up TMEM2   
1.46 down 2.10 down 1.44 down TMEM2 NM_013390 
7.08 down 3.74 down 1.89 up TMEM236 NM_001098844 
1.40 up 2.07 up 1.48 up TMEM80 NM_001042463 
1.28 down 2.22 down 1.73 down TMEM87B NM_032824 
1.07 down 3.16 up 3.38 up TMIE NM_147196 
1.62 down 1.64 up 2.65 up TMIGD2 NM_144615 
2.59 up 2.41 up 1.08 down TMPO NM_003276 
25.33 up 46.53 up 1.84 up TMPRSS11B NM_182502 
1.53 up 3.17 down 4.87 down TMPRSS13 NM_001206790 
5.15 up 2.35 up 2.19 down TMPRSS2 NM_005656 
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3.67 up 3.42 up 1.07 down TMSB4Y NM_004202 
2.58 up 1.57 up 1.64 down TMTC2 NM_152588 
1.82 down 4.76 down 2.61 down TNC NM_002160 
2.60 up 2.62 up 1.01 up TNFAIP2 NM_006291 
2.13 down 1.55 up 3.31 up TNFAIP8L2 NM_024575 
1.51 down 3.12 down 2.06 down TNFRSF12A NM_016639 
1.14 up 2.54 up 2.24 up TNFRSF14 NM_003820 
1.32 down 1.94 up 2.55 up TNFSF14 NM_003807 
3.70 up 2.05 up 1.80 down TNFSF15 NM_005118 
2.42 down 2.08 up 5.02 up TNXB NM_019105 
2.74 down 2.58 up 7.07 up TNXB NM_032470 
3.92 up 1.41 up 2.77 down TONSL NM_013432 
2.28 up 1.92 up 1.18 down TOPBP1 NM_007027 
4.04 up 1.93 up 2.09 down TP53 NM_000546 
2.69 up 1.47 up 1.83 down TP73 NM_001204186 
1.77 up 2.81 up 1.59 up TP73-AS1 NR_033711 
1.00 up 2.36 down 2.37 down TPBG NM_006670 
2.46 up 2.89 up 1.17 up TPD52 NM_001025252 
1.28 down 2.96 down 2.30 down TPM1 NM_000366 
1.22 down 2.41 down 1.98 down TPM4 NM_003290 
1.14 down 2.36 down 2.07 down TPM4 NM_003290 
1.78 up 3.95 up 2.21 up TRAF1 NM_005658 
1.02 down 2.14 up 2.19 up TRIM22 NM_006074 
2.91 up 1.63 up 1.78 down TRIM45 NM_025188 
3.45 up 5.88 up 1.70 up TRIM50 NM_178125 
1.25 up 2.02 up 1.62 up TRIM66 NM_014818 
1.53 down 2.79 down 1.83 down TRMT12 NM_017956 
3.29 up 2.29 up 1.44 down TROAP NM_005480 
4.80 up 1.91 up 2.51 down TRPV4 NM_147204 
2.41 up 1.80 up 1.34 down TSC2 NM_000548 
4.36 down 1.46 down 2.99 up TSIX NR_003255 
7.60 down 1.99 down 3.82 up TSIX NR_003255 
10.95 down 1.62 down 6.76 up TSIX NR_003255 
2.35 down 3.63 down 1.55 down TTC7B NM_001010854 
1.19 down 2.00 down 1.69 down TTC8 NM_144596 
2.46 up 1.96 up 1.25 down TTC9C AF289605 
3.21 up 2.60 up 1.23 down TTTY14 NR_001543 
27.02 up 2.94 up 9.20 down TTTY15 NR_001545 
1.65 down 3.00 down 1.82 down TUBA4A NM_006000 
1.72 down 2.99 down 1.74 down TUBA4A NM_006000 
1.73 down 2.75 down 1.59 down TUBA4A NM_006000 
2.02 down 1.85 down 1.09 up TUBA8 NM_018943 
1.39 down 2.37 down 1.70 down TUBB2A NM_001069 
1.90 down 2.86 down 1.50 down TUBB2A NM_001069 
1.72 down 5.07 down 2.95 down TUBB3 NM_006086 
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44.51 up 4.37 up 10.18 down TXLNG2P NR_045128 
57.70 up 4.48 up 12.88 down TXLNG2P NR_045128 
61.01 up 3.48 up 17.55 down TXLNG2P NR_045129 
3.01 up 2.58 up 1.17 down TYMS NM_001071 
1.14 up 2.35 up 2.06 up UBA7 NM_003335 
1.08 down 3.18 up 3.43 up UBASH3A NM_018961 
3.29 up 5.70 up 1.73 up UBD NM_006398 
1.10 down 2.41 down 2.18 down UBE2H NM_003344 
1.98 down 2.09 down 1.05 down UBE2Q2P1 NR_003661 
1.58 down 2.05 down 1.30 down UBE2Q2P1 NR_003661 
2.00 down 1.26 down 1.59 up UBR1 NM_174916 
1.69 down 2.08 down 1.23 down UBTD1 NM_024954 
2.80 up 1.44 up 1.94 down UHRF1 NM_013282 
2.18 up 1.63 up 1.34 down UHRF1 NM_013282 
3.03 up 1.90 up 1.59 down UNC119B NM_001080533 
2.64 up 1.97 up 1.34 down UNC13B NM_006377 
1.45 down 1.53 up 2.21 up UNC13D NM_199242 
2.31 up 1.66 up 1.39 down UNG NM_003362 
4.83 up 6.33 up 1.31 up UPB1 NM_016327 
2.08 up 2.38 up 1.15 up URB1 NM_014825 
2.56 up 2.12 up 1.21 down USP18 NM_017414 
2.53 up 2.05 up 1.23 down USP41 XM_036729 
10.09 up 2.42 up 4.17 down USP9Y NM_004654 
140.9
4 up 4.35 up 32.43 down USP9Y NM_004654 
28.68 up 4.09 up 7.01 down UTY BC012581 
5.03 up 3.66 up 1.37 down UTY NM_007125 
16.10 up 3.38 up 4.77 down UTY NM_182660 
3.12 up 7.29 up 2.33 up VCAM1 NM_001078 
1.29 down 2.63 down 2.04 down VCX2 NM_016378 
2.62 down 2.52 down 1.04 up VEGFC NM_005429 
3.76 down 1.75 down 2.15 up VGLL3 NM_016206 
2.49 up 1.12 up 2.23 down VKORC1 AK125618 
2.42 down 1.45 down 1.67 up VMAC NM_001017921 
1.43 down 2.43 down 1.69 down VMO1 NM_182566 
6.89 up 2.87 up 2.40 down VWDE NM_001135924 
2.07 down 1.06 down 1.95 up VWF NM_000552 
2.36 up 1.84 up 1.28 down WDR34 NM_052844 
2.95 down 10.46 down 3.55 down WDR66 NM_144668 
2.58 up 2.29 up 1.13 down WDR76 NM_024908 
1.59 up 1.37 down 2.18 down WDYHV1 NM_018024 
2.39 up 1.86 up 1.28 down WEE1 NM_003390 
2.93 up 2.08 up 1.41 down WHSC1 NM_133330 
3.62 up 4.49 up 1.24 up WIPF3 AK094250 
1.17 down 3.80 down 3.25 down WISP1 NM_080838 
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27.62 up 23.03 up 1.20 down WNK2 NM_006648 
6.14 up 6.81 up 1.11 up WNK2 NM_006648 
1.22 down 4.29 down 3.51 down WNT7A NM_004625 
1.06 down 3.04 down 2.88 down WNT7B NM_058238 
3.86 down 1.82 down 2.11 up XIST NR_001564 
235.0
8 down 3.22 down 73.02 up XIST NR_001564 
####
# down 5.82 down 
241.7
3 up XIST NR_001564 
####
# down 7.74 down 
151.3
1 up XIST NR_001564 
605.1
5 down 4.06 down 
149.0
1 up XIST NR_001564 
519.5
9 down 4.55 down 
114.1
6 up XIST NR_001564 
####
# down 10.46 down 
162.3
6 up XIST NR_001564 
####
# down 7.08 down 
306.6
7 up XIST NR_001564 
4.82 up 14.71 up 3.05 up XKR4 NM_052898 
2.25 up 1.42 up 1.58 down XLOC_000048   
3.44 up 3.65 up 1.06 up XLOC_000363   
2.47 up 2.81 up 1.14 up XLOC_000441 AK023394 
1.46 down 3.36 down 2.30 down XLOC_000527 XR_108329 
1.54 down 4.56 down 2.96 down XLOC_000527 XR_108330 
2.26 down 11.52 down 5.11 down XLOC_000587 AK124056 
2.58 down 15.11 down 5.86 down XLOC_000587   
1.01 up 2.46 up 2.45 up XLOC_000746   
1.69 down 8.40 down 4.98 down XLOC_000778   
3.25 up 3.74 up 1.15 up XLOC_000956 BX089534 
6.04 down 2.09 down 2.89 up XLOC_001011 AB042556 
1.82 down 1.55 up 2.81 up XLOC_001035   
2.01 down 3.14 down 1.56 down XLOC_001148 EF413001 
3.91 down 2.41 down 1.62 up XLOC_001209 BF216856 
2.84 down 1.75 down 1.62 up XLOC_00126   
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3.51 down 1.44 down 2.44 up XLOC_001266   
1.39 up 6.15 up 4.43 up XLOC_001286   
2.39 down 10.78 down 4.51 down XLOC_001546   
3.48 up 2.78 up 1.25 down XLOC_001576 BG219825 
1.30 up 2.20 down 2.86 down XLOC_001775   
1.13 down 5.72 down 5.04 down XLOC_001826   
1.28 down 2.37 down 1.86 down XLOC_001826   
1.07 down 3.26 down 3.04 down XLOC_001826   
1.58 down 2.38 down 1.51 down XLOC_001869   
7.47 down 3.49 down 2.14 up XLOC_002142   
1.94 down 2.04 down 1.05 down XLOC_002484 AK307257 
2.13 down 2.74 up 5.85 up XLOC_002749   
9.85 up 6.46 up 1.52 down XLOC_002830   
1.79 down 3.05 down 1.70 down XLOC_003077   
2.08 up 1.40 up 1.49 down XLOC_003386   
2.41 up 2.88 up 1.19 up XLOC_003498   
1.73 down 6.50 down 3.76 down XLOC_003834   
1.82 up 3.06 up 1.68 up XLOC_004456   
1.62 up 2.39 up 1.48 up XLOC_004456   
1.21 up 2.12 up 1.75 up XLOC_004457   
1.02 up 2.51 up 2.46 up XLOC_004467   
2.64 up 3.01 up 1.14 up XLOC_004643 DB301429 
1.44 down 4.25 down 2.95 down XLOC_004929 XR_110563 
1.29 down 3.97 down 3.09 down XLOC_005105 BX096383 
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1.19 up 2.39 up 2.00 up XLOC_005244   
1.81 down 2.64 down 1.46 down XLOC_005303   
2.14 down 4.31 down 2.01 down XLOC_005369   
1.87 up 1.10 down 2.05 down XLOC_005514   
1.81 down 3.18 down 1.76 down XLOC_005748   
1.83 down 7.05 down 3.85 down XLOC_005935 CB123670 
2.50 down 9.46 down 3.79 down XLOC_005935 CB123670 
4.81 up 3.83 up 1.25 down XLOC_005940   
2.59 down 1.58 down 1.65 up XLOC_006178 CD693121 
4.29 down 14.18 down 3.31 down XLOC_006200 BC040593 
2.16 down 2.08 down 1.04 up XLOC_006915 DA998032 
1.45 up 2.64 down 3.84 down XLOC_007531   
18.35 up 4.98 up 3.68 down XLOC_007734 BC043560 
76.43 down 2.84 down 26.96 up XLOC_008015   
4.38 down 1.78 down 2.45 up XLOC_008015   
1.54 up 2.31 up 1.51 up XLOC_008152   
38.27 down 2.31 down 16.58 up XLOC_008185   
4.64 up 2.43 up 1.91 down XLOC_008276   
4.34 up 2.48 up 1.75 down XLOC_008276   
18.70 up 2.84 up 6.59 down XLOC_008323   
2.15 down 1.59 down 1.36 up XLOC_008542   
2.21 up 1.84 up 1.20 down XLOC_008583   
5.10 down 7.50 down 1.47 down XLOC_008700   
1.84 down 12.51 down 6.79 down XLOC_008711   
2.23 down 1.88 down 1.18 up XLOC_00918 BM717049 
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1 
1.07 down 2.25 up 2.39 up XLOC_009294   
2.57 up 2.35 up 1.09 down XLOC_009428   
3.31 up 4.46 up 1.35 up XLOC_009507 AK054718 
1.15 down 3.93 down 3.43 down XLOC_009788   
2.03 down 7.06 down 3.47 down XLOC_009788 DA697821 
1.89 down 2.84 down 1.51 down XLOC_009790   
1.86 down 2.80 down 1.51 down XLOC_009810   
1.30 down 2.36 down 1.81 down XLOC_009994   
1.66 up 3.67 up 2.21 up XLOC_010117   
2.69 up 2.93 up 1.09 up XLOC_010245   
4.79 down 1.74 down 2.75 up XLOC_010275   
1.00 up 2.00 down 2.01 down XLOC_010321   
1.17 down 2.72 down 2.32 down XLOC_010390 AJ412054 
2.27 down 4.47 down 1.97 down XLOC_010825   
2.19 down 2.18 down 1.00 up XLOC_010879   
1.15 down 2.94 down 2.55 down XLOC_010881   
2.33 down 4.24 down 1.82 down XLOC_011047 BX648502 
1.36 down 3.50 down 2.57 down XLOC_011052   
1.33 up 2.36 up 1.78 up XLOC_011309   
4.66 up 5.98 up 1.28 up XLOC_011545   
2.79 up 2.95 up 1.06 up XLOC_012079   
3.42 up 3.13 up 1.09 down XLOC_012237 CR739285 
2.10 down 18.16 down 8.64 down XLOC_012452 BC084573 
2.13 down 1.08 down 1.97 up XLOC_012768   
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2.57 down 1.46 down 1.76 up XLOC_012833 BC031271 
3.31 up 3.66 up 1.11 up XLOC_012895   
1.29 down 2.08 down 1.62 down XLOC_013093   
1.81 down 3.16 down 1.75 down XLOC_013364   
5.87 up 7.61 up 1.30 up XLOC_013483   
2.28 down 6.08 down 2.66 down XLOC_013541 BX116929 
2.42 down 7.79 down 3.22 down XLOC_013542   
1.60 down 3.10 down 1.93 down XLOC_013832   
1.21 up 2.66 up 2.19 up XLOC_013866   
1.35 down 1.79 up 2.41 up XLOC_013921   
3.58 up 2.10 up 1.70 down XLOC_013981 BX105611 
3.11 down 1.84 down 1.69 up XLOC_013983   
2.52 up 2.37 up 1.06 down XLOC_014073 AY204750 
4.75 up 3.08 up 1.54 down XLOC_014111 DB312214 
4.01 up 5.74 up 1.43 up XLOC_014257   
2.01 down 6.34 down 3.16 down XLOC_014263   
1.45 up 2.16 up 1.49 up XLOC_014288   
1.70 up 2.16 up 1.27 up XLOC_014288   
1.62 down 2.09 down 1.29 down XLOC_014300   
5.60 up 3.89 up 1.44 down XLOC_014388 XR_109724 
4.84 up 3.75 up 1.29 down XLOC_014513 BC017979 
1.46 up 2.59 up 1.78 up XLOC_l2_000080 AK311553 
2.36 up 4.12 up 1.75 up XLOC_l2_000417   
2.75 up 1.61 down 4.43 down XLOC_l2_001011 BC030750 
1.77 up 2.30 up 1.30 up XLOC_l2_00   
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6.41 down 1.42 down 4.53 up XLOC_l2_002171 AF086154 
1.81 down 1.81 up 3.28 up XLOC_l2_002761   
2.83 up 4.44 up 1.57 up XLOC_l2_003293 
XM_00311952
4 
5.72 up 3.92 up 1.46 down XLOC_l2_003293 
XM_00311952
4 
4.56 up 3.29 up 1.38 down XLOC_l2_003293 
XM_00311952
4 
2.94 up 3.75 up 1.28 up XLOC_l2_003293 
XM_00171589
7 
5.61 up 4.15 up 1.35 down XLOC_l2_003293   
1.13 up 2.15 up 1.91 up XLOC_l2_003627   
2.68 up 7.62 up 2.84 up XLOC_l2_003881   
1.41 up 6.52 up 4.62 up XLOC_l2_004315   
3.75 up 9.08 up 2.42 up XLOC_l2_004317 CR620068 
5.66 down 2.19 down 2.58 up XLOC_l2_004562   
1.88 up 2.22 up 1.18 up XLOC_l2_005179   
2.27 up 4.54 down 10.31 down XLOC_l2_006021 DB117598 
6.17 up 3.81 up 1.62 down XLOC_l2_006152   
1.54 up 2.15 up 1.40 up XLOC_l2_006152 AK311448 
1.68 down 2.10 down 1.25 down XLOC_l2_006595   
3.36 up 2.42 up 1.39 down XLOC_l2_006745   
1.18 up 2.27 up 1.92 up XLOC_l2_007449   
3.57 up 3.68 up 1.03 up XLOC_l2_007478   
3.06 up 5.10 up 1.66 up XLOC_l2_007478   
1.19 down 3.25 down 2.74 down XLOC_l2_007928   
2.15 down 2.24 down 1.04 down XLOC_l2_007928   
2.79 up 2.33 up 1.20 down XLOC_l2_007931   
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2.10 up 2.74 up 1.31 up XLOC_l2_008151   
1.28 up 1.63 down 2.08 down XLOC_l2_008203   
2.39 up 2.14 down 5.10 down XLOC_l2_008910 BC039367 
1.61 up 4.59 up 2.84 up XLOC_l2_009136   
3.72 up 3.09 up 1.20 down XLOC_l2_009273 AK127572 
2.60 up 2.56 up 1.02 down XLOC_l2_009273 AK127572 
5.24 up 8.46 up 1.61 up XLOC_l2_009301   
4.87 up 5.11 up 1.05 up XLOC_l2_009316   
5.06 up 6.18 up 1.22 up XLOC_l2_009668   
1.15 down 2.36 down 2.05 down XLOC_l2_010139   
2.12 down 5.23 down 2.47 down XLOC_l2_010141 DA697996 
2.06 up 1.73 up 1.19 down XLOC_l2_010239   
3.62 down 2.31 down 1.56 up XLOC_l2_010267   
2.08 up 2.16 up 1.04 up XLOC_l2_010558   
2.14 up 2.00 up 1.07 down XLOC_l2_011011 BC036795 
18.37 up 8.46 up 2.17 down XLOC_l2_011146   
1.38 down 2.26 down 1.64 down XLOC_l2_011204 BX104493 
1.50 down 2.22 down 1.48 down XLOC_l2_011204 BX104493 
1.18 down 2.13 down 1.80 down XLOC_l2_011204 BX104493 
1.25 up 2.00 up 1.60 up XLOC_l2_011265 BU852287 
2.31 up 2.79 up 1.21 up XLOC_l2_011649   
1.36 up 2.10 up 1.54 up XLOC_l2_012083 AL049987 
3.03 down 3.06 down 1.01 down XLOC_l2_012871 AL043857 
1.50 down 2.12 down 1.42 down XLOC_l2_012925   
1.78 down 2.35 down 1.32 down XLOC_l2_01 AJ606331 
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1.03 up 2.55 down 2.62 down XLOC_l2_013145 BG532141 
2.64 down 2.46 down 1.07 up XLOC_l2_013293 BQ441651 
4.36 down 2.42 down 1.80 up XLOC_l2_013293 BQ441651 
5.22 down 3.24 down 1.61 up XLOC_l2_013293   
3.43 up 4.14 up 1.20 up XLOC_l2_013301 XR_108746 
3.35 up 5.19 up 1.55 up XLOC_l2_013301 XR_108746 
3.20 up 3.89 up 1.21 up XLOC_l2_013301 XR_108746 
2.84 up 1.87 up 1.52 down XLOC_l2_013485   
1.45 up 4.85 down 7.05 down XLOC_l2_013530 BG192435 
1.93 down 2.03 down 1.05 down XLOC_l2_015907   
3.86 up 1.76 up 2.19 down XLOC_l2_015950   
2.31 down 1.69 down 1.37 up XPNPEP3 NM_001204827 
2.17 up 1.93 up 1.13 down XRCC1 NM_006297 
3.06 up 2.26 up 1.36 down XYLB NM_005108 
12.89 up 6.74 up 1.91 down YBX2 NM_015982 
1.55 up 2.37 up 1.53 up YPEL1 NM_013313 
1.36 down 2.24 down 1.65 down YWHAZ NM_145690 
1.31 down 2.49 down 1.90 down ZAK NM_016653 
1.77 up 2.52 up 1.42 up ZBED3 NM_032367 
2.46 up 1.15 up 2.14 down ZBTB8A NM_001040441 
1.10 up 2.24 up 2.03 up ZC3H12D NM_207360 
2.19 up 2.43 up 1.11 up ZCWPW1 NM_017984 
2.05 up 2.70 up 1.32 up ZCWPW1 NM_017984 
2.59 up 3.24 up 1.25 up ZDHHC23 NM_173570 
1.09 down 2.54 down 2.32 down ZDHHC9 NM_016032 
1.25 down 2.15 down 1.73 down ZFAND3 NM_021943 
2.42 up 2.69 up 1.12 up ZFP14 NM_020917 
1.91 up 2.88 up 1.51 up ZFP3 NM_153018 
1.50 up 2.21 up 1.47 up ZFP62 NM_152283 
1.13 up 2.26 up 2.01 up ZFP62 NM_152283 
1.54 down 2.54 down 1.65 down ZFP64 NM_199427 
47.55 up 3.03 up 15.70 down ZFY NM_003411 
1.46 down 2.18 down 1.50 down ZHX3 NM_015035 
1.02 down 3.70 up 3.77 up ZMAT1 NM_00101165
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1.13 up 4.17 up 3.69 up ZMAT1 NM_001011657 
1.82 up 2.15 up 1.18 up ZMIZ2 NM_031449 
3.67 down 7.74 down 2.11 down ZNF114 NM_153608 
1.92 down 2.39 down 1.25 down ZNF134 NM_003435 
2.32 down 2.90 down 1.25 down ZNF134 NM_003435 
1.82 up 2.19 up 1.20 up ZNF248 NM_021045 
2.18 down 1.31 down 1.66 up ZNF254 NM_203282 
2.10 down 1.46 down 1.43 up ZNF254 NM_203282 
2.60 up 1.11 down 2.89 down ZNF284 NM_001037813 
2.38 up 2.45 up 1.03 up ZNF300 NM_052860 
1.42 down 2.05 down 1.44 down ZNF343 NM_024325 
1.90 up 2.79 up 1.47 up ZNF346 NM_012279 
3.68 up 2.78 up 1.32 down ZNF367 NM_153695 
2.51 up 2.35 up 1.07 down ZNF367 NM_153695 
4.06 down 1.75 down 2.32 up ZNF385D NM_024697 
2.24 up 1.74 up 1.28 down ZNF397 NM_032347 
2.59 up 1.54 up 1.68 down ZNF473 NM_015428 
1.70 up 2.04 up 1.20 up ZNF512 NM_032434 
5.01 up 2.23 up 2.25 down ZNF519 NM_145287 
1.24 up 4.74 up 3.84 up ZNF540 NM_152606 
21.93 up 49.12 up 2.24 up ZNF541 NM_001101419 
2.14 down 2.01 down 1.06 up ZNF608 NM_020747 
1.35 up 2.06 up 1.52 up ZNF620 NM_175888 
1.58 up 1.44 down 2.27 down ZNF623 NM_001082480 
1.92 down 2.34 down 1.22 down ZNF655 NM_024061 
4.01 down 2.27 down 1.77 up ZNF726 BC046415 
1.83 down 2.16 down 1.18 down ZNF773 NM_198542 
2.57 down 2.25 down 1.14 up ZNF788 NR_027049 
2.38 up 1.49 up 1.60 down ZNF827 NM_178835 
1.48 up 2.39 up 1.61 up ZNF862 NM_001099220 
2.07 up 3.51 up 1.70 up ZNF879 NM_001136116 
1.91 down 4.64 down 2.44 down ZP1 NM_207341 
2.42 up 1.96 up 1.24 down ZWINT NM_032997 
27.32 up 9.17 up 2.98 down ZYG11A NM_001004339 
3.22 down 7.20 down 2.24 down   XM_003118909 
1.62 up 3.26 up 2.01 up   BC034587 
1.62 up 3.94 up 2.43 up   AJ312027 
4.47 up 3.63 up 1.23 down   XR_109724 
8.57 up 6.91 up 1.24 down   AK129565 
 273 
2.92 up 2.10 up 1.39 down   BC119676 
2.09 up 2.10 up 1.00 up   CR737729 
1.60 down 2.36 up 3.77 up   AY312959 
1.23 up 2.94 up 2.39 up   CR594811 
1.08 up 2.86 down 3.09 down   DR007930 
1.55 down 5.73 up 8.90 up   GQ232939 
1.10 up 1.84 down 2.03 down   XR_110878 
4.43 up 2.24 up 1.98 down   AF461897 
1.12 up 5.39 up 4.79 up   JF810271 
2.01 up 1.67 up 1.21 down   XR_109661 
3.67 down 3.00 down 1.22 up   BC034319 
1.33 up 1.68 down 2.24 down   CU677870 
2.23 up 5.67 up 2.54 up   AJ312026 
1.35 up 1.77 down 2.39 down   XR_109904 
1.20 down 2.11 up 2.54 up   AK129975 
2.95 up 4.52 up 1.53 up   BC069683 
1.98 up 4.60 up 2.33 up   DA110513 
2.23 up 1.30 up 1.71 down   XR_133123 
1.78 up 2.65 up 1.49 up   BC044655 
6.67 up 3.98 up 1.67 down   AK027667 
3.07 down 1.83 down 1.68 up   BC104424 
3.81 down 1.42 down 2.68 up   BF216856 
6.96 up 5.34 up 1.30 down   AL832737 
1.01 down 2.49 up 2.52 up   AK096443 
1.03 down 2.91 up 2.99 up   X58736 
6.29 up 4.04 up 1.55 down   XM_003119524 
1.12 up 1.85 down 2.07 down   DM107643 
3.73 down 3.14 down 1.19 up   BC034319 
14.19 up 8.64 up 1.64 down   AF452715 
1.00 down 2.17 down 2.17 down   XR_132519 
1.24 up 5.72 up 4.62 up   XM_003403666 
4.08 down 3.11 down 1.31 up   BC034319 
1.37 down 3.31 up 4.53 up   BC043411 
1.33 up 2.45 up 1.85 up   AK057820 
3.06 up 2.38 up 1.28 down   AY203941 
1.72 up 3.75 up 2.18 up   AL389942 
1.30 up 7.94 up 6.09 up   Z18824 
2.69 up 3.87 up 1.44 up   AK129520 
2.47 down 1.25 down 1.98 up   BC039399 
1.03 down 7.76 up 8.01 up   XM_002346274 
4.44 up 7.76 up 1.75 up   AF289562 
3.64 down 3.81 down 1.05 down   L19779 
2.56 down 5.01 down 1.95 down   BC073826 
3.12 up 1.88 up 1.66 down   AK127966 
7.59 up 4.55 up 1.67 down   XR_111273 
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4.66 down 1.08 down 4.33 up   BC038366 
9.80 up 8.09 up 1.21 down   AK094554 
3.16 up 3.25 up 1.03 up   AY129018 
1.89 up 7.71 up 4.08 up   AF119797 
2.22 up 2.07 up 1.07 down   AK096917 
2.58 down 3.02 down 1.17 down   AF400227 















APPENDIX C - DEG HPV-INACTIVE VS HPV-NEGATIVE 
Table C.1: AA and EA HPV-Inactive vs HPV-Negative Tumors - KW - p0.02 FC2 
AA - HPV 
Inact vs AA - 
HPV Neg 
AA - HPV 
Inact vs EA - 
HPV Inact 
AA - HPV Inact 
vs EA - HPV 
Neg 
AA - HPV Neg 
vs EA - HPV 
Inact 
AA - HPV Neg 
vs EA - HPV 
Neg 
EA - HPV Inact 



































1.65 down 3.00 down 3.25 down 1.81 down 1.96 down 1.08 down ABHD2 NM_007011 
1.73 down 2.91 down 1.87 down 1.69 down 1.08 down 1.56 up ADAL NM_001012969 
1.13 up 2.37 down 1.15 down 2.68 down 1.30 down 2.06 up ADAM28 
NM_02177
7 
2.74 up 2.02 down 3.23 up 5.54 down 1.18 up 6.53 up ADIPOQ NM_004797 
2.29 down 1.45 down 1.55 up 1.58 up 3.55 up 2.25 up ALDH7A1 
NM_00118
2 
1.89 down 1.76 down 1.54 up 1.08 up 2.91 up 2.70 up ALDH7A1 
NM_00118
2 
1.45 up 1.75 up 2.24 up 1.21 up 1.54 up 1.28 up ANKRD43 
NM_17587
3 
2.39 down 10.85 down 1.93 down 4.55 down 1.23 up 5.61 up AOX1 NM_001159 
1.37 up 1.19 down 1.57 down 1.64 down 2.15 down 1.31 down ARHGAP1 
NM_00430
8 




2.11 down 1.93 down 3.48 down 1.09 up 1.65 down 1.80 down ATP2B4 NM_001684 
1.75 down 2.10 down 2.36 down 1.20 down 1.35 down 1.12 down ATP2B4 NM_001001396 
2.01 down 1.23 down 2.95 down 1.64 up 1.47 down 2.41 down ATP2B4 NM_001001396 
1.56 up 1.02 down 2.03 down 1.60 down 3.18 down 1.98 down ATP9A NM_006045 
1.24 down 1.20 down 2.31 down 1.03 up 1.87 down 1.93 down ATXN1 NM_000332 
1.43 up 1.49 down 1.80 down 2.14 down 2.59 down 1.21 down AVIL NM_006576 
1.94 up 6.01 up 1.01 up 3.09 up 1.93 down 5.97 down BAIAP2L1 
NM_01884
2 
1.35 down 1.77 up 1.10 down 2.38 up 1.22 up 1.95 down BANF1 NM_003860 
1.36 up 1.14 up 1.69 down 1.20 down 2.30 down 1.92 down BCAS3 NM_017679 
2.10 down 1.57 down 1.14 down 1.34 up 1.84 up 1.38 up BCL2A1 NM_004049 
1.90 down 1.73 down 2.15 down 1.10 up 1.13 down 1.24 down BMS1 NM_014753 
1.87 down 1.57 down 2.01 down 1.19 up 1.08 down 1.28 down BMS1 NM_014753 
1.98 down 2.06 down 1.49 down 1.04 down 1.33 up 1.38 up BNIP2 AK125533 
2.28 down 3.65 down 5.74 down 1.60 down 2.52 down 1.57 down BREA2 NR_015445 
2.64 up 2.28 up 1.10 up 1.16 down 2.40 down 2.07 down C10orf114 
NM_00101
0911 
1.22 down 2.25 up 1.59 up 2.75 up 1.95 up 1.41 down C10orf120 
NM_00101
0912 




1.65 down 2.01 down 3.18 down 1.22 down 1.93 down 1.58 down C14orf45 NM_025057 
1.78 down 2.08 down 1.18 down 1.17 down 1.51 up 1.77 up C15orf57 NM_052849 
1.38 down 1.85 down 2.70 down 1.33 down 1.95 down 1.46 down C17orf100 
NM_00110
5520 
1.50 up 1.64 up 3.82 up 1.09 up 2.55 up 2.33 up C17orf105 
NM_00113
6483 
1.14 down 2.94 down 1.83 down 2.58 down 1.60 down 1.61 up C18orf18 NR_026849 
1.54 up 1.80 up 2.34 up 1.17 up 1.52 up 1.30 up C1orf140 NR_024236 
2.13 down 4.29 up 1.30 up 9.13 up 2.76 up 3.31 down C1orf210 NM_182517 
1.19 up 1.16 down 1.76 down 1.38 down 2.10 down 1.52 down C20orf108 
NM_08082
1 
6.15 down 9.77 down 4.17 down 1.59 down 1.48 up 2.35 up C20orf26 NM_015585 
1.17 up 1.79 up 2.48 up 1.53 up 2.12 up 1.38 up C21orf33 
 
2.03 up 2.34 up 1.33 down 1.15 up 2.71 down 3.12 down C4orf26 NM_178497 
2.29 down 1.56 down 1.10 down 1.46 up 2.09 up 1.43 up C5orf44 NR_003545 
2.15 down 4.22 down 2.12 down 1.96 down 1.02 up 1.99 up CATSPER2 
NM_17209
5 
1.17 up 1.08 down 2.51 down 1.27 down 2.95 down 2.31 down CCDC40 NM_001243342 
2.38 down 4.01 down 1.24 down 1.69 down 1.91 up 3.23 up CCDC69 NM_015621 
1.48 down 4.51 down 1.10 down 3.05 down 1.34 up 4.11 up CD1B NM_001764 




2.27 down 7.41 down 3.33 down 3.27 down 1.47 down 2.22 up CEACAM21 
NM_03354
3 
2.25 down 1.70 down 1.77 down 1.32 up 1.27 up 1.04 down CGRRF1 NM_006568 
1.63 up 2.13 up 1.09 down 1.31 up 1.77 down 2.32 down CKAP4 NM_006825 
1.95 down 1.11 up 2.34 down 2.16 up 1.20 down 2.59 down CLDN12 NM_012129 
2.83 up 2.26 down 3.31 up 6.39 down 1.17 up 7.49 up CLEC3B NM_003278 
4.79 down 4.83 down 2.09 down 1.01 down 2.29 up 2.31 up CLEC4A NM_016184 
5.68 down 11.18 down 2.12 down 1.97 down 2.68 up 5.29 up CLEC9A NM_207345 
1.02 up 1.49 up 1.64 down 1.46 up 1.68 down 2.44 down CLIC4 NM_013943 
1.44 down 1.32 down 2.29 down 1.09 up 1.59 down 1.73 down CLIC4 NM_013943 
1.02 down 1.12 up 2.97 down 1.14 up 2.91 down 3.31 down COL27A1 BC007696 
1.18 up 1.17 up 1.99 down 1.01 down 2.35 down 2.33 down COL27A1 AK021957 
1.05 down 1.24 down 2.06 up 1.18 down 2.16 up 2.55 up CPA5 NM_001127442 
2.36 up 1.30 up 1.79 up 1.82 down 1.32 down 1.38 up CRIP1 AB527908 
1.16 up 3.40 up 3.43 up 2.94 up 2.96 up 1.01 up CRYBB2 NM_000496 
1.14 up 2.96 up 3.22 up 2.59 up 2.82 up 1.09 up CRYBB2P1 
NR_03373
4 
4.29 up 2.29 up 3.45 up 1.87 down 1.24 down 1.51 up CXCL12 NM_001033886 
3.35 down 1.92 down 1.43 down 1.74 up 2.35 up 1.35 up CYB5RL BC071735 





2.88 up 6.36 up 1.76 down 2.21 up 5.08 down 11.22 down DNAH17 
 
2.82 down 3.33 down 2.23 up 1.18 down 6.28 up 7.42 up DNASE1L3 
NM_00494
4 
1.30 up 3.15 up 1.70 up 2.42 up 1.30 up 1.85 down DOK7 AK075037 
1.37 up 1.49 up 2.28 up 1.09 up 1.66 up 1.52 up EFCAB4A 
NM_17358
4 
1.18 down 1.50 up 1.44 down 1.77 up 1.22 down 2.16 down EIF2C2 NM_012154 
1.81 up 2.67 up 1.25 down 1.48 up 2.25 down 3.33 down EIF4EBP1 
NM_00409
5 
5.75 up 3.65 up 1.02 up 1.58 down 5.64 down 3.58 down ENKUR NM_145010 
1.98 down 7.37 down 2.05 down 3.72 down 1.04 down 3.59 up ENPP3 NM_005021 
1.54 up 2.38 up 1.04 up 1.54 up 1.48 down 2.28 down ERC1 NM_178040 
2.77 up 3.88 up 1.18 up 1.40 up 2.35 down 3.29 down ERVMER34-1 
NM_02453
4 
1.57 down 1.16 up 2.03 down 1.83 up 1.29 down 2.36 down EXD2 NM_018199 
1.52 up 1.64 up 1.23 down 1.08 up 1.87 down 2.02 down F11R NM_016946 
1.65 up 1.51 up 1.62 down 1.09 down 2.66 down 2.44 down FAM114A1 
NM_13838
9 
6.40 down 9.87 down 2.87 down 1.54 down 2.23 up 3.44 up FAM65B NM_015864 
1.41 down 2.38 down 1.33 down 1.68 down 1.06 up 1.79 up FAM82A1 
NM_14471
3 
2.30 up 1.18 up 1.20 down 1.95 down 2.75 down 1.41 down FAM87B XR_112085 




1.24 up 1.66 up 2.53 down 1.34 up 3.14 down 4.21 down FAT1 NM_005245 
6.27 up 4.22 up 3.21 up 1.49 down 1.95 down 1.31 down FBLL1 NR_024356 




1.39 up 1.05 down 1.57 down 1.46 down 2.18 down 1.49 down FLJ20021 
NR_03387
4 
1.27 down 1.74 down 1.30 up 1.37 down 1.64 up 2.26 up FLJ33630 
NR_01536
0 
1.11 up 1.98 down 1.48 down 2.20 down 1.64 down 1.34 up FLJ37453 
NR_02427
9 
1.03 down 2.85 down 1.44 down 2.76 down 1.39 down 1.98 up FLJ39639 
NR_03390
4 
4.44 down 7.17 down 5.14 down 1.62 down 1.16 down 1.39 up FLJ43663 
NR_01543
1 
1.09 down 1.87 down 2.57 down 1.71 down 2.35 down 1.37 down FRG1B BC095491 
2.06 down 1.28 up 1.25 down 2.64 up 1.65 up 1.60 down GEMIN2 NM_003616 
2.33 down 3.78 down 1.04 down 1.63 down 2.24 up 3.64 up GFRA2 NM_001495 
1.46 up 2.76 up 3.26 up 1.89 up 2.24 up 1.18 up GNASAS  
1.06 up 1.41 up 1.47 down 1.32 up 1.56 down 2.07 down GPR172A 
NM_02453
1 
2.33 down 1.77 down 1.50 down 1.32 up 1.55 up 1.18 up GTF2H2D 
NM_00104
2490 
2.15 up 2.71 up 3.40 up 1.26 up 1.58 up 1.26 up HAGHL NM_032304 
1.88 down 1.52 down 2.60 down 1.23 up 1.39 down 1.71 down HCFC1 NM_005334 






2.13 up 1.37 up 1.22 down 1.55 down 2.59 down 1.67 down HGSNAT 
NM_15241
9 
2.42 down 4.03 down 1.20 down 1.67 down 2.02 up 3.37 up HHEX NM_002729 
2.72 up 7.52 up 2.54 up 2.77 up 1.07 down 2.96 down HK2 NM_000189 
1.49 down 2.22 down 2.44 down 1.49 down 1.63 down 1.10 down HMBOX1 
NM_02456
7 
1.00 up 1.37 up 2.05 down 1.37 up 2.05 down 2.80 down HOMER3 
NM_00114
5722 
1.32 up 2.11 up 2.59 up 1.60 up 1.96 up 1.22 up HOPX NM_001145460 
11.11 up 4.65 up 2.53 up 2.39 down 4.38 down 1.83 down HORMAD1 
NM_03213
2 
7.61 up 2.86 up 3.22 up 2.66 down 2.37 down 1.13 up HOXA4 NM_002141 
1.50 up 1.95 up 2.07 up 1.30 up 1.38 up 1.06 up HSPB9 NM_033194 
1.67 up 2.14 up 1.26 up 1.28 up 1.32 down 1.69 down HSPG2 NM_005529 
1.00 down 2.06 down 2.36 down 2.05 down 2.35 down 1.15 down HTATSF1P2 BX648511 
1.03 up 1.22 down 5.02 down 1.26 down 5.17 down 4.11 down IBSP NM_004967 
1.49 up 1.45 up 1.41 down 1.03 down 2.10 down 2.04 down IER5L NM_203434 
1.21 up 2.05 up 1.89 up 1.70 up 1.57 up 1.08 down IGF2-AS NR_028044 
6.37 down 1.53 up 1.53 down 9.76 up 4.16 up 2.35 down IL1R2 NM_004633 
3.62 down 8.28 down 1.91 down 2.29 down 1.89 up 4.32 up IL22RA2 NM_052962 





1.61 up 8.96 up 1.03 down 5.57 up 1.66 down 9.24 down IRF6 NM_006147 
1.41 up 1.61 up 1.35 down 1.14 up 1.90 down 2.17 down IRGQ NM_001007561 
1.78 down 2.39 down 2.35 down 1.34 down 1.32 down 1.01 up ITGB1BP2 
NM_01227
8 
1.94 up 1.29 up 3.22 up 1.51 down 1.66 up 2.51 up JPH4 BC109228 
4.16 down 4.84 down 2.28 down 1.16 down 1.82 up 2.12 up KBTBD8 NM_032505 
2.45 up 4.36 up 2.25 up 1.78 up 1.09 down 1.94 down KDM4B NM_015015 
1.03 up 1.13 up 1.98 down 1.11 up 2.03 down 2.24 down KDM5B NM_006618 
2.06 down 2.62 down 4.01 down 1.27 down 1.94 down 1.53 down KIAA0319L AB058740 
1.55 down 1.75 down 2.29 down 1.13 down 1.48 down 1.31 down KIAA0556 
NM_01520
2 
1.42 up 1.88 up 2.41 down 1.32 up 3.43 down 4.54 down KIAA1549 
NM_00116
4665 
1.48 up 1.48 up 2.15 up 1.00 up 1.45 up 1.45 up KLRG2 NM_198508 
1.67 up 2.43 up 1.20 up 1.45 up 1.39 down 2.03 down KREMEN1 
NM_00103
9570 
1.44 up 1.33 up 1.84 down 1.08 down 2.65 down 2.46 down LARP6 NM_018357 
1.96 down 8.20 down 1.51 down 4.17 down 1.30 up 5.42 up LDLRAD2 
NM_00101
3693 
5.41 up 2.48 up 1.05 down 2.18 down 5.68 down 2.60 down LIF NM_002309 
1.60 up 1.26 up 2.12 down 1.28 down 3.40 down 2.67 down LINC00174 
NR_02687
3 





1.53 up 1.48 up 2.17 up 1.03 down 1.42 up 1.46 up LOC100130741 AK127222 
4.49 up 1.70 down 1.33 up 7.64 down 3.39 down 2.26 up LOC100240735 
NR_02665
8 
1.66 up 2.38 up 3.67 up 1.43 up 2.21 up 1.54 up LOC100289079 
XM_00234
4448 
1.17 up 2.14 down 1.69 down 2.50 down 1.98 down 1.26 up LOC100289097 
XM_00234
3891 
1.10 down 2.29 down 1.43 down 2.08 down 1.30 down 1.60 up LOC100505495 
NR_04010
9 
1.02 down 2.96 down 1.86 down 2.91 down 1.82 down 1.59 up LOC100505495 
NR_04010
9 
4.63 down 78.65 down 49.21 down 16.99 down 10.63 down 1.60 up LOC100505495 
NR_04010
9 
1.13 down 2.48 down 1.50 down 2.19 down 1.32 down 1.65 up LOC100505495 
NR_04010
9 
1.80 up 2.31 up 2.34 up 1.28 up 1.30 up 1.01 up LOC100505657 
XM_00311
8895 
2.75 down 1.75 down 1.55 down 1.57 up 1.77 up 1.13 up LOC100505681 
NR_03845
2 
1.75 down 1.09 down 6.01 down 1.60 up 3.43 down 5.50 down LOC100505912 
NR_03787
7 
1.06 down 1.55 down 2.03 down 1.47 down 1.91 down 1.30 down LOC100506075 
XR_10970
6 
9.33 down 1.05 down 5.63 down 8.87 up 1.66 up 5.35 down LOC100506328 AK055877 
6.89 down 1.11 down 3.25 down 6.23 up 2.12 up 2.94 down LOC100506328 AK055877 
1.12 down 2.71 down 2.19 down 2.43 down 1.96 down 1.24 up LOC100506342 
XR_10886
2 




1.01 down 2.14 down 1.91 down 2.12 down 1.89 down 1.12 up LOC100506516 
XR_10876
3 
1.30 down 2.80 down 2.10 down 2.16 down 1.62 down 1.33 up LOC100506990 
NR_04009
2 
3.16 up 2.48 up 3.18 up 1.27 down 1.01 up 1.28 up LOC100507055 BX379759 
5.58 up 1.20 up 1.06 up 4.64 down 5.25 down 1.13 down LOC100507150 
XR_10853
6 
2.76 down 10.56 down 3.66 down 3.82 down 1.32 down 2.89 up LOC100507307 
XR_10995
2 
1.83 up 1.21 down 1.99 down 2.22 down 3.64 down 1.64 down LOC100507460 
XR_10989
4 
1.61 up 1.77 up 2.36 up 1.10 up 1.47 up 1.33 up LOC100507558 
XR_10878
6 
1.77 down 3.64 down 2.58 down 2.06 down 1.46 down 1.41 up LOC100507602 
XR_11008
1 
1.58 up 2.10 up 1.96 up 1.33 up 1.24 up 1.07 down LOC100509196 
XM_00311
9833 
1.09 up 1.79 up 2.28 up 1.65 up 2.10 up 1.27 up LOC100652730 
XR_13267
0 
1.40 up 2.16 up 1.89 up 1.55 up 1.36 up 1.14 down LOC100652807 
XM_00340
3510 
1.51 down 1.44 up 1.02 up 2.17 up 1.53 up 1.42 down LOC100652895 
XR_13273
9 
1.05 down 4.16 down 1.33 down 3.97 down 1.26 down 3.14 up LOC100652951 
XR_13288
8 
1.69 down 3.37 down 1.29 down 2.00 down 1.31 up 2.62 up LOC145820 
NR_02713
2 
2.05 down 1.02 up 2.24 up 2.08 up 4.59 up 2.20 up LOC219347 
NR_02742
8 
2.81 up 1.87 down 1.29 down 5.25 down 3.63 down 1.45 up LOC283861 AK098143 





1.22 up 2.61 up 2.02 up 2.14 up 1.65 up 1.29 down LOC388796 
NR_01536
6 
1.19 up 1.21 down 1.81 up 1.43 down 1.53 up 2.19 up LOC400499 
XM_00311
8689 
1.59 up 3.74 down 1.68 down 5.94 down 2.67 down 2.22 up LOC441204 
NR_01536
4 
2.71 up 2.07 up 3.27 up 1.31 down 1.21 up 1.58 up LOC497257 BC030211 
1.57 up 3.36 up 3.16 up 2.14 up 2.01 up 1.06 down LOC51145 
XR_10899
7 
1.47 down 1.49 down 2.66 down 1.01 down 1.81 down 1.79 down LOC541471 
NR_01539
5 
1.02 up 1.04 down 1.97 down 1.06 down 2.02 down 1.89 down LOC541471 
NR_01539
5 
1.23 up 2.28 up 1.85 up 1.85 up 1.51 up 1.23 down LOC643529 
NR_03838
2 
1.79 up 2.79 up 1.73 up 1.56 up 1.04 down 1.62 down LOC644242 
NR_03654
0 
1.11 up 2.14 down 1.51 down 2.38 down 1.68 down 1.42 up LOC728903 AK093722 
1.52 up 1.51 down 1.20 down 2.29 down 1.83 down 1.26 up LOC729013 
NR_03413
7 
9.30 up 8.15 up 1.15 up 1.14 down 8.09 down 7.09 down LOC729444 
NR_03838
8 
1.74 up 1.28 down 1.06 down 2.22 down 1.85 down 1.20 up LOC729887 BC052334 
1.19 down 2.02 down 2.31 down 1.69 down 1.93 down 1.14 down LOC90784 
NR_02698
4 
2.17 down 1.38 down 2.15 down 1.57 up 1.01 up 1.56 down LRRC42 
 
1.96 up 3.45 up 3.11 up 1.76 up 1.58 up 1.11 down LRRC72 NM_001195280 





4.75 down 16.54 down 6.08 down 3.49 down 1.28 down 2.72 up LY75 NM_002349 
1.21 down 1.95 down 1.33 up 1.61 down 1.61 up 2.58 up LYSMD2 
NM_15337
4 
4.07 up 2.09 up 2.09 up 1.94 down 1.95 down 1.00 down MAGI2 NM_012301 
1.79 down 4.33 down 3.45 down 2.42 down 1.93 down 1.25 up MAN1B1 CR749534 
1.76 down 2.75 down 1.42 down 1.57 down 1.23 up 1.94 up MAP3K8 NM_005204 
1.79 down 2.25 down 1.34 down 1.26 down 1.34 up 1.68 up MBLAC2 
NM_20340
6 
1.53 up 1.22 down 2.47 down 1.86 down 3.79 down 2.03 down MCOLN3 BC060765 
3.06 down 6.32 down 4.39 down 2.07 down 1.44 down 1.44 up MIAT NR_003491 
1.02 down 1.52 up 2.30 down 1.56 up 2.24 down 3.50 down MN1 NM_002430 
1.57 up 2.07 up 1.76 up 1.32 up 1.12 up 1.18 down MPND NM_032868 
9.82 down #### down 16.92 down 16.15 down 1.72 down 9.37 up MYBPC2 
NM_00453
3 
1.63 down 2.41 down 1.13 down 1.48 down 1.44 up 2.13 up MYCBP2 
NM_01505
7 
1.69 up 3.26 up 6.37 up 1.93 up 3.76 up 1.95 up MZT2A 
 
1.68 down 3.13 down 2.01 down 1.86 down 1.20 down 1.56 up N4BP2L2 
NM_03311
1 
1.40 down 2.07 down 1.13 down 1.48 down 1.24 up 1.83 up N4BP2L2 
NM_01488
7 
1.37 down 2.44 down 1.71 up 1.78 down 2.35 up 4.18 up NCR3 NM_001145467 




1.23 down 2.26 down 4.23 down 1.84 down 3.45 down 1.87 down NEK10 AK057247 
1.52 up 2.32 up 1.80 up 1.52 up 1.18 up 1.29 down NHLRC1 NM_198586 
1.02 up 1.39 down 2.32 down 1.42 down 2.37 down 1.67 down NME7 NM_013330 
1.14 down 1.75 down 1.52 up 1.54 down 1.73 up 2.66 up NOSTRIN 
NM_05294
6 
1.91 down 2.04 down 1.14 up 1.07 down 2.18 up 2.33 up NPHS1 NM_004646 
1.04 up 2.41 up 1.86 up 2.31 up 1.78 up 1.29 down NQO2 NM_000904 
1.02 up 1.05 down 2.41 down 1.08 down 2.46 down 2.29 down NRP2 NM_201264 
1.02 down 1.39 up 1.95 down 1.42 up 1.92 down 2.72 down NRP2 NM_201266 
1.28 down 1.20 up 2.26 down 1.54 up 1.76 down 2.72 down NT5DC3 NM_001031701 
1.28 up 2.06 up 1.36 up 1.61 up 1.07 up 1.51 down OBP2B NM_014581 
1.22 up 2.62 down 1.54 down 3.19 down 1.87 down 1.71 up OGT NM_181672 
1.74 up 2.16 up 2.77 up 1.24 up 1.59 up 1.28 up OR10G8 NM_001004464 
1.85 up 2.07 up 2.83 up 1.12 up 1.53 up 1.36 up OR1K1 NM_080859 
4.17 down 3.47 down 4.32 down 1.20 up 1.04 down 1.25 down PAFAH1B2 
NM_00118
4746 
1.85 up 1.67 up 1.38 down 1.10 down 2.54 down 2.31 down PALLD NM_001166109 
1.42 up 1.91 up 1.18 down 1.34 up 1.68 down 2.25 down PAWR NM_002583 






2.27 down 3.64 down 5.05 down 1.60 down 2.23 down 1.39 down PER3 NM_016831 
1.77 up 1.28 down 1.48 up 2.27 down 1.19 down 1.90 up PGM5 NM_021965 
1.76 down 1.14 up 1.29 down 2.00 up 1.36 up 1.48 down PHF23 NM_024297 
4.43 up 12.36 down 9.65 down 54.75 down 42.74 down 1.28 up PIGR NM_002644 
1.36 up 1.43 up 2.17 up 1.05 up 1.60 up 1.52 up PKD1 NM_000296 
1.67 down 3.14 down 2.07 down 1.88 down 1.24 down 1.52 up PKIG NM_181805 
1.01 up 1.18 up 2.01 down 1.17 up 2.03 down 2.38 down PLEC NM_201380 
1.05 down 1.32 up 1.87 down 1.38 up 1.78 down 2.46 down PLEKHG3 
NM_01554
9 
1.66 down 6.66 down 3.02 down 4.02 down 1.82 down 2.21 up PLGLB1 NM_001032392 
1.76 up 1.18 down 1.35 up 2.08 down 1.30 down 1.60 up PLSCR4 NM_020353 
2.26 down 1.73 down 2.66 down 1.30 up 1.18 down 1.54 down PNMA1 NM_006029 
1.14 up 4.38 up 2.03 up 3.83 up 1.78 up 2.16 down POLR1A NM_015425 
1.60 down 1.94 down 2.58 down 1.21 down 1.61 down 1.33 down POU5F1 NM_002701 
2.40 down 1.75 down 1.81 down 1.37 up 1.33 up 1.03 down PRDX3 NM_006793 
1.86 up 1.60 up 2.75 up 1.16 down 1.48 up 1.72 up psiTPTE22 AK226145 
1.41 down 5.82 up 3.74 up 8.18 up 5.26 up 1.55 down PSPH NM_004577 





1.39 up 1.76 down 2.19 up 2.45 down 1.57 up 3.86 up PTPRN2 NM_002847 
4.66 down 13.29 down 2.53 down 2.85 down 1.84 up 5.26 up PYGM NM_005609 
1.19 down 3.00 down 1.10 up 2.53 down 1.30 up 3.29 up Q6TXI9 
 
2.07 down 1.69 down 1.57 down 1.22 up 1.31 up 1.07 up QRSL1 NM_018292 
2.40 up 1.12 up 1.42 up 2.15 down 1.69 down 1.28 up RADIL NM_018059 
1.38 up 2.39 up 2.72 up 1.73 up 1.97 up 1.14 up RASGEF1C 
NM_17506
2 
2.03 down 4.05 down 1.04 down 1.99 down 1.95 up 3.88 up RASGRP2 
NM_15381
9 
2.33 down 4.12 down 1.10 down 1.77 down 2.12 up 3.75 up RASGRP2 
NM_15381
9 
2.41 down 2.13 down 1.69 down 1.13 up 1.42 up 1.26 up RB1 NM_000321 
1.27 down 2.11 down 1.50 down 1.66 down 1.18 down 1.41 up RBM5 NM_005778 
1.38 up 2.08 down 1.87 down 2.86 down 2.58 down 1.11 up RBPMS AK057533 
1.72 up 2.01 up 1.20 up 1.17 up 1.44 down 1.68 down RFX8 NM_001145664 
1.55 down 1.71 up 1.67 down 2.66 up 1.07 down 2.86 down RGNEF NM_001177693 
2.13 down 2.04 up 1.90 down 4.34 up 1.12 up 3.87 down RGNEF NM_001177693 
3.18 down 4.02 down 1.65 down 1.26 down 1.93 up 2.44 up RGS18 NM_130782 
2.31 down 4.37 down 2.01 down 1.89 down 1.15 up 2.17 up RGS3 NM_017790 




3.08 down 5.59 down 1.68 down 1.81 down 1.84 up 3.34 up RNF125 NM_017831 
2.46 down 1.84 down 1.88 down 1.34 up 1.31 up 1.02 down RNF6 NM_005977 
2.44 down 4.38 down 1.95 down 1.80 down 1.25 up 2.24 up RPGR NM_001034853 
1.37 up 1.32 up 2.52 up 1.04 down 1.84 up 1.91 up RPS26 NM_001029 
1.13 up 2.64 up 1.39 down 2.33 up 1.58 down 3.68 down RTKN NM_033046 
1.60 up 1.68 up 2.39 up 1.05 up 1.50 up 1.42 up S100A5 NM_002962 
1.63 down 2.19 down 1.43 down 1.34 down 1.14 up 1.54 up SACM1L 
NM_01401
6 
1.31 up 2.79 up 1.98 up 2.13 up 1.51 up 1.41 down SACS-AS1 
XR_11010
6 
1.01 down 1.65 up 1.27 down 1.66 up 1.27 down 2.10 down SAMD1 NM_138352 
4.44 down 4.49 down 2.53 down 1.01 down 1.75 up 1.77 up SAMSN1 
NM_02213
6 
1.26 down 2.99 down 1.16 up 2.37 down 1.46 up 3.46 up SCARNA16 
NR_00301
3 
1.28 down 2.92 down 1.11 up 2.28 down 1.42 up 3.24 up SCARNA16 
NR_00301
3 
2.12 down 1.04 down 2.96 down 2.03 up 1.40 down 2.85 down SDC4 NM_002999 
1.70 down 2.07 down 2.78 down 1.22 down 1.64 down 1.35 down SEC62 NM_003262 
3.15 down 4.40 down 1.45 down 1.40 down 2.16 up 3.03 up SERPINB9 
NM_00415
5 
2.14 up 1.69 up 2.17 up 1.27 down 1.02 up 1.29 up SETMAR 
NM_00651
5 





1.70 up 2.45 up 2.40 up 1.45 up 1.42 up 1.02 down SHOX NM_006883 
1.07 up 4.74 down 2.35 down 5.08 down 2.52 down 2.01 up SIGLECP3 
NR_00280
4 
2.91 up 1.13 up 1.37 down 2.57 down 3.99 down 1.55 down SIX5 NM_175875 
1.49 up 2.03 up 1.36 up 1.36 up 1.10 down 1.49 down SLC25A1 
NM_00598
4 
1.47 down 3.60 down 2.75 down 2.45 down 1.88 down 1.31 up SLC25A27 
NM_00427
7 
8.44 down 2.27 down 1.56 down 3.72 up 5.41 up 1.45 up SLC27A2 
NM_00364
5 
1.33 down 2.16 down 2.16 down 1.63 down 1.62 down 1.00 up SLC35E2 
NM_18283
8 
1.40 up 1.83 up 2.01 up 1.30 up 1.43 up 1.10 up SLC9A5 NM_004594 
1.62 up 1.24 up 2.62 down 1.31 down 4.24 down 3.24 down SLITRK6 
NM_03222
9 
1.34 up 2.09 up 4.52 down 1.56 up 6.07 down 9.46 down SLITRK6 
NM_03222
9 
1.15 down 1.20 down 2.33 down 1.04 down 2.03 down 1.95 down SLMO1 NM_006553 
1.44 up 2.26 down 1.71 down 3.26 down 2.46 down 1.32 up SMA4 NR_029426 
1.11 up 1.04 up 2.24 up 1.07 down 2.01 up 2.15 up SNORD105 
NR_00438
1 
1.17 down 1.15 down 2.79 up 1.02 up 3.27 up 3.20 up SNORD34 
NR_00001
9 
1.05 up 1.08 down 2.20 up 1.14 down 2.10 up 2.39 up SNORD59B 
NR_00304
6 






2.78 down 8.14 down 1.04 up 2.93 down 2.90 up 8.49 up SNX22 NM_024798 
2.74 down 4.92 down 5.06 down 1.80 down 1.85 down 1.03 down SNX29 BC029857 
2.78 down 6.38 down 2.41 down 2.30 down 1.15 up 2.65 up SORCS1 NM_052918 
1.71 up 2.10 up 1.36 down 1.23 up 2.33 down 2.85 down SOX4 NM_003107 
10.39 up 12.14 up 4.16 up 1.17 up 2.50 down 2.92 down SP9 
 
1.41 down 1.62 up 1.96 down 2.29 up 1.39 down 3.18 down SPAG1 NM_003114 
1.24 up 1.38 up 2.56 up 1.12 up 2.07 up 1.85 up SPEG 
 
1.18 down 1.52 up 2.68 up 1.80 up 3.17 up 1.77 up SPINK7 NM_032566 
1.70 up 1.84 up 2.27 up 1.08 up 1.34 up 1.24 up SPTSSB BC130565 
1.28 up 1.48 up 1.45 down 1.16 up 1.85 down 2.14 down SRGAP1 NM_020762 
1.06 down 1.39 up 1.87 down 1.47 up 1.77 down 2.59 down STX1A NM_004603 
1.47 up 1.70 up 2.18 up 1.15 up 1.48 up 1.28 up SYNJ2 AK296242 
2.07 down 1.28 down 1.27 down 1.62 up 1.63 up 1.01 up TAF9 NM_001015891 
1.60 up 2.35 up 2.47 up 1.47 up 1.54 up 1.05 up TAT NM_000353 
3.10 down 2.55 down 2.66 down 1.22 up 1.17 up 1.04 down TBC1D22A AK125705 
3.33 up 2.52 up 1.25 up 1.32 down 2.65 down 2.01 down TCF7L2 NM_030756 
1.32 down 1.10 up 2.55 down 1.46 up 1.93 down 2.81 down TCTN2 NM_024809 
1.51 up 2.11 up 2.28 up 1.40 up 1.52 up 1.08 up TDRD1 NM_198795 




1.77 down 4.67 down 2.10 down 2.65 down 1.19 down 2.23 up TFPI NM_006287 
1.69 down 4.39 down 2.54 down 2.60 down 1.51 down 1.73 up TFPI AB209866 
1.06 down 2.06 up 1.29 up 2.18 up 1.36 up 1.60 down TIMM44 NM_006351 
1.56 up 1.49 up 2.03 up 1.05 down 1.31 up 1.37 up TJP2 AF083893 
3.59 down 22.98 down 1.80 down 6.41 down 1.99 up 12.76 up TLR10 NM_030956 
1.06 down 1.18 up 4.02 down 1.25 up 3.79 down 4.75 down TMEM190 
NM_13917
2 
1.35 down 2.48 down 2.18 down 1.84 down 1.62 down 1.14 up TMEM192 
NM_00110
0389 
1.52 up 2.00 up 2.38 up 1.31 up 1.57 up 1.19 up TMEM50B BG220668 
1.04 up 1.40 down 1.94 up 1.46 down 1.86 up 2.72 up TMIGD2 NM_144615 
2.76 up 1.68 up 3.18 up 1.64 down 1.15 up 1.89 up TNXB NM_019105 
1.34 up 1.90 down 2.88 down 2.54 down 3.85 down 1.52 down TOB2P1 NR_002936 
1.44 up 1.55 down 1.21 down 2.24 down 1.74 down 1.28 up TPCN1 NM_001143819 
1.98 down 2.75 down 1.24 down 1.39 down 1.60 up 2.22 up TPK1 NM_022445 
5.12 down 4.72 down 1.99 down 1.08 up 2.58 up 2.37 up TREML2 NM_024807 
1.13 down 3.73 down 2.71 down 3.31 down 2.41 down 1.37 up TSGA10 NM_025244 
1.85 down 2.54 down 1.91 down 1.37 down 1.03 down 1.33 up USP47 NM_017944 
1.72 up 3.85 up 1.97 down 2.24 up 3.38 down 7.59 down VGF NM_003378 





2.92 down 4.73 down 2.64 down 1.62 down 1.11 up 1.79 up VPRBP NM_014703 
1.30 down 2.29 down 2.14 down 1.75 down 1.64 down 1.07 up WDR19 NM_025132 
1.41 up 1.82 up 2.04 up 1.29 up 1.44 up 1.12 up WIBG NM_032345 
2.13 up 1.21 down 1.29 down 2.58 down 2.75 down 1.06 down XIAP NM_001167 
1.08 up 1.41 down 2.45 down 1.52 down 2.64 down 1.73 down XLOC_000647 CR617576 
2.05 down 2.44 down 1.02 down 1.19 down 2.01 up 2.38 up XLOC_001266  
1.49 up 2.35 up 1.59 up 1.58 up 1.07 up 1.48 down XLOC_001364  
1.68 up 2.73 up 2.62 up 1.62 up 1.56 up 1.04 down XLOC_001856  
1.39 up 1.42 up 2.10 up 1.02 up 1.50 up 1.48 up XLOC_002249  
1.83 up 2.03 up 4.01 up 1.11 up 2.19 up 1.98 up XLOC_002323  
2.88 up 4.30 up 3.50 up 1.49 up 1.22 up 1.23 down XLOC_002968  
1.53 up 2.65 up 2.10 up 1.73 up 1.37 up 1.26 down XLOC_003354  
1.22 up 2.07 up 2.57 up 1.69 up 2.11 up 1.25 up XLOC_003546 AL833514 
1.52 up 1.92 up 2.47 up 1.26 up 1.63 up 1.29 up XLOC_003825  
1.92 up 1.87 down 2.19 down 3.60 down 4.21 down 1.17 down XLOC_004229  




4.64 down 3.72 down 2.22 down 1.25 up 2.09 up 1.67 up XLOC_004456  
1.39 up 1.47 up 2.05 up 1.06 up 1.48 up 1.39 up XLOC_004576  
1.46 up 2.45 up 2.48 up 1.67 up 1.70 up 1.01 up XLOC_005056  
2.37 up 1.04 down 1.45 down 2.46 down 3.43 down 1.40 down XLOC_005361  
2.31 down 1.12 down 2.27 down 2.06 up 1.02 up 2.02 down XLOC_005514  
1.37 up 1.63 up 2.40 up 1.19 up 1.75 up 1.48 up XLOC_005737 BC035191 
2.04 up 1.60 up 3.09 up 1.28 down 1.51 up 1.94 up XLOC_005859  
1.27 up 2.38 down 2.35 down 3.02 down 2.98 down 1.01 up XLOC_006721  
2.11 up 2.50 down 1.50 down 5.29 down 3.17 down 1.67 up XLOC_007467  
1.48 up 1.88 up 2.05 up 1.27 up 1.39 up 1.09 up XLOC_007600  
1.43 down 1.04 up 1.51 up 1.49 up 2.16 up 1.45 up XLOC_007607  
1.50 up 2.77 up 2.29 up 1.84 up 1.52 up 1.21 down XLOC_007867  
1.44 up 3.41 up 2.10 up 2.36 up 1.46 up 1.62 down XLOC_007972  
1.36 up 2.13 up 1.53 up 1.56 up 1.12 up 1.39 down XLOC_008061  
1.23 up 2.32 up 1.48 up 1.89 up 1.20 up 1.57 down XLOC_008311  
4.49 up 8.77 up 7.65 up 1.95 up 1.70 up 1.15 down XLOC_008554  






1.30 up 2.37 up 1.46 up 1.82 up 1.12 up 1.63 down XLOC_010255  
1.55 up 2.69 up 1.74 up 1.73 up 1.12 up 1.55 down XLOC_011014  
3.21 down 3.93 down 6.80 down 1.22 down 2.12 down 1.73 down XLOC_011047 BX648502 
1.93 up 1.62 up 2.95 up 1.19 down 1.53 up 1.82 up XLOC_011107  
1.58 up 2.05 up 2.47 up 1.30 up 1.57 up 1.20 up XLOC_012304  
1.55 up 2.01 up 1.99 up 1.29 up 1.28 up 1.01 down XLOC_013562  
1.35 down 2.23 up 2.64 up 3.01 up 3.56 up 1.18 up XLOC_013737 AK090932 
1.34 up 2.17 up 2.93 up 1.62 up 2.18 up 1.35 up XLOC_014172  
1.27 up 1.85 up 2.01 up 1.46 up 1.58 up 1.09 up XLOC_014364 AI525606 
5.60 up 1.41 up 2.28 up 3.97 down 2.46 down 1.61 up XLOC_014508 
XR_11094
0 


























































































1.57 down 1.53 up 1.17 down 2.39 up 1.34 up 1.79 down YWHAE NM_006761 
1.49 up 1.14 up 1.50 down 1.31 down 2.24 down 1.71 down ZBED1 NM_001171135 
4.44 down 1.22 down 1.95 down 3.64 up 2.27 up 1.60 down ZBED2 NM_024508 
1.45 down 1.15 up 1.96 down 1.67 up 1.36 down 2.26 down ZBED4 NM_014838 
1.13 up 3.06 up 1.61 up 2.71 up 1.42 up 1.90 down ZDHHC20 
NM_15325
1 
1.66 down 1.09 up 2.60 down 1.80 up 1.56 down 2.82 down ZNF284 NM_001037813 
1.80 down 1.23 up 1.52 down 2.21 up 1.18 up 1.87 down ZNF286A 
NM_02065
2 
1.01 down 1.81 down 2.15 down 1.79 down 2.12 down 1.19 down ZNF514 NM_032788 
1.12 up 2.06 up 1.27 up 1.85 up 1.13 up 1.63 down ZNF562 NM_001130031 
2.00 down 1.77 down 3.26 down 1.13 up 1.62 down 1.84 down ZNF778 NM_001201407 





1.77 down 1.64 up 1.30 down 2.91 up 1.37 up 2.13 down 
 
CU691765 
1.89 up 6.63 up 2.14 up 3.51 up 1.13 up 3.10 down 
 
DR007930 
1.63 up 1.83 up 2.65 up 1.12 up 1.62 up 1.45 up 
 
DA734158 
2.93 up 2.77 down 1.06 up 8.11 down 2.76 down 2.94 up 
 
BC025320 
1.06 down 1.69 up 1.94 up 1.78 up 2.04 up 1.15 up 
 
BC071639 




2.14 up 1.38 down 1.08 up 2.94 down 1.98 down 1.49 up 
 
BC044655 
1.34 down 6.93 down 2.18 down 5.17 down 1.63 down 3.17 up 
 
X58740 
1.51 down 1.04 up 1.37 up 1.58 up 2.07 up 1.31 up 
 
AF239727 
1.38 down 3.73 down 1.02 up 2.70 down 1.41 up 3.81 up 
 
CR625008 




2.17 up 1.10 down 1.41 down 2.39 down 3.06 down 1.28 down 
 
AK130638 




1.87 down 5.63 down 1.06 up 3.01 down 1.97 up 5.94 up 
 
AK128421 
1.62 up 2.29 up 2.79 up 1.42 up 1.72 up 1.22 up 
 
BC131768 









APPENDIX D-DEG AA HPV-INACTIVE VS HPV-NEGATIVE 
Table D.1: AA – HPV-Inactive vs HPV-Negative Tumors - MW 0.02 FC 2 
FC (abs) Direction of change Gene symbol Genbank accession 
2.01 up ABCC6 NM_001079528 
2.44 down ABHD13 NM_032859 
4.96 down ABLIM2 NM_032432 
3.98 down ABLIM2 NM_001130083 
2.96 down ABLIM2 NM_001130088 
2.51 down AGER NM_001206966 
2.63 up ALDH1L2 NM_001034173 
3.46 down ALS2 NM_020919 
2.87 down ANKRD33B NM_001164440 
2.22 up ARHGAP44 NM_014859 
2.12 down ATP2B4 NM_001684 
2.02 down ATP2B4 NM_001001396 
9.97 up ATP8B3 NM_138813 
4.20 up BCHE NM_000055 
4.10 down BCL2A1 NM_004049 
2.15 down BCL2A1 NM_004049 
2.22 down BLCAP NM_006698 
2.01 down BNIP2 AK125533 
2.17 up BRD3 NM_007371 
4.33 up C11orf53 NM_198498 
2.84 up C15orf59 NM_001039614 
2.33 up C17orf82 NM_203425 
2.39 down C20orf106 NM_001012971 
5.73 down C20orf26 NM_015585 
2.00 up C2orf70 NM_001105519 
2.31 down C5orf44 NR_003545 
2.48 down C9orf123 NM_033428 
2.16 down CATSPER2 NM_172095 
2.71 down CDC42 NM_044472 
2.01 down CEP76 NM_024899 
2.27 down CGRRF1 NM_006568 
4.90 down CLEC4A NM_016184 
2.45 up COPZ2 NM_016429 
2.32 up CRIP1 AB527908 
2.02 down CRTAP NM_006371 
2.09 down CTRL NM_001907 
4.35 up CXCL12 NM_001033886 
 301 
2.07 down DCAF13 NM_015420 
5.22 down EMR3 NM_032571 
2.02 up EN2 NM_001427 
2.10 up ERBB3 NM_001982 
2.54 up ERBB3 NM_001005915 
2.03 down ERCC8 NM_000082 
3.00 up ERVMER34-1 NM_024534 
2.80 up ERVMER34-1 NM_024534 
3.47 down FADS3 NM_021727 
2.19 up FAM127C NM_001078173 
6.47 down FAM65B NM_015864 
2.57 down FAR1 NM_032228 
2.65 down FLJ35024 NR_015375 
4.27 down FLJ43663 NR_015431 
3.29 down FLVCR2 NM_017791 
8.21 down FPR2 NM_001462 
2.07 down GEMIN2 NM_003616 
2.04 down GFM2 NM_170681 
3.73 down GJA3 NM_021954 
3.19 up GPR143 NM_000273 
2.38 down GTF2H2D NM_001042490 
2.18 up GYLTL1B NM_152312 
3.42 up HEY1 NM_001040708 
11.02 up HORMAD1 NM_032132 
9.83 up HORMAD1 NM_032132 
7.71 up HOXA4 NM_002141 
2.18 up HOXA5 NM_019102 
2.32 up HOXA6 NM_024014 
3.84 up HOXA6 NM_024014 
4.88 up HOXC6 NM_153693 
2.06 down HSPA8 NM_153201 
6.03 down IL6 NM_000600 
3.02 down IL6ST NM_002184 
2.03 down INTS4 NM_033547 
4.21 down KBTBD8 NM_032505 
2.32 down KCNE1L NM_012282 
2.21 down KIAA0040 NM_001162893 
2.07 down KIAA0319L AB058740 
2.39 down KLHL12 NM_021633 
2.93 down KMO NM_003679 
2.69 up KRTAP1-3 NM_030966 
2.43 up KRTAP2-4 NM_033184 
2.56 up LEPREL2 NM_014262 
3.42 up LEPREL4 NM_006455 
3.05 down LIMS3L NM_001205288 
2.26 up LINC00087 NR_024493 
2.09 up LINC00087 NR_024493 
2.01 up LOC100130547 XR_113275 
 302 
2.78 down LOC100505681 NR_038452 
8.99 down LOC100506328 AK055877 
7.08 down LOC100506328 AK055877 
6.29 down LOC100506328 AK055877 
2.71 up LOC100506433 NR_039996 
5.88 up LOC100506783 NR_038435 
2.93 down LOC100506860 XR_108813 
2.40 down LOC100652952 XR_132749 
2.95 down LOC100653245 XM_003403831 
2.83 up LOC283861 AK098143 
2.20 up LOC285577 NR_033898 
3.92 down LOC339290 NR_015389 
2.17 up LOC400238 NR_033986 
4.24 down LOC440900 NR_034128 
2.73 up LOC497257 BC030211 
2.98 down LOC646329 NR_034120 
2.37 down LYRM7 NM_181705 
4.10 up MAGI2 NM_012301 
2.38 up MAST1 NM_014975 
14.00 up MATN3 NM_002381 
3.21 up MDK NM_001012334 
2.71 up MECOM NM_005241 
2.75 up MECOM NM_001164000 
3.67 up MECOM NM_004991 
2.19 down MED23 NM_015979 
2.02 down MIPEP NM_005932 
2.20 up MIR100HG NR_024430 
2.64 down MNS1 NM_018365 
2.46 down MTHFD2L NM_001144978 
2.15 down NEK4 NM_003157 
3.52 up OSR2 NM_053001 
6.90 down OTOP3 NM_178233 
2.90 up OXT NM_000915 
2.93 down P2RX5 NM_175080 
2.67 down PAG1 NM_018440 
3.08 down PITPNC1 NM_181671 
2.32 up PLD1 NM_002662 
2.28 down PNMA1 NM_006029 
2.45 down PRDX3 NM_006793 
2.01 down PTGR2 NM_152444 
5.20 up PTH2R NM_005048 
2.08 down QRSL1 NM_018292 
2.64 down RAD17 NM_002873 
2.41 up RADIL NM_018059 
2.06 down RASGRP2 NM_153819 
2.36 down RASGRP2 NM_153819 
2.47 down RB1 NM_000321 
2.43 down RBBP4 NM_005610 
 303 
2.19 down REM2 NM_173527 
2.37 up RHPN2 NM_033103 
3.11 down RNF125 NM_017831 
2.47 down RNF6 NM_005977 
2.31 down RPA1 NM_002945 
2.51 down RRP15 NM_016052 
4.53 down SAMSN1 NM_022136 
2.16 down SDC4 NM_002999 
2.09 down SEC61A2 NM_018144 
4.74 down SHC3 NM_016848 
3.22 up SHOX2 NM_003030 
2.05 up SIGLEC15 NM_213602 
2.12 down SLA2 NM_032214 
2.54 up SLC26A10 NM_133489 
8.14 down SLC27A2 NM_003645 
9.18 up SP9   
2.33 up SPHK1 NM_182965 
2.18 up SRPX2 NM_014467 
3.52 up SSC5D NM_001144950 
5.55 up SYN2 NM_003178 
2.11 down TAF9 NM_001015891 
3.36 up TCF7L2 NM_030756 
4.11 up TET1 NM_030625 
2.22 up TMEM145 NM_173633 
2.90 up TMEM63C NM_020431 
2.77 up TNXB NM_019105 
2.86 down TPM3 NM_001043352 
4.79 down TREML2 NM_024807 
3.00 down TRIB2 NM_021643 
2.08 down TRIM23 NM_001656 
4.55 down UNC5CL NM_173561 
2.95 down VPRBP NM_014703 
2.17 up VWA5B1 AK057346 
2.61 up WWOX NM_130844 
5.44 down XLOC_001595   
2.90 up XLOC_002968   
4.34 down XLOC_004456   
2.54 up XLOC_010570 BX091314 
2.81 up XLOC_012170 XR_109456 
3.05 up XLOC_014246   
2.14 down XLOC_014388 XR_109724 
5.04 up XLOC_014508 XR_110940 
2.65 up XLOC_l2_005871   
2.37 up XLOC_l2_011901 DA338254 
2.25 up XLOC_l2_015034   
2.06 down XPO4 NM_022459 
3.09 down XPO6 NM_015171 
4.60 down ZBED2 NM_024508 
 304 
2.67 up ZNF423 NM_015069 
2.53 up ZNF771 NM_016643 
2.02 down ZNF778 NM_001201407 
4.76 up   XM_002342405 
2.17 up   AK130638 



















APPENDIX E - DEG EA HPV-INACTIVE VS HPV-NEGATIVE 
Table E.1: EA – HPV-Inactive vs HPV-Negative Tumors - MW p0.02 FC 2 
FC (abs) Regulation GeneSymbol GenbankAccession 
2.91 up ACSL5 NM_203380 
2.32 up ADCY4 NM_139247 
7.21 up ADIPOQ NM_004797 
2.46 down AGPAT4 NM_020133 
3.84 up AIRE NM_000658 
4.73 up AMICA1 NM_153206 
2.67 up ANKDD1A NM_182703 
2.60 down ANKRD13B NM_152345 
5.54 up AOX1 NM_001159 
5.24 up AOX1 NM_001159 
5.50 down AP1M2 NM_005498 
2.08 down AP1S1 NM_001283 
3.06 up APBB1IP NM_019043 
3.96 up APBB1IP NM_019043 
3.39 down APLN NM_017413 
2.74 up APOL3 NM_145641 
2.05 up AQP1 NM_198098 
3.64 up ARHGAP15 NM_018460 
2.47 down ARHGAP39 NM_025251 
2.29 down ARHGAP5 NM_001030055 
2.04 down ARHGAP5 NM_001030055 
 306 
3.02 up ARHGAP9 NM_032496 
3.16 down ARTN NM_057090 
2.74 down ARVCF NM_001670 
6.48 up ASPA NM_000049 
2.00 down ATN1 NM_001007026 
2.82 up ATOH8 NM_032827 
2.35 up ATP2A3 NM_174958 
2.39 down ATP2B4 NM_001001396 
2.00 down B4GALT2 NM_003780 
5.80 down BAIAP2L1 NM_018842 
8.79 up BANK1 NM_017935 
2.09 up BDH2 NM_020139 
5.15 up BMX NM_001721 
2.08 down BOP1 NM_015201 
2.05 down BTBD7 NM_001002860 
5.60 up C10orf105 NM_001164375 
2.73 up C10orf128 NM_001010863 
2.17 up C11orf21 NM_001142946 
3.62 down C11orf41 NM_012194 
3.60 down C12orf70 NM_001145010 
2.80 down C14orf128 NR_027263 
3.00 down C14orf128 NR_027263 
2.90 up C14orf182 AK090420 
4.53 up C16orf54 NM_175900 
2.59 up C17orf67 NM_001085430 
2.04 down C18orf45 NM_032933 
3.39 down C1orf74 NM_152485 
 307 
2.49 up C20orf160 NM_080625 
3.15 down C4orf47 NM_001114357 
5.14 up C5orf20 NM_130848 
2.28 down C6orf228 NM_001135575 
7.13 up C7 NM_000587 
3.11 up C8orf68 BC038783 
2.53 down C9orf30-TMEFF1 NM_001198812 
15.19 down CA9 NM_001216 
4.30 down CAPSL NM_144647 
2.87 up CARD8 NM_014959 
2.29 up CARD9 NM_052813 
4.39 up CBFA2T3 NM_005187 
2.56 up CBX7 NM_175709 
3.25 down CCDC147 NM_001008723 
2.22 down CCDC19 NM_012337 
2.30 down CCDC40 NM_001243342 
3.21 up CCDC69 NM_015621 
10.90 up CCL14 NM_032963 
3.93 up CCR2 NM_001123041 
2.41 up CD163L1 NM_174941 
4.08 up CD1B NM_001764 
5.63 up CD1C NM_001765 
8.48 up CD1E NM_001042583 
7.11 up CD36 NM_001001547 
3.13 up CD3D NM_000732 
2.58 up CD74 NM_001025158 
7.76 up CD79B NM_001039933 
 308 
2.11 down CDC42BPA NM_003607 
2.67 up CDC42SE2 NM_020240 
2.88 up CEACAM21 NM_001098506 
2.39 up CELF2 NM_001025077 
3.38 up CFI NM_000204 
5.50 up CFP NM_002621 
11.39 up CHI3L2 NM_001025199 
2.51 up CHST8 NM_022467 
5.29 up CIDEA NM_001279 
2.27 down CKAP4 NM_006825 
3.95 up CLCN4 NM_001830 
7.14 up CLEC10A NM_182906 
7.07 up CLEC3B NM_003278 
2.28 up CLEC4A NM_016184 
9.37 up CLEC4G NM_198492 
20.33 up CLEC4G NM_198492 
5.87 up CLECL1 NM_172004 
2.72 up CLIC2 NM_001289 
2.39 down CLIC4 NM_013943 
2.15 down CLOCK NM_004898 
3.35 up CNR2 NM_001841 
3.29 down COL27A1 BC007696 
6.85 up COL4A4 NM_000092 
2.06 up COTL1 NM_021149 
5.59 up CR1L NM_175710 
6.35 up CTSG NM_001911 
3.62 up CX3CR1 NM_001337 
 309 
7.54 up CXCR5 NM_032966 
2.36 up CYBASC3 NM_153611 
2.00 up CYLD NM_015247 
2.75 up CYSLTR1 NM_006639 
6.06 up DARC NM_002036 
3.10 up DENND1C NM_024898 
11.62 down DNAH17   
7.12 up DNASE1L3 NM_004944 
3.18 up DNM1P46 NR_003260 
2.13 up DNMT3A NM_175630 
2.67 down DNMT3B NM_175850 
2.29 up DOK2 NM_003974 
2.90 up DPP4 NM_001935 
2.56 up EGR1 NM_001964 
2.13 down EIF2C2 NM_012154 
3.05 up ELANE NM_001972 
3.61 down EN1 NM_001426 
3.55 down ENKUR NM_145010 
3.64 up ENPP3 NM_005021 
2.52 down ENTPD7 NM_020354 
2.67 down EPB41L5 NM_001184938 
3.00 up EPHX2 NM_001979 
2.26 down ERC1 NM_178040 
6.07 down ESM1 NM_007036 
6.67 down ETV4 NM_001079675 
3.44 up EVI2B NM_006495 
2.36 down EXD2 NM_018199 
 310 
2.32 down EXT1 NM_000127 
2.22 up FAIM2 NM_012306 
3.30 up FAIM3 NM_005449 
3.47 up FAM107A NM_007177 
2.42 down FAM114A1 NM_138389 
3.42 up FAM65B NM_015864 
2.42 down FAM91A1 NM_144963 
2.39 down FAM92A3 NR_003612 
2.67 down FBN2 NM_001999 
4.61 up FCER1A NM_002001 
3.23 up FCGR2B NM_004001 
3.93 up FCN1 NM_002003 
3.35 up FCN1 NM_002003 
8.57 up FCRL3 AK301257 
6.33 up FCRLA NM_032738 
2.36 up FGD2 NM_173558 
3.22 up FGD3 NM_033086 
3.73 up FGL2 NM_006682 
2.64 up FLI1 NM_002017 
2.25 up FLJ33630 NR_015360 
4.51 down FOXD1 NM_004472 
2.16 up FRMD3 NM_174938 
2.25 up FSCN3 NM_020369 
2.20 down FSD1L NM_031919 
3.94 up GAPT NM_152687 
2.51 up GCA NM_012198 
2.75 up GCFC1-AS1 NR_038879 
 311 
10.56 up GDF10 NM_004962 
3.58 up GFRA2 NM_001495 
4.14 up GGTA1P NR_003191 
4.89 up GHRL NM_016362 
3.67 up GIMAP2 NM_015660 
2.61 up GJA4 NM_002060 
2.53 up GLRX NM_002064 
2.57 down GLT25D1 NM_024656 
3.22 up GMFG NM_004877 
3.16 up GNA14 NM_004297 
3.34 down GNG4 NM_001098722 
2.21 up GPR132 NM_013345 
2.12 down GPR135 NM_022571 
2.94 down GPR161 NM_153832 
2.01 down GPR172A NM_024531 
2.27 up GPR34 NM_001097579 
3.08 down GPRIN1 NM_052899 
4.88 down GRHL2 NM_024915 
6.99 down GRIN2D NM_000836 
2.53 up GYPC NM_002101 
2.07 down H2AFY2 NM_018649 
2.54 up H3F3B NM_005324 
3.00 up HDC NM_002112 
2.06 up HERC2 NM_004667 
3.34 up HHEX NM_002729 
3.12 down HILS1 NR_024193 
2.79 up HLA-DMA NM_006120 
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2.63 up HLA-DMA NM_006120 
3.31 up HLA-DOA NM_002119 
3.37 up HLA-DPB1 NM_002121 
2.78 up HLA-DPB1 NM_002121 
2.87 up HLA-DPB1 NM_002121 
3.37 up HLA-DPB2 NR_001435 
3.30 up HLA-DRB4 NM_021983 
2.66 up HLA-DRB5 NM_002125 
2.12 up HMGCLL1 NM_019036 
3.11 up HMHA1 NM_012292 
2.84 down HOMER3 NM_004838 
2.70 down HOMER3 NM_001145722 
2.71 up ICAM3 NM_002162 
2.45 up ID2 NM_002166 
2.64 down IFT81 NM_031473 
3.41 up IGFN1 NM_001164586 
3.84 up IL16 NM_004513 
2.42 up IL2RB NM_000878 
3.30 up INMT NM_001199219 
3.50 up INPP5D NM_001017915 
2.44 down IQCD NM_138451 
9.13 down IRF6 NM_006147 
2.15 down IRGQ NM_001007561 
2.56 up ITIH1 NM_002215 
4.39 up ITM2A NM_004867 
3.21 up JAK3 NM_000215 
2.14 up KANK3 NM_198471 
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2.56 up KAT2B NM_003884 
3.29 up KCNA3 NM_002232 
2.30 up KCNH2 NM_000238 
2.59 down KCNQ1OT1 NR_002728 
2.21 down KDM5B NM_006618 
2.17 up KIAA0748 NM_001098815 
2.32 down KIAA1217 NM_001098500 
2.28 up KIAA1370 NM_019600 
4.50 down KIAA1549 NM_001164665 
2.95 down KIAA1671 NM_001145206 
2.40 down KIF13A NM_022113 
3.01 down KIF26B NM_018012 
2.06 down KIF3C NM_002254 
2.36 down KIF4A NM_012310 
4.00 up KLF2 NM_016270 
4.96 up KLRB1 NM_002258 
2.40 up KLRC4 NM_013431 
2.92 up LAT2 NM_032464 
5.74 up LDLRAD2 NM_001013693 
2.63 down LINC00174 NR_026873 
3.58 up LINC00426 NR_024464 
2.64 up LIPE NM_005357 
2.94 down LMO7 AK092052 
3.46 up LOC100128420 NR_038461 
4.82 down LOC100128881 NR_036480 
2.09 down LOC100130009 XM_001718914 
6.86 up LOC100288273 XR_110262 
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5.56 down LOC100505882 XR_110336 
5.47 down LOC100505912 NR_037877 
3.75 up LOC100505921 XR_108739 
2.79 up LOC100505976 XR_110096 
4.37 up LOC100506304 XR_108932 
2.01 up LOC100506651 XR_110002 
4.13 up LOC100506779 NR_038410 
2.81 up LOC100506882 XR_109418 
18.58 down LOC100507033 XR_110380 
4.89 up LOC100507492 XR_109121 
9.14 up LOC100507616 XR_110328 
3.84 up LOC100508196 XR_111691 
3.83 up LOC100508196 XR_111691 
4.08 up LOC100508196 XR_111691 
2.37 up LOC100652740 XM_003403462 
3.11 up LOC100652951 XR_132888 
2.61 up LOC145820 NR_027132 
2.73 down LOC254128 NR_037857 
6.10 up LOC283663 NR_024433 
2.27 down LOC286109 AK092172 
3.46 up LOC389834 NR_027420 
4.19 up LOC400456 NR_034095 
2.18 up LOC400499 XM_003118689 
2.63 up LOC440149 AK057085 
3.77 up LOC572558 NR_015423 
2.65 up LOC643733 NR_034079 
3.17 up LOC643733 NR_034079 
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3.72 up LOC729468 BU567215 
4.96 down LPAR3 NM_012152 
2.61 up LRRC33 NM_198565 
3.33 up LRRC70 NM_181506 
6.98 down LRRC8E NM_025061 
3.52 up LRRK2 AK127729 
3.17 up LRRK2 NM_198578 
2.74 up LTA NM_000595 
2.26 down LTBR NM_002342 
2.53 up LYSMD2 NM_153374 
10.56 up LYVE1 NM_006691 
2.03 up MALAT1 NR_002819 
3.03 up MAN1C1 NM_020379 
3.08 up MAN1C1 NM_020379 
2.03 up MAP3K8 AB209539 
2.85 down MAP3K9 NM_033141 
3.09 down MAP7 NM_003980 
3.31 down MARVELD3 NM_001017967 
7.74 up MEOX2 NM_005924 
3.49 up METTL7A NM_014033 
5.49 down MEX3A NM_001093725 
3.11 up MFNG NM_002405 
2.45 up MGC39372 NR_033851 
2.04 down MIB2 NM_080875 
3.11 down MIPOL1 NM_138731 
3.08 down MIPOL1 NM_001195296 
16.75 up MMRN1 NM_007351 
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2.55 down MOV10L1 NM_018995 
2.01 up MSRA NM_012331 
3.01 down MTMR11 NM_181873 
2.08 up MYCBP2 NM_015057 
2.31 down MYO19 NM_001033580 
2.29 up MYO1F NM_012335 
4.42 up MYRIP NM_015460 
3.29 up NAPSA NM_004851 
4.12 up NCR3 NM_001145467 
4.13 down NLGN4Y NM_014893 
4.15 up NLRC3 NM_178844 
2.06 up NLRP3 NM_001079821 
2.63 up NOSTRIN NM_052946 
2.12 up NR2F2 NM_021005 
5.12 up NR3C2 NM_000901 
2.25 down NRP2 NM_201264 
2.28 down NRP2 NM_201264 
2.71 down NRP2 NM_201266 
2.71 down NT5DC3 NM_001031701 
2.21 up NTN3 NM_006181 
3.40 down ODF3L1 NM_175881 
2.89 down ODZ3 NM_001080477 
2.10 down OTUD7B NM_020205 
2.58 down OXTR NM_000916 
4.08 up P2RY10 NM_014499 
6.89 up P2RY12 NM_022788 
3.97 up P2RY13 NM_176894 
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4.53 up P2RY14 NM_014879 
2.98 up PATL2 NM_001145112 
2.20 down PAWR NM_002583 
3.13 down PCDHGB1 NM_032095 
2.09 up PCM1 NM_006197 
2.82 up PDE1A NM_001003683 
2.15 up PECAM1 NM_000442 
6.06 up PGM5 NM_021965 
28.33 up PI16 NM_153370 
5.12 up PLA1A NM_015900 
3.64 up PLD4 NM_138790 
2.32 down PLEC NM_201380 
2.47 down PLEKHA5 NM_019012 
2.40 down PLEKHG3 NM_015549 
2.41 down PLEKHG3 NM_015549 
2.03 down PLEKHG4B NM_052909 
2.98 down POLE NM_006231 
2.14 down POLR1A NM_015425 
2.01 down POMT2 NM_013382 
4.20 down PPAP2C NM_177543 
2.24 down PPFIBP1 NM_177444 
2.14 down PPP1R14B NM_138689 
2.06 up PPP1R16B NM_015568 
3.20 down PPP1R1C NM_001080545 
2.31 up PRG2 NM_002728 
3.23 up PRKAR2B NM_002736 
2.85 up PRKAR2B NM_002736 
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5.14 up PRKCB NM_002738 
6.60 up PTGDS NM_000954 
5.10 up PTGFR NM_001039585 
3.15 down PTK7 NM_002821 
3.53 down PTPRF BC048416 
3.82 up PTPRN2 NM_002847 
3.90 up PYHIN1 NM_198930 
3.27 up Q6TXI9   
2.42 up RAB33A NM_004794 
4.24 up RAB37 NM_175738 
2.21 up RAI2 NM_021785 
2.36 up RAMP3 NM_005856 
3.63 up RASAL3 NM_022904 
2.49 up RASGRP1 NM_005739 
3.76 up RASGRP2 NM_153819 
3.67 up RASGRP2 NM_153819 
5.31 up RASGRP2 NM_153819 
3.53 up RASSF2 NM_014737 
2.10 down RCC2 NM_018715 
2.84 down RGNEF NM_001177693 
8.77 up RGS13 NM_002927 
3.29 up RINL NM_001195833 
2.55 up RLTPR NM_001013838 
3.29 up RNF125 NM_017831 
3.18 down RNF217 NM_152553 
2.21 down RNF7 NR_037702 
3.10 up RNU4ATAC DW419002 
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2.43 down RPL28 NM_001136136 
2.09 up RPP30 NM_001104546 
439.85 down RPS4Y2 NM_001039567 
3.62 down RTKN NM_033046 
3.28 down S100A11 NM_005620 
2.92 up S1PR1 NM_001400 
3.80 up S1PR4 NM_003775 
2.09 down SAMD1 NM_138352 
3.38 up SCARNA16 NR_003013 
3.17 up SCARNA16 NR_003013 
3.25 up SCARNA9 NR_002569 
4.50 up SCML4 NM_198081 
2.63 down SCN8A NM_014191 
2.94 down SDK2 NM_001144952 
4.29 up SELP NM_003005 
5.81 up SELP NM_003005 
2.54 up SEMA4D NM_001142287 
2.05 up SEPT8 NM_001098811 
2.67 up SERP2 NM_001010897 
2.50 up SH2D3C NM_170600 
2.68 up SHE NM_001010846 
2.67 up SIDT1 NM_017699 
2.59 down SLC39A4 NM_017767 
2.26 up SMAD9 NM_005905 
2.29 down SMYD3 NM_022743 
4.33 up SNORA12 NR_002954 
4.17 up SNORA12 AA378382 
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2.80 up SNORD71 NR_003059 
3.06 up SNX20 NM_182854 
8.33 up SNX22 NM_024798 
2.83 down SOX4 NM_003107 
3.28 down SPAG1 NM_003114 
2.33 up SPARCL1 NM_004684 
2.53 up SPI1 NM_001080547 
7.66 up SPIB NM_003121 
2.25 down SPIRE1 NM_001128626 
3.49 up SPNS3 NM_182538 
2.12 down SRGAP1 NM_020762 
2.01 down STIP1 NM_006819 
2.55 down STX1A NM_004603 
2.08 down SUPT3H NM_003599 
3.00 up SUSD3 NM_145006 
2.24 up SVEP1 NM_153366 
4.76 up SVEP1 BC030816 
3.04 up TAGAP NM_054114 
4.97 up TBC1D10C NM_198517 
2.63 down TBX3 NM_016569 
3.18 down TBX3 NM_016569 
2.82 down TCTN2 NM_024809 
7.89 up TDRD12 NM_001110822 
3.01 up TESC NM_017899 
2.52 up TGFBR2 NM_001024847 
5.25 up TIFAB NM_001099221 
12.81 up TLR10 NM_030956 
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3.65 up TMBIM4 NM_016056 
4.16 up TMEM100 NM_018286 
2.59 up TMEM170B NM_001100829 
4.68 down TMEM190 NM_139172 
3.34 up TMIE NM_147196 
3.35 up TNFAIP8L2 NM_024575 
4.69 down TNFRSF19 NM_018647 
2.56 up TNFSF14 NM_003807 
5.12 up TNXB NM_019105 
7.27 up TNXB NM_032470 
2.77 down TONSL NM_013432 
2.19 up TPK1 NM_022445 
2.01 down TPM4 NM_003290 
2.09 down TPM4 NM_003290 
2.54 down TRIP13 NM_001166260 
3.20 up TSPAN33 NM_178562 
2.01 down TTLL5 NM_015072 
4.06 down TUBAL3 NM_024803 
17.62 down TXLNG2P NR_045129 
2.71 up TXNIP NM_006472 
2.20 down UBE2H NM_003344 
2.22 up UNC13D NM_199242 
7.49 down VGF NM_003378 
2.19 down VKORC1 AK125618 
2.13 up WDFY4 NM_020945 
3.83 up WDFY4 NM_020945 
2.19 down WDYHV1 NM_018024 
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2.53 down XLOC_000282   
4.96 down XLOC_000778   
2.82 up XLOC_001035   
2.40 up XLOC_001266   
4.36 up XLOC_001286   
2.19 up XLOC_002221   
5.74 up XLOC_002749   
4.91 up XLOC_003738 BC040914 
2.11 up XLOC_004263 DB030232 
2.02 down XLOC_005514   
3.77 down XLOC_007531   
2.12 up XLOC_007775 XR_108974 
4.35 down XLOC_l2_001011 BC030750 
3.30 up XLOC_l2_002761   
4.22 up XLOC_l2_004840 BG107090 
2.70 down XLOC_l2_007928   
2.09 down XLOC_l2_008203   
4.87 down XLOC_l2_008910 BC039367 
2.03 down XLOC_l2_010139   
2.83 up XLOC_l2_010636   
2.60 up XLOC_l2_010636   
2.56 up XLOC_l2_012847   
2.65 up XLOC_l2_012847   
2.04 up XLOC_l2_013267   
6.83 down XLOC_l2_013530 BG192435 
2.14 down XLOC_l2_013873   
2.27 down ZBED4 NM_014838 
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2.16 down ZBTB8A NM_001040441 
2.35 down ZDHHC9 NM_016032 
2.28 up ZFYVE28 NM_020972 
2.02 up ZNF117 NM_015852 
2.84 down ZNF284 NM_001037813 
2.49 down ZNF618 NM_133374 
2.27 down ZNF623 NM_001082480 
3.42 down ZNF695 NM_001204221 
2.23 down   XM_003118909 
8.11 up   BX161420 
3.77 up   AY312959 
2.56 down   XR_109904 
2.21 down   CU677870 
2.36 down   XR_109904 
3.26 up   X58740 
2.05 down   DM107643 
2.16 down   XR_132519 
4.04 up   CR625008 
2.44 up   M21784 
4.30 up   BC038366 
2.84 up   AV659465 




APPENDIX F - DEG AA HPV-NEGATIVE VS EA HPV-NEGATIVE 
Table F.1: AA HPV-Negative vs EA HPV-Negative tumors p 0.02, FC 2 
FC (abs) Direction of change Gene Symbol Genbank Accession 
2.52 down AADAT NM_016228 
2.87 down ABCC6 NM_001079528 
4.09 down ADAM12 NM_021641 
2.25 down ADC NM_052998 
3.75 down ADRA2C NM_000683 
2.46 up AIF1L NM_001185096 
3.59 up ALDH7A1 NM_001182 
2.95 up ALDH7A1 NM_001182 
2.80 down ANKK1 NM_178510 
2.13 down ARHGAP1 NM_004308 
2.37 up ATG4C NM_032852 
3.23 down ATP9A NM_006045 
2.48 down ATP9A NM_006045 
2.60 down AVIL NM_006576 
3.16 down BBS5 NM_152384 
2.33 down BCAS3 NM_017679 
2.59 up BFSP2 NM_003571 
2.54 down BHLHB9 NM_030639 
2.42 down C10orf114 NM_001010911 
5.76 down C11orf53 NM_198498 
4.42 down C11orf70 NM_001195005 
3.46 down C11orf70 NM_032930 
2.43 down C14orf132 NR_023938 
2.58 up C17orf105 NM_001136483 
3.74 down C19orf21 NM_173481 
2.79 up C1orf210 NM_182517 
2.09 down C20orf108 NM_080821 
2.13 up C21orf33   
2.53 down C4orf47 NM_001114357 
2.11 up C5orf44 NR_003545 
2.17 down C8orf42 NM_175075 
2.96 down CCDC40 NM_001243342 
2.03 down CD151 NM_004357 
2.57 down CDH13 NM_001257 
6.94 down CFHR4 NM_006684 
4.15 down CHST6 NM_021615 
2.34 down COL27A1 AK021957 
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2.70 down COL7A1 NM_000094 
2.16 up CPA5 NM_001127442 
2.68 down CPAMD8 NM_015692 
3.00 up CRYBB2 NM_000496 
2.85 up CRYBB2P1 NR_033734 
6.27 down CST2 NM_001322 
2.71 down CXCR7 NM_020311 
2.37 up CYB5RL BC071735 
4.18 down CYP27C1 NM_001001665 
2.18 down DCBLD1 NM_173674 
3.39 down DDX11L9 NR_034090 
2.26 down DHRS3 NM_004753 
5.16 down DNAH17   
8.43 down DNAH5 NM_001369 
6.31 up DNASE1L3 NM_004944 
2.76 down DYNLRB2 NM_130897 
2.18 up ECEL1P2 NR_028501 
2.41 down EFCAB1 NM_001142857 
2.61 down EFHC2 NM_025184 
4.40 up EIF2A NM_032025 
2.06 down ENC1 NM_003633 
5.71 down ENKUR NM_145010 
2.92 down EPHA3 NM_005233 
2.69 down FAM114A1 NM_138389 
4.00 down FAM164A NM_016010 
2.79 down FAM87B XR_112085 
3.14 down FAT1 NM_005245 
3.02 down FBXO32 NM_058229 
2.06 up FCER1G   
3.13 down FHOD3 NM_025135 
2.19 down FLJ20021 NR_033874 
4.39 down FLJ37644 XR_109424 
2.73 down FLJ45671 AK127576 
3.62 down FLJ45983 NR_024256 
2.36 down FRG1B BC095491 
4.56 up FUT7 NM_004479 
2.39 down FZD1 NM_003505 
3.03 down GHR NM_001242462 
2.26 up GNASAS   
2.20 down GOLGA6L10 NM_001164465 
2.10 down GOLGA6L10 NM_001164465 
2.12 down GOLGA6L9 NM_198181 
2.07 down GOLGA6L9 NM_198181 
2.42 down GPR125 NM_145290 
2.33 up GPR31 NM_005299 
2.35 down GPR56 NM_201525 
6.94 down GUCY1B2 NR_003923 
2.60 down HGSNAT NM_152419 
2.01 down HHAT NM_018194 
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2.04 up HHEX NM_002729 
2.03 down HOMER3 NM_001145722 
2.55 down HSPG2 NM_005529 
2.35 down HTATSF1P2 BX648511 
5.34 down IBSP NM_004967 
2.11 down IER5L NM_203434 
4.20 up IL1R2 NM_004633 
2.11 down ITGAV NM_002210 
2.07 down ITGB4 NM_000213 
2.11 down ITGB5 NM_002213 
2.25 down JAG1 NM_000214 
2.04 down KDM5B NM_006618 
3.49 down KIAA1549 NM_001164665 
2.12 down KIF16B NM_001199866 
2.02 down KIF16B NM_024704 
3.63 down KIF26B NM_018012 
4.27 down LARP6 NM_197958 
2.66 down LARP6 NM_018357 
2.39 down LCA5 NM_181714 
2.58 down LEPR NM_001003680 
5.78 down LIF NM_002309 
3.49 down LIMCH1 NM_014988 
3.45 down LINC00174 NR_026873 
8.75 down LINGO2 NM_152570 
2.11 up LOC100128164 NR_027622 
2.13 down LOC100130027 XR_110587 
2.07 up LOC100131581 AK092544 
2.44 up LOC100132147 BC036435 
2.80 down LOC100133299 XR_108564 
2.08 up LOC100133612 NR_024455 
2.01 down LOC100170939 NR_024054 
3.75 down LOC100216001 NR_024475 
3.46 down LOC100216001 NR_024475 
3.45 down LOC100240735 NR_026658 
2.64 down LOC100270746 NR_026776 
3.15 down LOC100288748 NR_034034 
3.46 up LOC100294145 NR_037177 
2.69 up LOC100294145 NR_037177 
10.94 down LOC100505495 NR_040109 
3.04 down LOC100505634 XR_109905 
3.47 down LOC100505912 NR_037877 
2.58 up LOC100506302 XR_108708 
2.80 up LOC100506328 XR_109927 
3.30 down LOC100506451 AK090817 
4.30 down LOC100506718 XR_110230 
5.50 down LOC100507150 XR_108536 
2.52 down LOC100507299 NR_039990 
3.57 up LOC100507429 XR_110179 
3.52 up LOC100507429 XR_110179 
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3.69 down LOC100507460 XR_109894 
3.42 down LOC100507460 XR_109894 
3.36 down LOC100507474 XR_109895 
4.82 down LOC100507580 XR_109752 
2.04 down LOC100507624 XR_110188 
2.99 up LOC100508384 XM_003119544 
2.31 up LOC100652730 XR_132670 
2.12 up LOC100652730 XR_132670 
2.06 down LOC100652838 XR_132689 
4.97 up LOC146880 NR_026899 
4.72 up LOC219347 NR_027428 
3.70 down LOC283861 AK098143 
3.10 up LOC388906 NR_036498 
2.25 up LOC440570 XR_113295 
2.74 down LOC441204 NR_015364 
2.01 down LOC541471 NR_015395 
2.13 down LOC645954 XR_109026 
8.39 down LOC729444 NR_038388 
2.50 down LRP12 NM_013437 
2.02 down MAGI2 NM_012301 
10.38 up MAL NM_002371 
3.83 down MCOLN3 BC060765 
2.96 down MECOM NM_004991 
3.60 down MGC4294 XR_109628 
2.78 down MIR143HG NR_027180 
26.40 down MMP7 NM_002423 
2.26 down MN1 NM_002430 
2.40 up MPRIP   
2.57 down MRC2 NM_006039 
3.82 up MZT2A   
2.08 down ND4L AK311996 
2.06 down NEAT1 AF001893 
3.51 down NEK10 AK057247 
4.66 down NLGN4X NM_020742 
3.82 down NLGN4Y NM_014893 
2.18 up NPHS1 NM_004646 
2.49 down NRP2 NM_201264 
2.12 down NRP2 NM_201264 
2.62 down NUAK1 NM_014840 
6.01 up OTOP3 NM_178233 
2.54 down PALLD NM_001166109 
2.03 down PALLD NM_016081 
2.05 down PBX3 NM_006195 
2.23 down PDXDC2P BX647358 
2.24 down PER3 NM_016831 
2.20 down PGM5P2 NR_002836 
4.12 down PLCB4 NM_182797 
2.02 down PLEC NM_201380 
3.50 down PMEPA1 NM_020182 
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3.12 down PMEPA1 NM_020182 
2.58 down PNMA6C NM_001170944 
3.01 down PPARGC1A NM_013261 
2.54 down PPP1R1C NM_001080545 
2.11 down PRICKLE1 NM_153026 
2.14 down PROCA1 NM_152465 
5.19 up PSPH NM_004577 
2.22 down PTPRG NM_002841 
2.38 down PTPRU NM_005704 
2.32 down RAI14 NM_015577 
2.42 down RASGEF1A NM_145313 
2.13 up RASGRP2 NM_153819 
2.00 up RAX NM_013435 
2.27 down RBMS3 NM_014483 
2.63 down RBPMS AK057533 
2.01 down RHOBTB1 NM_001242359 
2.50 up RNF112 NM_007148 
2.48 down RPS23 NM_001025 
2.07 up RSPH9 AK055407 
2.03 up RXRG NR_033824 
5.41 down SALL4 NM_020436 
2.19 down SEC14L2 NM_033382 
3.20 down SEPW1 NM_003009 
2.44 down SH3PXD2A NM_014631 
2.01 down SH3PXD2A NM_014631 
7.50 down SHISA2 NM_001007538 
2.24 up SHMT1 NM_004169 
4.01 down SIX5 NM_175875 
5.51 up SLC27A2 NM_003645 
6.11 down SLITRK6 NM_032229 
4.32 down SLITRK6 NM_032229 
2.04 down SLMO1 NM_006553 
2.49 down SMA4 NR_029426 
2.02 up SNORD105 NR_004381 
2.17 up SNORD119 NR_003684 
3.31 up SNORD34 NR_000019 
3.15 up SNORD45B NR_002748 
2.12 up SNORD59B NR_003046 
2.28 up SNORD65 NR_003054 
2.16 up SNORD67 NR_003056 
2.35 down SOX4 NM_003107 
2.07 up SPEG   
3.16 up SPINK7 NM_032566 
3.63 down SPOCK1 NM_004598 
2.72 down STRA6 NM_001142620 
2.68 down TCF7L2 NM_030756 
2.17 down TCP11L1 NM_018393 
4.78 down TEKT2 NM_014466 
2.14 down TJP2   
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3.25 down TMCC2 NM_014858 
4.15 down TMEM108 NM_023943 
3.83 down TMEM190 NM_139172 
2.26 down TMEM63C NM_020431 
4.43 down TNFRSF12A NM_016639 
3.93 down TOB2P1 NR_002936 
2.43 down TPST1 NM_003596 
2.59 up TREML2 NM_024807 
3.73 down TTC25 NM_031421 
3.62 down TTLL7 NM_024686 
2.39 down TTLL7 NM_024686 
3.43 down VGF NM_003378 
2.18 up VTRNA1-1 NR_026703 
3.34 down WDR86 NM_198285 
2.78 down WNT3 NM_030753 
2.37 down WNT5B NM_030775 
2.77 down XIAP NM_001167 
4.61 down XLOC_000587   
3.77 down XLOC_000587 AK124056 
2.66 down XLOC_000647 CR617576 
2.21 up XLOC_002323   
2.12 down XLOC_003515 BX110533 
2.12 up XLOC_003546 AL833514 
4.34 down XLOC_004229   
2.09 up XLOC_004456   
3.13 up XLOC_004643 DB301429 
3.54 down XLOC_005361   
2.50 up XLOC_005490   
3.02 down XLOC_006721   
3.20 down XLOC_007467   
2.17 up XLOC_007607   
4.23 up XLOC_009120   
3.35 down XLOC_011052   
2.80 down XLOC_012467   
3.62 up XLOC_013737 AK090932 
3.67 down XLOC_l2_001011 BC030750 
5.61 up XLOC_l2_003897   
2.48 up XLOC_l2_008009   
2.01 down XLOC_l2_008031   
3.16 down XLOC_l2_008203   
2.73 down XLOC_l2_008203   
2.69 down XLOC_l2_008288 CD557693 
9.53 down XLOC_l2_009332 AK096564 
2.91 down XLOC_l2_009332   
3.62 up XLOC_l2_009539   
2.12 down XLOC_l2_011204 BX104493 
2.01 down XLOC_l2_011204 BX104493 
2.90 down XLOC_l2_012925   
2.25 up XLOC_l2_015878   
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2.26 down ZBED1 NM_001171135 
2.15 down ZNF514 NM_032788 
2.10 up ZNF799 NM_001080821 
3.10 down   AK130638 
3.02 up   BX115224 
2.62 up   Y15200 
2.30 up   BU535024 
2.22 up   X15019 
2.17 down   AF264629 
2.13 up   DB028131 
2.08 up   AF239727 
2.07 down   XM_003118656 
2.05 up   BC071639 




APPENDIX G-DEG EA HPV-INACTIVE VS AA HPV-INACTIVE 
Table G.1: EA HPV-Inactive vs AA HPV-Inactive tumors p 0.05, FC 2 
FC (abs)  Direction of change  Gene symbol Genbank accession 
4.59 up ABCA6 NM_080284 
5.33 up ABCB1 NM_000927 
2.37 up ABHD13 NM_032859 
7.76 up ABI3BP NM_015429 
7.85 up ABI3BP NM_015429 
2.06 up ABP1 NM_001091 
2.39 up ABTB1 NM_032548 
2.27 up ACBD4 NM_024722 
6.13 down ACBD4 NM_024722 
2.12 down ACPT NM_033068 
2.73 up ACSM3 NM_202000 
4.59 up ACSM5 NM_017888 
227.45 up ACTA1 NM_001100 
2.84 up ADAL NM_001012969 
3.67 down ADAM11 NM_002390 
2.27 up ADAM19 NM_033274 
2.31 up ADAM28 NM_021777 
2.50 up ADAM8 NM_001109 
2.55 up ADCY4 NM_139247 
5.50 up ADCYAP1 NM_001099733 
2.88 up ADHFE1 NM_144650 
3.32 up ADHFE1 NM_144650 
5.37 up ADORA2A NM_000675 
2.95 up ADRBK2 NM_005160 
2.78 up AGER NM_001206966 
2.43 up AGTPBP1 NM_015239 
4.00 up AIF1 NM_004847 
2.94 down AK4 NM_001005353 
3.84 up AKAP2 NM_001004065 
2.24 up ALS2 AK090992 
3.65 up ALS2CR8 NM_024744 
6.85 up AMICA1 NM_153206 
11.66 up AMPD1 NM_000036 
2.10 up AMZ2P1 NR_026903 
12.75 up ANGPTL1 NM_004673 
4.73 up ANK1 NM_000037 
2.77 up ANKDD1A NM_182703 
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3.36 up ANKDD1A NM_182703 
2.58 up ANKRD10 NM_017664 
2.51 up ANKRD10-IT1 XR_109155 
2.06 up ANKRD12 NM_001204056 
2.46 down ANKRD13B NM_152345 
5.61 up ANKRD23 NM_144994 
2.07 down ANKRD24 NM_133475 
3.23 up ANKRD33B NM_001164440 
2.24 up ANKRD42 NM_182603 
2.35 down ANO8 NM_020959 
2.87 up ANTXR2 NM_058172 
9.09 down ANXA10 NM_007193 
8.04 up AOX1 NM_001159 
10.37 up AOX1 NM_001159 
6.27 down AP1M2 NM_005498 
2.66 up AP1S2 NM_003916 
2.02 down AP4M1 NM_004722 
4.17 up APBB1IP NM_019043 
5.09 up APBB1IP NM_019043 
2.72 down APC2 NM_005883 
2.15 down APOA1BP NM_144772 
3.30 up APOL6 NM_030641 
4.75 down ARG2 NM_001172 
2.17 up ARHGAP12 NM_018287 
6.15 up ARHGAP15 NM_018460 
3.10 up ARHGAP24 NM_001025616 
3.50 up ARHGAP24 AK130576 
3.92 up ARHGAP25 NM_001007231 
4.74 up ARHGAP30 NM_001025598 
2.09 down ARHGAP39 NM_025251 
3.01 up ARHGAP6 NM_013427 
5.82 up ARHGAP9 NM_032496 
3.78 up ARHGDIB NM_001175 
2.21 up ARHGEF3 NM_019555 
6.07 up ARHGEF6 NM_004840 
3.97 up ARHGEF7 NM_145735 
2.32 up ARL17A NM_016632 
2.41 up ARL6IP5 NM_006407 
2.15 down ARMC10 NM_031905 
3.32 up ARMCX4 NR_028407 
2.30 down ARPC1A NM_006409 
3.62 up ARSG AB023218 
3.08 down ARTN NM_057090 
3.23 up ASGR2 NM_080912 
4.54 up ASPA NM_000049 
2.20 up ASRGL1 NM_001083926 
2.24 up ATG16L2 NM_033388 
5.15 up ATOH8 NM_032827 
29.99 up ATP1A2 NM_000702 
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9.65 up ATP2A3 NM_174953 
2.11 up ATP2B4 NM_001001396 
6.77 up ATP8A1 NM_006095 
8.37 down ATP8B3 NM_138813 
4.17 up B2M NM_004048 
2.21 down B4GALT2 NM_003780 
5.84 down BAIAP2L1 NM_018842 
6.28 down BAIAP2L2 NM_025045 
18.36 up BANK1 NM_017935 
2.63 up BDH2 NM_020139 
2.00 up BEST1 NM_004183 
4.99 up BHMT2 NM_017614 
5.21 up BIRC3 NM_001165 
24.11 up BLK NM_001715 
2.32 up BMF NM_001003940 
4.00 up BMX NM_001721 
2.06 up BNIP2 AK125533 
2.22 up BRWD1 NM_018963 
2.69 up BST1 NM_004334 
2.80 up BTD NM_000060 
2.34 up BTG2 NM_006763 
4.46 up BTK NM_000061 
4.80 up BTK NM_000061 
9.44 up BTLA NM_181780 
2.23 down C10orf120 NM_001010912 
5.66 up C10orf128 NM_001010863 
3.77 up C14orf64 NR_015430 
2.06 up C15orf57 NM_052849 
9.26 up C16orf54 NM_175900 
3.11 up C16orf86 NM_001012984 
4.16 up C17orf87 AK057142 
2.87 up C18orf18 NR_026849 
3.59 up C1orf162 NM_174896 
2.07 down C1orf183 NM_019099 
2.91 down C1orf61 XR_108361 
2.76 up C20orf106 NM_001012971 
9.08 up C20orf26 NM_015585 
4.85 up C21orf7 NM_020152 
2.11 down C2CD4C NM_001136263 
3.82 up C2orf84 NM_001040710 
5.06 down C3orf67 NM_198463 
3.04 up C3orf71 NM_001123040 
4.95 up C4B NM_001002029 
6.15 up C5orf20 NM_130848 
2.17 up C6orf192 NM_052831 
2.63 up C7orf41 NM_152793 
2.07 up C8orf60 AK022255 
2.44 up C9orf102 NM_001010895 
3.67 up C9orf123 NM_033428 
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5.26 up C9orf128 NM_001012446 
2.14 down C9orf131 NM_203299 
2.10 up C9orf64   
2.82 up C9orf72 NM_145005 
2.14 up CA5B NM_007220 
2.82 up CA5B   
3.10 up CA8 NM_004056 
6.80 down CA9 NM_001216 
2.10 up CAB39L NM_030925 
2.18 down CACNB3 NM_000725 
4.77 up CACNB4 NM_001005747 
15.82 up CACNG6 NM_145814 
4.94 down CAMK2N2 NM_033259 
2.48 up CANX NM_001746 
2.87 up CAPN3 NM_000070 
5.10 up CAPN7 NM_014296 
2.42 up CARD8 NM_001184904 
3.36 up CARD8 NM_014959 
2.44 up CARD9 NM_052814 
2.99 up CARD9 NM_052813 
4.01 up CARNS1 NM_001166222 
2.55 up CASP8 NM_033358 
13.62 up CASQ2 NM_001232 
4.06 up CATSPER2 NM_172095 
4.72 up CATSPER2 NM_172097 
2.17 up CBR4 NM_032783 
4.19 up CBX7 NM_175709 
3.87 up CCDC69 NM_015621 
10.61 up CCL14 NM_032963 
16.52 up CCL18 NM_002988 
4.32 up CCL2 NM_002982 
33.06 up CCL21 NM_002989 
33.56 up CCL21 NM_002989 
9.38 up CCL23 NM_005064 
2.00 down CCNE1 NM_001238 
3.67 up CCNG2 NM_004354 
2.28 up CCR1 NM_001295 
9.28 up CCR2 NM_001123041 
5.33 up CCR4 NM_005508 
2.78 up CCR6 NM_031409 
9.17 up CCR7 NM_001838 
3.66 up CD163L1 NM_174941 
4.38 up CD1B NM_001764 
12.59 up CD1C NM_001765 
10.66 up CD1E NM_001042583 
2.68 up CD200 NM_001004196 
3.18 up CD200R1 NM_138939 
7.04 up CD200R1 NM_138806 
5.23 up CD209 NM_021155 
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6.49 up CD209 NM_001144897 
8.32 up CD209 NM_021155 
9.06 up CD22 NM_001771 
2.53 down CD244 NM_001166663 
10.79 up CD247 NM_198053 
9.51 up CD28 NM_006139 
2.58 up CD300A NM_007261 
3.13 up CD302 NM_014880 
3.47 up CD302 NM_014880 
5.82 up CD3G NM_000073 
2.09 up CD40 NM_001250 
2.51 up CD40 NM_001250 
12.34 up CD40LG NM_000074 
5.80 up CD53 NM_001040033 
5.68 up CD6 NM_006725 
8.76 up CD69 AK303383 
11.41 up CD69 NM_001781 
4.30 up CD74 NM_001025158 
11.26 up CD79B NM_001039933 
6.75 up CD96 NM_198196 
2.81 up CD97 NM_078481 
2.65 down CD99P1 NR_033381 
2.86 down CD99P1 NR_033381 
3.97 up CDC42SE2 NM_020240 
3.73 down CDC6 NM_001254 
3.40 down CEACAM20 NM_001102598 
6.39 up CEACAM21 NM_033543 
7.62 up CEACAM21 NM_001098506 
2.88 up CELF2 NM_001025077 
3.52 up CELF2 NM_001025076 
2.16 up CFH NM_001014975 
2.36 up CFH NM_000186 
2.54 up CFH NM_001014975 
2.18 up CFHR3 NM_021023 
3.50 up CFI NM_000204 
4.36 up CFI NM_000204 
7.33 up CFP NM_002621 
2.26 up CG030 NR_026928 
2.90 down CHAT NM_020549 
2.11 up CHCHD7 NM_001011667 
16.53 up CHI3L2 NM_001025199 
25.95 up CHRDL1 NM_001143981 
3.93 up CHURC1 NM_145165 
16.70 up CKMT2 NM_001825 
5.05 up CLEC10A NM_182906 
4.95 up CLEC2D NM_013269 
4.68 up CLEC4A NM_016184 
12.22 up CLEC4G NM_198492 
72.21 up CLEC4G NM_198492 
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12.56 up CLEC4GP1 NR_002931 
10.57 up CLEC9A NM_207345 
6.14 up CLECL1 NM_172004 
3.19 up CLIC2 NM_001289 
2.64 up CLIC5 NM_016929 
4.63 up CLIC5 NM_016929 
2.16 up CLK1 NM_004071 
2.39 up CLN5 NM_006493 
2.11 down CLPS NM_001832 
2.21 up CLSTN3 NM_014718 
2.17 up CMAHP NR_002174 
2.29 up CMAHP NR_002174 
2.61 up CMAHP NR_002174 
3.33 up CMKLR1 NM_001142343 
2.71 up CMTM7 NM_138410 
7.46 up CNR1 NM_033181 
2.09 up CNTRL NM_007018 
3.49 up CNTRL   
4.65 up COL14A1 NM_021110 
5.76 up COL4A3 NM_000091 
4.66 down CORIN NM_006587 
4.30 up CORO1A NM_007074 
2.86 up COTL1 NM_021149 
4.22 up CPA3 NM_001870 
2.11 down CPT1C NM_001199752 
2.49 down CPT1C NM_001199752 
5.59 up CPVL NM_019029 
4.23 up CR1L NM_175710 
6.40 down CRB3 NM_139161 
2.95 up CREBL2 NM_001310 
5.33 up CRTAC1 NM_018058 
2.54 down CRYBA2 NM_005209 
3.31 down CRYBB2 NM_000496 
2.89 down CRYBB2P1 NR_033734 
2.54 up CSF1R NM_005211 
3.01 up CSF2RA NM_172249 
2.11 up CTC1 NM_025099 
7.13 up CTLA4 NM_005214 
9.23 up CTLA4 NM_005214 
8.38 up CTSG NM_001911 
2.11 up CX3CR1 NM_001337 
3.10 up CXCL12 NM_000609 
9.74 up CXCL12 NM_199168 
3.90 up CXCL2 NM_002089 
3.37 up CXCR4 NM_001008540 
5.76 up CXCR6 NM_006564 
3.98 up CXorf21 NM_025159 
3.48 down CXorf48 NM_001031705 
14.26 up CXorf65 NM_001025265 
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2.59 up CXXC5 NM_016463 
2.09 up CYB5B NM_030579 
2.42 up CYBASC3 NM_153611 
4.23 up CYBB NM_000397 
2.73 up CYLD NM_015247 
2.59 down CYP11A1 NM_000781 
3.43 up CYP2E1 NM_000773 
3.04 down CYP51A1 NM_000786 
3.03 up CYSLTR1 NM_006639 
3.80 up CYTH4 NM_013385 
5.82 up CYTIP NM_004288 
7.96 up CYTL1 NM_018659 
8.41 up CYTL1 NM_018659 
2.76 up DACH1 NM_080759 
2.99 up DACH1 NM_080759 
2.49 up DBNL AB209486 
2.28 down DCAKD NM_024819 
3.11 down DDX11L2 NR_024005 
2.20 up DDX17 NM_006386 
3.52 up DDX26B NM_182540 
3.57 up DDX26B NM_182540 
2.17 up DENND1B NM_001195215 
4.15 up DENND1C NM_024898 
2.36 up DENND3 AK125506 
2.76 up DENND3 NM_014957 
4.29 up DENND4C AK000627 
3.50 down DHCR7 NM_001360 
5.79 up DIO3OS NR_002770 
2.28 up DISC1 NM_018662 
2.40 up DISC1 NM_001164544 
2.23 up DKFZP586I1420 NR_002186 
3.03 down DNAJB1 NM_006145 
2.87 up DNMT3A NM_175630 
4.22 up DOCK10 NM_014689 
2.49 up DOCK11 NM_144658 
6.00 up DOCK2 NM_004946 
9.36 up DOCK2 NM_004946 
2.02 down DOCK7 NM_033407 
3.02 up DOCK8 NM_203447 
3.82 up DOK2 NM_003974 
3.05 down DOK7 AK075037 
4.92 up DPP4 NM_001935 
2.76 up DPYD NM_000110 
2.55 down DSCR10 NR_027695 
3.17 down DSCR9 NR_026719 
7.30 up DUSP26 NM_024025 
5.22 down DUSP5P NR_002834 
2.45 up DYNLT1 AK026669 
2.93 up EAF2 NM_018456 
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3.34 up EBF3 NM_001005463 
3.10 up EBI3 NM_005755 
2.47 up EDNRB NM_003991 
5.69 down EGFL6 NM_001167890 
2.00 up EGR1 NM_001964 
2.85 up EGR3 NM_004430 
2.30 up EHD1 NM_006795 
2.70 down EIF4EBP1 NM_004095 
2.78 down ELOVL6 NM_024090 
2.01 up EMP3 NM_001425 
4.77 up EMR3 NM_032571 
2.90 down ENO2 NM_001975 
8.05 up ENO3 NM_001976 
5.64 up ENPP2 NM_006209 
6.60 up ENPP3 NM_005021 
2.32 up ENTPD1 NM_001776 
4.29 down ERBB3 NM_001005915 
2.32 down ERC1 NM_178040 
5.79 up ERLIN2 NM_001003790 
3.75 down ERVMER34-1 NM_024534 
4.61 down ERVMER34-1 NM_024534 
5.93 down ERVMER34-1 NM_024534 
3.35 up ESR1 NM_000125 
3.32 up ETS1 NM_005238 
5.28 down ETV2 NM_014209 
3.90 up EVI2A NM_001003927 
2.08 down EXOSC4 NM_019037 
2.15 down F11R NM_016946 
5.35 up F5 NM_000130 
2.50 up FAM105A NM_019018 
2.56 up FAM106CP NR_026810 
5.75 up FAM107A NM_007177 
3.70 up FAM107B NM_031453 
4.96 up FAM107B NM_031453 
2.55 up FAM113B NM_138371 
2.48 up FAM118A NM_017911 
2.41 up FAM122C NM_138819 
2.18 down FAM125A NM_138401 
2.90 up FAM125B NM_033446 
3.87 up FAM13A-AS1 NR_002806 
4.72 up FAM150B NM_001002919 
2.36 down FAM162A NM_014367 
2.19 down FAM166A NM_001001710 
10.51 down FAM183A AK309744 
2.89 up FAM189A2 NM_004816 
7.82 up FAM65B NM_014722 
9.54 up FAM65B NM_015864 
2.93 up FAM65C NM_080829 
3.42 up FAM78A NM_033387 
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2.08 up FAM7A3 NR_026859 
2.32 up FAM82A1 NM_144713 
2.93 up FAM95B1 NR_026759 
3.91 down FANK1   
2.43 down FASN NM_004104 
3.46 up FAT4 NM_024582 
4.00 down FBLL1 NR_024356 
2.37 down FBXO22-AS1 NR_003136 
5.32 up FCER1A NM_002001 
3.10 up FCGR2B NM_004001 
2.25 up FCGRT NM_004107 
8.97 up FCRL2 NM_030764 
30.69 up FCRL3 AK301257 
9.61 up FCRLA NM_032738 
2.13 up FES NM_002005 
2.04 down FGD1 NM_004463 
5.84 up FGL2 NM_006682 
3.80 up FITM1 NM_203402 
2.92 up FLI1 NM_002017 
3.33 up FLJ27354 NR_033981 
2.15 up FLJ31306 NR_029434 
2.78 up FLJ39639 NR_033904 
2.11 down FLJ40039 AK097358 
3.84 up FLJ43663 NR_015431 
3.92 up FLJ43663 NR_015431 
4.36 up FLJ43663 NR_015431 
4.65 up FLJ43663 NR_015431 
6.82 up FLJ43663 NR_015431 
4.10 down FLJ43860 NM_207414 
2.03 down FLJ46906 NR_033896 
4.99 up FLT3 NM_004119 
2.35 up FLVCR1-AS1 NR_027286 
2.19 up FLVCR2 NM_017791 
2.21 up FMOD NM_002023 
2.57 up FNBP1 AK023681 
2.74 up FNBP1 NM_015033 
2.57 up FOS NM_005252 
4.91 down FOXD2 NM_004474 
2.55 up FOXP3 NM_014009 
2.04 up FPGT-TNNI3K BX640903 
2.73 up FPR2 NM_001462 
2.70 up FRY NM_023037 
3.11 up FRY BX537670 
5.79 down FSIP2 NM_173651 
15.66 down FTSJD2 NM_015050 
3.40 up FUCA1 NM_000147 
2.44 up FXYD1 NM_005031 
6.25 up FYB NM_001465 
2.70 up FYN NM_002037 
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5.22 down FZD9 NM_003508 
3.35 up G0S2 NM_015714 
5.53 down GABRR1 NM_002042 
3.37 down GALNT9 NM_021808 
6.90 up GAPT NM_152687 
5.12 down GAST NM_000805 
2.13 up GBP3 NM_018284 
3.12 up GCA NM_012198 
3.33 down GCAT NM_014291 
4.95 up GCFC1-AS1 NR_038879 
10.63 up GDF10 NM_004962 
2.23 down GDF11 NM_005811 
4.76 up GFI1 NM_005263 
3.61 up GFRA1 NM_005264 
3.69 up GFRA2 NM_001495 
2.21 up GGA2 NM_015044 
2.25 down GGT3P NR_003267 
3.22 up GGTA1P NR_003191 
5.23 up GHRL NM_016362 
2.42 up GHRLOS NR_004431 
4.89 up GIMAP2 NM_015660 
3.65 up GIMAP4 NM_018326 
5.37 up GIMAP5 NM_018384 
3.76 up GIMAP6 NM_024711 
5.63 up GIMAP7 NM_153236 
2.79 up GIMAP8 NM_175571 
4.50 up GLCCI1 NM_138426 
2.88 up GLRX NM_002064 
2.60 up GLT1D1 NM_144669 
3.17 up GLYCTK NM_145262 
4.91 up GMFG NM_004877 
2.83 up GNA14 NM_004297 
2.10 up GNAI2 NM_002070 
5.39 up GNAO1 NM_020988 
2.84 up GNG2 NM_053064 
6.06 down GNG4 NM_001098722 
2.77 up GNGT2 NM_031498 
2.20 up GNMT NM_018960 
2.40 down GNRH2 NM_178332 
2.48 down GP9 NM_000174 
5.13 up GPR183 NM_004951 
3.10 up GPR34 NM_001097579 
3.38 down GPRIN1 NM_052899 
5.84 up GPRIN3 NM_198281 
2.01 up GRASP NM_181711 
2.02 down GRIN2A NM_001134408 
4.34 down GRIN2D NM_000836 
4.19 down GSTT2 NM_000854 
4.78 down GSTT2B NM_001080843 
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5.46 up GUCY2C NM_004963 
2.12 down GUCY2GP NR_028134 
2.75 up GUSBP2 NR_003504 
2.58 down H2AFY2 NM_018649 
3.23 up H3F3B NM_005324 
3.33 up H6PD NM_004285 
2.06 up HACL1 NM_012260 
7.96 down HAPLN1 NM_001884 
6.99 up HCG26 NR_002812 
3.43 up HCK NM_002110 
4.69 up HCLS1 NM_005335 
4.17 up HDC NM_002112 
2.10 down HEATR5A BC062720 
2.37 up HELQ NM_133636 
2.49 up HESX1 NM_003865 
2.42 up HEXDC NM_173620 
3.89 up HHEX NM_002729 
3.76 down HILS1 NR_024193 
3.63 up HIVEP3 NM_024503 
6.93 down HK2 NM_000189 
2.53 up HLA-A NM_002116 
2.82 up HLA-A NM_002116 
2.40 up HLA-B NM_005514 
5.21 up HLA-DMB NM_002118 
6.01 up HLA-DOA NM_002119 
5.07 up HLA-DPA1 NM_033554 
5.33 up HLA-DPA1 NM_001242524 
4.87 up HLA-DPB1 NM_002121 
5.21 up HLA-DPB1 NM_002121 
5.31 up HLA-DPB1 NM_002121 
5.65 up HLA-DPB1 NM_002121 
4.19 up HLA-DPB2 NR_001435 
4.65 up HLA-DQB1 NM_001243962 
5.86 up HLA-DQB1 NM_002123 
7.71 up HLA-DQB1 NM_001243961 
10.05 up HLA-DQB1 NM_001243962 
6.73 up HLA-DQB2 NM_001198858 
4.93 up HLA-DRA NM_019111 
4.55 up HLA-DRB1 NM_002124 
4.50 up HLA-DRB4 NM_021983 
6.00 up HLA-DRB5 NM_002125 
2.57 up HLA-E NM_005516 
3.48 up HLA-F NM_018950 
2.96 up HLA-G NM_002127 
3.07 up HLA-J NR_024240 
2.21 up HMBOX1 NM_024567 
2.41 up HMBOX1 NM_024567 
3.14 up HMGA1P4 XR_108949 
4.40 up HMHA1 NM_012292 
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2.78 down HOXA4 NM_002141 
2.11 down HOXA6 NM_024014 
2.64 down HOXC8 NM_022658 
11.31 up HPR NM_020995 
5.07 down HSD17B1 NM_000413 
2.06 down HSP90AA5P AY956761 
5.58 down HSPA4L NM_014278 
2.99 down HSPB1 NM_001540 
2.13 down HSPG2 NM_005529 
3.13 down HTR4 NM_001040172 
4.15 up HVCN1 NM_001040107 
4.68 up HVCN1 NM_001040107 
2.84 up ICA1 NM_004968 
6.16 up ICOS NM_012092 
2.14 up ID2 NM_002166 
2.19 up ID2 NM_002166 
6.20 up IDO2 NM_194294 
2.14 up IFFO1 NM_001039670 
2.61 down IFT81 NM_031473 
2.08 up IFT88 NM_175605 
2.00 down IGF2-AS NR_028044 
31.06 down IGFL3 NM_207393 
6.65 up IGFN1 NM_001164586 
5.78 up IGJ NM_144646 
4.42 up IGSF10 NM_178822 
6.22 up IKZF1 NM_006060 
2.47 up IKZF2 NM_001079526 
7.26 up IKZF3 NM_012481 
4.87 up IL10RA NM_001558 
4.87 up IL16 NM_004513 
2.91 up IL18RAP NM_003853 
7.29 up IL22RA2 NM_052962 
9.07 up IL22RA2 NM_181310 
7.24 up IL2RB NM_000878 
7.68 up IL2RG NM_000206 
3.09 up IL32 NM_001012631 
2.03 up IL4R NM_000418 
2.23 up IL6R NM_001206866 
2.59 up IL6ST NM_002184 
3.27 up IL6ST NM_001190981 
3.42 up IL6ST NM_001190981 
4.12 up IL6ST NM_002184 
5.07 up IL7 NM_000880 
3.74 up IL7R NM_002185 
4.72 up INPP5D NM_001017915 
2.03 down INPP5F NM_001243195 
2.50 down IQGAP3 NM_178229 
11.02 up IRF4 NM_002460 
8.65 down IRF6 NM_006147 
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7.95 up IRF8 NM_002163 
4.14 down IRX5 NM_005853 
2.02 up ISCU NM_014301 
3.57 up ITGA4 NM_000885 
4.36 up ITGA4 NM_000885 
2.33 up ITGB1BP2 NM_012278 
6.92 up ITIH4 NM_002218 
2.40 up ITIH5 NM_001001851 
20.88 up ITK NM_005546 
5.97 up ITM2A NM_004867 
3.36 up ITPR1 NM_002222 
2.15 up ITPR2 NM_002223 
2.08 up JAK3 NM_000215 
5.60 up JAK3 NM_000215 
2.11 up JPH3 AB593088 
2.50 down JPH3 NM_020655 
3.27 up JPH4 NM_032452 
66.39 up KBTBD10 NM_006063 
3.53 up KBTBD11 NM_014867 
4.77 up KBTBD8 NM_032505 
2.18 down KCNA10 NM_005549 
5.60 up KCNN4 NM_002250 
4.28 down KDM4B NM_015015 
5.43 up KIAA0226L NM_025113 
2.17 up KIAA1147 NM_001080392 
2.15 down KIAA1671 NM_001145206 
3.39 down KIAA1671 NM_001145206 
2.67 up KIF19 NM_153209 
2.90 up KIT NM_000222 
3.53 up KIT NM_001093772 
2.42 up KL NM_004795 
2.79 up KLF2 NM_016270 
2.45 up KLF9 NM_001206 
4.81 up KLHDC1 NM_172193 
4.93 up KLHL3 NM_017415 
3.38 up KLHL6 NM_130446 
12.83 up KLRB1 NM_002258 
5.65 up KLRC4 NM_013431 
5.58 up KLRF1 NM_016523 
10.48 up KLRF1 NM_016523 
5.56 down KLRG2 NM_198508 
5.96 up KLRK1 NM_007360 
3.14 up KMO NM_003679 
2.42 down KREMEN1 NM_001039570 
3.98 up KRT222 NM_152349 
2.94 down KRT8 NM_002273 
3.11 down KRT9 NM_000226 
2.80 down KRTAP1-3 NM_030966 
4.97 up KRTAP19-2 NM_181608 
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2.36 down KRTAP19-7 NM_181614 
2.35 down KRTAP20-2 NM_181616 
2.57 down KRTAP6-1 NM_181602 
3.38 down KRTCAP3 NM_173853 
2.94 up L3MBTL3 NM_032438 
2.73 up LAIR1 NM_002287 
4.67 up LAPTM5 NM_006762 
3.49 up LAT2 NM_032464 
3.55 up LCP2 NM_005565 
3.41 down LCTL NM_207338 
7.35 up LDLRAD2 NM_001013693 
9.42 up LEPR NM_001003679 
5.85 up LIMS3L NM_001205288 
2.06 up LINC00277 NR_026949 
3.50 down LINC00319 NR_026960 
2.99 up LINC00339 NR_023918 
8.60 up LINC00426 NR_024464 
2.60 up LINC00476 NR_023389 
2.84 up LMO2 NM_005574 
6.91 up LOC100128420 NR_038461 
6.57 up LOC100128531 NR_038941 
2.66 down LOC100128703 AK128830 
6.34 down LOC100128881 NR_036480 
5.05 up LOC100129973 AF007131 
2.32 down LOC100130009 XM_001718914 
2.24 down LOC100130015 NR_027335 
3.63 down LOC100130238 NR_024563 
2.93 down LOC100130522 NR_028340 
2.85 down LOC100130673 NR_038454 
2.31 down LOC100130776 NR_027032 
2.44 up LOC100131089 NR_040059 
3.20 up LOC100131089 NR_040062 
3.52 up LOC100131089 NR_040059 
4.20 up LOC100131089 NR_040059 
2.89 up LOC100132111 NR_024237 
2.78 down LOC100132354 NR_024478 
4.53 up LOC100132707 BC050402 
2.35 up LOC100133445 NR_037844 
2.46 down LOC100190939 NR_024458 
2.01 up LOC100216545 NR_024586 
3.30 up LOC100270804 NR_026885 
3.35 up LOC100270804 NR_026885 
4.15 up LOC100287188 XM_003119104 
2.60 down LOC100287765 NR_038988 
2.00 down LOC100499194 NR_034130 
2.25 up LOC100505495 NR_040109 
2.44 up LOC100505495 NR_040109 
2.97 up LOC100505495 NR_040109 
73.11 up LOC100505495 NR_040109 
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2.78 up LOC100505500 XR_108722 
2.18 down LOC100505504 XR_110921 
6.80 up LOC100505576 NR_038847 
3.55 up LOC100505648 NR_040058 
2.25 down LOC100505657 XM_003118895 
3.06 up LOC100505687 NR_038301 
6.52 up LOC100505746 NR_038311 
2.25 up LOC100505894 CR625773 
2.14 down LOC100505903 XR_110201 
3.29 up LOC100506036 XR_109916 
4.68 up LOC100506178 NR_038393 
2.64 up LOC100506342 XR_108862 
2.90 down LOC100506374 XR_109498 
3.77 down LOC100506374 XR_109498 
2.10 up LOC100506516 XR_108763 
3.60 up LOC100506553 XR_109636 
10.46 up LOC100506582 XR_109454 
6.44 up LOC100506779 NR_038410 
4.56 up LOC100506802 XR_132718 
2.29 up LOC100506860 XR_108813 
2.32 up LOC100506922 XR_109888 
2.72 up LOC100506990 NR_040092 
2.75 up LOC100506990 NR_040092 
7.43 down LOC100507003 NM_001195256 
7.01 up LOC100507042 XR_108778 
2.44 down LOC100507055 BX379759 
2.64 up LOC100507062 NR_038286 
2.16 down LOC100507077 XR_110527 
2.41 up LOC100507204 XR_108902 
3.89 up LOC100507254 NR_038981 
5.83 up LOC100507254 NR_038981 
3.00 up LOC100507280 XR_110418 
10.01 up LOC100507307 XR_109952 
5.71 up LOC100507309 XR_109012 
5.07 up LOC100507347 XR_109013 
3.09 up LOC100507360 XR_109953 
2.27 up LOC100507373   
2.36 down LOC100507420 XR_110876 
2.13 down LOC100507520 XR_109439 
3.78 down LOC100507588 NM_001195259 
2.59 down LOC100507591 XR_109528 
3.52 up LOC100507602 XR_110081 
8.42 up LOC100507616 XR_110328 
17.35 up LOC100507616 XR_110328 
4.42 up LOC100507632 NR_038236 
2.05 down LOC100509196 XM_003119833 
2.18 up LOC100527964 NR_037642 
2.12 down LOC100652807 XM_003403510 
2.16 down LOC100652869 XM_003403453 
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4.02 up LOC100652951 XR_132888 
2.11 down LOC100652993 XR_132786 
5.28 up LOC100653030 XR_132913 
2.33 up LOC100653033 XR_132874 
3.55 up LOC100653060 XM_003403393 
2.17 down LOC100653323 XM_003403859 
2.76 up LOC115110 NR_026927 
4.36 up LOC115110 NR_026927 
3.26 up LOC145820 NR_027132 
4.72 up LOC145820 NR_027133 
2.20 down LOC151171 NR_037809 
2.08 down LOC154860 NR_036484 
2.73 up LOC155060 NR_036573 
4.51 down LOC201651 NR_026915 
3.84 down LOC283553 NR_038358 
3.89 up LOC283624 NR_038970 
7.58 up LOC283663 NR_024433 
2.17 down LOC284889 NR_038911 
5.40 up LOC285419 NR_027105 
2.34 down LOC285577 NR_033898 
3.76 up LOC285957 AK097526 
5.46 up LOC339290 NR_015389 
3.49 down LOC387647 NR_003930 
2.37 up LOC388242 NR_002556 
2.62 down LOC388796 NR_015366 
2.83 down LOC388796 NR_027241 
2.86 down LOC388796 NR_027241 
2.89 down LOC388796 NR_027241 
2.90 down LOC388796 NR_027241 
3.77 up LOC389634 NR_024420 
5.14 up LOC400456 NR_034095 
2.14 down LOC400662 AK055411 
2.02 down LOC401074 NR_040005 
4.02 up LOC439949 NR_036502 
5.19 up LOC440900 NR_034128 
6.15 up LOC440900 NR_034128 
2.06 up LOC440993 XR_110395 
4.33 up LOC441179 XR_112948 
2.27 down LOC441204 NR_015364 
2.12 down LOC554207 BC031469 
2.22 down LOC643529 NR_038382 
3.30 up LOC643733 NR_034079 
3.96 up LOC643733 NR_034079 
2.78 down LOC644242 NR_036540 
4.04 up LOC645431 NR_024334 
4.83 up LOC645586 AK057937 
2.93 up LOC646329 NR_034120 
2.01 down LOC649201 XM_001127211 
3.94 up LOC728802 XM_001713923 
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2.23 up LOC728875 NR_024584 
2.11 up LOC728903 AK093722 
8.47 down LOC729080 NR_033244 
4.98 up LOC729468 BU567215 
3.18 down LOC729995 XR_110198 
2.15 down LOC92659 NR_015454 
6.68 up LONRF3   
2.40 up LPIN2 NM_014646 
3.08 up LPXN NM_004811 
6.15 up LRMP NM_006152 
2.22 down LRRC1 NM_018214 
2.27 down LRRC23 NM_006992 
2.27 up LRRC25 NM_145256 
2.34 up LRRC33 NM_198565 
8.05 up LRRC39 NM_144620 
3.18 up LRRC70 NM_181506 
3.39 down LRRC72 NM_001195280 
6.26 down LRRC8E NM_025061 
3.69 up LRRK2 AK127729 
3.78 up LRRK2 NM_198578 
2.19 down LSR NM_205834 
4.24 up LST1 NM_007161 
15.42 up LTB NM_002341 
2.04 down LTBR NM_002342 
18.39 up LTF NM_002343 
15.19 up LY75 NM_002349 
7.54 up LYVE1 NM_006691 
2.64 up LZTFL1 NM_020347 
3.44 down LZTS2 AK097997 
4.09 up MAB21L2 NM_006439 
2.10 down MAGED4B NM_030801 
2.13 up MALAT1 NR_002819 
2.23 up MALAT1 NR_002819 
2.32 up MALAT1 NR_002819 
5.21 down MAML3 NM_018717 
4.26 up MAN1B1 CR749534 
3.64 up MAN1C1 NM_020379 
2.94 up MAOB NM_000898 
2.70 up MAP3K8 NM_005204 
6.02 up MAP4K1 NM_001042600 
4.65 down MAP7 NM_003980 
2.30 up MAP7D3 NM_001173517 
2.36 up MAPRE2 NM_014268 
2.29 down MARVELD3 NM_001017967 
2.43 down MAST1 NM_014975 
2.25 up MAST3 NM_015016 
2.20 up MBLAC2 NM_203406 
2.04 up MBP NM_001025100 
2.09 up ME3 NM_001014811 
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2.11 up ME3 NM_001014811 
2.04 down MEA1 NM_014623 
2.62 up MED23 NM_015979 
6.01 up MEF2C NM_002397 
5.49 up MEOX1 NM_004527 
6.64 up MEOX2 NM_005924 
3.48 up MGAT4A NM_012214 
2.04 up MGC21881 NR_015363 
2.19 up MGC21881 NR_015363 
2.26 up MGC21881 NR_015363 
2.99 up MIA3 NM_198551 
6.00 up MIAT NR_003491 
2.05 down MIB2 NM_080875 
2.03 up MICAL1 NM_022765 
2.94 up MILR1 NM_001085423 
2.58 up MIPEPP3 AK093279 
2.06 down MLXIP NM_014938 
20.13 up MMRN1 NM_007351 
3.42 up MNDA NM_002432 
2.05 up MOB3B NM_024761 
3.92 down MORN4 BC022054 
2.14 down MPDU1 AK027742 
3.67 up MPEG1 NM_001039396 
5.66 up MPEG1 NM_001039396 
2.04 down MPND NM_032868 
2.45 up MRPL19   
2.17 up MRPL42P5 NR_002208 
2.25 down MRPS18A NM_018135 
2.96 up MS4A14 NM_032597 
3.23 up MS4A2 NM_000139 
2.28 up MS4A6A NM_152852 
3.50 up MS4A6A NM_022349 
2.29 up MS4A7 NM_021201 
4.63 down MTMR11 NM_181873 
9.55 up MUSTN1 NM_205853 
28.90 up MYBPC1 NM_206819 
128.51 up MYBPC2 NM_004533 
39.03 up MYBPH NM_004997 
2.08 up MYCBP2 NM_015057 
2.44 up MYCBP2 NM_015057 
9.49 up MYH3 NM_002470 
103.19 up MYL1 NM_079420 
2.41 down MYO19 NM_001033580 
2.98 up MYO1F NM_012335 
3.86 up MYO1G NM_033054 
3.18 down MZT2A   
3.76 up N4BP2L1 NM_052818 
2.09 up N4BP2L2 NM_014887 
3.07 up N4BP2L2 NM_033111 
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2.16 up NAAA NM_001042402 
2.80 up NAALADL1 NM_005468 
2.65 up NAIP NM_004536 
2.98 up NAIP NM_004536 
3.77 up NAIP NM_004536 
3.26 up NAPSA NM_004851 
9.44 up NCR3 NM_147130 
2.71 down NEDD4L NM_015277 
3.47 down NEDD4L NM_001144967 
2.07 up NEK3 NM_002498 
4.00 up NEK8 NM_178170 
4.42 up NEURL NM_004210 
3.05 up NFAM1 NM_145912 
2.26 down NHLRC1 NM_198586 
2.13 up NINJ1 NM_004148 
2.09 up NKTR NM_005385 
8.71 up NLRC3 NM_178844 
2.22 up NLRP1 NM_033004 
2.43 up NLRP1 NM_001033053 
9.42 up NLRP2 NM_017852 
3.27 up NLRP3 NM_001243133 
3.85 up NLRP3 NM_001079821 
2.71 down NMB NM_021077 
2.02 down NME4 NM_005009 
3.21 up NMT2 NM_004808 
2.95 up NOTCH2NL NM_203458 
2.39 down NQO2 NM_000904 
2.35 up NR2F2 NM_021005 
2.47 down NR2F6 NM_005234 
7.08 up NR3C2 NM_000901 
2.34 up NR5A2 NM_205860 
72.87 up NRAP NM_198060 
2.02 down NSDHL NM_001129765 
3.53 down NUDT8 NM_001243750 
2.27 up NXPH3 NM_007225 
2.06 down OBP2B NM_014581 
2.66 up OGT NM_181672 
2.11 down OR10G8 NM_001004464 
2.02 down OR13H1 NM_001004486 
2.08 down OR7E14P NR_045002 
3.37 up ORMDL1 AK126336 
3.03 up OXNAD1 NM_138381 
2.84 down OXT NM_000915 
3.05 up P2RX5 NM_175080 
5.44 up P2RY10 NM_014499 
6.19 up P2RY12 NM_022788 
6.35 up P2RY13 NM_176894 
12.42 up P2RY14 NM_014879 
3.57 up P2RY8 NM_178129 
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2.05 up P4HTM NM_177938 
2.43 up PAG1 NM_018440 
2.82 up PAG1 NM_018440 
2.29 down PALM3 NM_001145028 
2.20 up PAN3 NM_175854 
3.41 up PAPLN NM_173462 
2.61 up PARP8 NM_024615 
2.34 up PARP9 NM_031458 
2.01 down PARS2 NM_152268 
2.42 down PC NM_001040716 
2.43 down PCDHB9 NM_019119 
2.21 down PCDHGA12 NM_032094 
2.03 down PCDHGC4 NM_032406 
3.88 up PDE4B NM_001037341 
3.72 up PDE4DIP NM_001198834 
5.46 up PDE4DIP NM_001198834 
5.47 up PDE4DIP NM_001198834 
5.48 up PDE4DIP NM_001198834 
5.85 up PDE4DIP NM_014644 
6.57 up PDE4DIP NM_001198832 
2.46 down PDLIM7 NM_005451 
2.49 up PEAR1 NM_001080471 
2.44 up PECAM1 NM_000442 
2.58 up PECAM1 NM_000442 
3.49 up PER3 NM_016831 
4.87 up PER3 NM_016831 
2.85 up PGLYRP1 NM_005091 
3.75 up PGM5 NM_021965 
9.87 up PGM5 NM_021965 
3.33 up PGPEP1L NM_001167902 
4.68 up PHACTR1 AB051520 
5.19 down PHLDB2 BC038806 
2.57 up PIK3CD NM_005026 
3.08 up PIK3CD NM_005026 
4.13 up PIK3CG NM_002649 
2.32 up PIK3IP1 NM_052880 
2.31 up PIK3R6 NM_001010855 
2.70 up PIKFYVE NM_015040 
3.13 up PIP4K2A NM_005028 
7.06 up PIP5K1B NM_003558 
3.71 up PITPNC1 NM_181671 
3.59 up PKIA NM_006823 
3.08 up PKIG NM_181805 
2.97 up PKNOX2 NM_022062 
7.84 up PLA1A NM_015900 
3.31 up PLA2G7 NM_005084 
3.54 up PLCB2 NM_004573 
3.00 up PLCL2 NM_015184 
3.34 up PLCL2 NM_015184 
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3.91 up PLD4 NM_138790 
5.51 up PLEKHA6 NM_014935 
2.14 down PLEKHG4B NM_052909 
2.12 up PLEKHM1 NM_014798 
6.15 up PLGLB1 NM_001032392 
3.22 up PNPLA7 NM_001098537 
2.57 down POLB NM_002690 
4.29 down POLR1A NM_015425 
2.28 down POLR2J4 NR_003655 
2.86 down POU6F2 NM_007252 
4.43 down PPAP2C NM_177543 
2.37 up PPM1M NM_144641 
3.35 up PPP1R12B NM_002481 
2.17 down PPP1R14B NM_138689 
2.00 up PPP3CC NM_005605 
2.61 up PRCP NM_199418 
4.27 up PRDM8 NM_020226 
2.57 up PREX1 NM_020820 
3.54 up PRG2 NM_002728 
12.58 up PRKCB NM_002738 
13.52 up PRKCB NM_002738 
2.23 up PRKD3 NM_005813 
2.74 up PRORSD1P NR_027258 
2.77 up PROS1 NM_000313 
3.21 down PRPH NM_006262 
3.76 up PRR18 NM_175922 
2.62 down PRR21 NM_001080835 
3.87 down PRRG4 NM_024081 
3.01 up PRSS30P NR_026864 
3.74 up PRSS36 NM_173502 
7.47 up PRUNE2 NM_015225 
9.33 up PRUNE2 NM_015225 
2.20 down PSMC3IP NM_013290 
5.87 down PSPH NM_004577 
47.40 down PSPHP1 BC065228 
4.24 up PTGFR NM_000959 
6.40 up PTGFR NM_001039585 
8.79 up PTGFR NM_001039585 
7.81 down PTH2 NM_178449 
6.33 down PTH2R NM_005048 
2.04 up PTP4A2 NM_080391 
3.52 up PTPN22 NM_015967 
5.58 up PTPRC NM_002838 
5.88 up PTPRC NM_002838 
6.46 up PTPRC NM_080923 
6.58 up PTPRC NM_002838 
5.58 up PTPRO NM_030667 
3.05 up PVALB NM_002854 
3.93 down PVRL1 NM_203286 
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2.19 up PXN NM_001243756 
12.21 up PYGM NM_005609 
6.74 up PYHIN1 NM_198930 
3.41 down Q6P4E4   
2.91 up Q6TXI9   
2.01 down Q7VPR2   
2.62 up Q8WNA4 AK090765 
3.82 up Q96G65 AK090765 
4.91 up Q9UJ41 BC017910 
5.06 up Q9UJ41 BC017910 
3.08 up RAB17 NM_022449 
2.04 up RAB27A NM_004580 
2.10 up RAB30 NM_014488 
3.30 up RAB33A NM_004794 
6.77 up RAB37 NM_175738 
2.60 up RABGAP1L NM_014857 
2.23 up RAD17 NM_002873 
2.75 up RAPGEF3 NM_006105 
3.25 up RAPGEF6 NM_016340 
2.40 up RASA3 NM_007368 
5.00 up RASAL3 NM_022904 
3.10 up RASGRF1 NM_002891 
4.03 up RASGRP2 NM_153819 
4.04 up RASGRP2 NM_153819 
7.85 up RASGRP2 NM_153819 
2.84 up RASGRP3 NM_170672 
2.29 up RASL10A NM_001007279 
5.02 up RASSF2 NM_014737 
3.79 up RASSF4 NM_032023 
2.31 up RASSF5 NM_182663 
2.13 up RB1 NM_000321 
3.03 up RBM26-AS1 NR_038991 
2.14 up RBM5 NM_005778 
2.05 up RBPMS AK057533 
5.26 down RCOR2 NM_173587 
5.42 up RCSD1 NM_052862 
3.31 up REPS2 NM_004726 
3.86 up RET NM_020975 
2.10 down RFX8 NM_001145664 
2.29 up RFXAP NM_000538 
3.29 up RGS1 NM_002922 
13.48 up RGS13 NM_002927 
3.91 up RGS18 NM_130782 
3.73 up RGS3 NM_017790 
6.24 up RHOH NM_004310 
2.26 up RHOJ NM_020663 
2.13 up RHOQ NM_012249 
2.18 up RILPL2 NM_145058 
5.17 up RLN1 NM_006911 
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2.06 up RN18S1 NR_003286 
2.92 up RNASE6 NM_005615 
2.00 down RNASEH2A NM_006397 
2.28 up RNF103 NM_001198952 
5.36 up RNF125 NM_017831 
2.03 up RNF150 NM_020724 
4.35 up RNU2-2 NR_002761 
4.47 up RORC NM_005060 
2.46 up RPA1 NM_002945 
2.33 up RPGR NM_000328 
2.81 up RPGR NM_000328 
4.27 up RPGR NM_001034853 
2.11 down RPP40 NM_006638 
2.35 up RPRD1A AK056810 
17.77 up RRAD NM_004165 
2.14 up RRP15 NM_016052 
2.59 down RTKN NM_033046 
3.87 up RUNX3 NM_001031680 
3.93 up RUNX3 NM_001031680 
2.41 down RUSC1-AS1 NM_001039517 
3.39 down S100A11 NM_005620 
4.72 up S100Z NM_130772 
3.57 up S1PR1 NM_001400 
4.99 up S1PR4 NM_003775 
5.17 up SAA2 NM_001127380 
2.17 up SACM1L NM_014016 
2.72 down SACS-AS1 XR_110106 
4.21 up SAMD3 NM_001017373 
4.37 up SAMSN1 NM_022136 
5.92 up SASH3 NM_018990 
2.89 up SCARNA16 NR_003013 
2.96 up SCARNA16 NR_003013 
3.44 up SCARNA17 NR_003003 
3.55 up SCARNA9 NR_002569 
10.53 up SCML4 NM_198081 
2.67 up SCN4B NM_174934 
2.48 up SDPR NM_004657 
2.64 up SEC31B NM_015490 
2.04 up SEC62 NM_003262 
2.33 up SECISBP2L NM_014701 
2.38 up SEL1L NM_005065 
4.74 up SELE NM_000450 
4.84 up SELE NM_000450 
11.09 up SELL NM_000655 
4.95 up SELP NM_003005 
8.22 up SELP NM_003005 
3.62 up SELPLG NM_003006 
3.87 up SEMA4D NM_006378 
2.25 down SEMA6C NM_001178061 
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2.13 up SENP7 NM_020654 
2.62 up SEPP1 NM_001093726 
2.85 up SEPP1 NM_005410 
3.32 up SEPT6 NM_145802 
3.92 up SEPT7P2 NR_024271 
2.62 up SERP2 NM_001010897 
4.29 up SERPINB9 NM_004155 
2.13 up SETDB2 NM_031915 
2.16 up SFMBT2 NM_001029880 
2.70 up SFMBT2 NM_001029880 
2.42 up SH2B3 NM_005475 
6.08 up SH2D1A NM_002351 
2.11 up SH3BGRL2 NM_031469 
2.92 up SH3KBP1 NM_001024666 
2.50 up SH3TC1 NM_018986 
2.60 up SHE NM_001010846 
3.46 down SHH NM_000193 
2.42 down SHOX NM_006883 
3.46 down SHOX2 NM_003030 
6.72 up SIGLEC10 NM_033130 
4.56 up SIGLECP3 NR_002804 
2.20 up SIRPB1 NM_006065 
2.86 up SIRPB1 NM_001135844 
6.52 up SIT1 NM_014450 
3.47 up SLA NM_001045556 
6.87 up SLAMF1 NM_003037 
2.62 down SLAMF9 NM_033438 
2.09 up SLC1A1 NM_004170 
2.51 up SLC24A4 NM_153646 
2.02 down SLC25A1 NM_005984 
3.52 up SLC25A27 NM_004277 
2.87 up SLC25A34 NM_207348 
2.37 up SLC2A14 BC060766 
3.73 up SLC2A3 NM_006931 
2.02 up SLC35E2 NM_182838 
2.12 up SLC35E2 NM_182838 
2.36 up SLC39A8 NM_022154 
2.57 up SLC39A8 NM_001135147 
4.68 up SLC40A1 NM_014585 
6.28 down SLC6A10P NR_003083 
4.05 down SLC6A8 U17986 
5.86 down SLC6A8 NM_005629 
4.91 up SLC8A3 NM_183002 
2.07 up SLC9A8 NM_015266 
2.40 up SLC9B1 NM_139173 
2.66 up SLCO2B1 NM_007256 
2.21 up SMA4 NR_029426 
2.06 up SMAD9 NM_005905 
2.23 up SMAP2 NM_022733 
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10.25 up SMPD3 NM_018667 
2.40 down SNAR-C4 BF570948 
2.60 down SNAR-I NR_024343 
2.25 up SNHG5 NR_003038 
2.35 up SNHG5 NR_003038 
2.71 down SNORA51 NR_002981 
2.07 down SNORA55 NR_002983 
2.36 up SNORD11 NR_003031 
2.38 up SNRK NM_017719 
7.59 up SNX22 NM_024798 
2.23 up SNX29 NM_032167 
2.34 up SNX29 BC029857 
4.53 up SNX29 BC029857 
3.66 up SOD3 NM_003102 
2.95 up SORBS2 NM_021069 
5.46 up SORCS1 NM_052918 
50.05 down SOST NM_025237 
2.06 down SOX4 NM_003107 
10.73 down SP9   
3.46 up SPARCL1 NM_004684 
2.11 down SPHK1 NM_182965 
11.24 up SPIB NM_003121 
5.37 up SPIN3 NM_001010862 
2.27 up SPN NM_001030288 
6.99 up SPOCK2 NM_014767 
2.32 down SRD5A1 NM_001047 
3.69 up SRGN NM_002727 
2.27 up SRSF6 NM_006275 
4.41 up ST6GAL1 NM_173216 
4.20 up ST6GALNAC3 NM_001160011 
2.84 up ST8SIA4 NM_005668 
2.17 up STAB1 NM_015136 
4.10 up STAB2 NM_017564 
5.36 up STAC3 NM_145064 
4.52 up STAMBPL1 NM_020799 
4.25 down STAP2 NM_001013841 
2.70 up STARD9 NM_020759 
4.37 up STAT4 NM_003151 
2.66 up STAT5A NM_003152 
5.37 down STC1 NM_003155 
2.03 down STIP1 NM_006819 
4.02 up STK10 NM_005990 
2.57 up STK17B NM_004226 
2.70 up STK17B NM_004226 
2.58 up STK4 NM_006282 
3.97 up STMN1 NM_001145454 
2.94 up STS NM_000351 
2.46 up SUFU NM_016169 
2.23 up SUN2 NM_015374 
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2.89 down SUPT3H NM_003599 
5.33 up SUSD3 NM_145006 
8.61 up SV2B NM_014848 
3.05 up SVEP1 NM_153366 
2.53 up SYBU NM_001099744 
4.63 up SYPL2 NM_001040709 
2.00 up TADA2B NM_152293 
3.72 up TAGAP NM_138810 
6.01 up TAGAP NM_054114 
2.34 down TAT NM_000353 
8.28 up TBC1D10C NM_198517 
2.54 up TBC1D22A AK125705 
3.40 up TBC1D4 NM_014832 
5.92 up TCF7 NM_003202 
2.22 up TDRD10 NM_182499 
7.73 up TFEC NM_012252 
6.62 up TFF3 NM_003226 
18.70 up TFF3 NM_003226 
25.41 up TFF3 NM_003226 
3.82 up TFPI NM_001032281 
4.24 up TFPI AB209866 
4.51 up TFPI NM_006287 
2.35 down TFR2 NM_003227 
3.66 up TGFBR2 NM_001024847 
6.49 up TGFBR3 NM_003243 
7.14 up TIGIT NM_173799 
2.03 down TIMM44 NM_006351 
21.49 up TLR10 NM_030956 
3.76 up TLR4 NM_138554 
5.07 up TLR7 NM_016562 
2.44 up TM6SF1 NM_023003 
3.29 up TMEM100 NM_018286 
4.24 up TMEM106A NM_145041 
2.06 down TMEM145 NM_173633 
2.84 up TMEM170B NM_001100829 
3.05 up TMEM176B NM_014020 
2.46 up TMEM192 NM_001100389 
2.51 down TMEM200B NM_001003682 
2.47 up TMEM55A NM_018710 
2.01 up TMEM62 NM_024956 
2.18 down TMEM63B NM_018426 
3.92 up TMOD1 NM_003275 
14.21 up TMOD4 NM_013353 
2.71 up TNFAIP8 NM_014350 
4.24 up TNFAIP8L2 NM_024575 
2.84 up TNFRSF10C NM_003841 
12.08 up TNFRSF11B NM_002546 
3.54 up TNFRSF1B NM_001066 
3.00 up TNFRSF8 NM_001243 
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8.26 up TNIK NM_015028 
41.48 up TNNC1 NM_003280 
28.60 up TNNC2 NM_003279 
40.32 up TNNT3 NM_001042780 
106.65 up TNNT3 NM_006757 
2.25 down TNP2 NM_005425 
2.08 down TOP1MT NM_052963 
5.76 up TOX NM_014729 
2.70 up TPK1 NM_022445 
8.23 up TPM3 NM_152263 
2.39 up TPP1 NM_000391 
3.64 down TPRG1 NM_198485 
2.74 up TPSAB1 NM_003294 
2.64 up TPSD1 NM_012217 
8.26 up TRAF1 NM_005658 
8.62 up TRAF3IP3 NM_025228 
8.68 up TRAF3IP3 NM_025228 
9.84 up TRAF3IP3 AK126139 
2.01 up TRAK2 NM_015049 
12.44 up TRAT1 NM_016388 
2.12 up TRDMT1 NM_004412 
2.02 up TRIB1 NM_025195 
3.06 up TRIB2   
36.34 up TRIM63 NM_032588 
3.02 up TRPV2 NM_016113 
3.58 up TSGA10 NM_025244 
2.85 down TSHB NM_000549 
2.26 up TTC21A NM_145755 
2.16 up TTC32 NM_001008237 
11.35 up TTN NM_133379 
21.88 up TTN NM_133379 
28.69 up TTN AF321609 
68.23 up TTN NM_133378 
9.68 up TXK NM_003328 
8.15 up TXLNB NM_153235 
2.85 up TXNIP NM_006472 
2.14 up U2AF1L4 NM_144987 
7.33 up UBASH3A NM_018961 
2.06 up UBE2D3   
2.44 up UBE2J1 NM_016021 
2.43 down UBE3B NM_183415 
2.34 down UHRF1 NM_013282 
2.04 up UPRT NM_145052 
2.15 up UQCRB NM_001199975 
2.69 up USP25 NM_013396 
2.48 up USP47 NM_017944 
2.08 up USP53 NM_019050 
2.16 up USPL1 NM_005800 
2.46 up VAPA NM_003574 
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3.79 up VAV1 NM_005428 
4.71 down VAX1 NM_001112704 
5.08 up VHLL NM_001004319 
3.14 up VNN1 NM_004666 
8.41 up VNN2 NM_004665 
2.38 up VOPP1 NM_030796 
4.67 up VPRBP NM_014703 
2.93 up VPS13C NM_020821 
2.91 down VSTM2A NM_182546 
2.20 down VWCE NM_152718 
2.49 up VWF NM_000552 
2.09 down WASF1 NM_003931 
3.20 down WBSCR27 NM_152559 
6.14 up WDFY4 NM_020945 
6.27 up WDFY4 NM_020945 
2.59 up WDPCP NM_015910 
2.07 up WDR19 NM_025132 
2.25 up WDR19 NM_025132 
4.02 up WDR63 NM_145172 
2.50 up WDR74 AK292330 
4.22 up WIPF1 BC110288 
2.91 up WNT6 NM_006522 
2.62 down WWTR1 NM_015472 
3.08 up XLOC_000044 BU566406 
4.87 up XLOC_000292   
3.85 down XLOC_000379   
2.70 down XLOC_000511   
2.93 down XLOC_000778   
11.75 down XLOC_000855 AF279783 
2.95 up XLOC_001035   
2.36 up XLOC_001266   
2.34 down XLOC_001364   
2.30 down XLOC_001452   
2.14 down XLOC_001453   
2.55 down XLOC_001775   
2.76 up XLOC_001788   
2.73 down XLOC_001856   
3.91 down XLOC_001856   
2.63 up XLOC_002221   
2.00 down XLOC_002323   
2.61 down XLOC_002560   
9.77 down XLOC_002603   
11.18 down XLOC_002603   
11.66 down XLOC_002603   
2.74 up XLOC_002643 XR_110001 
2.73 up XLOC_002675   
7.13 up XLOC_002749   
2.47 down XLOC_002948   
4.13 down XLOC_002968   
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2.97 up XLOC_002997 XR_110395 
13.38 up XLOC_003176   
2.48 down XLOC_003225   
2.12 up XLOC_003479   
2.06 down XLOC_003546 AL833514 
6.90 down XLOC_003629   
2.00 down XLOC_004308   
3.99 up XLOC_004350 BG207267 
3.51 up XLOC_004456   
4.77 up XLOC_004577   
4.84 down XLOC_004929 XR_110563 
2.43 down XLOC_005056   
4.00 down XLOC_005143   
2.45 down XLOC_005297 AL157439 
2.18 down XLOC_005327   
2.46 down XLOC_005343 BX101229 
2.95 up XLOC_005405   
4.43 up XLOC_005764   
2.06 down XLOC_005921   
2.20 down XLOC_006091 BC042120 
2.37 up XLOC_006178 CD693121 
2.04 down XLOC_006596 DB059001 
3.86 up XLOC_006699   
4.51 up XLOC_006846   
6.42 up XLOC_007038   
2.62 up XLOC_007052 BX500531 
3.66 down XLOC_007290 AL832443 
2.28 down XLOC_007408 BC021182 
2.05 down XLOC_007684   
2.16 down XLOC_007696   
5.00 up XLOC_007710 CR627148 
2.00 down XLOC_007745 BC042427 
2.25 up XLOC_007775 XR_108974 
2.72 down XLOC_007867   
2.09 down XLOC_007868   
3.36 down XLOC_007972   
2.08 down XLOC_008061   
2.26 up XLOC_008149   
2.41 down XLOC_008254   
2.28 down XLOC_008311   
5.48 down XLOC_008323   
5.60 up XLOC_008370 AF088007 
7.14 up XLOC_008370 AF088007 
8.27 down XLOC_008554   
6.00 up XLOC_008681   
9.48 up XLOC_009016   
3.50 up XLOC_009181 BM717049 
3.51 up XLOC_009181 BX956036 
3.53 up XLOC_009181 BX956036 
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3.25 up XLOC_009243   
5.06 up XLOC_009255 AK055250 
3.46 up XLOC_009349   
15.55 down XLOC_010146   
2.30 up XLOC_010152 BF674433 
5.66 down XLOC_010211   
2.31 down XLOC_010255   
6.05 up XLOC_010556   
3.34 up XLOC_010891   
6.25 up XLOC_010922   
2.62 down XLOC_011014   
6.01 up XLOC_011132   
4.34 up XLOC_011704   
2.10 up XLOC_012079   
8.71 up XLOC_012288   
2.02 down XLOC_012304   
2.55 down XLOC_012505   
4.14 down XLOC_012682 DA696352 
10.91 up XLOC_012776 BG213346 
2.19 down XLOC_012826 AK309717 
2.14 down XLOC_012857   
2.66 up XLOC_013621   
2.25 up XLOC_013921   
2.31 down XLOC_014020 BU933671 
4.76 up XLOC_014115 CR741364 
2.16 down XLOC_014172   
17.72 up XLOC_014244   
2.47 down XLOC_014246   
2.40 down XLOC_l2_000217 XR_132795 
2.44 down XLOC_l2_000641   
2.46 up XLOC_l2_002204   
3.88 down XLOC_l2_002351 BG676222 
3.12 up XLOC_l2_002761   
5.14 up XLOC_l2_002886   
2.65 up XLOC_l2_003674   
2.40 up XLOC_l2_003732   
2.24 down XLOC_l2_005880   
3.07 down XLOC_l2_007147   
2.54 up XLOC_l2_008221   
8.02 up XLOC_l2_008221 XR_109879 
3.44 down XLOC_l2_008313   
2.05 down XLOC_l2_009029   
10.46 up XLOC_l2_009332 AK096564 
2.07 down XLOC_l2_009441   
4.36 up XLOC_l2_009905   
6.95 down XLOC_l2_010014 CR749396 
2.14 down XLOC_l2_010149 DA924772 
4.08 up XLOC_l2_010489   
3.24 down XLOC_l2_011873   
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3.03 down XLOC_l2_011901 DA338254 
6.69 down XLOC_l2_011922 CD110012 
2.95 up XLOC_l2_012473   
3.22 up XLOC_l2_012847   
5.82 up XLOC_l2_012847   
2.26 down XLOC_l2_013000   
2.01 down XLOC_l2_013056   
5.34 up XLOC_l2_013193   
2.57 up XLOC_l2_013267   
2.26 down XLOC_l2_013481   
3.79 up XLOC_l2_014289   
5.12 up XLOC_l2_014694   
2.26 down XLOC_l2_014821   
2.03 down XLOC_l2_015034   
3.16 down XLOC_l2_015441   
2.10 up XLOC_l2_015578   
2.70 down XLOC_l2_015938   
2.01 up XPC NM_004628 
2.06 up YPEL2 NM_001005404 
3.96 up YTHDC1 NM_001031732 
3.17 down YTHDF1 NM_017798 
6.07 up ZAP70 NM_001079 
2.18 up ZBTB20 NM_015642 
2.27 up ZBTB25 NM_006977 
2.05 up ZDHHC17 NM_015336 
2.97 down ZDHHC20 NM_153251 
2.78 up ZEB2 NR_033258 
4.28 up ZFP82 NM_133466 
2.74 up ZFYVE28 NM_020972 
5.36 up ZIK1 NM_001010879 
2.65 up ZMYM2 AL136621 
2.06 up ZMYM6NB NM_001195156 
2.38 up ZNF331   
2.50 up ZNF345 NM_003419 
3.34 up ZNF366 NM_152625 
2.02 up ZNF37A NM_001007094 
2.94 up ZNF385D NM_024697 
2.06 up ZNF41 NM_153380 
2.30 up ZNF445 NM_181489 
2.32 up ZNF493 NM_001076678 
3.30 up ZNF506 AL136548 
2.04 down ZNF562 NM_001130031 
2.01 up ZNF568 NM_198539 
2.02 up ZNF577 NM_032679 
3.36 up ZNF671 NM_024833 
2.14 up ZNF75D NM_007131 
5.81 down ZNF812 NM_001199814 
2.68 up ZNF815 NR_023382 
3.00 up ZNF827 NM_178835 
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17.37 up ZNF831 NM_178457 
2.82 up ZNRD1-AS1 NR_026751 
2.11 up   AF495725 
2.12 down   AK092751 
2.12 down   XM_001721393 
2.17 up   XR_109114 
2.24 down   BC131768 
2.25 up   AK124695 
2.26 down   BC032956 
2.27 down   CU692315 
2.27 up   AK090610 
2.36 down   BE795749 
2.46 up   CN285977 
2.57 down   AK092249 
2.61 up   AK021432 
2.71 up   BC066989 
2.73 down   BC058012 
2.79 down   BX109507 
2.82 up   AY262164 
2.97 up   AK023156 
3.09 down   AK128457 
3.15 up   CR627426 
3.34 up   AL833206 
3.47 up   CR625008 
3.54 up   AB209470 
3.57 up   AF150244 
3.74 up   D13077 
3.91 up   X04925 
4.12 up   BC043411 
4.61 up   AK096792 
4.69 up   AB306151 
5.16 up   AY358259 
5.31 up   AK093811 
5.34 up   AB305952 
5.35 up   CU677518 
5.46 up   AK128421 
5.64 up   AB305714 
5.96 up   X58740 
6.03 up   AB305972 
6.30 up   XR_110942 
6.33 up   AB306238 
6.44 down   DR007930 
7.61 up   X04931 
9.38 down   BX476374 
11.46 up   AY312959 
14.34 up   BX161420 
 
